<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Nutritional supplementation for hip fracture aftercare in older people - Avenell, A - 2016 | Cochrane Library</title> <meta content="Nutritional supplementation for hip fracture aftercare in older people - Avenell, A - 2016 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001880.pub6/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Nutritional supplementation for hip fracture aftercare in older people - Avenell, A - 2016 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001880.pub6/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD001880.pub6" name="dc.identifier" scheme="DOI"/> <meta content="Nutritional supplementation for hip fracture aftercare in older people" name="citation_title"/> <meta content="Alison Avenell" name="citation_author"/> <meta content="University of Aberdeen" name="citation_author_institution"/> <meta content="a.avenell@abdn.ac.uk" name="citation_author_email"/> <meta content="Toby O Smith" name="citation_author"/> <meta content="University of East Anglia" name="citation_author_institution"/> <meta content="James P Curtain" name="citation_author"/> <meta content="Addenbrookes NHS Trust, Cambridge University Hospital" name="citation_author_institution"/> <meta content="Jenson CS Mak" name="citation_author"/> <meta content="Gosford Hospital" name="citation_author_institution"/> <meta content="Phyo K Myint" name="citation_author"/> <meta content="University of Aberdeen" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="11" name="citation_issue"/> <meta content="10.1002/14651858.CD001880.pub6" name="citation_doi"/> <meta content="2016" name="citation_date"/> <meta content="2016/11/30" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001880.pub6/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001880.pub6/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001880.pub6/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Aftercare; *Dietary Supplements [adverse effects]; Cause of Death; Hip Fractures [*complications, mortality]; Malnutrition [*diet therapy, mortality]; Nutritional Support [adverse effects, *methods]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001880.pub6&amp;doi=10.1002/14651858.CD001880.pub6&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001880.pub6&amp;doi=10.1002/14651858.CD001880.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001880.pub6&amp;doi=10.1002/14651858.CD001880.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001880.pub6&amp;doi=10.1002/14651858.CD001880.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001880.pub6&amp;doi=10.1002/14651858.CD001880.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001880.pub6&amp;doi=10.1002/14651858.CD001880.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001880.pub6&amp;doi=10.1002/14651858.CD001880.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001880.pub6&amp;doi=10.1002/14651858.CD001880.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001880.pub6&amp;doi=10.1002/14651858.CD001880.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001880.pub6&amp;doi=10.1002/14651858.CD001880.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001880.pub6&amp;doi=10.1002/14651858.CD001880.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001880.pub6&amp;doi=10.1002/14651858.CD001880.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001880.pub6&amp;doi=10.1002/14651858.CD001880.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001880.pub6&amp;doi=10.1002/14651858.CD001880.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001880.pub6&amp;doi=10.1002/14651858.CD001880.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001880.pub6&amp;doi=10.1002/14651858.CD001880.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001880.pub6&amp;doi=10.1002/14651858.CD001880.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001880.pub6&amp;doi=10.1002/14651858.CD001880.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001880.pub6&amp;doi=10.1002/14651858.CD001880.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001880.pub6&amp;doi=10.1002/14651858.CD001880.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001880.pub6&amp;doi=10.1002/14651858.CD001880.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001880.pub6&amp;doi=10.1002/14651858.CD001880.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001880.pub6&amp;doi=10.1002/14651858.CD001880.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="PMzGcYGP";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD001880\x2epub6\x26doi\x3d10\x2e1002\x2f14651858\x2eCD001880\x2epub6\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001880\x2epub6\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001880\x2epub6\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","zh_HANT","ru","pt","ko","ms","ja","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD001880.pub6",title:"Nutritional supplementation for hip fracture aftercare in older people",firstPublishedDate:"Nov 30, 2016 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Bone, Joint and Muscle Trauma Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=PMzGcYGP&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001880.pub6&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD001880.pub6';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD001880.pub6/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD001880.pub6/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001880.pub6%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD001880.PUB6" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;アブストラクト&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD001880.pub6/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD001880.PUB6" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD001880.pub6/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD001880.pub6/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>9699 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD001880.pub6" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001880.pub6/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001880.pub6/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001880.pub6/full#CD001880-abs-0007"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001880.pub6/full#CD001880-sec-0159"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001880.pub6/full#CD001880-sec-0043"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001880.pub6/full#CD001880-sec-0044"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001880.pub6/full#CD001880-sec-0049"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001880.pub6/full#CD001880-sec-0050"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001880.pub6/full#CD001880-sec-0076"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001880.pub6/full#CD001880-sec-0144"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001880.pub6/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001880.pub6/appendices#CD001880-sec-0164"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001880.pub6/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001880.pub6/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/table_n/CD001880StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/table_n/CD001880StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001880.pub6/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001880.pub6/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001880.pub6/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD001880.pub6/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD001880.pub6/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD001880.pub6/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2016 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> <li aria-label="There has been an important change to the conclusions of the review." class="status-item up-to-date custom-tooltip" data-status="conclusionchanged" title="There has been an important change to the conclusions of the review."> <a class="btn secondary" href="information#history">Conclusions changed</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Nutritional supplementation for hip fracture aftercare in older people</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001880.pub6/information#CD001880-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Alison Avenell</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001880.pub6/information#CD001880-cr-0003">Toby O Smith</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001880.pub6/information#CD001880-cr-0004">James P Curtain</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001880.pub6/information#CD001880-cr-0005">Jenson CS Mak</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001880.pub6/information#CD001880-cr-0006">Phyo K Myint</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/information/en#CD001880-sec-0179">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 30 November 2016 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD001880.pub6">https://doi.org/10.1002/14651858.CD001880.pub6</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD001880-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001880-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD001880-abs-0006">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD001880-abs-0017">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD001880-abs-0005">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD001880-abs-0004">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD001880-abs-0003">한국어</a> </li> <li class="section-language"> <a class="" href="full/pt#CD001880-abs-0002">Português</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD001880-abs-0001" lang="en"> <section id="CD001880-sec-0001"> <h3 class="title" id="CD001880-sec-0001">Background</h3> <p>Older people with hip fractures are often malnourished at the time of fracture, and subsequently have poor food intake. This is an update of a Cochrane review first published in 2000, and previously updated in 2010. </p> </section> <section id="CD001880-sec-0002"> <h3 class="title" id="CD001880-sec-0002">Objectives</h3> <p>To review the effects (benefits and harms) of nutritional interventions in older people recovering from hip fracture. </p> </section> <section id="CD001880-sec-0003"> <h3 class="title" id="CD001880-sec-0003">Search methods</h3> <p>We searched the Cochrane Bone, Joint and Muscle Trauma Group Specialised Register, CENTRAL, MEDLINE, MEDLINE In‐Process &amp; Other Non‐Indexed Citations, Embase, CAB Abstracts, CINAHL, trial registers and reference lists. The search was last run in November 2015. </p> </section> <section id="CD001880-sec-0004"> <h3 class="title" id="CD001880-sec-0004">Selection criteria</h3> <p>Randomised and quasi‐randomised controlled trials of nutritional interventions for people aged over 65 years with hip fracture where the interventions were started within the first month after hip fracture. </p> </section> <section id="CD001880-sec-0005"> <h3 class="title" id="CD001880-sec-0005">Data collection and analysis</h3> <p>Two review authors independently selected trials, extracted data and assessed risk of bias. Where possible, we pooled data for primary outcomes which were: all cause mortality; morbidity; postoperative complications (e.g. wound infections, pressure sores, deep venous thromboses, respiratory and urinary infections, cardiovascular events); and 'unfavourable outcome' defined as the number of trial participants who died plus the number of survivors with complications. We also pooled data for adverse events such as diarrhoea. </p> </section> <section id="CD001880-sec-0006"> <h3 class="title" id="CD001880-sec-0006">Main results</h3> <p>We included 41 trials involving 3881 participants. Outcome data were limited and risk of bias assessment showed that trials were often methodologically flawed, with less than half of trials at low risk of bias for allocation concealment, incomplete outcome data, or selective reporting of outcomes. The available evidence was judged of either low or very low quality indicating that we were uncertain or very uncertain about the estimates. </p> <p>Eighteen trials evaluated oral multinutrient feeds that provided non‐protein energy, protein, vitamins and minerals. There was low‐quality evidence that oral feeds had little effect on mortality (24/486 versus 31/481; risk ratio (RR) 0.81 favouring supplementation, 95% confidence interval (CI) 0.49 to 1.32; 15 trials). Thirteen trials evaluated the effect of oral multinutrient feeds on complications (e.g. pressure sore, infection, venous thrombosis, pulmonary embolism, confusion). There was low‐quality evidence that the number of participants with complications may be reduced with oral multinutrient feeds (123/370 versus 157/367; RR 0.71, 95% CI 0.59 to 0.86; 11 trials). Based on very low‐quality evidence from six studies (334 participants), oral supplements may result in lower numbers with 'unfavourable outcome' (death or complications): RR 0.67, 95% CI 0.51 to 0.89. There was very low‐quality evidence for six studies (442 participants) that oral supplementation did not result in an increased incidence of vomiting and diarrhoea (RR 0.99, 95% CI 0.47 to 2.05). </p> <p>Only very low‐quality evidence was available from the four trials examining nasogastric multinutrient feeding. Pooled data from three heterogeneous trials showed no evidence of an effect of supplementation on mortality (14/142 versus 14/138; RR 0.99, 95% CI 0.50 to 1.97). One trial (18 participants) found no difference in complications. None reported on unfavourable outcome. Nasogastric feeding was poorly tolerated. One study reported no cases of aspiration pneumonia. </p> <p>There is very low‐quality evidence from one trial (57 participants, mainly men) of no evidence for an effect of tube feeding followed by oral supplementation on mortality or complications. Tube feeding, however, was poorly tolerated. </p> <p>There is very low‐quality evidence from one trial (80 participants) that a combination of intravenous feeding and oral supplements may not affect mortality but could reduce complications. However, this expensive intervention is usually reserved for people with non‐functioning gastrointestinal tracts, which is unlikely in this trial. </p> <p>Four trials tested increasing protein intake in an oral feed. These provided low‐quality evidence for no clear effect of increased protein intake on mortality (30/181 versus 21/180; RR 1.42, 95% CI 0.85 to 2.37; 4 trials) or number of participants with complications but very low‐quality and contradictory evidence of a reduction in unfavourable outcomes (66/113 versus 82/110; RR 0.78, 95% CI 0.65 to 0.95; 2 trials). There was no evidence of an effect on adverse events such as diarrhoea. </p> <p>Trials testing intravenous vitamin B1 and other water soluble vitamins, oral 1‐alpha‐hydroxycholecalciferol (vitamin D), high dose bolus vitamin D, different oral doses or sources of vitamin D, intravenous or oral iron, ornithine alpha‐ketoglutarate versus an isonitrogenous peptide supplement, taurine versus placebo, and a supplement with vitamins, minerals and amino acids, provided low‐ or very low‐quality evidence of no clear effect on mortality or complications, where reported. </p> <p>Based on low‐quality evidence, one trial evaluating the use of dietetic assistants to help with feeding indicated that this intervention may reduce mortality (19/145 versus 36/157; RR 0.57, 95% CI 0.34 to 0.95) but not the number of participants with complications (79/130 versus 84/125). </p> </section> <section id="CD001880-sec-0007"> <h3 class="title" id="CD001880-sec-0007">Authors' conclusions</h3> <p>There is low‐quality evidence that oral multinutrient supplements started before or soon after surgery may prevent complications within the first 12 months after hip fracture, but that they have no clear effect on mortality. There is very low‐quality evidence that oral supplements may reduce 'unfavourable outcome' (death or complications) and that they do not result in an increased incidence of vomiting and diarrhoea. Adequately sized randomised trials with robust methodology are required. In particular, the role of dietetic assistants, and peripheral venous feeding or nasogastric feeding in very malnourished people require further evaluation. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD001880-abs-0007" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001880-abs-0007">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD001880-abs-0008">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD001880-abs-0016">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD001880-abs-0018">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD001880-abs-0015">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD001880-abs-0014">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD001880-abs-0012">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD001880-abs-0013">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pt#CD001880-abs-0011">Português</a> </li> <li class="section-language"> <a class="" href="full/ru#CD001880-abs-0010">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD001880-abs-0009">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD001880-abs-0007" lang="en"> <h3>Nutritional supplementation for older people after hip fracture</h3> <p><b>Background and aim</b> </p> <p>Older people with hip fractures are often malnourished at the time of their fracture and many have poor food intake while in hospital. Malnutrition may hinder recovery after hip fracture. We reviewed the effects of nutritional interventions in older people recovering from hip fracture. </p> <p><b>Search results</b> </p> <p>We searched the scientific literature up to November 2015 and include 41 studies including 3881 participants. All nutritional interventions were started within one month of hip fracture. The studies had flaws in their methods that may affect the validity of their results. Some evidence was very low quality which means we are very unsure of the results. </p> <p><b>Key results</b> </p> <p>Eighteen studies examined the use of additional oral feeds that provided energy from sources other than protein, protein, some vitamins and minerals. There was low‐quality evidence that these multinutrient oral feeds may not reduce mortality but that they may reduce the number of people with complications (e.g. pressure sore, infection, venous thrombosis, pulmonary embolism, confusion). There was very low‐quality evidence that oral multinutrient feeds may reduce unfavourable outcome (death or complications) and that they did not result in increased vomiting and diarrhoea. </p> <p>Four studies examined nasogastric tube feeding, where liquid food is delivered via a tube inserted into the nose and passed down into the stomach, with non‐protein energy, protein, some vitamins and minerals. These studies provided very low‐quality evidence that tube feeding, which was poorly tolerated, did not seem to make a difference to mortality or complications. Unfavourable outcome was not recorded and there was insufficient evidence on adverse events. </p> <p>One study provided very low‐quality evidence that nasogastric tube feeding followed by oral feeds may not affect mortality or complications. It reported that tube feeding was poorly tolerated. </p> <p>One study provided very low‐quality evidence that giving feed into a vein initially and then by mouth may not affect mortality but may reduce complications. However, we were surprised that this intervention was being used in people who seemed to be able to take nutrition orally. </p> <p>Increasing protein intake in an oral feed was tested in four studies. These provided low‐quality evidence of no clear effect on mortality or complications and very low‐quality evidence for a reduction in unfavourable outcome. </p> <p>Studies testing intravenous vitamin B1 and other water soluble vitamins, oral 1‐alpha‐hydroxycholecalciferol (vitamin D), high dose bolus vitamin D, different oral doses or sources of vitamin D, intravenous or oral iron, ornithine alpha‐ketoglutarate versus an isonitrogenous peptide supplement, taurine versus placebo, and a supplement with vitamins, minerals and amino acids, provided low‐ or very low‐quality evidence of no clear effect on mortality or complications, where reported. </p> <p>One study, evaluating the use of dietetic assistants to help with feeding, provided low‐quality evidence that this may reduce mortality but not the numbers of people with complications. </p> <p><b>Conclusions</b> </p> <p>Oral supplements with non‐protein energy, protein, vitamins and minerals started before or soon after surgery may prevent complications after hip fracture in older people but may not affect mortality. Adequately sized randomised studies with better design are required. We suggest that the role of dietetic assistants, and of peripheral venous feeding or nasogastric feeding in very malnourished patients, require further evaluation. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD001880-sec-0159" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001880-sec-0159">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD001880-sec-0223">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD001880-sec-0159"></div> <h3 class="title" id="CD001880-sec-0160">Implications for practice</h3> <section id="CD001880-sec-0160"> <p>There is low‐quality evidence that oral multinutrient supplements (comprising non‐protein energy, protein, and some vitamins and minerals) started before or soon after surgery may prevent complications within the first 12 months after hip fracture, but that they have no clear effect on mortality. There is very low‐quality evidence that oral supplements may reduce 'unfavourable outcome' (death or complications) and that they do not result in an increased incidence of adverse events, namely vomiting and diarrhoea. </p> <p>There is very low‐quality evidence of no clear effect on mortality or complications of nasogastric multinutrient feeding. Nasogastric feeding was poorly tolerated, but this and the insufficiency of the evidence from randomised trials does not rule out consideration of this intervention for very malnourished patients with extremely poor intakes not responsive to multinutrient oral supplements. </p> <p>There is low‐quality evidence that increasing protein intake in an oral feed had no clear effect on mortality or complications. </p> <p>Although tested in just one trial and needing confirmation, there is low‐quality evidence suggesting the use of dietetic assistants to help with feeding may reduce mortality but not the number of participants with complications. </p> <p>Since the evidence for other comparisons made usually by single trials was of very low quality and insufficient to inform practice, these are not described here. </p> </section> <h3 class="title" id="CD001880-sec-0161">Implications for research</h3> <section id="CD001880-sec-0161"> <p>Large, well‐designed, adequately powered, preferably multi‐centre trials are required. Such trials should stratify allocation according to basic nutritional status to enable robust a priori subgroup analysis. Future research should examine functional status (using standardised methods), the level of care required, compliance, patient‐perceived quality of life, and direct and indirect costs after hip fracture. These are in addition to mortality, individual complications and length of stay in hospital and rehabilitation. An independent observer should assess outcomes and the period of follow‐up should be at least one year. The design and reporting of any future trial should conform to the CONSORT statement or any future development of it (<a href="./references#CD001880-bbs2-0101" title="BeggC , ChoM , EastwoodS , HortonR , MoherD , OlkinI , et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA1996;276:637‐9. ">Begg 1996</a>; <a href="./references#CD001880-bbs2-0133" title="MoherD , SchulzKF , AltmanDG , for the CONSORT group. The CONSORT statement: revised recommendations for improving the quality of reports of parallel‐group randomised trials. Lancet2001;357:1191‐4. ">Moher 2001</a>; <a href="./references#CD001880-bbs2-0137" title="SchulzKF , AltmanDG , MoherD , for the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ2010;340(7748):698‐702. ">Schulz 2010</a>). We propose the focus of these randomised trials should be on the following. </p> <p> <ul id="CD001880-list-0004"> <li> <p>Oral multinutrient supplementation, by sip feeds and changes to the hospital diet and snacks. These trials should seek to be as inclusive of the patient population as possible. As well as provision of these supplements, the use of extra staff to help with feeding, e.g. dietetic assistants, should be explored further. </p> </li> <li> <p>Nasogastric or intravenous multinutrient supplementation. These trials should be conducted only in the most malnourished patients, where oral supplementation is unable to provide sufficient intake. </p> </li> </ul> </p> <p>Additionally, information on nutritional status and use of supplements should be collected in audits of hip fracture management. Such data could be used to investigate the relationship of nutritional status to outcome. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD001880-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD001880-sec-0043"></div> <div class="table" id="CD001880-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Multinutrient supplements (oral) versus control for hip fracture aftercare in older people</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Multinutrient supplements (oral) versus control for hip fracture aftercare in older people</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Older people undergoing hip fracture aftercare<br/> <b>Settings:</b> Acute hospital<br/> <b>Intervention:</b> Multinutrient supplements (<b>oral</b> route) in addition to standard care. (Typically, supplements were started either pre‐operatively or within 2 days postoperatively and continued for at least a month) </p> <p><b>Comparison:</b> Standard postoperative nutritional support and care in control groups </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Multinutrient supplements (oral) versus control</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Mortality by end of study</b> </p> <p>Follow‐up: 1‐12 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.81</b> <br/> (0.49 to 1.31) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>968<br/> (15 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>The statistical test for subgroup differences between the results for the 5 trials targeting malnourished participants and those 10 trials not targeting malnourished participants did not confirm a difference between the two subgroups for mortality </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>72 per 1000<sup>1</sup> </b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>59 per 1000</b> <br/> (36 to 95) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>High risk<sup>2</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>250 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>203 per 1000</b> <br/> (123 to 328) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Participants with complications (e.g. pressure sore, chest infection) at end of study</b> <br/> Follow‐up: 1‐12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.71</b> <br/> (0.59 to 0.86) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>727<br/> (11 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Only 2 trials targeting malnourished people reported these data</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>443 per 1000<sup>4</sup> </b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>315 per 1000</b> <br/> (262 to 381) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Moderate risk<sup>5</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>290 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>206 per 1000</b> <br/> (171 to 250) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Unfavourable outcome <sup>7</sup> by end of study</b> </p> <p>Follow‐up: 1‐12 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.67</b> </p> <p>(0.51 to 0.89)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>334</p> <p>(6 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>8</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Only 1 trial targeting malnourished people reported these data</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>500 per 1000<sup>4</sup> </b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>335 per 1000</p> <p>(255 to 445)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Putative side effects of treatment (e.g. vomiting and diarrhoea)</b> </p> <p>Follow‐up: during supplementation period</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>RR 0.99</b> </p> <p>(0.47 to 2.05)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>442</p> <p>(6 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>9</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Three of the 6 trials reported no adverse effects</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>50 per 1000<sup>4</sup> </b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>50 per 1000</p> <p>(24 to 103)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1.</sup> The control group risk is the median control group risk across the 9 studies that reported one or more deaths in the control group.<br/> <sup>2.</sup> The high control group risk is based on the one‐year mortality rate derived from <a href="./references#CD001880-bbs2-0102" title="BentlerSE , LiuL , ObrizanM , CookEA , WrightKB , GewekeJF , et al. The aftermath of hip fracture: discharge placement, functional status change, and mortality. American Journal of Epidemiology2009;170(10):1290‐9. ">Bentler 2009</a> (26%) and <a href="./references#CD001880-bbs2-0130" title="MaricondaM , CostaGG , CerbasiS , RecanoP , AitantiE , GambacortaM , et al. The determinants of mortality and morbidity during the year following fracture of the hip. Bone and Joint Journal2015;97(3):383‐90. ">Mariconda 2015</a> (24.7% for those over 80 years). Pooled estimate includes no effect and 95% confidence intervals encompass relative risk increase greater than 25%.<br/> <sup>3.</sup> Downgraded 1 level for high risk of bias and 1 level for imprecision.<br/> <sup>4.</sup> The control group risk is the median control group risk across studies.<br/> <sup>5.</sup> Moderate control risk is derived from participants whilst in hospital in <a href="./references#CD001880-bbs2-0130" title="MaricondaM , CostaGG , CerbasiS , RecanoP , AitantiE , GambacortaM , et al. The determinants of mortality and morbidity during the year following fracture of the hip. Bone and Joint Journal2015;97(3):383‐90. ">Mariconda 2015</a>.<br/> <sup>6.</sup> Downgraded 2 levels for very serious risk of bias.<br/> <sup>7.</sup> Unfavourable outcome was defined as the number of trial participants who died plus the number of survivors with complications. Where these data were unavailable, we accepted a slightly different definition (mortality or survivors with a major complication or two or more minor complications) provided in 3 trials.<br/> <sup>8.</sup> Downgraded 2 levels for serious risk of bias and 1 for indirectness reflecting the mixed definition of the outcome measure.<br/> 9. Downgraded 3 levels individually for risk of bias, inconsistency and imprecision. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD001880-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Multinutrient supplements (nasogastric) versus control for hip fracture aftercare in older people</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Multinutrient supplements (nasogastric) versus control for hip fracture aftercare in older people<sup>7</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Older people undergoing hip fracture aftercare<br/> <b>Settings:</b> Acute hospitals<br/> <b>Intervention:</b> Multinutrient supplements (nasogastric). (Started within 5 days of surgery and continued usually until oral intake was sufficient or hospital discharge.)<sup>1</sup> </p> <p><b>Comparison:</b> Standard postoperative nutritional support and care in control groups </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Multinutrient supplements (nasogastric) versus control</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Mortality by end of study</b> <br/> Follow‐up: 1‐12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study Population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR: 0.99</b> </p> <p>(0.50 to 1.97)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>280</p> <p>(3 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low<sup>3</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Only 1 trial targeting malnourished participants reported these data</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>156 per 1000<sup>2</sup> </b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>155 per 1000</b> </p> <p>(78 to 308)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Participants with complications (e.g. pressure sore, aspiration pneumonia) at end of study</b> <br/> Follow‐up: 6 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study Population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR: 1.09</b> </p> <p>(0.73 to 1.64)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>18</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low<sup>5</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>For consistency we have presented 95% CI here but have used 99% CI for single trial data in the main text: 99% CI 0.64 to 1.86.<sup>6</sup> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>800 per 1000<sup>4</sup> </b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>872 per 1000</b> </p> <p>(584 to 1000)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unfavourable outcome</b> </p> <p>Follow‐up: 1‐12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Putative side effects of treatment (e.g. aspiration pneumonia)</b> </p> <p>Follow‐up: during supplementation period</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Insufficient data to draw any conclusions. However, poor toleration of tube feeding was noted.<sup>1</sup> </p> <p>There was no report of aspiration pneumonia (1 study; 140 participants). One study reported 18 (28% of 64) participants in the intervention group developed diarrhoea ‐ this was ascribed to antibiotics in 16 ‐ but did not report on the control group. One study (18 participants) reported 3 cases of "bloating" in the intervention group; it found no feed‐induced diarrhoea </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change </p> <p>the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1.</sup> Nasogatric feeding was poorly tolerated but varied between studies. One study reported only 26% of the intervention group tolerated tube feeding for the full two weeks; another reported 78% completed the course (until hospital discharge).<br/> <sup>2.</sup> The control group risk is the median control group risk across studies.<br/> <sup>3.</sup> Downgraded 2 levels for serious risk of bias and one for inconsistency reflecting considerable heterogeneity (I<sup>2</sup> = 69%)<br/> <sup>4.</sup> The control group risk is that of the control group in the sole study contributing data.<br/> <sup>5.</sup> Downloaded 2 levels for serious risk of bias and one level for imprecision.<br/> <sup>6.</sup> The choice of 99% CIs reflected the extra burden of proof we considered appropriate for individual trials, in view of their generally poor quality. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD001880-sec-0044" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001880-sec-0044">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD001880-sec-0193">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD001880-sec-0044"></div> <section id="CD001880-sec-0045"> <h3 class="title" id="CD001880-sec-0045">Description of the condition</h3> <p>Hip (proximal femur) fractures are a common cause of substantial morbidity and mortality in older people living in industrialised societies (<a href="./references#CD001880-bbs2-0119" title="KanisJA , OdénA , McCloskeyEV , JohanssonH , WahlDA , Cooper C on behalf of the IOF Working Group on Epidemiology and Quality of Life. A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporosis International2012;23(9):2239–56. ">Kanis 2012</a>). Nine months after their hip fracture people still have poorer quality of life than age and sex matched controls (<a href="./references#CD001880-bbs2-0104" title="CranneyAB , CoyleD , HopmanWM , HumV , PowerB , TugwellPS . Prospective evaluation of preferences and quality of life in women with hip fractures. Journal of Rheumatology2005;32(12):2393‐9. [MEDLINE: 16331770] ">Cranney 2005</a>). Many people fail to return to their own homes and previous state of mobility after a hip fracture. In industrialised societies, mortality in the year after hip fracture may be as high as 30% (<a href="./references#CD001880-bbs2-0102" title="BentlerSE , LiuL , ObrizanM , CookEA , WrightKB , GewekeJF , et al. The aftermath of hip fracture: discharge placement, functional status change, and mortality. American Journal of Epidemiology2009;170(10):1290‐9. ">Bentler 2009</a>; <a href="./references#CD001880-bbs2-0130" title="MaricondaM , CostaGG , CerbasiS , RecanoP , AitantiE , GambacortaM , et al. The determinants of mortality and morbidity during the year following fracture of the hip. Bone and Joint Journal2015;97(3):383‐90. ">Mariconda 2015</a>), and averages 11% during the first few months after fracture (<a href="./references#CD001880-bbs2-0128" title="LyonsAR . Clinical outcomes and treatment of hip fractures. American Journal of Medicine1997;103(2A):51S‐64S. ">Lyons 1997</a>). Mortality in the first four months after hip fracture surgery is age dependent. For instance, mortality was reported as 5% in people aged 50 to 69 years, compared with 28% in those people aged 90 years or over in the Scottish Hip Fracture Audit Report (<a href="./references#CD001880-bbs2-0116" title="HoltG , SmithR , DuncanK , FinlaysonDF , GregoriA . Early mortality after surgical fixation of hip fractures in the elderly. Journal of Bone and Joint Surgery ‐ British Volume2008;90B:1357‐63. ">Holt 2008</a>). A meta‐analysis of prospective studies found the relative hazard for mortality during the first three months following hip fracture to be 5.75 (95% CI 4.94 to 6.67) for women, and higher in men at 7.95 (95% CI 6.13 to 10.30) (<a href="./references#CD001880-bbs2-0113" title="HaentjensP , MagazinerJ , Colon‐EmericCS , VanderschuerenD , MilisenK , VelkeniersB , et al. Meta‐analysis: excess mortality after hip fracture among older women and men. Annals of Internal Medicine2010;152(6):380‐90. ">Haentjens 2010</a>). Excess mortality was also found to persist for as long as 10 years after hip fracture for both men and women. For those who survive, acute hospital costs are substantial, but long‐term costs in rehabilitation and extra care in the community are even greater (<a href="./references#CD001880-bbs2-0107" title="DolanP , TorgersonDJ . The cost of treating osteoporotic fractures in the United Kingdom female population. Osteoporosis International1998;8:611‐7. ">Dolan 1998</a>; <a href="./references#CD001880-bbs2-0112" title="HaentjensP , LamraskiG , BoonenS . Costs and consequences of hip fracture occurrence in old age: an economic perspective. Disability and Rehabilitation2005;27(18‐19):1129‐41. [MEDLINE: 16278182] ">Haentjens 2005</a>; <a href="./references#CD001880-bbs2-0118" title="JohnellO . The socioeconomic burden of fractures: today and in the 21st century. American Journal of Medicine1997;103:20S‐6S. ">Johnell 1997</a>). </p> <p>People with hip fractures, who are more likely to be older and frailer, are often malnourished or at risk of becoming malnourished at the time of the fracture (<a href="./references#CD001880-bbs2-0044" title="Bachrach‐LindstromM , UnossonM , EkAC , ArnqvistHJ . Assessment of nutritional status using biochemical and anthropometric variables in a nutritional intervention study of women with hip fracture. Clinical Nutrition2001;20(3):217‐23. ">Bachrach 2001</a>; <a href="./references#CD001880-bbs2-0099" title="BastowMD , RawlingsJ , AllisonSP . Undernutrition, hypothermia, and injury in elderly women with fractured femur: an injury response to altered metabolism?. Lancet1983;1(8317):143‐6. ">Bastow 1983a</a>; <a href="./references#CD001880-bbs2-0121" title="Koren‐HakimT , WeissA , HershkovitzA , OtzrateniI , GrosmanB , FrishmanS , et al. The relationship between nutritional status of hip fracture operated elderly patients and their functioning, comorbidity and outcome. Clinical Nutrition2012;31(6):917‐21. ">Koren‐Hakim 2012</a>; <a href="./references#CD001880-bbs2-0127" title="LumbersM , NewSA , GibsonS , MurphyMC . Nutritional status in elderly female hip fracture patients: comparison with an age‐matched home living group attending day centres. British Journal of Nutrition2001;85:733‐40. [MEDLINE: 11430778] ">Lumbers 2001</a>). Social, psychological, physical, economic, medical and cognitive influences may all contribute to the risk of malnutrition. Dietary intake in people recovering from hip fracture in hospital is frequently suboptimal (<a href="./references#CD001880-bbs2-0045" title="BellJJ , BauerJD , CapraS , PulleRC . Multidisciplinary, multi‐modal nutritional care in acute hip fracture inpatients ‐ results of a pragmatic intervention. Clinical Nutrition2014;33(6):1101‐7. [DOI: 10.1016/j.clnu.2013.12.003; PUBMED: 24388594] ">Bell 2014</a>; <a href="./references#CD001880-bbs2-0117" title="JallutD , TappyL , KohutM , BloeschD , MungerR , SchutzY , et al. Energy balance in elderly patients after surgery for a femoral neck fracture. Journal of Parenteral and Enteral Nutrition1990;14:563‐8. ">Jallut 1990</a>; <a href="./references#CD001880-bbs2-0127" title="LumbersM , NewSA , GibsonS , MurphyMC . Nutritional status in elderly female hip fracture patients: comparison with an age‐matched home living group attending day centres. British Journal of Nutrition2001;85:733‐40. [MEDLINE: 11430778] ">Lumbers 2001</a>; <a href="./references#CD001880-bbs2-0134" title="NematyM , HicksonM , BrynesAE , RuxtonC , FrostGS . A pilot survey to investigate the nutritional status of patients with a fractured neck of femur and level of nutritional support provided during treatment. Proceedings of the Nutrition Society2004;63:77A. ">Nematy 2004</a>; <a href="./references#CD001880-bbs2-0135" title="PattersonBM , CornellCN , CarboneB , LevineB , ChapmanD . Protein depletion and metabolic stress in elderly patients who have a fracture of the hip. Journal of Bone and Joint Surgery ‐ American Volume1992;74:251‐60. ">Patterson 1992</a>; <a href="./references#CD001880-bbs2-0035" title="StableforthPG . Supplement feeds and nitrogen and calorie balance following femoral neck fracture. British Journal of Surgery1986;73:651‐5. ">Stableforth 1986</a>). </p> <p>Under‐nutrition leads to depressed mood, muscle wasting and reduced muscle power, and impaired cardiac function (<a href="./references#CD001880-bbs2-0120" title="KeysA , BrozekJ , HenschelA , MickelsenO , TaylorHL , editors. The Biology of Human Starvation. Minneapolis: University of Minnesota, 1950. ">Keys 1950</a>). All of these will impair mobility and increase the tendency to develop postoperative medical complications (e.g. pneumonia, pressure sores, deep venous thrombosis) and hinder recovery, both in hospital and subsequently (<a href="./references#CD001880-bbs2-0123" title="Lennard‐Jones , J E (editor) . A positive approach to nutrition as treatment. Report on the role of enteral and parenteral feeding in hospital and at home. Working party chaired by J E Lennard‐Jones. London: King's Fund Centre, 1992. [ISBN 1857170164. pbk] ">Lennard‐Jones 1992</a>), increasing health and social care costs. Malnutrition also impairs the immune response, which will enhance the risk of postoperative infection (<a href="./references#CD001880-bbs2-0124" title="LesourdBM . Nutrition and immunity in the elderly: modification of immune responses with nutritional treatments. American Journal of Clinical Nutrition1997;66:478S‐84S. ">Lesourd 1997</a>). Poor nutritional status is associated with an increased risk of pressure ulcers after hip fracture (<a href="./references#CD001880-bbs2-0125" title="LindholmC , SternerE , RomanelliM , PinaE , Torray Bou J , HietanenH , et al. Hip fracture and pressure ulcers ‐ the Pan‐European Pressure Ulcer Study ‐ intrinsic and extrinsic risk factors. International Wound Journal2008;5:315‐28. [MEDLINE: 18494637] ">Lindholm 2008</a>). </p> </section> <section id="CD001880-sec-0046"> <h3 class="title" id="CD001880-sec-0046">Description of the intervention</h3> <p>Examined in this review are nutritional interventions started within the first month after a hip fracture that are aimed at improving recovery from hip fracture by increasing the intake of energy, protein, vitamins and minerals, alone or in combination. Nutrition interventions can be provided by various routes: oral (by mouth), enteral (tube feeding into the stomach or small bowel, including percutaneous endoscopic gastrostomy) or parenteral (intravenous and intramuscular), also alone or in combination. Also considered are interventions that revolve round the administration of nutrition, such as the use of dietetic assistants in hospital. </p> </section> <section id="CD001880-sec-0047"> <h3 class="title" id="CD001880-sec-0047">How the intervention might work</h3> <p>There is an association between frailty, including that related to nutrition, and unfavourable outcomes following a hip fracture. Modification of nutritional status in the rehabilitation period, particularly early on, could be beneficial in reducing functional decline and reducing complications. </p> <p>Making links between nutritional status and fracture recovery is complicated by the fact that markers of dietary protein depletion measured in blood, such as albumin, prealbumin, and transferrin are partly affected by fluid shifts and responses to injury and infection. Nevertheless, associations have been shown between low serum albumin and increased postoperative complications and poorer survival (<a href="./references#CD001880-bbs2-0108" title="FosterMR , HeppenstallRB , FriedenbergZB , HozackWJ . A prospective assessment of nutritional status and complications in patients with fractures of the hip. Journal of Orthopaedic Trauma1990;4:49‐57. ">Foster 1990</a>; <a href="./references#CD001880-bbs2-0135" title="PattersonBM , CornellCN , CarboneB , LevineB , ChapmanD . Protein depletion and metabolic stress in elderly patients who have a fracture of the hip. Journal of Bone and Joint Surgery ‐ American Volume1992;74:251‐60. ">Patterson 1992</a>). Another factor that has been implicated is vitamin C, which is required for an effective immune response and collagen formation required for wound healing. Low leucocyte vitamin C levels have been associated with the development of pressure sores in people with hip fracture (<a href="./references#CD001880-bbs2-0103" title="BrownKM , SeabrookNA . Nutritional influences on recovery and length of hospital stay in elderly women following femoral fracture. Proceedings of the Nutrition Society1992;51:132A. ">Brown 1992a</a>; <a href="./references#CD001880-bbs2-0110" title="GoodeHF , BurnsE , WalkerBE . Vitamin C depletion and pressure sores in elderly patients with femoral neck fracture. BMJ1992;305:925‐7. ">Goode 1992</a>). </p> <p>More direct markers of nutritional status are anthropometric indices, such as weight in relation to height, triceps skinfold for body fat, and mid‐upper arm circumference for muscle and fat mass. People with hip fracture have lower triceps skinfold and mid‐upper arm circumference than healthy people in the same age category (<a href="./references#CD001880-bbs2-0129" title="MansellPI , RawlingsJ , AllisonSP , BendallMJ , PearsonM , BasseyEJ , et al. Low anthropometric indices in elderly females with fractured neck of femur. Clinical Nutrition1990;9:190‐4. ">Mansell 1990</a>; <a href="./references#CD001880-bbs2-0134" title="NematyM , HicksonM , BrynesAE , RuxtonC , FrostGS . A pilot survey to investigate the nutritional status of patients with a fractured neck of femur and level of nutritional support provided during treatment. Proceedings of the Nutrition Society2004;63:77A. ">Nematy 2004</a>). In a study of 744 people with hip fracture, <a href="./references#CD001880-bbs2-0099" title="BastowMD , RawlingsJ , AllisonSP . Undernutrition, hypothermia, and injury in elderly women with fractured femur: an injury response to altered metabolism?. Lancet1983;1(8317):143‐6. ">Bastow 1983a</a> found that low triceps skinfold and arm muscle circumference was associated with lower calorie intake on the ward and predicted poorer survival after hip fracture. </p> </section> <section id="CD001880-sec-0048"> <h3 class="title" id="CD001880-sec-0048">Why it is important to do this review</h3> <p>As described above, people with hip fracture are sometimes undernourished, and poor food intake may occur during routine care, hindering recovery. There is therefore an argument for nutritional supplementation in this group, and consequently a need to evaluate the use of nutrition interventions in this group of people by examining the evidence from relevant randomised controlled trials. This is the seventh update of our Cochrane review first published in 2000, and previously updated in 2010. The previous update (<a href="./references#CD001880-bbs2-0146" title="AvenellA , HandollHHG . Nutritional supplementation for hip fracture aftercare in older people. Cochrane Database of Systematic Reviews2010, Issue 1. [DOI: 10.1002/14651858.CD001880.pub5] ">Avenell 2010</a>) continued to point to the insufficiency of the available evidence to draw robust conclusions. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD001880-sec-0049" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001880-sec-0049">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD001880-sec-0198">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD001880-sec-0049"></div> <p>To review the effects (benefits and harms) of nutritional interventions in older people recovering from hip fracture. </p> <p>We considered comparisons where people with hip fracture, who were randomly allocated a nutritional intervention, including supplements, were compared with those allocated to no intervention or placebo. Where possible, effects were examined according to pre‐existing nutritional status: malnourished or not malnourished. </p> <p>We also considered comparisons between nutritional interventions if these were compared in a randomised controlled trial. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD001880-sec-0050" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001880-sec-0050">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD001880-sec-0199">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD001880-sec-0050"></div> <section id="CD001880-sec-0051"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD001880-sec-0052"> <h4 class="title">Types of studies</h4> <p>We included all randomised controlled trials (RCTs) and quasi‐randomised (e.g. allocation by date of birth or hospital record number) controlled trials of nutritional supplements post hip fracture. We also included trials that could not be analysed on an intention‐to‐treat basis, and those that lacked blinding or use of placebo treatment. </p> <p>Studies of nutritional interventions that examined the secondary prevention of osteoporotic fractures after hip fracture were not considered in this review. </p> </section> <section id="CD001880-sec-0053"> <h4 class="title">Types of participants</h4> <p>We included trials of older people recovering from any type of hip fracture. It was anticipated that most participants would be over 65 years of age. If the number of younger participants was relatively small, and provided there was adequate randomisation with unbiased distribution of this age group between the intervention and control groups, we retained them. Trials that focused specifically or mainly on younger people, people with multiple trauma or people with pathological fractures (e.g. cancer‐related fractures) were excluded. We also excluded trials published before 1980 with undefined geriatric populations or with mixed populations with fewer than five participants with hip fracture in each intervention group. </p> <p>Studies reporting results on mixed populations of orthopaedic or other geriatric patients were only included, either if separate data were available from the participants with fracture of the hip, or when contact with the study authors resulted in the provision of such data. </p> <p>The participants studied may have resided in a hospital or in a rehabilitation unit or any location after discharge from either of these facilities. </p> </section> <section id="CD001880-sec-0054"> <h4 class="title">Types of interventions</h4> <p>We included trials of nutritional interventions aimed to improve the recovery from hip fracture by increasing the intake of energy, protein, vitamins and minerals, alone or in combination. Nutritional interventions were provided by oral (by mouth), enteral (tube feeding into the stomach or small bowel, including percutaneous endoscopic gastrostomy) or parenteral (intravenous and intramuscular) routes, alone or in combination. Interventions included those evaluating the administration of nutrition, such as the use of dietetic assistants. The interventions examined were started within the first month after hip fracture, and given for up to one year. Trials evaluating intravenous fluid administration in the immediate postoperative period for hydration purposes were excluded. </p> <p>Interventions included multinutrient supplements (providing non‐protein energy, protein, vitamins and minerals) given orally, enterally or intravenously, compared with supplements containing less or none of these components, or no treatment. We included interventions of vitamins, minerals, amino acids or related compounds compared with lower doses, placebo or no treatment. We also included trials examining different policies to provide nutrition, for example, additional assistance from dietetic assistants. </p> </section> <section id="CD001880-sec-0055"> <h4 class="title">Types of outcome measures</h4> <p>We sought information on the following outcomes, which we split into main outcomes (and further categorised into primary and secondary outcomes) and other outcomes. Additionally, we made the collection of 'unfavourable outcome' explicit. </p> <section id="CD001880-sec-0056"> <h5 class="title">Main outcomes</h5> </section> <section id="CD001880-sec-0057"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD001880-list-0001"> <li> <p>All cause mortality</p> </li> <li> <p>Morbidity, postoperative complications (e.g. wound infections, pressure sores, deep venous thromboses, respiratory and urinary infections, cardiovascular events) </p> </li> <li> <p>'Unfavourable outcome'. This was defined as the number of trial participants who died plus the number of survivors with complications. Alternatively, where these data were unavailable, we accepted a slightly different definition (mortality or survivors with a major complication or two or more minor complications) originally presented in <a href="./references#CD001880-bbs2-0011" title="BonjourJP , RapinCH , RizzoliR , TkatchL , DelmiM , ChevalleyT , et al. Hip fracture, femoral bone mineral density, and protein supply in elderly patients. In: MunroHN , SchlierfG editor(s). Nutrition of the elderly. Nestlé nutrition workshop series. Vol. 29, New York: Raven Press, 1992:151‐9. [ISBN 0881678740 ] BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. BonjourJP , SchürchMA , RizzoliR . Nutritional aspects of hip fractures. Bone1996;18(3 Suppl):139S‐44S. BonjourJP , SchürchMA , RizzoliR . Proteins and bone health. Pathologie‐Biologie1997;45(1):57‐9. DelmiM , RapinC‐H , BengoaJ‐M , DelmasPD , VaseyH , BonjourJ‐P . Dietary supplementation in elderly patients with fractured neck of the femur. Lancet1990;335:1013‐6. [MEDLINE: 1970070] RapinCH , BengoaJM , KahnJM , DelmiM , BonjourJP , VaseyH . A prospective randomised control study of oral dietary supplementation in patients with fractured necks of femur. Journal of Parenteral and Enteral Nutrition1989;13(1):9S. ">Delmi 1990</a>. </p> </li> </ul> </p> </section> <section id="CD001880-sec-0058"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD001880-list-0002"> <li> <p>Length of hospital and rehabilitation unit stay</p> </li> <li> <p>Postoperative functional status (cognitive functioning, mobility and ability to perform activities of daily living) </p> </li> <li> <p>The level of care and extent of support required after discharge</p> </li> <li> <p>Patient perceived quality of life after discharge</p> </li> <li> <p>Fracture healing</p> </li> <li> <p>Putative side effects of treatment (e.g. diarrhoea, aspiration pneumonia, specific intravenous line complications) </p> </li> </ul> </p> <section id="CD001880-sec-0059"> <h6 class="title">Other outcomes</h6> <p> <ul id="CD001880-list-0003"> <li> <p>Patient tolerance of/compliance with nutrition interventions</p> </li> <li> <p>Carer burden and stress</p> </li> <li> <p>Economic outcomes</p> </li> </ul> </p> <p>For this update, we shortened the list of 'other outcomes' that appeared in previous versions of this review (<a href="./references#CD001880-bbs2-0146" title="AvenellA , HandollHHG . Nutritional supplementation for hip fracture aftercare in older people. Cochrane Database of Systematic Reviews2010, Issue 1. [DOI: 10.1002/14651858.CD001880.pub5] ">Avenell 2010</a>). The removed outcomes are listed in <a href="#CD001880-sec-0183">Differences between protocol and review</a>. </p> </section> </section> </section> </section> <section id="CD001880-sec-0060"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD001880-sec-0061"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Bone, Joint and Muscle Trauma Group Specialised Register (9 October 2014), the Cochrane Central Register of Controlled Trials (CENTRAL; 2015 issue 12) in <i>The Cochrane Library</i>, MEDLINE (1966 to October Week 5 2015), MEDLINE In‐Process &amp; Other Non‐Indexed Citations (10 November 2015), Embase (1980 to 2015 Week 45), CAB Abstracts (1973 to 2015 Week 44), and the Cumulative Index to Nursing and Allied Health Literature (CINAHL) (1982 to 10 November 2015). For this update, the search results were limited from 2008 onwards. </p> <p>In MEDLINE (Ovid), we combined the sensitivity‐maximizing version of the Cochrane Highly Sensitive Search Strategy for identifying randomised trials (<a href="./references#CD001880-bbs2-0122" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Lefebvre 2011</a>) with subject‐specific terms. We modified this strategy for use in the other databases (see <a href="./appendices#CD001880-sec-0165">Appendix 1</a> for search strategies). </p> <p>We also searched the <a href="http://controlled-trials.com/" target="_blank">ISRCTN registry</a> (17 February 2015), the <a href="http://apps.who.int/trialsearch/Default.aspx" target="_blank">WHO International Clinical Trials Registry Platform</a> (17 February 2015), the <a href="https://www.ukctg.nihr.ac.uk/#popoverSearchDivId" target="_blank">UK Clinical Research Network Study Portfolio</a> (17 February 2015), to identify ongoing trials. </p> <p>We did not apply any language restrictions. We have given details of the search methods used for the previous version of the review in <a href="./appendices#CD001880-sec-0172">Appendix 2</a>. </p> </section> <section id="CD001880-sec-0062"> <h4 class="title">Searching other resources</h4> <p>We checked reference lists of articles, searched books related to orthopaedics, geriatric medicine and nutrition, and corresponded with colleagues and investigators. </p> </section> </section> <section id="CD001880-sec-0063"> <h3 class="title" id="CD001880-sec-0063">Data collection and analysis</h3> <section id="CD001880-sec-0064"> <h4 class="title">Selection of studies</h4> <p>Two review authors (from AA, TS, JC) independently assessed reports of potentially eligible studies and resolved any differences by discussion. </p> </section> <section id="CD001880-sec-0065"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (from AA, TS, JC, JM) independently extracted data. We resolved all differences by discussion. We extracted data using a pre‐derived data extraction form and entered the agreed results into Review Manager (RevMan) (<a href="./references#CD001880-bbs2-0136" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). If necessary, we contacted trialists for further information on methodology and data. </p> </section> <section id="CD001880-sec-0066"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>In this update, two review authors (from AA, TS, JC, JM) independently assessed risk of bias in all included trials using the Cochrane 'Risk of bias' tool (<a href="./references#CD001880-bbs2-0115" title="HigginsJPT , AltmanDG , SterneJAC . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org. ">Higgins 2011</a>). This assesses sequence generation, allocation concealment, blinding of participants or personnel, blinding of outcome assessment, completeness of outcome data, selective outcome reporting and other potential sources of bias. We considered primary and secondary outcomes separately in our assessment of blinding of outcome assessment and completeness of outcome data. We resolved any differences of opinion by consensus or by consulting a third party. </p> <p>Our risk of bias assessment superceded our assessment of methodological quality in previous versions of this review (<a href="./references#CD001880-bbs2-0146" title="AvenellA , HandollHHG . Nutritional supplementation for hip fracture aftercare in older people. Cochrane Database of Systematic Reviews2010, Issue 1. [DOI: 10.1002/14651858.CD001880.pub5] ">Avenell 2010</a>); see <a href="#CD001880-sec-0183">Differences between protocol and review</a>. </p> </section> <section id="CD001880-sec-0067"> <h4 class="title">Measures of treatment effect</h4> <p>For each study, risk ratios and 99% confidence intervals (CI) were calculated for dichotomous outcomes and mean differences and 99% CIs for continuous outcomes. The choice of 99% CIs reflects the extra burden of proof we considered appropriate for individual trials, in view of their generally poor quality. Summary estimates for meta‐analysis are provided as 95% CIs. </p> </section> <section id="CD001880-sec-0068"> <h4 class="title">Unit of analysis issues</h4> <p>Although we would have included cluster‐randomised trials, the unit of randomisation in all included trials was the individual participant. </p> </section> <section id="CD001880-sec-0069"> <h4 class="title">Dealing with missing data</h4> <p>We have presented mortality results using denominators based on the numbers of participants at randomisation (intention‐to‐treat analysis), where available. Generally, we presented the results for other outcomes using denominators based on the numbers of participants available at follow‐up. In some cases, we investigated the effect of drop outs and exclusions by conducting worst scenario analyses for the primary outcomes, where those who were missing to follow‐up in the intervention group were assumed to have the poorer outcome but not those who were missing in the control group. We were alert to the potential mislabelling or non identification of standard errors and standard deviations. Unless missing standard deviations could be derived from confidence intervals or standard errors, we did not assume values in order to present these in the analyses. </p> </section> <section id="CD001880-sec-0070"> <h4 class="title">Assessment of heterogeneity</h4> <p>Heterogeneity was assessed by visual inspection of the forest plot (analysis) along with consideration of the Chi² test for heterogeneity and the I² statistic (<a href="./references#CD001880-bbs2-0114" title="HigginsJPT , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327:557‐60. ">Higgins 2003</a>). </p> </section> <section id="CD001880-sec-0071"> <h4 class="title">Assessment of reporting biases</h4> <p>We considered that there were sufficient data available to present funnel plots to explore the potential for publication bias for multinutrient supplements and the outcomes of mortality and complications. Our search of 'grey literature', dogged pursuit of trials listed in clinical trial registers and contact with trial authors should have helped to avoid some publication bias. </p> </section> <section id="CD001880-sec-0072"> <h4 class="title">Data synthesis</h4> <p>Where appropriate, we combined the results of comparable groups of trials using both fixed‐effect, as the main analysis, and random‐effects models. We have presented all data for individual trials in meta‐analyses as 99% CIs, and pooled data with 95% CIs. </p> </section> <section id="CD001880-sec-0073"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Our primary subgroup analysis was based on pre‐existing nutritional status (malnourished targeted versus malnourished not targeted). We also presented data on multinutrient supplements stratified by route of delivery: oral supplements, nasogastric tube feeding, nasogastric tube feeding and oral supplements, and intravenous feeding and oral supplements. To test whether the subgroups were statistically significantly different from one another, we tested the interaction using the inbuilt facility in <a href="./references#CD001880-bbs2-0136" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a> that is based on methods outlined by <a href="./references#CD001880-bbs2-0105" title="DeeksJJ , HigginsJPT , AltmanDG . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Deeks 2011</a> in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (Chapter 9). </p> </section> <section id="CD001880-sec-0074"> <h4 class="title">Sensitivity analysis</h4> <p>We planned sensitivity analyses based on aspects of trial and review methodology. We have explored the risk of bias associated with inadequate concealment of allocation (unclear or high risk of selection bias) and the choice of statistical model for pooling data (fixed‐effect versus random‐effects). </p> <section id="CD001880-sec-0075"> <h5 class="title">'Summary of findings' tables and assessment of the quality of the evidence</h5> <p>We have presented the results for mortality, participants with complications and unfavourable outcomes (our primary outcome measures) and adverse events (e.g. vomiting and diarrhoea) in separate 'Summary of findings' tables for the comparisons of oral multinutrient supplements versus control and nasogastric multinutrient supplements versus control. For each outcome for each comparison, we graded the evidence as 'very low', 'low', 'moderate' or 'high' in accordance with the GRADE working group criteria (<a href="./references#CD001880-bbs2-0111" title="GuyattGH , OxmanAD , VistGE , KunzR , Falck‐YtterY , Alonso‐CoelloP , et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ2008;336:924. ">Guyatt 2008</a>). </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD001880-sec-0076" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD001880-sec-0076"></div> <section id="CD001880-sec-0077"> <h3 class="title">Description of studies</h3> <section id="CD001880-sec-0078"> <h4 class="title">Results of the search</h4> <p>We updated the search from 2008 to November 2015. We screened a total of 2459 records from the following databases: Cochrane Bone, Joint and Muscle Trauma Group Specialised Register (7), CENTRAL (340), MEDLINE (483), Embase (847), CAB Abstracts (234), and CINAHL (548). We did not identify any additional new trials from Current Controlled Trials, the WHO International Clinical Trials Registry Platform or the UK clinical research network study portfolio. We also identified one potentially eligible study from contact with the author (<a href="./references#CD001880-bbs2-0024" title="LuoM . Personal communication 17 November 2014. LuoM , GolubevG , KlyukvinI , ReznikL , KuropatkinG , OliverJS , et al. Oral nutrition supplement improved nutritional status in malnourished hip fracture patients: a randomized controlled study. Journal of Scientific Research and Reports2015;4(6):480‐9. LuoM , GolybevG , KlyukvinI , ReznikL , KuropatkinG , VossAC . Oral nutritional supplement (ONS) improved nutritional status in malnourished patients receiving hip fracture surgery. Clinical Nutrition Supplements2011;6:151. SwearenginB . Effect of a medical food supplement in hospitalized patients recovering from surgery. clinicaltrials.gov/ct2/show/NCT01011608 (accessed 4 December 2015). ">Luo 2015</a>). </p> <p>The search update resulted in the identification of 32 new studies (many published in multiple articles) for potential inclusion, for which we obtained reports. Upon study selection, we found 17 trials eligible for inclusion (<a href="./references#CD001880-bbs2-0001" title="AnbarR , BelooseskyY , CohenJ , MadarZ , WeissA , TheillaM , et al. Tight calorie control in geriatric patients following hip fracture decreases complications: a randomized, controlled study. Clinical Nutrition2014;33:23‐8. AnbarR , BelooseskyY , MadarZ , TheillaM , Koren‐HakimT , WeissA , et al. Tight calorie control (TICACOS) in geriatric hip fracture patients. Clinical Nutrition, Supplement2012;7(1):18. AnbarR , BelooseskyY , MadarZ , TheillaM , Koren‐HakimT , WeissA , et al. Tight calorie control in geriatric hip fracture patients: preliminary results of the geriatric TICACOS study. Clinical Nutrition, Supplement2011;6(1):155. SingerP . Tight caloric balance in geriatric patients (TICACOSiGP). clinicaltrials.gov/show/NCT01735435 (accessed 3 December 2015). ">Anbar 2014</a>; <a href="./references#CD001880-bbs2-0004" title="Bischoff‐FerrariH . Early rehabilitation after hip fracture. clinicaltrials.gov/ct2/show/NCT00133640 (accessed 7 September 2015). Bischoff‐FerrariH , Dawson‐HughesB , OravE , WillettW , EgliA , MaetzelA , et al. The economic consequences of hip fractures: impact of home exercise and high dose‐vitamin D. 32nd Annual Meeting of the American Society for Bone and Mineral Research Annual Meeting; 2010 Oct 15‐9; Toronto, Canada. (accessed 3 December 2015); Vol. www.asbmr.org/education/2010‐abstracts. Bischoff‐FerrariHA , Dawson‐HughesB , PlatzA , OravEJ , StahelinHB , WillettWC , et al. Effect of high‐dosage cholecalciferol and extended physiotherapy on complications after hip fracture. A randomized controlled trial. Archives of Internal Medicine2010;170(9):813‐20. ">Bischoff‐Ferrari 2010</a>; <a href="./references#CD001880-bbs2-0006" title="Botella‐CarreteroJI . Personal communication 26 October 2014. Botella‐CarreteroJI , IglesiasB , BalsaJA , ArrietaF , ZamarronI , VazquezC . Perioperative oral nutritional supplements in normally and mildly undernourished geriatric patients submitted to surgery for hip fracture: a randomized clinical trial. Clinical Nutrition2010;29(5):574‐9. ">Botella‐Carretero 2010</a>; <a href="./references#CD001880-bbs2-0009" title="ChevalleyT . Personal communication 14 October 2014. ChevalleyT , HoffmeyerP , BonjourJ‐P , RizzoliR . Early serum IGF‐I response to oral protein supplements in elderly women with a recent hip fracture. Clinical Nutrition2010;29(1):78‐83. ">Chevalley 2010</a>; <a href="./references#CD001880-bbs2-0015" title="FabianE , GerstorferI , ThalerHW , StundnerH , BiswasP , ElmadfaI . Nutritional supplementation affects postoperative oxidative stress and duration of hospitalization in patients with hip fracture. Wiener Klinische Wochenschrift2011;123(3‐4):88‐93. ">Fabian 2011</a>; <a href="./references#CD001880-bbs2-0016" title="FlodinL . Effects of bisphosphonates and nutritional supplementation after a hip fracture. clinicaltrials.gov/show/NCT01950169 2013 (accessed 3 December 2015). FlodinL . Personal communication. Personal communication 15 December 2014. FlodinL , SaafM , CederholmT , Al‐AniAN , AckermannPW , SanegardE , et al. Additive effects of nutritional supplementation, together with bisphosphonates, on bone mineral density after hip fracture: a 12‐month randomized controlled study. Clinical Interventions in Aging2014;9:1043‐50. ">Flodin 2014</a>; <a href="./references#CD001880-bbs2-0018" title="ChewG , GlendenningP , TarantoM , InderjeethC . Ergocalciferol and cholecalciferol induce comparable increases in vitamin D binding protein and free 25‐hydroxy‐vitamin D with no significant change in free 1,25‐dihydroxyvitamin D in hip fracture patients. 32nd Annual Meeting of the American Society for Bone and Mineral Research Annual Meeting; Oct 15‐9; Toronto, Canada 2010 (accessed 3 December 2015); Vol. www.asbmr.org/education/2010‐abstracts. GlendenningP , ChewGT , InderjeethCA , TarantoM , FraserWD . Calculated free and bioavailable vitamin D metabolite concentrations in vitamin D‐deficient hip fracture patients after supplementation with cholecalciferol and ergocalciferol. Bone2013;56(2):271‐5. GlendenningP , ChewGT , SeymourHM , GillettMJ , GoldswainPR , InderjeethCA , et al. Serum 25‐hydroxyvitamin D levels in vitamin D‐insufficent hip fracture patients after supplementation with ergocalciferol and cholecalciferol. Bone2009;45(5):870‐5. ">Glendenning 2009</a>; <a href="./references#CD001880-bbs2-0023" title="KangJH , ShinDW , BaikHW , HongJ . Short‐term oral nutritional supplements and nutrition intervention in elderly patients after hip fracture surgery: a randomized controlled clinical trial. Clinical Nutrition, Supplement2012;7(1):280. ">Kang 2012</a>; <a href="./references#CD001880-bbs2-0024" title="LuoM . Personal communication 17 November 2014. LuoM , GolubevG , KlyukvinI , ReznikL , KuropatkinG , OliverJS , et al. Oral nutrition supplement improved nutritional status in malnourished hip fracture patients: a randomized controlled study. Journal of Scientific Research and Reports2015;4(6):480‐9. LuoM , GolybevG , KlyukvinI , ReznikL , KuropatkinG , VossAC . Oral nutritional supplement (ONS) improved nutritional status in malnourished patients receiving hip fracture surgery. Clinical Nutrition Supplements2011;6:151. SwearenginB . Effect of a medical food supplement in hospitalized patients recovering from surgery. clinicaltrials.gov/ct2/show/NCT01011608 (accessed 4 December 2015). ">Luo 2015</a>; <a href="./references#CD001880-bbs2-0027" title="MyintMW . Personal communication 6 January 2015. MyintMW , WuJ , WongE , ChanSP , ToTS , ChauMW , et al. Clinical benefits of oral nutritional supplementation for elderly hip fracture patients: a single blind randomised controlled trial. Age and Ageing2013;42(1):39‐45. MyintMWW . A randomized controlled study of nutritional intervention for geriatric hip fracture patients and its effect on rehabilitation outcomes. clinicaltrials.gov/ct2/show/NCT01088139 (accessed 4 December 2015). ">Myint 2013</a>; <a href="./references#CD001880-bbs2-0029" title="PapaioannouA . A randomised, controlled comparison of vitamin D strategies in acute hip fracture patients. clinicaltrials.gov/show/NCT00424619 (accessed 4 December 2015). PapaioannouA , KennedyCC , GiangregorioL , IoannidisG , PritchardJ , HanleyDA , et al. A randomized controlled trial of vitamin D dosing strategies after acute hip fracture: no advantage of loading doses over daily supplementation. BMC Musculoskeletal Disorders2011;12:135. PapaioannouA , KennedyCC , IoannidisG , AdachiJD , HanleyD , GiangregorioL , et al. High versus low vitamin D in acute hip fracture patients: a randomised, controlled trial. Osteoporosis International2010;21(Suppl 1):S201. ">Papaioannou 2011</a>; <a href="./references#CD001880-bbs2-0030" title="ParkerM . Personal communication 16 October 2014. ParkerM . Randomised trial comparing iron supplementation versus placebo in the treatment of anaemia after hip fracture. clinicaltrials.gov/show/NCT00919230 (accessed 4 December 2015). ParkerMJ . Iron supplementation for anemia after hip fracture surgery. A randomized trial of 300 patients. Journal of Bone and Joint Surgery ‐ American Volume2010;92(2):265‐9. ">Parker 2010</a>; <a href="./references#CD001880-bbs2-0031" title="PrasadN . Personal communication 24 October 2014. PrasadN , RajamaniV , HullinD , MurrayJM . Post‐operative anaemia in femoral neck fracture patients: does it need treatment? A single blinded prospective randomised controlled trial. Injury2009;40(10):1073‐6. ">Prasad 2009</a>; <a href="./references#CD001880-bbs2-0033" title="DerossiD , BoA , BergonziR , ScivolettoG . Six‐week administration of a mixture of ergogenic and osteotrophic ingredients (RestorfastTM) improves the clinical course of elderly patients after hip fracture surgery [La somministrazione per sei settimane di un composto a base di sostanze osteotrofiche ed ergogene (RestorfastTM) migliora il decorso clinico in anziani sottoposti a chirurgia del femore]. Trends in Medicine2009;9(4):235‐42. ScivolettoG , BoA , DerossiD , BergonziR . Ten week administration of a polynutritional supplement with muscle tone action (RiabylexTM) improves the functional recovery in elderly hip fracture patients during home rehabilitation [In anziani in terapia riabilitativa domiciliare per pregressa frattura del femore, l'assunzione di un polinutriente ad azione muscolotonica (RiabylexTM) per 10 settimane migliora il recupero funzionale]. Trends in Medicine2010;10(2):113‐20. ">Scivoletto 2010</a>; <a href="./references#CD001880-bbs2-0034" title="Serrano‐TrenasJA , UgaldePF , CabelloLM , ChoflesLC , LazaroPS , BenitezPC . Role of perioperative intravenous iron therapy in elderly hip fracture patients: a single‐center randomized controlled trial. Transfusion2011;51(1):97‐104. ">Serrano‐Trenas 2011</a>; <a href="./references#CD001880-bbs2-0040" title="HoudijkAPJ . The effect of taurine on morbidity and mortality in the elderly hip fracture patient. clinicaltrials.gov/ct2/show/NCT00497978 (accessed 15 December 2015). VanStijnMF , BruinsAA , VermeulenMA , WitloxJ , TeerlinkT , SchoorlMG , et al. Effect of oral taurine on morbidity and mortality in elderly hip fracture patients: a randomized trial. International Journal of Molecular Sciences2015;16(6):12288‐306. [DOI: 10.3390/ijms160612288; PUBMED: 26035756] ">Van Stijn 2015</a>; <a href="./references#CD001880-bbs2-0041" title="Breedveld‐PetersJ , ReijvenPL , WyersCE , HendrikxAA , VerburgAD , ScholsJM , et al. Qualitative analysis of barriers and facilitators for nutritional intervention in hip fracture patients. Clinical Nutrition, Supplement2012;7(1):234. Breedveld‐PetersJJ , ReijvenPL , WyersCE , HendrikxAA , VerburgAD , ScholsJM , et al. Barriers and facilitators of nutritional intervention after hip fracture in integrated care as perceived by the different health care professionals: a qualitative interview study. e‐SPEN Journal2012;7(5):e182‐8. Breedveld‐PetersJJ , ReijvenPL , WyersCE , VanHeldenS , ArtsJJ , MeestersB , et al. Integrated nutritional intervention in the elderly after hip fracture. A process evaluation. Clinical Nutrition, Supplement2012;31(1):199‐205. Breedveld‐PetersJJ , ReijvenPL , WyersCE , VanHeldenS , ArtsJJ , MeestersB , et al. Integrated nutritional intervention in the elderly after hip fracture. A process evaluation. Clinical Nutrition, Supplement2012;7(1):43. DagneliePC . Effectiveness and cost‐effectiveness of nutritional screening and intervention in elderly subjects after hip fracture. clinicaltrials.gov/show/NCT00523575 (accessed 8 November 2009). WyersC , ReijvenPL , EversSM , WillemsPC , HeyligersIC , VerburgAD , et al. Cost‐effectiveness of nutritional intervention in hip fracture patients: a multi‐centre randomised controlled trial (RCT). Clinical Nutrition, Supplement2012;7(1):49. WyersCE . PhD thesis. Maastricht, the Netherlands: Maastricht University, 2012. WyersCE , Breedveld‐PetersJJ , ReijvenPL , ArtsC , ThomassenBJ , VerburgAD , et al. Effect of nutritional intervention on nutritional intake and status in hip fracture patients: a multicentre randomised controlled trial (RCT). Clinical Nutrition, Supplement2012;7(1):50‐1. WyersCE , Breedveld‐PetersJJ , ReijvenPL , VanHeldenS , GuldemondNA , SeverensJL , et al. Efficacy and cost‐effectiveness of nutritional intervention in elderly after hip fracture: design of a randomized controlled trial. BMC Public Health2010;10:212. WyersCE , ReijvenPL , EversSM , WillemsPC , HeyligersIC , VerburgAD , et al. Cost‐effectiveness of nutritional intervention in elderly subjects after hip fracture. A randomized controlled trial. Osteoporosis International2013;24(1):151‐62. ">Wyers 2013</a>), we excluded six studies (<a href="./references#CD001880-bbs2-0045" title="BellJJ , BauerJD , CapraS , PulleRC . Multidisciplinary, multi‐modal nutritional care in acute hip fracture inpatients ‐ results of a pragmatic intervention. Clinical Nutrition2014;33(6):1101‐7. [DOI: 10.1016/j.clnu.2013.12.003; PUBMED: 24388594] ">Bell 2014</a>; <a href="./references#CD001880-bbs2-0057" title="GunnarssonAK , LonnK , GunningbergL . Does nutritional intervention for patients with hip fractures reduce postoperative complications and improve rehabilitation?. Journal of Clinical Nursing2009;18(9):1325‐33. ">Gunnarsson 2009</a>; <a href="./references#CD001880-bbs2-0061" title="HitzMF , JensenJE , EskildsenPC . Bone mineral density and bone markers in patients with a recent low‐energy fracture: effect of 1 y of treatment with calcium and vitamin D. American Journal of Clinical Nutrition2007;86(1):251‐9. ">Hitz 2007</a>; <a href="./references#CD001880-bbs2-0062" title="HoekstraJC , GoosenJH , DeWolfGS , VerheyenCC . Effectiveness of multidisciplinary nutritional care on nutritional intake, nutritional status and quality of life in patients with hip fractures: a controlled prospective cohort study. Clinical Nutrition2011;30(4):455‐61. ">Hoekstra 2011</a>; <a href="./references#CD001880-bbs2-0063" title="HolstM , RasmussenHH , LaursenMB , RasmussenS , PorupL , HaalsDS . Standard plan for nutrition treatment in hip fracture patients: room for improvement. Clinical Nutrition, Supplement2012;7(1):118‐9. ">Holst 2012</a>; <a href="./references#CD001880-bbs2-0070" title="LiHJ , ChengHS , LiangJ , WuCC , ShyuYI . Functional recovery of older people with hip fracture: does malnutrition make a difference?. Journal of Advanced Nursing2012;69(8):1691‐703. ">Li 2012</a>), we placed five in ongoing trials (<a href="./references#CD001880-bbs2-0091" title="MillerM . Personal communication 7 September 2014. MillerM . Does a high dose fish oil intervention improve outcomes in older adults recovering from hip fracture?. www.anzctr.org.au/ACTRN12609000241235.aspx (accessed 8 November 2009). ">ACTRN12609000241235</a>; <a href="./references#CD001880-bbs2-0093" title="HarperM . Does Intravenous iron therapy reduce the need for blood transfusion and improve post operative blood count following surgery for broken neck of femur. www.anzctr.org.au/TrialSearch.aspx?searchTxt=362379&amp;isBasic=True (accessed 23 September 2016). ">ACTRN12612000448842</a>; <a href="./references#CD001880-bbs2-0095" title="MalafarinaV . Hyperprotein nutritional intervention in elderly patients with hip fracture and sarcopenia (HIPERPROT). clinicaltrials.gov/ct2/show/NCT01404195 (accessed 4 December 2015). MalafarinaV , Uriz‐OtanoF , Gil‐GuerreroL , IniestaR , ZuletMA , MartinezJA . Study protocol: high‐protein nutritional intervention based on β‐hydroxy‐β‐methylbutirate, vitamin D3 and calcium on obese and lean aged patients with hip fractures and sarcopenia. The HIPERPROT‐GER study. Maturitas2013;76(2):123‐8. ">NCT01404195</a>; <a href="./references#CD001880-bbs2-0096" title="Bischoff‐FerrariH . Hip fracture surgery and oral nutritional supplements (HIATUS). clinicaltrials.gov/ct2/show/NCT01505985 (accessed 9 December 2015). ">NCT01505985</a>; <a href="./references#CD001880-bbs2-0097" title="RowlandsM , ForwardDP , SahotaO , MoppettIK . The effect of intravenous iron on postoperative transfusion requirements in hip fracture patients: study protocol for a randomized controlled trial. Trials2013;14(1):288. ">Rowlands</a>) and four await classification (<a href="./references#CD001880-bbs2-0085" title="BenatiG , BoschiF , BrandoliniF , CoppolaD , DelvecchioS , LijoiF , et al. Effects of a perioperative specific oral supplementation in hip fracture old patients. European Wound Management Association Journal2011;Suppl 2:129. ">Benati 2011</a>; <a href="./references#CD001880-bbs2-0086" title="Efficacy of ferric carboxymaltose with or without EPO reducing red‐cell transfusion packs in hip fracture perioperative period (PAHFRAC). clinicaltrials.gov/ct2/show/NCT01154491 (accessed 4 December 2015). Bernabeu‐WittelM . Personal communication 22 September 2014. Bernabeu‐WittelM , AparicoR , RomeroM , Murcia‐ZaragozaJ , Monte‐SecadesR , RossoC , et al. Ferric carboxymaltose with or without erythropoietin for the prevention of red‐cell transfusions in the perioperative period of osteoporotic hip fractures: a randomized controlled trial. The PAHFRAC‐01 project. BMC Musculoskeletal Disorders2012;13:27. Bernabeu‐WittelM , RomeroM , Ollero‐BaturoneM , AparicioR , Murcia‐ZaragozaJ , Rincon‐GomezM , et al. Ferric carboxymaltose with or without erythropoietin in anemic patients with hip fracture: a randomized clinical trial. Transfusion2016;56(9):2199‐211. ">Bernabeu‐Wittel 2016</a>; <a href="./references#CD001880-bbs2-0087" title="EkinciO , YanikS , TerziogluB , Yilmaz AkyuzE , DokuyucuA , ErdemS . The effect of calcium β‐hydroxy‐β‐methylbutyrate, vitamin D and protein supplementation on postoperative immobilization in elderly malnourished patients with hip fracture: a randomized controlled study. Clinical Nutrition2015;34(Suppl 1):S102. ">Ekinci 2015</a>; <a href="./references#CD001880-bbs2-0089" title="Ish‐ShalomS , SegalE , SalganikT , RazB , BrombergIL , ViethR . Comparison of daily, weekly and monthly vitamin D3 in ethanol dosing protocols for two months in elderly hip fracture patients. Journal of Clinical Endocrinology and Metabolism2008;93(9):3430‐5. ">Ish‐Shalom 2008</a>). </p> <p>We excluded one previously ongoing study (<a href="./references#CD001880-bbs2-0050" title="AuL , CameronI , KurrleS , UyC . Effectiveness of oral nutritional supplementation for older women with hip and other fractures. Australian Society of Geriatric Medicine Annual Scientific Meeting; 2003 June 16‐18; Melbourne (Australia). 2003. CameronID . Personal communication. 26 November 2014. CameronID , KurrleSE , UyC , LockwoodKA , AuL , SchaafsmaFG . Effectiveness of oral nutritional supplementation for older women after fracture: rationale, design and study of the feasibility of a randomized controlled study. BMC Geriatrics2011;11:32. ">Cameron 2011</a>). A second (NCT00523575) was published and is now an included study (<a href="./references#CD001880-bbs2-0041" title="Breedveld‐PetersJ , ReijvenPL , WyersCE , HendrikxAA , VerburgAD , ScholsJM , et al. Qualitative analysis of barriers and facilitators for nutritional intervention in hip fracture patients. Clinical Nutrition, Supplement2012;7(1):234. Breedveld‐PetersJJ , ReijvenPL , WyersCE , HendrikxAA , VerburgAD , ScholsJM , et al. Barriers and facilitators of nutritional intervention after hip fracture in integrated care as perceived by the different health care professionals: a qualitative interview study. e‐SPEN Journal2012;7(5):e182‐8. Breedveld‐PetersJJ , ReijvenPL , WyersCE , VanHeldenS , ArtsJJ , MeestersB , et al. Integrated nutritional intervention in the elderly after hip fracture. A process evaluation. Clinical Nutrition, Supplement2012;31(1):199‐205. Breedveld‐PetersJJ , ReijvenPL , WyersCE , VanHeldenS , ArtsJJ , MeestersB , et al. Integrated nutritional intervention in the elderly after hip fracture. A process evaluation. Clinical Nutrition, Supplement2012;7(1):43. DagneliePC . Effectiveness and cost‐effectiveness of nutritional screening and intervention in elderly subjects after hip fracture. clinicaltrials.gov/show/NCT00523575 (accessed 8 November 2009). WyersC , ReijvenPL , EversSM , WillemsPC , HeyligersIC , VerburgAD , et al. Cost‐effectiveness of nutritional intervention in hip fracture patients: a multi‐centre randomised controlled trial (RCT). Clinical Nutrition, Supplement2012;7(1):49. WyersCE . PhD thesis. Maastricht, the Netherlands: Maastricht University, 2012. WyersCE , Breedveld‐PetersJJ , ReijvenPL , ArtsC , ThomassenBJ , VerburgAD , et al. Effect of nutritional intervention on nutritional intake and status in hip fracture patients: a multicentre randomised controlled trial (RCT). Clinical Nutrition, Supplement2012;7(1):50‐1. WyersCE , Breedveld‐PetersJJ , ReijvenPL , VanHeldenS , GuldemondNA , SeverensJL , et al. Efficacy and cost‐effectiveness of nutritional intervention in elderly after hip fracture: design of a randomized controlled trial. BMC Public Health2010;10:212. WyersCE , ReijvenPL , EversSM , WillemsPC , HeyligersIC , VerburgAD , et al. Cost‐effectiveness of nutritional intervention in elderly subjects after hip fracture. A randomized controlled trial. Osteoporosis International2013;24(1):151‐62. ">Wyers 2013</a>). </p> <p>Overall, there are now 41 included studies, 43 excluded studies, seven ongoing trials and six studies awaiting classification. </p> <p>Further details of the process of screening and selecting studies for inclusion in the review are illustrated in <a href="#CD001880-fig-0001">Figure 1</a>. The results of the search reported in the previous version of the review (<a href="./references#CD001880-bbs2-0146" title="AvenellA , HandollHHG . Nutritional supplementation for hip fracture aftercare in older people. Cochrane Database of Systematic Reviews2010, Issue 1. [DOI: 10.1002/14651858.CD001880.pub5] ">Avenell 2010</a>) can be found in <a href="./appendices#CD001880-sec-0175">Appendix 3</a>. </p> <div class="figure" id="CD001880-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram" data-id="CD001880-fig-0001" src="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> </div> </section> <section id="CD001880-sec-0079"> <h4 class="title">Included studies</h4> <p>Details of study methods, population, interventions and outcomes of individual trials are provided in the <a href="./references#CD001880-sec-0189" title="">Characteristics of included studies</a>. </p> <p>We obtained further details (including clarifications) on methodology, trial participants and outcomes, from trialists of 23 studies (<a href="./references#CD001880-bbs2-0002" title="AllisonSP . Personal communication 15 February 2000. AllisonSP . Reflections on a study of nutrition support in patients with femur neck fracture. Nutrition1995;11(3):322‐7. BastowMD , RawlingsJ , AllisonSP . Benefits of supplementary tube feeding after fractured neck of femur: a randomised controlled trial. British Medical Journal (Clinical Research Edition)1983;287(6405):1589‐92. [MEDLINE: 6416514] BastowMD , RawlingsJ , AllisonSP . Controlled trial showing clinical benefit of tube feeding in elderly patients with fractured femur. Clinical Nutrition1984;2 Suppl:57. BastowMD , RawlingsJ , AllisonSP . Overnight nasogastric tube feeding. Clinical Nutrition1985;4(1):7‐11. ">Bastow 1983b</a>; <a href="./references#CD001880-bbs2-0005" title="Botella‐CarreteroJI . Personal communication 23 January 2009. Botella‐CarreteroJI , IglesiasB , BalsaJA , ZamarronI , ArrietaF , VazquezC . Effects of oral nutritional supplements in normally nourished or mildly undernourished geriatric patients after surgery for hip fracture: a randomized clinical trial. Journal of Parenteral and Enteral Nutrition2008;32(2):120‐8. [MEDLINE: 18407904] IglesiasB , Botella‐CarreteroJI , BalsaJA , ArrietaF , ZamarronI , VazquezC . Effects of oral nutritional supplements in geriatric patients after surgery for hip fracture. Clinical Nutrition Supplements2007;2(2):97. ">Botella‐Carretero 2008</a>; <a href="./references#CD001880-bbs2-0006" title="Botella‐CarreteroJI . Personal communication 26 October 2014. Botella‐CarreteroJI , IglesiasB , BalsaJA , ArrietaF , ZamarronI , VazquezC . Perioperative oral nutritional supplements in normally and mildly undernourished geriatric patients submitted to surgery for hip fracture: a randomized clinical trial. Clinical Nutrition2010;29(5):574‐9. ">Botella‐Carretero 2010</a>; <a href="./references#CD001880-bbs2-0007" title="BrownKM . Personal communicationMay 1999. BrownKM , SeabrookNA . Effect of nutrition on recovery after fractured femur. Medical Audit News1992;2(1):10‐2. BrownKM , SeabrookNA . Nutritional influences on recovery and length of hospital stay in elderly women following femoral fracture. Proceedings of the Nutrition Society1992;51(2):132A. ">Brown 1992b</a>; <a href="./references#CD001880-bbs2-0008" title="BruceD . Personal communication. October 2003. BruceD , LauranceI , McGuinessM , RidleyM , GoldswainP . Nutritional supplements after hip fracture: poor compliance limits effectiveness. Clinical Nutrition2003;22(5):497‐500. [MEDLINE: 14512038] ">Bruce 2003</a>; <a href="./references#CD001880-bbs2-0009" title="ChevalleyT . Personal communication 14 October 2014. ChevalleyT , HoffmeyerP , BonjourJ‐P , RizzoliR . Early serum IGF‐I response to oral protein supplements in elderly women with a recent hip fracture. Clinical Nutrition2010;29(1):78‐83. ">Chevalley 2010</a>; <a href="./references#CD001880-bbs2-0010" title="DayJJ . Personal communication 27 May 1999. DayJJ , BayerAJ , McMahonM , PathyMS , SpraggBP , RowlandsDC . Thiamine status, vitamin supplements and postoperative confusion. Age and Ageing1988;17:29‐34. ">Day 1988</a>; <a href="./references#CD001880-bbs2-0012" title="DuncanD . Personal communication March 15 2006. DuncanD , MurisonJ , MartinR , BeckS , JohansenA . Adequacy of oral feeding among elderly patients with hip fracture. Age and Ageing2001;30(Suppl 2):22. DuncanDG , BeckSJ . Using dietetic assistants to improve the outcome of hip fracture ‐ a randomised controlled trial of nutritional support in an acute trauma ward. Clinical Nutrition2002;21(Suppl 1):41. DuncanDG , BeckSJ , HoodK , JohansenA . Using dietetic assistants to improve the outcome of hip fracture ‐ a randomised controlled trial of nutritional support in an acute trauma ward. Age and Ageing2006;35(Suppl 3):i43. DuncanDG , BeckSJ , HoodK , JohansenA . Using dietetic assistants to improve the outcome of hip fracture: a randomised controlled trial of nutritional support in an acute trauma ward. Age and Ageing2006;35(2):148‐53. [MEDLINE: 16354710] DuncanDG , BeckSJ , JohansenA . Using dietetic assistants to improve the outcome of hip fracture ‐ a randomised controlled trial of nutritional support in an acute trauma ward. Journal of Human Nutrition and Dietetics2002;15:461. JohansenA . Using dietetic assistants to improve the outcome of hip fracture. In: The National Research Register, Issue 1, 2002. Oxford: Update Software2002. ">Duncan 2006</a>; <a href="./references#CD001880-bbs2-0013" title="EnerothM . Personal communication 10 February 2009. EnerothM . Personal communication 17 March 2006. EnerothM , OlssonU‐B , ThorngrenK‐G . Combined parenteral and oral nutritional supplementation decreases fracture‐related complications. A prospective randomised trial of 80 patients with hip fractures. Journal of Bone and Joint Surgery ‐ British Volume2006;88(Suppl 1):44. EnerothM , OlssonU‐B , ThorngrenK‐G . Insufficient fluid and energy intake in hospitalised patients with hip fracture. A prospective randomised study of 80 patients. Clinical Nutrition2005;24:297‐303. [MEDLINE: 15784492] EnerothM , OlssonUB , ThorngrenKG . Nutritional supplementation decreases hip fracture‐related complications. Clinical Orthopaedics and Related Research2006;(451):212‐7. [MEDLINE: 16770284] ">Eneroth 2006</a>; <a href="./references#CD001880-bbs2-0014" title="EspaulellaJ , GuyerH , Diaz‐EscriuF , Mellado‐NavasJA , CastellsM , PladevallM . Nutritional supplementation of elderly hip fracture patients. A randomized, double‐blind, placebo‐controlled trial. Age and Ageing2000;29(5):425‐31. [MEDLINE: 11108415] GuyerH . Personal communication 13 June 2000. ">Espaulella 2000</a>; <a href="./references#CD001880-bbs2-0016" title="FlodinL . Effects of bisphosphonates and nutritional supplementation after a hip fracture. clinicaltrials.gov/show/NCT01950169 2013 (accessed 3 December 2015). FlodinL . Personal communication. Personal communication 15 December 2014. FlodinL , SaafM , CederholmT , Al‐AniAN , AckermannPW , SanegardE , et al. Additive effects of nutritional supplementation, together with bisphosphonates, on bone mineral density after hip fracture: a 12‐month randomized controlled study. Clinical Interventions in Aging2014;9:1043‐50. ">Flodin 2014</a>; <a href="./references#CD001880-bbs2-0019" title="HankinsC . Dietary supplementation with sustagen in elderly patients with fractured neck of femur [MSc dissertation]. Sydney (Australia): University of Sydney, 1996. HankinsC . Personal communication 11 June 1999. ">Hankins 1996</a>; <a href="./references#CD001880-bbs2-0020" title="HartgrinkHH . Personal communication 23 June 1999. HartgrinkHH , WilleJ , KönigP , HermansJ , BreslauPJ . Pressure sores and tube feeding in patients with a fracture of the hip: a randomized clinical trial. Clinical Nutrition1998;17:287‐92. ">Hartgrink 1998</a>; <a href="./references#CD001880-bbs2-0022" title="HouwingR . Personal communication 29 October 2003. HouwingR , RozendaalM , Wouters‐WesselingW , BeulensJ , BuskensE , HaalboomJ . The effect of nutritional supplementation on the prevention of pressure ulcers (PU) in hip‐fracture patients. Clinical Nutrition2002;21(Suppl 1):84. HouwingRH , RozendaalM , Wouters‐WesselingW , BeulensJW , BuskensE , HaalboomJR . A randomised, double‐blind assessment of the effect of nutritional supplementation on the prevention of pressure ulcers in hip‐fracture patients. Clinical Nutrition2003;22(4):401‐5. [MEDLINE: 12880608] ">Houwing 2003</a>; <a href="./references#CD001880-bbs2-0024" title="LuoM . Personal communication 17 November 2014. LuoM , GolubevG , KlyukvinI , ReznikL , KuropatkinG , OliverJS , et al. Oral nutrition supplement improved nutritional status in malnourished hip fracture patients: a randomized controlled study. Journal of Scientific Research and Reports2015;4(6):480‐9. LuoM , GolybevG , KlyukvinI , ReznikL , KuropatkinG , VossAC . Oral nutritional supplement (ONS) improved nutritional status in malnourished patients receiving hip fracture surgery. Clinical Nutrition Supplements2011;6:151. SwearenginB . Effect of a medical food supplement in hospitalized patients recovering from surgery. clinicaltrials.gov/ct2/show/NCT01011608 (accessed 4 December 2015). ">Luo 2015</a>; <a href="./references#CD001880-bbs2-0026" title="CrottyM . Personal communication 20 February 2009. DanielsLA , MillerM , BannermanE , WhiteheadC , CrottyM . Weight loss post lower limb fracture despite an intensive oral nutrition and exercise intervention. Clinical Nutrition2003;22 Suppl:S86. DanielsLA , MillerMD , BannermannE , CrottyM . Adherence to nutritional supplements amongst orthopedic patients: an important clinical and study design issue. Clinical Nutrition2005;24:535. MillerMD , BannermanE , DanielsLA , CrottyM . Lower limb fracture, cognitive impairment and risk of subsequent malnutrition: a prospective evaluation of dietary energy and protein intake on an orthopaedic ward. European Journal of Clinical Nutrition2006;60(7):853‐61. [MEDLINE: 16452913] MillerMD , CrottyM , WhiteheadC , BannermanE , DanielsLA . Nutritional supplementation and resistance training in nutritionally at risk older adults following lower limb fracture: a randomized controlled trial. Clinical Rehabilitation2006;20(4):311‐23. MillerMD , DanielsLA , BannermanE , CrottyM . Adherence to nutrition supplements among patients with a fall‐related lower limb fracture. Nutrition in Clinical Practice2005;20(5):569‐78. [MEDLINE: 16207699] ">Miller 2006</a>; <a href="./references#CD001880-bbs2-0027" title="MyintMW . Personal communication 6 January 2015. MyintMW , WuJ , WongE , ChanSP , ToTS , ChauMW , et al. Clinical benefits of oral nutritional supplementation for elderly hip fracture patients: a single blind randomised controlled trial. Age and Ageing2013;42(1):39‐45. MyintMWW . A randomized controlled study of nutritional intervention for geriatric hip fracture patients and its effect on rehabilitation outcomes. clinicaltrials.gov/ct2/show/NCT01088139 (accessed 4 December 2015). ">Myint 2013</a>; <a href="./references#CD001880-bbs2-0028" title="JensenG . Personal communication 6 January 2005. NeumannM , FriedmannJ , RoyMA , JensenGL . Provision of high‐protein supplement for patients recovering from hip fracture. Nutrition2004;20(5):415‐9. [MEDLINE: 15105027] NeumannMM , FriedmannJM , JensenGL . Provision of high protein supplement for patients recovering from hip fracture. Journal of Parenteral and Enteral Nutrition2004;28(Suppl 1):S30. ">Neumann 2004</a>; <a href="./references#CD001880-bbs2-0030" title="ParkerM . Personal communication 16 October 2014. ParkerM . Randomised trial comparing iron supplementation versus placebo in the treatment of anaemia after hip fracture. clinicaltrials.gov/show/NCT00919230 (accessed 4 December 2015). ParkerMJ . Iron supplementation for anemia after hip fracture surgery. A randomized trial of 300 patients. Journal of Bone and Joint Surgery ‐ American Volume2010;92(2):265‐9. ">Parker 2010</a>; <a href="./references#CD001880-bbs2-0031" title="PrasadN . Personal communication 24 October 2014. PrasadN , RajamaniV , HullinD , MurrayJM . Post‐operative anaemia in femoral neck fracture patients: does it need treatment? A single blinded prospective randomised controlled trial. Injury2009;40(10):1073‐6. ">Prasad 2009</a>; <a href="./references#CD001880-bbs2-0036" title="SullivanDH . Personal communication 10 February 2000. SullivanDH , NelsonCL , BoppMM , Puskarich‐MayCL , WallsRC . Nightly enteral nutrition support of elderly fracture patients: a phase I trial. Journal of the American College of Nutrition1998;17(1):155‐61. ">Sullivan 1998</a>; <a href="./references#CD001880-bbs2-0037" title="SullivanDH . Personal communication 14 April 2006. SullivanDH , NelsonCL , KlimbergVS , BoppMM . Nightly enteral nutrition support of elderly hip fracture patients: a pilot study. Journal of the American College of Nutrition2004;23(6):683‐91. [MEDLINE: 15637216] ">Sullivan 2004</a>; <a href="./references#CD001880-bbs2-0038" title="CarlssonP , TidermarkJ , PonzerS , SoderqvistA , CederholmT . Food habits and appetite of elderly women at the time of a femoral neck fracture and after nutritional and anabolic support. Journal of Human Nutrition and Dietetics2005;18(2):117‐20. [MEDLINE: 15788020] TengstrandB , CederholmT , SoderqvistA , TidermarkJ . Effects of protein‐rich supplementation and nandrolone on bone tissue after a hip fracture. Clinical Nutrition2007;26(4):460‐5. [MEDLINE: 17498850] TidermarkJ . Personal communication 14 October 2004. TidermarkJ . Quality of life and femoral neck fractures. Acta Orthopaedica Scandinavica. Supplementum2003;74(309):1‐42. TidermarkJ , PonzerS , CarlssonP , SoderqvistA , BrismarK , TengstrandB , et al. Effects of protein‐rich supplementation and nandrolone in lean elderly women with femoral neck fractures. Clinical Nutrition2004;23(4):587‐96. TidermarkJ , PonzerS , TengstrandB , CederholmT . Liquid supplementation and nandrolone to elderly women. Clinical Nutrition2002;21(Suppl 1):40. ">Tidermark 2004</a>) and other sources for two trials (Ronald Koretz for <a href="./references#CD001880-bbs2-0017" title="GallagherJ , SchermbeckJ , DixonL , Labbe‐BellM . Aggressive early management of malnutrition in hip fracture patients. Journal of Parenteral and Enteral Nutrition1992;16(1):19S. KoretzR . Personal communication 7 September 1999. ">Gallagher 1992</a>; Jane Robertson for <a href="./references#CD001880-bbs2-0021" title="HoikkaV , AlhavaEM , AroA , KarjalainenP , RehnbergV . Treatment of osteoporosis with 1‐alpha‐hydroxycholecalciferol and calcium. Acta Medica Scandinavica1980;207(3):221‐4. [MEDLINE: 6989171] RobertsonJ . Personal communication 2 February 1999. ">Hoikka 1980</a>). </p> <section id="CD001880-sec-0080"> <h5 class="title">Design</h5> <p>Thirty‐seven trials were RCTs. The other four trials were quasi‐randomised trials (<a href="./references#CD001880-bbs2-0002" title="AllisonSP . Personal communication 15 February 2000. AllisonSP . Reflections on a study of nutrition support in patients with femur neck fracture. Nutrition1995;11(3):322‐7. BastowMD , RawlingsJ , AllisonSP . Benefits of supplementary tube feeding after fractured neck of femur: a randomised controlled trial. British Medical Journal (Clinical Research Edition)1983;287(6405):1589‐92. [MEDLINE: 6416514] BastowMD , RawlingsJ , AllisonSP . Controlled trial showing clinical benefit of tube feeding in elderly patients with fractured femur. Clinical Nutrition1984;2 Suppl:57. BastowMD , RawlingsJ , AllisonSP . Overnight nasogastric tube feeding. Clinical Nutrition1985;4(1):7‐11. ">Bastow 1983b</a>; <a href="./references#CD001880-bbs2-0007" title="BrownKM . Personal communicationMay 1999. BrownKM , SeabrookNA . Effect of nutrition on recovery after fractured femur. Medical Audit News1992;2(1):10‐2. BrownKM , SeabrookNA . Nutritional influences on recovery and length of hospital stay in elderly women following femoral fracture. Proceedings of the Nutrition Society1992;51(2):132A. ">Brown 1992b</a>; <a href="./references#CD001880-bbs2-0008" title="BruceD . Personal communication. October 2003. BruceD , LauranceI , McGuinessM , RidleyM , GoldswainP . Nutritional supplements after hip fracture: poor compliance limits effectiveness. Clinical Nutrition2003;22(5):497‐500. [MEDLINE: 14512038] ">Bruce 2003</a>; <a href="./references#CD001880-bbs2-0021" title="HoikkaV , AlhavaEM , AroA , KarjalainenP , RehnbergV . Treatment of osteoporosis with 1‐alpha‐hydroxycholecalciferol and calcium. Acta Medica Scandinavica1980;207(3):221‐4. [MEDLINE: 6989171] RobertsonJ . Personal communication 2 February 1999. ">Hoikka 1980</a>). There were no cluster or cross‐over randomised trials. </p> </section> <section id="CD001880-sec-0081"> <h5 class="title">Sample sizes</h5> <p>The 41 included studies involved a total of 3881 participants. Sample size ranged from 10 participants in <a href="./references#CD001880-bbs2-0007" title="BrownKM . Personal communicationMay 1999. BrownKM , SeabrookNA . Effect of nutrition on recovery after fractured femur. Medical Audit News1992;2(1):10‐2. BrownKM , SeabrookNA . Nutritional influences on recovery and length of hospital stay in elderly women following femoral fracture. Proceedings of the Nutrition Society1992;51(2):132A. ">Brown 1992b</a> to 318 participants in <a href="./references#CD001880-bbs2-0012" title="DuncanD . Personal communication March 15 2006. DuncanD , MurisonJ , MartinR , BeckS , JohansenA . Adequacy of oral feeding among elderly patients with hip fracture. Age and Ageing2001;30(Suppl 2):22. DuncanDG , BeckSJ . Using dietetic assistants to improve the outcome of hip fracture ‐ a randomised controlled trial of nutritional support in an acute trauma ward. Clinical Nutrition2002;21(Suppl 1):41. DuncanDG , BeckSJ , HoodK , JohansenA . Using dietetic assistants to improve the outcome of hip fracture ‐ a randomised controlled trial of nutritional support in an acute trauma ward. Age and Ageing2006;35(Suppl 3):i43. DuncanDG , BeckSJ , HoodK , JohansenA . Using dietetic assistants to improve the outcome of hip fracture: a randomised controlled trial of nutritional support in an acute trauma ward. Age and Ageing2006;35(2):148‐53. [MEDLINE: 16354710] DuncanDG , BeckSJ , JohansenA . Using dietetic assistants to improve the outcome of hip fracture ‐ a randomised controlled trial of nutritional support in an acute trauma ward. Journal of Human Nutrition and Dietetics2002;15:461. JohansenA . Using dietetic assistants to improve the outcome of hip fracture. In: The National Research Register, Issue 1, 2002. Oxford: Update Software2002. ">Duncan 2006</a>. </p> </section> <section id="CD001880-sec-0082"> <h5 class="title">Setting</h5> <p>The publication dates of the trials span 35 years, <a href="./references#CD001880-bbs2-0021" title="HoikkaV , AlhavaEM , AroA , KarjalainenP , RehnbergV . Treatment of osteoporosis with 1‐alpha‐hydroxycholecalciferol and calcium. Acta Medica Scandinavica1980;207(3):221‐4. [MEDLINE: 6989171] RobertsonJ . Personal communication 2 February 1999. ">Hoikka 1980</a> being the earliest. Most of the trials were based in a single centre. Trials were conducted in 15 countries (Australia, Austria, Canada, China, Finland, Israel, Italy, Korea, the Netherlands, Russia, Spain, Sweden, Switzerland, UK, USA), with eight trials being conducted in the UK, five each in Australia and Switzerland, four in the USA, three in Spain, and three each in the Netherlands and Sweden. </p> </section> <section id="CD001880-sec-0083"> <h5 class="title">Participants</h5> <p>The majority of participants were female and in 10 studies all participants were female (<a href="./references#CD001880-bbs2-0002" title="AllisonSP . Personal communication 15 February 2000. AllisonSP . Reflections on a study of nutrition support in patients with femur neck fracture. Nutrition1995;11(3):322‐7. BastowMD , RawlingsJ , AllisonSP . Benefits of supplementary tube feeding after fractured neck of femur: a randomised controlled trial. British Medical Journal (Clinical Research Edition)1983;287(6405):1589‐92. [MEDLINE: 6416514] BastowMD , RawlingsJ , AllisonSP . Controlled trial showing clinical benefit of tube feeding in elderly patients with fractured femur. Clinical Nutrition1984;2 Suppl:57. BastowMD , RawlingsJ , AllisonSP . Overnight nasogastric tube feeding. Clinical Nutrition1985;4(1):7‐11. ">Bastow 1983b</a>; <a href="./references#CD001880-bbs2-0003" title="BeanN , ReddenJ , GoodeH , GrimbleG , AllisonSP . Double‐blind pilot trial, in elderly women with fractured femur, of ornithine alpha‐ketoglutarate v. a defined formula oral supplement. Proceedings of the Nutrition Society1994;53(3):203A. ">Bean 1994</a>; <a href="./references#CD001880-bbs2-0007" title="BrownKM . Personal communicationMay 1999. BrownKM , SeabrookNA . Effect of nutrition on recovery after fractured femur. Medical Audit News1992;2(1):10‐2. BrownKM , SeabrookNA . Nutritional influences on recovery and length of hospital stay in elderly women following femoral fracture. Proceedings of the Nutrition Society1992;51(2):132A. ">Brown 1992b</a>; <a href="./references#CD001880-bbs2-0008" title="BruceD . Personal communication. October 2003. BruceD , LauranceI , McGuinessM , RidleyM , GoldswainP . Nutritional supplements after hip fracture: poor compliance limits effectiveness. Clinical Nutrition2003;22(5):497‐500. [MEDLINE: 14512038] ">Bruce 2003</a>; <a href="./references#CD001880-bbs2-0009" title="ChevalleyT . Personal communication 14 October 2014. ChevalleyT , HoffmeyerP , BonjourJ‐P , RizzoliR . Early serum IGF‐I response to oral protein supplements in elderly women with a recent hip fracture. Clinical Nutrition2010;29(1):78‐83. ">Chevalley 2010</a>; <a href="./references#CD001880-bbs2-0012" title="DuncanD . Personal communication March 15 2006. DuncanD , MurisonJ , MartinR , BeckS , JohansenA . Adequacy of oral feeding among elderly patients with hip fracture. Age and Ageing2001;30(Suppl 2):22. DuncanDG , BeckSJ . Using dietetic assistants to improve the outcome of hip fracture ‐ a randomised controlled trial of nutritional support in an acute trauma ward. Clinical Nutrition2002;21(Suppl 1):41. DuncanDG , BeckSJ , HoodK , JohansenA . Using dietetic assistants to improve the outcome of hip fracture ‐ a randomised controlled trial of nutritional support in an acute trauma ward. Age and Ageing2006;35(Suppl 3):i43. DuncanDG , BeckSJ , HoodK , JohansenA . Using dietetic assistants to improve the outcome of hip fracture: a randomised controlled trial of nutritional support in an acute trauma ward. Age and Ageing2006;35(2):148‐53. [MEDLINE: 16354710] DuncanDG , BeckSJ , JohansenA . Using dietetic assistants to improve the outcome of hip fracture ‐ a randomised controlled trial of nutritional support in an acute trauma ward. Journal of Human Nutrition and Dietetics2002;15:461. JohansenA . Using dietetic assistants to improve the outcome of hip fracture. In: The National Research Register, Issue 1, 2002. Oxford: Update Software2002. ">Duncan 2006</a>; <a href="./references#CD001880-bbs2-0015" title="FabianE , GerstorferI , ThalerHW , StundnerH , BiswasP , ElmadfaI . Nutritional supplementation affects postoperative oxidative stress and duration of hospitalization in patients with hip fracture. Wiener Klinische Wochenschrift2011;123(3‐4):88‐93. ">Fabian 2011</a>; <a href="./references#CD001880-bbs2-0034" title="Serrano‐TrenasJA , UgaldePF , CabelloLM , ChoflesLC , LazaroPS , BenitezPC . Role of perioperative intravenous iron therapy in elderly hip fracture patients: a single‐center randomized controlled trial. Transfusion2011;51(1):97‐104. ">Serrano‐Trenas 2011</a>; <a href="./references#CD001880-bbs2-0035" title="StableforthPG . Supplement feeds and nitrogen and calorie balance following femoral neck fracture. British Journal of Surgery1986;73:651‐5. ">Stableforth 1986</a>; <a href="./references#CD001880-bbs2-0038" title="CarlssonP , TidermarkJ , PonzerS , SoderqvistA , CederholmT . Food habits and appetite of elderly women at the time of a femoral neck fracture and after nutritional and anabolic support. Journal of Human Nutrition and Dietetics2005;18(2):117‐20. [MEDLINE: 15788020] TengstrandB , CederholmT , SoderqvistA , TidermarkJ . Effects of protein‐rich supplementation and nandrolone on bone tissue after a hip fracture. Clinical Nutrition2007;26(4):460‐5. [MEDLINE: 17498850] TidermarkJ . Personal communication 14 October 2004. TidermarkJ . Quality of life and femoral neck fractures. Acta Orthopaedica Scandinavica. Supplementum2003;74(309):1‐42. TidermarkJ , PonzerS , CarlssonP , SoderqvistA , BrismarK , TengstrandB , et al. Effects of protein‐rich supplementation and nandrolone in lean elderly women with femoral neck fractures. Clinical Nutrition2004;23(4):587‐96. TidermarkJ , PonzerS , TengstrandB , CederholmT . Liquid supplementation and nandrolone to elderly women. Clinical Nutrition2002;21(Suppl 1):40. ">Tidermark 2004</a>). <a href="./references#CD001880-bbs2-0036" title="SullivanDH . Personal communication 10 February 2000. SullivanDH , NelsonCL , BoppMM , Puskarich‐MayCL , WallsRC . Nightly enteral nutrition support of elderly fracture patients: a phase I trial. Journal of the American College of Nutrition1998;17(1):155‐61. ">Sullivan 1998</a> and <a href="./references#CD001880-bbs2-0037" title="SullivanDH . Personal communication 14 April 2006. SullivanDH , NelsonCL , KlimbergVS , BoppMM . Nightly enteral nutrition support of elderly hip fracture patients: a pilot study. Journal of the American College of Nutrition2004;23(6):683‐91. [MEDLINE: 15637216] ">Sullivan 2004</a> were the only studies where male participants formed the majority. Where reported, the mean age of participants was usually over 80 years. <a href="./references#CD001880-bbs2-0024" title="LuoM . Personal communication 17 November 2014. LuoM , GolubevG , KlyukvinI , ReznikL , KuropatkinG , OliverJS , et al. Oral nutrition supplement improved nutritional status in malnourished hip fracture patients: a randomized controlled study. Journal of Scientific Research and Reports2015;4(6):480‐9. LuoM , GolybevG , KlyukvinI , ReznikL , KuropatkinG , VossAC . Oral nutritional supplement (ONS) improved nutritional status in malnourished patients receiving hip fracture surgery. Clinical Nutrition Supplements2011;6:151. SwearenginB . Effect of a medical food supplement in hospitalized patients recovering from surgery. clinicaltrials.gov/ct2/show/NCT01011608 (accessed 4 December 2015). ">Luo 2015</a> and <a href="./references#CD001880-bbs2-0029" title="PapaioannouA . A randomised, controlled comparison of vitamin D strategies in acute hip fracture patients. clinicaltrials.gov/show/NCT00424619 (accessed 4 December 2015). PapaioannouA , KennedyCC , GiangregorioL , IoannidisG , PritchardJ , HanleyDA , et al. A randomized controlled trial of vitamin D dosing strategies after acute hip fracture: no advantage of loading doses over daily supplementation. BMC Musculoskeletal Disorders2011;12:135. PapaioannouA , KennedyCC , IoannidisG , AdachiJD , HanleyD , GiangregorioL , et al. High versus low vitamin D in acute hip fracture patients: a randomised, controlled trial. Osteoporosis International2010;21(Suppl 1):S201. ">Papaioannou 2011</a> had younger participants with a mean age of 69 years. <a href="./references#CD001880-bbs2-0017" title="GallagherJ , SchermbeckJ , DixonL , Labbe‐BellM . Aggressive early management of malnutrition in hip fracture patients. Journal of Parenteral and Enteral Nutrition1992;16(1):19S. KoretzR . Personal communication 7 September 1999. ">Gallagher 1992</a> gave no details on age, but the rest of the details provided in the abstract were compatible with an older population. Only <a href="./references#CD001880-bbs2-0003" title="BeanN , ReddenJ , GoodeH , GrimbleG , AllisonSP . Double‐blind pilot trial, in elderly women with fractured femur, of ornithine alpha‐ketoglutarate v. a defined formula oral supplement. Proceedings of the Nutrition Society1994;53(3):203A. ">Bean 1994</a> applied an upper age limit, this being 85 years. </p> <p>All studies (except <a href="./references#CD001880-bbs2-0026" title="CrottyM . Personal communication 20 February 2009. DanielsLA , MillerM , BannermanE , WhiteheadC , CrottyM . Weight loss post lower limb fracture despite an intensive oral nutrition and exercise intervention. Clinical Nutrition2003;22 Suppl:S86. DanielsLA , MillerMD , BannermannE , CrottyM . Adherence to nutritional supplements amongst orthopedic patients: an important clinical and study design issue. Clinical Nutrition2005;24:535. MillerMD , BannermanE , DanielsLA , CrottyM . Lower limb fracture, cognitive impairment and risk of subsequent malnutrition: a prospective evaluation of dietary energy and protein intake on an orthopaedic ward. European Journal of Clinical Nutrition2006;60(7):853‐61. [MEDLINE: 16452913] MillerMD , CrottyM , WhiteheadC , BannermanE , DanielsLA . Nutritional supplementation and resistance training in nutritionally at risk older adults following lower limb fracture: a randomized controlled trial. Clinical Rehabilitation2006;20(4):311‐23. MillerMD , DanielsLA , BannermanE , CrottyM . Adherence to nutrition supplements among patients with a fall‐related lower limb fracture. Nutrition in Clinical Practice2005;20(5):569‐78. [MEDLINE: 16207699] ">Miller 2006</a>, which included participants with lower limb fractures) included only participants with hip fracture. We obtained separate data for participants with hip fracture for <a href="./references#CD001880-bbs2-0026" title="CrottyM . Personal communication 20 February 2009. DanielsLA , MillerM , BannermanE , WhiteheadC , CrottyM . Weight loss post lower limb fracture despite an intensive oral nutrition and exercise intervention. Clinical Nutrition2003;22 Suppl:S86. DanielsLA , MillerMD , BannermannE , CrottyM . Adherence to nutritional supplements amongst orthopedic patients: an important clinical and study design issue. Clinical Nutrition2005;24:535. MillerMD , BannermanE , DanielsLA , CrottyM . Lower limb fracture, cognitive impairment and risk of subsequent malnutrition: a prospective evaluation of dietary energy and protein intake on an orthopaedic ward. European Journal of Clinical Nutrition2006;60(7):853‐61. [MEDLINE: 16452913] MillerMD , CrottyM , WhiteheadC , BannermanE , DanielsLA . Nutritional supplementation and resistance training in nutritionally at risk older adults following lower limb fracture: a randomized controlled trial. Clinical Rehabilitation2006;20(4):311‐23. MillerMD , DanielsLA , BannermanE , CrottyM . Adherence to nutrition supplements among patients with a fall‐related lower limb fracture. Nutrition in Clinical Practice2005;20(5):569‐78. [MEDLINE: 16207699] ">Miller 2006</a>. Nineteen studies provided information on the types of hip fractures suffered by the participants (<a href="./references#CD001880-bbs2-0001" title="AnbarR , BelooseskyY , CohenJ , MadarZ , WeissA , TheillaM , et al. Tight calorie control in geriatric patients following hip fracture decreases complications: a randomized, controlled study. Clinical Nutrition2014;33:23‐8. AnbarR , BelooseskyY , MadarZ , TheillaM , Koren‐HakimT , WeissA , et al. Tight calorie control (TICACOS) in geriatric hip fracture patients. Clinical Nutrition, Supplement2012;7(1):18. AnbarR , BelooseskyY , MadarZ , TheillaM , Koren‐HakimT , WeissA , et al. Tight calorie control in geriatric hip fracture patients: preliminary results of the geriatric TICACOS study. Clinical Nutrition, Supplement2011;6(1):155. SingerP . Tight caloric balance in geriatric patients (TICACOSiGP). clinicaltrials.gov/show/NCT01735435 (accessed 3 December 2015). ">Anbar 2014</a>; <a href="./references#CD001880-bbs2-0010" title="DayJJ . Personal communication 27 May 1999. DayJJ , BayerAJ , McMahonM , PathyMS , SpraggBP , RowlandsDC . Thiamine status, vitamin supplements and postoperative confusion. Age and Ageing1988;17:29‐34. ">Day 1988</a>; <a href="./references#CD001880-bbs2-0011" title="BonjourJP , RapinCH , RizzoliR , TkatchL , DelmiM , ChevalleyT , et al. Hip fracture, femoral bone mineral density, and protein supply in elderly patients. In: MunroHN , SchlierfG editor(s). Nutrition of the elderly. Nestlé nutrition workshop series. Vol. 29, New York: Raven Press, 1992:151‐9. [ISBN 0881678740 ] BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. BonjourJP , SchürchMA , RizzoliR . Nutritional aspects of hip fractures. Bone1996;18(3 Suppl):139S‐44S. BonjourJP , SchürchMA , RizzoliR . Proteins and bone health. Pathologie‐Biologie1997;45(1):57‐9. DelmiM , RapinC‐H , BengoaJ‐M , DelmasPD , VaseyH , BonjourJ‐P . Dietary supplementation in elderly patients with fractured neck of the femur. Lancet1990;335:1013‐6. [MEDLINE: 1970070] RapinCH , BengoaJM , KahnJM , DelmiM , BonjourJP , VaseyH . A prospective randomised control study of oral dietary supplementation in patients with fractured necks of femur. Journal of Parenteral and Enteral Nutrition1989;13(1):9S. ">Delmi 1990</a>; <a href="./references#CD001880-bbs2-0013" title="EnerothM . Personal communication 10 February 2009. EnerothM . Personal communication 17 March 2006. EnerothM , OlssonU‐B , ThorngrenK‐G . Combined parenteral and oral nutritional supplementation decreases fracture‐related complications. A prospective randomised trial of 80 patients with hip fractures. Journal of Bone and Joint Surgery ‐ British Volume2006;88(Suppl 1):44. EnerothM , OlssonU‐B , ThorngrenK‐G . Insufficient fluid and energy intake in hospitalised patients with hip fracture. A prospective randomised study of 80 patients. Clinical Nutrition2005;24:297‐303. [MEDLINE: 15784492] EnerothM , OlssonUB , ThorngrenKG . Nutritional supplementation decreases hip fracture‐related complications. Clinical Orthopaedics and Related Research2006;(451):212‐7. [MEDLINE: 16770284] ">Eneroth 2006</a>; <a href="./references#CD001880-bbs2-0014" title="EspaulellaJ , GuyerH , Diaz‐EscriuF , Mellado‐NavasJA , CastellsM , PladevallM . Nutritional supplementation of elderly hip fracture patients. A randomized, double‐blind, placebo‐controlled trial. Age and Ageing2000;29(5):425‐31. [MEDLINE: 11108415] GuyerH . Personal communication 13 June 2000. ">Espaulella 2000</a>; <a href="./references#CD001880-bbs2-0016" title="FlodinL . Effects of bisphosphonates and nutritional supplementation after a hip fracture. clinicaltrials.gov/show/NCT01950169 2013 (accessed 3 December 2015). FlodinL . Personal communication. Personal communication 15 December 2014. FlodinL , SaafM , CederholmT , Al‐AniAN , AckermannPW , SanegardE , et al. Additive effects of nutritional supplementation, together with bisphosphonates, on bone mineral density after hip fracture: a 12‐month randomized controlled study. Clinical Interventions in Aging2014;9:1043‐50. ">Flodin 2014</a>; <a href="./references#CD001880-bbs2-0020" title="HartgrinkHH . Personal communication 23 June 1999. HartgrinkHH , WilleJ , KönigP , HermansJ , BreslauPJ . Pressure sores and tube feeding in patients with a fracture of the hip: a randomized clinical trial. Clinical Nutrition1998;17:287‐92. ">Hartgrink 1998</a>; <a href="./references#CD001880-bbs2-0027" title="MyintMW . Personal communication 6 January 2015. MyintMW , WuJ , WongE , ChanSP , ToTS , ChauMW , et al. Clinical benefits of oral nutritional supplementation for elderly hip fracture patients: a single blind randomised controlled trial. Age and Ageing2013;42(1):39‐45. MyintMWW . A randomized controlled study of nutritional intervention for geriatric hip fracture patients and its effect on rehabilitation outcomes. clinicaltrials.gov/ct2/show/NCT01088139 (accessed 4 December 2015). ">Myint 2013</a>; <a href="./references#CD001880-bbs2-0030" title="ParkerM . Personal communication 16 October 2014. ParkerM . Randomised trial comparing iron supplementation versus placebo in the treatment of anaemia after hip fracture. clinicaltrials.gov/show/NCT00919230 (accessed 4 December 2015). ParkerMJ . Iron supplementation for anemia after hip fracture surgery. A randomized trial of 300 patients. Journal of Bone and Joint Surgery ‐ American Volume2010;92(2):265‐9. ">Parker 2010</a>; <a href="./references#CD001880-bbs2-0031" title="PrasadN . Personal communication 24 October 2014. PrasadN , RajamaniV , HullinD , MurrayJM . Post‐operative anaemia in femoral neck fracture patients: does it need treatment? A single blinded prospective randomised controlled trial. Injury2009;40(10):1073‐6. ">Prasad 2009</a>; <a href="./references#CD001880-bbs2-0032" title="BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. RizzoliR , SchürchMA , BonjourJP . Protein supplements after osteoporotic hip fracture. Annals of Internal Medicine1998;129:1076. SchürchM‐A , BonjourJ‐P , SlosmanD , RizzoliR . Protein supplements favourably influence the outcome after hip fracture [Un supplement proteique ameliore les suites d'une fracture du femur proximal]. Medecine et Hygiene1999;57(2271):1876‐8. SchürchMA , RizzoliR , SlosmanD , BonjourJP . Protein supplements increase serum IGF‐1 and decrease proximal femur bone loss in patients with a recent hip fracture. Osteoporosis 1996: Proceedings of the 1996 World Congress on Osteoporosis; 1996 May 18‐23; Amsterdam, The Netherlands. Amsterdam: Elsevier, 1996:327‐9. SchürchMA , RizzoliR , SlosmanD , VadasL , VergnaudP , BonjourJP . Protein supplements increase serum insulin‐like growth factor‐I levels and attenuate proximal femur bone loss in patients with recent hip fracture. A randomized, double‐blind, placebo‐controlled trial. Annals of Internal Medicine1998;128(10):801‐9. ">Schürch 1998</a>; <a href="./references#CD001880-bbs2-0033" title="DerossiD , BoA , BergonziR , ScivolettoG . Six‐week administration of a mixture of ergogenic and osteotrophic ingredients (RestorfastTM) improves the clinical course of elderly patients after hip fracture surgery [La somministrazione per sei settimane di un composto a base di sostanze osteotrofiche ed ergogene (RestorfastTM) migliora il decorso clinico in anziani sottoposti a chirurgia del femore]. Trends in Medicine2009;9(4):235‐42. ScivolettoG , BoA , DerossiD , BergonziR . Ten week administration of a polynutritional supplement with muscle tone action (RiabylexTM) improves the functional recovery in elderly hip fracture patients during home rehabilitation [In anziani in terapia riabilitativa domiciliare per pregressa frattura del femore, l'assunzione di un polinutriente ad azione muscolotonica (RiabylexTM) per 10 settimane migliora il recupero funzionale]. Trends in Medicine2010;10(2):113‐20. ">Scivoletto 2010</a>; <a href="./references#CD001880-bbs2-0034" title="Serrano‐TrenasJA , UgaldePF , CabelloLM , ChoflesLC , LazaroPS , BenitezPC . Role of perioperative intravenous iron therapy in elderly hip fracture patients: a single‐center randomized controlled trial. Transfusion2011;51(1):97‐104. ">Serrano‐Trenas 2011</a>; <a href="./references#CD001880-bbs2-0035" title="StableforthPG . Supplement feeds and nitrogen and calorie balance following femoral neck fracture. British Journal of Surgery1986;73:651‐5. ">Stableforth 1986</a>; <a href="./references#CD001880-bbs2-0036" title="SullivanDH . Personal communication 10 February 2000. SullivanDH , NelsonCL , BoppMM , Puskarich‐MayCL , WallsRC . Nightly enteral nutrition support of elderly fracture patients: a phase I trial. Journal of the American College of Nutrition1998;17(1):155‐61. ">Sullivan 1998</a>; <a href="./references#CD001880-bbs2-0037" title="SullivanDH . Personal communication 14 April 2006. SullivanDH , NelsonCL , KlimbergVS , BoppMM . Nightly enteral nutrition support of elderly hip fracture patients: a pilot study. Journal of the American College of Nutrition2004;23(6):683‐91. [MEDLINE: 15637216] ">Sullivan 2004</a>; <a href="./references#CD001880-bbs2-0038" title="CarlssonP , TidermarkJ , PonzerS , SoderqvistA , CederholmT . Food habits and appetite of elderly women at the time of a femoral neck fracture and after nutritional and anabolic support. Journal of Human Nutrition and Dietetics2005;18(2):117‐20. [MEDLINE: 15788020] TengstrandB , CederholmT , SoderqvistA , TidermarkJ . Effects of protein‐rich supplementation and nandrolone on bone tissue after a hip fracture. Clinical Nutrition2007;26(4):460‐5. [MEDLINE: 17498850] TidermarkJ . Personal communication 14 October 2004. TidermarkJ . Quality of life and femoral neck fractures. Acta Orthopaedica Scandinavica. Supplementum2003;74(309):1‐42. TidermarkJ , PonzerS , CarlssonP , SoderqvistA , BrismarK , TengstrandB , et al. Effects of protein‐rich supplementation and nandrolone in lean elderly women with femoral neck fractures. Clinical Nutrition2004;23(4):587‐96. TidermarkJ , PonzerS , TengstrandB , CederholmT . Liquid supplementation and nandrolone to elderly women. Clinical Nutrition2002;21(Suppl 1):40. ">Tidermark 2004</a>; <a href="./references#CD001880-bbs2-0039" title="BonjourJP , RapinCH , RizzoliR , TkatchL , DelmiM , ChevalleyT , et al. Hip fracture, femoral bone mineral density, and protein supply in elderly patients. In: MunroH , SchlierfG editor(s). Nutrition of the elderly. Nestle nutrition workshop series. Vol. 29, New York: Raven Press, 1992:151‐9. BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. BonjourJP , SchürchMA , RizzoliR . Nutritional aspects of hip fractures. Bone1996;18(Suppl 3):139S‐44S. BonjourJP , SchürchMA , RizzoliR . Proteins and bone health. Patholgie‐Biologie1997;45(1):57‐9. TkatchL , RapinCH , RizzoliR , SlosmanD , NydeggerV , VaseyH , et al. Benefits of oral protein supplementation in elderly patients with fracture of the proximal femur. Journal of the American College of Nutrition1992;11(5):519‐25. ">Tkatch 1992</a>; <a href="./references#CD001880-bbs2-0041" title="Breedveld‐PetersJ , ReijvenPL , WyersCE , HendrikxAA , VerburgAD , ScholsJM , et al. Qualitative analysis of barriers and facilitators for nutritional intervention in hip fracture patients. Clinical Nutrition, Supplement2012;7(1):234. Breedveld‐PetersJJ , ReijvenPL , WyersCE , HendrikxAA , VerburgAD , ScholsJM , et al. Barriers and facilitators of nutritional intervention after hip fracture in integrated care as perceived by the different health care professionals: a qualitative interview study. e‐SPEN Journal2012;7(5):e182‐8. Breedveld‐PetersJJ , ReijvenPL , WyersCE , VanHeldenS , ArtsJJ , MeestersB , et al. Integrated nutritional intervention in the elderly after hip fracture. A process evaluation. Clinical Nutrition, Supplement2012;31(1):199‐205. Breedveld‐PetersJJ , ReijvenPL , WyersCE , VanHeldenS , ArtsJJ , MeestersB , et al. Integrated nutritional intervention in the elderly after hip fracture. A process evaluation. Clinical Nutrition, Supplement2012;7(1):43. DagneliePC . Effectiveness and cost‐effectiveness of nutritional screening and intervention in elderly subjects after hip fracture. clinicaltrials.gov/show/NCT00523575 (accessed 8 November 2009). WyersC , ReijvenPL , EversSM , WillemsPC , HeyligersIC , VerburgAD , et al. Cost‐effectiveness of nutritional intervention in hip fracture patients: a multi‐centre randomised controlled trial (RCT). Clinical Nutrition, Supplement2012;7(1):49. WyersCE . PhD thesis. Maastricht, the Netherlands: Maastricht University, 2012. WyersCE , Breedveld‐PetersJJ , ReijvenPL , ArtsC , ThomassenBJ , VerburgAD , et al. Effect of nutritional intervention on nutritional intake and status in hip fracture patients: a multicentre randomised controlled trial (RCT). Clinical Nutrition, Supplement2012;7(1):50‐1. WyersCE , Breedveld‐PetersJJ , ReijvenPL , VanHeldenS , GuldemondNA , SeverensJL , et al. Efficacy and cost‐effectiveness of nutritional intervention in elderly after hip fracture: design of a randomized controlled trial. BMC Public Health2010;10:212. WyersCE , ReijvenPL , EversSM , WillemsPC , HeyligersIC , VerburgAD , et al. Cost‐effectiveness of nutritional intervention in elderly subjects after hip fracture. A randomized controlled trial. Osteoporosis International2013;24(1):151‐62. ">Wyers 2013</a>). Seventeen studies excluded people with dementia or severe cognitive dysfunction. Many studies excluded people with a wide range of medical conditions (<a href="./references#CD001880-bbs2-0001" title="AnbarR , BelooseskyY , CohenJ , MadarZ , WeissA , TheillaM , et al. Tight calorie control in geriatric patients following hip fracture decreases complications: a randomized, controlled study. Clinical Nutrition2014;33:23‐8. AnbarR , BelooseskyY , MadarZ , TheillaM , Koren‐HakimT , WeissA , et al. Tight calorie control (TICACOS) in geriatric hip fracture patients. Clinical Nutrition, Supplement2012;7(1):18. AnbarR , BelooseskyY , MadarZ , TheillaM , Koren‐HakimT , WeissA , et al. Tight calorie control in geriatric hip fracture patients: preliminary results of the geriatric TICACOS study. Clinical Nutrition, Supplement2011;6(1):155. SingerP . Tight caloric balance in geriatric patients (TICACOSiGP). clinicaltrials.gov/show/NCT01735435 (accessed 3 December 2015). ">Anbar 2014</a>; <a href="./references#CD001880-bbs2-0002" title="AllisonSP . Personal communication 15 February 2000. AllisonSP . Reflections on a study of nutrition support in patients with femur neck fracture. Nutrition1995;11(3):322‐7. BastowMD , RawlingsJ , AllisonSP . Benefits of supplementary tube feeding after fractured neck of femur: a randomised controlled trial. British Medical Journal (Clinical Research Edition)1983;287(6405):1589‐92. [MEDLINE: 6416514] BastowMD , RawlingsJ , AllisonSP . Controlled trial showing clinical benefit of tube feeding in elderly patients with fractured femur. Clinical Nutrition1984;2 Suppl:57. BastowMD , RawlingsJ , AllisonSP . Overnight nasogastric tube feeding. Clinical Nutrition1985;4(1):7‐11. ">Bastow 1983b</a>; <a href="./references#CD001880-bbs2-0003" title="BeanN , ReddenJ , GoodeH , GrimbleG , AllisonSP . Double‐blind pilot trial, in elderly women with fractured femur, of ornithine alpha‐ketoglutarate v. a defined formula oral supplement. Proceedings of the Nutrition Society1994;53(3):203A. ">Bean 1994</a>; <a href="./references#CD001880-bbs2-0004" title="Bischoff‐FerrariH . Early rehabilitation after hip fracture. clinicaltrials.gov/ct2/show/NCT00133640 (accessed 7 September 2015). Bischoff‐FerrariH , Dawson‐HughesB , OravE , WillettW , EgliA , MaetzelA , et al. The economic consequences of hip fractures: impact of home exercise and high dose‐vitamin D. 32nd Annual Meeting of the American Society for Bone and Mineral Research Annual Meeting; 2010 Oct 15‐9; Toronto, Canada. (accessed 3 December 2015); Vol. www.asbmr.org/education/2010‐abstracts. Bischoff‐FerrariHA , Dawson‐HughesB , PlatzA , OravEJ , StahelinHB , WillettWC , et al. Effect of high‐dosage cholecalciferol and extended physiotherapy on complications after hip fracture. A randomized controlled trial. Archives of Internal Medicine2010;170(9):813‐20. ">Bischoff‐Ferrari 2010</a>; <a href="./references#CD001880-bbs2-0007" title="BrownKM . Personal communicationMay 1999. BrownKM , SeabrookNA . Effect of nutrition on recovery after fractured femur. Medical Audit News1992;2(1):10‐2. BrownKM , SeabrookNA . Nutritional influences on recovery and length of hospital stay in elderly women following femoral fracture. Proceedings of the Nutrition Society1992;51(2):132A. ">Brown 1992b</a>; <a href="./references#CD001880-bbs2-0009" title="ChevalleyT . Personal communication 14 October 2014. ChevalleyT , HoffmeyerP , BonjourJ‐P , RizzoliR . Early serum IGF‐I response to oral protein supplements in elderly women with a recent hip fracture. Clinical Nutrition2010;29(1):78‐83. ">Chevalley 2010</a>; <a href="./references#CD001880-bbs2-0011" title="BonjourJP , RapinCH , RizzoliR , TkatchL , DelmiM , ChevalleyT , et al. Hip fracture, femoral bone mineral density, and protein supply in elderly patients. In: MunroHN , SchlierfG editor(s). Nutrition of the elderly. Nestlé nutrition workshop series. Vol. 29, New York: Raven Press, 1992:151‐9. [ISBN 0881678740 ] BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. BonjourJP , SchürchMA , RizzoliR . Nutritional aspects of hip fractures. Bone1996;18(3 Suppl):139S‐44S. BonjourJP , SchürchMA , RizzoliR . Proteins and bone health. Pathologie‐Biologie1997;45(1):57‐9. DelmiM , RapinC‐H , BengoaJ‐M , DelmasPD , VaseyH , BonjourJ‐P . Dietary supplementation in elderly patients with fractured neck of the femur. Lancet1990;335:1013‐6. [MEDLINE: 1970070] RapinCH , BengoaJM , KahnJM , DelmiM , BonjourJP , VaseyH . A prospective randomised control study of oral dietary supplementation in patients with fractured necks of femur. Journal of Parenteral and Enteral Nutrition1989;13(1):9S. ">Delmi 1990</a>; <a href="./references#CD001880-bbs2-0013" title="EnerothM . Personal communication 10 February 2009. EnerothM . Personal communication 17 March 2006. EnerothM , OlssonU‐B , ThorngrenK‐G . Combined parenteral and oral nutritional supplementation decreases fracture‐related complications. A prospective randomised trial of 80 patients with hip fractures. Journal of Bone and Joint Surgery ‐ British Volume2006;88(Suppl 1):44. EnerothM , OlssonU‐B , ThorngrenK‐G . Insufficient fluid and energy intake in hospitalised patients with hip fracture. A prospective randomised study of 80 patients. Clinical Nutrition2005;24:297‐303. [MEDLINE: 15784492] EnerothM , OlssonUB , ThorngrenKG . Nutritional supplementation decreases hip fracture‐related complications. Clinical Orthopaedics and Related Research2006;(451):212‐7. [MEDLINE: 16770284] ">Eneroth 2006</a>; <a href="./references#CD001880-bbs2-0014" title="EspaulellaJ , GuyerH , Diaz‐EscriuF , Mellado‐NavasJA , CastellsM , PladevallM . Nutritional supplementation of elderly hip fracture patients. A randomized, double‐blind, placebo‐controlled trial. Age and Ageing2000;29(5):425‐31. [MEDLINE: 11108415] GuyerH . Personal communication 13 June 2000. ">Espaulella 2000</a>; <a href="./references#CD001880-bbs2-0016" title="FlodinL . Effects of bisphosphonates and nutritional supplementation after a hip fracture. clinicaltrials.gov/show/NCT01950169 2013 (accessed 3 December 2015). FlodinL . Personal communication. Personal communication 15 December 2014. FlodinL , SaafM , CederholmT , Al‐AniAN , AckermannPW , SanegardE , et al. Additive effects of nutritional supplementation, together with bisphosphonates, on bone mineral density after hip fracture: a 12‐month randomized controlled study. Clinical Interventions in Aging2014;9:1043‐50. ">Flodin 2014</a>; <a href="./references#CD001880-bbs2-0024" title="LuoM . Personal communication 17 November 2014. LuoM , GolubevG , KlyukvinI , ReznikL , KuropatkinG , OliverJS , et al. Oral nutrition supplement improved nutritional status in malnourished hip fracture patients: a randomized controlled study. Journal of Scientific Research and Reports2015;4(6):480‐9. LuoM , GolybevG , KlyukvinI , ReznikL , KuropatkinG , VossAC . Oral nutritional supplement (ONS) improved nutritional status in malnourished patients receiving hip fracture surgery. Clinical Nutrition Supplements2011;6:151. SwearenginB . Effect of a medical food supplement in hospitalized patients recovering from surgery. clinicaltrials.gov/ct2/show/NCT01011608 (accessed 4 December 2015). ">Luo 2015</a>; <a href="./references#CD001880-bbs2-0027" title="MyintMW . Personal communication 6 January 2015. MyintMW , WuJ , WongE , ChanSP , ToTS , ChauMW , et al. Clinical benefits of oral nutritional supplementation for elderly hip fracture patients: a single blind randomised controlled trial. Age and Ageing2013;42(1):39‐45. MyintMWW . A randomized controlled study of nutritional intervention for geriatric hip fracture patients and its effect on rehabilitation outcomes. clinicaltrials.gov/ct2/show/NCT01088139 (accessed 4 December 2015). ">Myint 2013</a>; <a href="./references#CD001880-bbs2-0032" title="BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. RizzoliR , SchürchMA , BonjourJP . Protein supplements after osteoporotic hip fracture. Annals of Internal Medicine1998;129:1076. SchürchM‐A , BonjourJ‐P , SlosmanD , RizzoliR . Protein supplements favourably influence the outcome after hip fracture [Un supplement proteique ameliore les suites d'une fracture du femur proximal]. Medecine et Hygiene1999;57(2271):1876‐8. SchürchMA , RizzoliR , SlosmanD , BonjourJP . Protein supplements increase serum IGF‐1 and decrease proximal femur bone loss in patients with a recent hip fracture. Osteoporosis 1996: Proceedings of the 1996 World Congress on Osteoporosis; 1996 May 18‐23; Amsterdam, The Netherlands. Amsterdam: Elsevier, 1996:327‐9. SchürchMA , RizzoliR , SlosmanD , VadasL , VergnaudP , BonjourJP . Protein supplements increase serum insulin‐like growth factor‐I levels and attenuate proximal femur bone loss in patients with recent hip fracture. A randomized, double‐blind, placebo‐controlled trial. Annals of Internal Medicine1998;128(10):801‐9. ">Schürch 1998</a>; <a href="./references#CD001880-bbs2-0033" title="DerossiD , BoA , BergonziR , ScivolettoG . Six‐week administration of a mixture of ergogenic and osteotrophic ingredients (RestorfastTM) improves the clinical course of elderly patients after hip fracture surgery [La somministrazione per sei settimane di un composto a base di sostanze osteotrofiche ed ergogene (RestorfastTM) migliora il decorso clinico in anziani sottoposti a chirurgia del femore]. Trends in Medicine2009;9(4):235‐42. ScivolettoG , BoA , DerossiD , BergonziR . Ten week administration of a polynutritional supplement with muscle tone action (RiabylexTM) improves the functional recovery in elderly hip fracture patients during home rehabilitation [In anziani in terapia riabilitativa domiciliare per pregressa frattura del femore, l'assunzione di un polinutriente ad azione muscolotonica (RiabylexTM) per 10 settimane migliora il recupero funzionale]. Trends in Medicine2010;10(2):113‐20. ">Scivoletto 2010</a>; <a href="./references#CD001880-bbs2-0038" title="CarlssonP , TidermarkJ , PonzerS , SoderqvistA , CederholmT . Food habits and appetite of elderly women at the time of a femoral neck fracture and after nutritional and anabolic support. Journal of Human Nutrition and Dietetics2005;18(2):117‐20. [MEDLINE: 15788020] TengstrandB , CederholmT , SoderqvistA , TidermarkJ . Effects of protein‐rich supplementation and nandrolone on bone tissue after a hip fracture. Clinical Nutrition2007;26(4):460‐5. [MEDLINE: 17498850] TidermarkJ . Personal communication 14 October 2004. TidermarkJ . Quality of life and femoral neck fractures. Acta Orthopaedica Scandinavica. Supplementum2003;74(309):1‐42. TidermarkJ , PonzerS , CarlssonP , SoderqvistA , BrismarK , TengstrandB , et al. Effects of protein‐rich supplementation and nandrolone in lean elderly women with femoral neck fractures. Clinical Nutrition2004;23(4):587‐96. TidermarkJ , PonzerS , TengstrandB , CederholmT . Liquid supplementation and nandrolone to elderly women. Clinical Nutrition2002;21(Suppl 1):40. ">Tidermark 2004</a>; <a href="./references#CD001880-bbs2-0039" title="BonjourJP , RapinCH , RizzoliR , TkatchL , DelmiM , ChevalleyT , et al. Hip fracture, femoral bone mineral density, and protein supply in elderly patients. In: MunroH , SchlierfG editor(s). Nutrition of the elderly. Nestle nutrition workshop series. Vol. 29, New York: Raven Press, 1992:151‐9. BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. BonjourJP , SchürchMA , RizzoliR . Nutritional aspects of hip fractures. Bone1996;18(Suppl 3):139S‐44S. BonjourJP , SchürchMA , RizzoliR . Proteins and bone health. Patholgie‐Biologie1997;45(1):57‐9. TkatchL , RapinCH , RizzoliR , SlosmanD , NydeggerV , VaseyH , et al. Benefits of oral protein supplementation in elderly patients with fracture of the proximal femur. Journal of the American College of Nutrition1992;11(5):519‐25. ">Tkatch 1992</a>; <a href="./references#CD001880-bbs2-0040" title="HoudijkAPJ . The effect of taurine on morbidity and mortality in the elderly hip fracture patient. clinicaltrials.gov/ct2/show/NCT00497978 (accessed 15 December 2015). VanStijnMF , BruinsAA , VermeulenMA , WitloxJ , TeerlinkT , SchoorlMG , et al. Effect of oral taurine on morbidity and mortality in elderly hip fracture patients: a randomized trial. International Journal of Molecular Sciences2015;16(6):12288‐306. [DOI: 10.3390/ijms160612288; PUBMED: 26035756] ">Van Stijn 2015</a>; <a href="./references#CD001880-bbs2-0041" title="Breedveld‐PetersJ , ReijvenPL , WyersCE , HendrikxAA , VerburgAD , ScholsJM , et al. Qualitative analysis of barriers and facilitators for nutritional intervention in hip fracture patients. Clinical Nutrition, Supplement2012;7(1):234. Breedveld‐PetersJJ , ReijvenPL , WyersCE , HendrikxAA , VerburgAD , ScholsJM , et al. Barriers and facilitators of nutritional intervention after hip fracture in integrated care as perceived by the different health care professionals: a qualitative interview study. e‐SPEN Journal2012;7(5):e182‐8. Breedveld‐PetersJJ , ReijvenPL , WyersCE , VanHeldenS , ArtsJJ , MeestersB , et al. Integrated nutritional intervention in the elderly after hip fracture. A process evaluation. Clinical Nutrition, Supplement2012;31(1):199‐205. Breedveld‐PetersJJ , ReijvenPL , WyersCE , VanHeldenS , ArtsJJ , MeestersB , et al. Integrated nutritional intervention in the elderly after hip fracture. A process evaluation. Clinical Nutrition, Supplement2012;7(1):43. DagneliePC . Effectiveness and cost‐effectiveness of nutritional screening and intervention in elderly subjects after hip fracture. clinicaltrials.gov/show/NCT00523575 (accessed 8 November 2009). WyersC , ReijvenPL , EversSM , WillemsPC , HeyligersIC , VerburgAD , et al. Cost‐effectiveness of nutritional intervention in hip fracture patients: a multi‐centre randomised controlled trial (RCT). Clinical Nutrition, Supplement2012;7(1):49. WyersCE . PhD thesis. Maastricht, the Netherlands: Maastricht University, 2012. WyersCE , Breedveld‐PetersJJ , ReijvenPL , ArtsC , ThomassenBJ , VerburgAD , et al. Effect of nutritional intervention on nutritional intake and status in hip fracture patients: a multicentre randomised controlled trial (RCT). Clinical Nutrition, Supplement2012;7(1):50‐1. WyersCE , Breedveld‐PetersJJ , ReijvenPL , VanHeldenS , GuldemondNA , SeverensJL , et al. Efficacy and cost‐effectiveness of nutritional intervention in elderly after hip fracture: design of a randomized controlled trial. BMC Public Health2010;10:212. WyersCE , ReijvenPL , EversSM , WillemsPC , HeyligersIC , VerburgAD , et al. Cost‐effectiveness of nutritional intervention in elderly subjects after hip fracture. A randomized controlled trial. Osteoporosis International2013;24(1):151‐62. ">Wyers 2013</a>). Eight studies indicated that consent (assent) was acceptable if given by a relative or guardian (<a href="./references#CD001880-bbs2-0010" title="DayJJ . Personal communication 27 May 1999. DayJJ , BayerAJ , McMahonM , PathyMS , SpraggBP , RowlandsDC . Thiamine status, vitamin supplements and postoperative confusion. Age and Ageing1988;17:29‐34. ">Day 1988</a>; <a href="./references#CD001880-bbs2-0012" title="DuncanD . Personal communication March 15 2006. DuncanD , MurisonJ , MartinR , BeckS , JohansenA . Adequacy of oral feeding among elderly patients with hip fracture. Age and Ageing2001;30(Suppl 2):22. DuncanDG , BeckSJ . Using dietetic assistants to improve the outcome of hip fracture ‐ a randomised controlled trial of nutritional support in an acute trauma ward. Clinical Nutrition2002;21(Suppl 1):41. DuncanDG , BeckSJ , HoodK , JohansenA . Using dietetic assistants to improve the outcome of hip fracture ‐ a randomised controlled trial of nutritional support in an acute trauma ward. Age and Ageing2006;35(Suppl 3):i43. DuncanDG , BeckSJ , HoodK , JohansenA . Using dietetic assistants to improve the outcome of hip fracture: a randomised controlled trial of nutritional support in an acute trauma ward. Age and Ageing2006;35(2):148‐53. [MEDLINE: 16354710] DuncanDG , BeckSJ , JohansenA . Using dietetic assistants to improve the outcome of hip fracture ‐ a randomised controlled trial of nutritional support in an acute trauma ward. Journal of Human Nutrition and Dietetics2002;15:461. JohansenA . Using dietetic assistants to improve the outcome of hip fracture. In: The National Research Register, Issue 1, 2002. Oxford: Update Software2002. ">Duncan 2006</a>; <a href="./references#CD001880-bbs2-0014" title="EspaulellaJ , GuyerH , Diaz‐EscriuF , Mellado‐NavasJA , CastellsM , PladevallM . Nutritional supplementation of elderly hip fracture patients. A randomized, double‐blind, placebo‐controlled trial. Age and Ageing2000;29(5):425‐31. [MEDLINE: 11108415] GuyerH . Personal communication 13 June 2000. ">Espaulella 2000</a>; <a href="./references#CD001880-bbs2-0019" title="HankinsC . Dietary supplementation with sustagen in elderly patients with fractured neck of femur [MSc dissertation]. Sydney (Australia): University of Sydney, 1996. HankinsC . Personal communication 11 June 1999. ">Hankins 1996</a>; <a href="./references#CD001880-bbs2-0022" title="HouwingR . Personal communication 29 October 2003. HouwingR , RozendaalM , Wouters‐WesselingW , BeulensJ , BuskensE , HaalboomJ . The effect of nutritional supplementation on the prevention of pressure ulcers (PU) in hip‐fracture patients. Clinical Nutrition2002;21(Suppl 1):84. HouwingRH , RozendaalM , Wouters‐WesselingW , BeulensJW , BuskensE , HaalboomJR . A randomised, double‐blind assessment of the effect of nutritional supplementation on the prevention of pressure ulcers in hip‐fracture patients. Clinical Nutrition2003;22(4):401‐5. [MEDLINE: 12880608] ">Houwing 2003</a>; <a href="./references#CD001880-bbs2-0030" title="ParkerM . Personal communication 16 October 2014. ParkerM . Randomised trial comparing iron supplementation versus placebo in the treatment of anaemia after hip fracture. clinicaltrials.gov/show/NCT00919230 (accessed 4 December 2015). ParkerMJ . Iron supplementation for anemia after hip fracture surgery. A randomized trial of 300 patients. Journal of Bone and Joint Surgery ‐ American Volume2010;92(2):265‐9. ">Parker 2010</a>; <a href="./references#CD001880-bbs2-0036" title="SullivanDH . Personal communication 10 February 2000. SullivanDH , NelsonCL , BoppMM , Puskarich‐MayCL , WallsRC . Nightly enteral nutrition support of elderly fracture patients: a phase I trial. Journal of the American College of Nutrition1998;17(1):155‐61. ">Sullivan 1998</a>; <a href="./references#CD001880-bbs2-0037" title="SullivanDH . Personal communication 14 April 2006. SullivanDH , NelsonCL , KlimbergVS , BoppMM . Nightly enteral nutrition support of elderly hip fracture patients: a pilot study. Journal of the American College of Nutrition2004;23(6):683‐91. [MEDLINE: 15637216] ">Sullivan 2004</a>). </p> <p>Eight studies, involving 616 participants, examined the effect of supplementation on malnourished participants (<a href="./references#CD001880-bbs2-0002" title="AllisonSP . Personal communication 15 February 2000. AllisonSP . Reflections on a study of nutrition support in patients with femur neck fracture. Nutrition1995;11(3):322‐7. BastowMD , RawlingsJ , AllisonSP . Benefits of supplementary tube feeding after fractured neck of femur: a randomised controlled trial. British Medical Journal (Clinical Research Edition)1983;287(6405):1589‐92. [MEDLINE: 6416514] BastowMD , RawlingsJ , AllisonSP . Controlled trial showing clinical benefit of tube feeding in elderly patients with fractured femur. Clinical Nutrition1984;2 Suppl:57. BastowMD , RawlingsJ , AllisonSP . Overnight nasogastric tube feeding. Clinical Nutrition1985;4(1):7‐11. ">Bastow 1983b</a>; <a href="./references#CD001880-bbs2-0003" title="BeanN , ReddenJ , GoodeH , GrimbleG , AllisonSP . Double‐blind pilot trial, in elderly women with fractured femur, of ornithine alpha‐ketoglutarate v. a defined formula oral supplement. Proceedings of the Nutrition Society1994;53(3):203A. ">Bean 1994</a>; <a href="./references#CD001880-bbs2-0007" title="BrownKM . Personal communicationMay 1999. BrownKM , SeabrookNA . Effect of nutrition on recovery after fractured femur. Medical Audit News1992;2(1):10‐2. BrownKM , SeabrookNA . Nutritional influences on recovery and length of hospital stay in elderly women following femoral fracture. Proceedings of the Nutrition Society1992;51(2):132A. ">Brown 1992b</a>; <a href="./references#CD001880-bbs2-0017" title="GallagherJ , SchermbeckJ , DixonL , Labbe‐BellM . Aggressive early management of malnutrition in hip fracture patients. Journal of Parenteral and Enteral Nutrition1992;16(1):19S. KoretzR . Personal communication 7 September 1999. ">Gallagher 1992</a>; <a href="./references#CD001880-bbs2-0019" title="HankinsC . Dietary supplementation with sustagen in elderly patients with fractured neck of femur [MSc dissertation]. Sydney (Australia): University of Sydney, 1996. HankinsC . Personal communication 11 June 1999. ">Hankins 1996</a>; <a href="./references#CD001880-bbs2-0024" title="LuoM . Personal communication 17 November 2014. LuoM , GolubevG , KlyukvinI , ReznikL , KuropatkinG , OliverJS , et al. Oral nutrition supplement improved nutritional status in malnourished hip fracture patients: a randomized controlled study. Journal of Scientific Research and Reports2015;4(6):480‐9. LuoM , GolybevG , KlyukvinI , ReznikL , KuropatkinG , VossAC . Oral nutritional supplement (ONS) improved nutritional status in malnourished patients receiving hip fracture surgery. Clinical Nutrition Supplements2011;6:151. SwearenginB . Effect of a medical food supplement in hospitalized patients recovering from surgery. clinicaltrials.gov/ct2/show/NCT01011608 (accessed 4 December 2015). ">Luo 2015</a>; <a href="./references#CD001880-bbs2-0026" title="CrottyM . Personal communication 20 February 2009. DanielsLA , MillerM , BannermanE , WhiteheadC , CrottyM . Weight loss post lower limb fracture despite an intensive oral nutrition and exercise intervention. Clinical Nutrition2003;22 Suppl:S86. DanielsLA , MillerMD , BannermannE , CrottyM . Adherence to nutritional supplements amongst orthopedic patients: an important clinical and study design issue. Clinical Nutrition2005;24:535. MillerMD , BannermanE , DanielsLA , CrottyM . Lower limb fracture, cognitive impairment and risk of subsequent malnutrition: a prospective evaluation of dietary energy and protein intake on an orthopaedic ward. European Journal of Clinical Nutrition2006;60(7):853‐61. [MEDLINE: 16452913] MillerMD , CrottyM , WhiteheadC , BannermanE , DanielsLA . Nutritional supplementation and resistance training in nutritionally at risk older adults following lower limb fracture: a randomized controlled trial. Clinical Rehabilitation2006;20(4):311‐23. MillerMD , DanielsLA , BannermanE , CrottyM . Adherence to nutrition supplements among patients with a fall‐related lower limb fracture. Nutrition in Clinical Practice2005;20(5):569‐78. [MEDLINE: 16207699] ">Miller 2006</a>; <a href="./references#CD001880-bbs2-0027" title="MyintMW . Personal communication 6 January 2015. MyintMW , WuJ , WongE , ChanSP , ToTS , ChauMW , et al. Clinical benefits of oral nutritional supplementation for elderly hip fracture patients: a single blind randomised controlled trial. Age and Ageing2013;42(1):39‐45. MyintMWW . A randomized controlled study of nutritional intervention for geriatric hip fracture patients and its effect on rehabilitation outcomes. clinicaltrials.gov/ct2/show/NCT01088139 (accessed 4 December 2015). ">Myint 2013</a>). <a href="./references#CD001880-bbs2-0017" title="GallagherJ , SchermbeckJ , DixonL , Labbe‐BellM . Aggressive early management of malnutrition in hip fracture patients. Journal of Parenteral and Enteral Nutrition1992;16(1):19S. KoretzR . Personal communication 7 September 1999. ">Gallagher 1992</a> and <a href="./references#CD001880-bbs2-0024" title="LuoM . Personal communication 17 November 2014. LuoM , GolubevG , KlyukvinI , ReznikL , KuropatkinG , OliverJS , et al. Oral nutrition supplement improved nutritional status in malnourished hip fracture patients: a randomized controlled study. Journal of Scientific Research and Reports2015;4(6):480‐9. LuoM , GolybevG , KlyukvinI , ReznikL , KuropatkinG , VossAC . Oral nutritional supplement (ONS) improved nutritional status in malnourished patients receiving hip fracture surgery. Clinical Nutrition Supplements2011;6:151. SwearenginB . Effect of a medical food supplement in hospitalized patients recovering from surgery. clinicaltrials.gov/ct2/show/NCT01011608 (accessed 4 December 2015). ">Luo 2015</a> defined participants as malnourished on the basis of serum albumin; other studies used anthropometric measurements, such as mid‐upper arm circumference. <a href="./references#CD001880-bbs2-0027" title="MyintMW . Personal communication 6 January 2015. MyintMW , WuJ , WongE , ChanSP , ToTS , ChauMW , et al. Clinical benefits of oral nutritional supplementation for elderly hip fracture patients: a single blind randomised controlled trial. Age and Ageing2013;42(1):39‐45. MyintMWW . A randomized controlled study of nutritional intervention for geriatric hip fracture patients and its effect on rehabilitation outcomes. clinicaltrials.gov/ct2/show/NCT01088139 (accessed 4 December 2015). ">Myint 2013</a> recruited participants if BMI was &lt; 25 kg/m<sup>2</sup>and mean BMI was actually 21.7 kg/m<sup>2</sup>. We discussed this with consultant geriatrician colleagues, who advised that participants in this trial be considered under 'malnourished targeted' category of subgroup analysis. </p> </section> <section id="CD001880-sec-0084"> <h5 class="title">Interventions</h5> <p>The 41 included trials evaluated a variety of nutritional supplements, mostly in comparison with a control group. We have provided details of these and the method of delivery in individual studies in the <a href="./references#CD001880-sec-0189" title="">Characteristics of included studies</a>. The comparisons under test fell into five categories (as detailed below). </p> <p>Four studies had three treatment groups each. <a href="./references#CD001880-bbs2-0025" title="MadiganC . Benefits of dietary supplementation in elderly patients with fractured neck of femur. Sydney (Australia): University of Sydney, 1994. ">Madigan 1994</a> had three groups: the two supplemented groups (one with a multivitamin and mineral supplement) were subsequently combined in the report, owing to small numbers at follow‐up. Since these two groups both fit the criterion in this review for a 'multinutrient' supplement group, the combined results for these two groups, compared with the control, are also presented here. <a href="./references#CD001880-bbs2-0005" title="Botella‐CarreteroJI . Personal communication 23 January 2009. Botella‐CarreteroJI , IglesiasB , BalsaJA , ZamarronI , ArrietaF , VazquezC . Effects of oral nutritional supplements in normally nourished or mildly undernourished geriatric patients after surgery for hip fracture: a randomized clinical trial. Journal of Parenteral and Enteral Nutrition2008;32(2):120‐8. [MEDLINE: 18407904] IglesiasB , Botella‐CarreteroJI , BalsaJA , ArrietaF , ZamarronI , VazquezC . Effects of oral nutritional supplements in geriatric patients after surgery for hip fracture. Clinical Nutrition Supplements2007;2(2):97. ">Botella‐Carretero 2008</a> also had three groups: oral protein and energy, oral protein, and control; both supplemented groups have been combined for this review, also owing to small numbers. <a href="./references#CD001880-bbs2-0029" title="PapaioannouA . A randomised, controlled comparison of vitamin D strategies in acute hip fracture patients. clinicaltrials.gov/show/NCT00424619 (accessed 4 December 2015). PapaioannouA , KennedyCC , GiangregorioL , IoannidisG , PritchardJ , HanleyDA , et al. A randomized controlled trial of vitamin D dosing strategies after acute hip fracture: no advantage of loading doses over daily supplementation. BMC Musculoskeletal Disorders2011;12:135. PapaioannouA , KennedyCC , IoannidisG , AdachiJD , HanleyD , GiangregorioL , et al. High versus low vitamin D in acute hip fracture patients: a randomised, controlled trial. Osteoporosis International2010;21(Suppl 1):S201. ">Papaioannou 2011</a> compared an initial oral bolus dose of 100,000 IU vitamin D2 versus 50,000 IU vitamin D2 versus placebo; followed by 1,000 IU vitamin D3 for 90 days in all groups. Finally, <a href="./references#CD001880-bbs2-0009" title="ChevalleyT . Personal communication 14 October 2014. ChevalleyT , HoffmeyerP , BonjourJ‐P , RizzoliR . Early serum IGF‐I response to oral protein supplements in elderly women with a recent hip fracture. Clinical Nutrition2010;29(1):78‐83. ">Chevalley 2010</a> compared three different protein sources: oral casein protein versus oral whey protein versus oral whey protein plus essential amino acids. </p> <p><a href="./references#CD001880-bbs2-0026" title="CrottyM . Personal communication 20 February 2009. DanielsLA , MillerM , BannermanE , WhiteheadC , CrottyM . Weight loss post lower limb fracture despite an intensive oral nutrition and exercise intervention. Clinical Nutrition2003;22 Suppl:S86. DanielsLA , MillerMD , BannermannE , CrottyM . Adherence to nutritional supplements amongst orthopedic patients: an important clinical and study design issue. Clinical Nutrition2005;24:535. MillerMD , BannermanE , DanielsLA , CrottyM . Lower limb fracture, cognitive impairment and risk of subsequent malnutrition: a prospective evaluation of dietary energy and protein intake on an orthopaedic ward. European Journal of Clinical Nutrition2006;60(7):853‐61. [MEDLINE: 16452913] MillerMD , CrottyM , WhiteheadC , BannermanE , DanielsLA . Nutritional supplementation and resistance training in nutritionally at risk older adults following lower limb fracture: a randomized controlled trial. Clinical Rehabilitation2006;20(4):311‐23. MillerMD , DanielsLA , BannermanE , CrottyM . Adherence to nutrition supplements among patients with a fall‐related lower limb fracture. Nutrition in Clinical Practice2005;20(5):569‐78. [MEDLINE: 16207699] ">Miller 2006</a> had four groups: a nutrition supplementation group, a physical activity intervention group, a combined intervention group, and an attention control group. We have only used data from the nutritional supplementation only and control groups here. <a href="./references#CD001880-bbs2-0004" title="Bischoff‐FerrariH . Early rehabilitation after hip fracture. clinicaltrials.gov/ct2/show/NCT00133640 (accessed 7 September 2015). Bischoff‐FerrariH , Dawson‐HughesB , OravE , WillettW , EgliA , MaetzelA , et al. The economic consequences of hip fractures: impact of home exercise and high dose‐vitamin D. 32nd Annual Meeting of the American Society for Bone and Mineral Research Annual Meeting; 2010 Oct 15‐9; Toronto, Canada. (accessed 3 December 2015); Vol. www.asbmr.org/education/2010‐abstracts. Bischoff‐FerrariHA , Dawson‐HughesB , PlatzA , OravEJ , StahelinHB , WillettWC , et al. Effect of high‐dosage cholecalciferol and extended physiotherapy on complications after hip fracture. A randomized controlled trial. Archives of Internal Medicine2010;170(9):813‐20. ">Bischoff‐Ferrari 2010</a> had a factorial design with randomisation to two different doses of vitamin D3 and standard or extended physiotherapy. </p> <p>We made the following comparisons:</p> <section id="CD001880-sec-0085"> <h6 class="title">Multinutrient supplements (oral, nasogastric, intravenous) versus control</h6> <p>The multinutrient supplements under investigation usually provided non‐protein energy, protein, some vitamins and minerals. These were delivered either orally, via a nasogastric tube, intravenously, or combinations of these. </p> <section id="CD001880-sec-0086"> <p><b>Oral supplements</b></p> <p>The 18 studies testing oral supplements involved 1190 participants (<a href="./references#CD001880-bbs2-0001" title="AnbarR , BelooseskyY , CohenJ , MadarZ , WeissA , TheillaM , et al. Tight calorie control in geriatric patients following hip fracture decreases complications: a randomized, controlled study. Clinical Nutrition2014;33:23‐8. AnbarR , BelooseskyY , MadarZ , TheillaM , Koren‐HakimT , WeissA , et al. Tight calorie control (TICACOS) in geriatric hip fracture patients. Clinical Nutrition, Supplement2012;7(1):18. AnbarR , BelooseskyY , MadarZ , TheillaM , Koren‐HakimT , WeissA , et al. Tight calorie control in geriatric hip fracture patients: preliminary results of the geriatric TICACOS study. Clinical Nutrition, Supplement2011;6(1):155. SingerP . Tight caloric balance in geriatric patients (TICACOSiGP). clinicaltrials.gov/show/NCT01735435 (accessed 3 December 2015). ">Anbar 2014</a>; <a href="./references#CD001880-bbs2-0005" title="Botella‐CarreteroJI . Personal communication 23 January 2009. Botella‐CarreteroJI , IglesiasB , BalsaJA , ZamarronI , ArrietaF , VazquezC . Effects of oral nutritional supplements in normally nourished or mildly undernourished geriatric patients after surgery for hip fracture: a randomized clinical trial. Journal of Parenteral and Enteral Nutrition2008;32(2):120‐8. [MEDLINE: 18407904] IglesiasB , Botella‐CarreteroJI , BalsaJA , ArrietaF , ZamarronI , VazquezC . Effects of oral nutritional supplements in geriatric patients after surgery for hip fracture. Clinical Nutrition Supplements2007;2(2):97. ">Botella‐Carretero 2008</a>; <a href="./references#CD001880-bbs2-0006" title="Botella‐CarreteroJI . Personal communication 26 October 2014. Botella‐CarreteroJI , IglesiasB , BalsaJA , ArrietaF , ZamarronI , VazquezC . Perioperative oral nutritional supplements in normally and mildly undernourished geriatric patients submitted to surgery for hip fracture: a randomized clinical trial. Clinical Nutrition2010;29(5):574‐9. ">Botella‐Carretero 2010</a>; <a href="./references#CD001880-bbs2-0007" title="BrownKM . Personal communicationMay 1999. BrownKM , SeabrookNA . Effect of nutrition on recovery after fractured femur. Medical Audit News1992;2(1):10‐2. BrownKM , SeabrookNA . Nutritional influences on recovery and length of hospital stay in elderly women following femoral fracture. Proceedings of the Nutrition Society1992;51(2):132A. ">Brown 1992b</a>; <a href="./references#CD001880-bbs2-0008" title="BruceD . Personal communication. October 2003. BruceD , LauranceI , McGuinessM , RidleyM , GoldswainP . Nutritional supplements after hip fracture: poor compliance limits effectiveness. Clinical Nutrition2003;22(5):497‐500. [MEDLINE: 14512038] ">Bruce 2003</a>; <a href="./references#CD001880-bbs2-0011" title="BonjourJP , RapinCH , RizzoliR , TkatchL , DelmiM , ChevalleyT , et al. Hip fracture, femoral bone mineral density, and protein supply in elderly patients. In: MunroHN , SchlierfG editor(s). Nutrition of the elderly. Nestlé nutrition workshop series. Vol. 29, New York: Raven Press, 1992:151‐9. [ISBN 0881678740 ] BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. BonjourJP , SchürchMA , RizzoliR . Nutritional aspects of hip fractures. Bone1996;18(3 Suppl):139S‐44S. BonjourJP , SchürchMA , RizzoliR . Proteins and bone health. Pathologie‐Biologie1997;45(1):57‐9. DelmiM , RapinC‐H , BengoaJ‐M , DelmasPD , VaseyH , BonjourJ‐P . Dietary supplementation in elderly patients with fractured neck of the femur. Lancet1990;335:1013‐6. [MEDLINE: 1970070] RapinCH , BengoaJM , KahnJM , DelmiM , BonjourJP , VaseyH . A prospective randomised control study of oral dietary supplementation in patients with fractured necks of femur. Journal of Parenteral and Enteral Nutrition1989;13(1):9S. ">Delmi 1990</a>; <a href="./references#CD001880-bbs2-0015" title="FabianE , GerstorferI , ThalerHW , StundnerH , BiswasP , ElmadfaI . Nutritional supplementation affects postoperative oxidative stress and duration of hospitalization in patients with hip fracture. Wiener Klinische Wochenschrift2011;123(3‐4):88‐93. ">Fabian 2011</a>; <a href="./references#CD001880-bbs2-0016" title="FlodinL . Effects of bisphosphonates and nutritional supplementation after a hip fracture. clinicaltrials.gov/show/NCT01950169 2013 (accessed 3 December 2015). FlodinL . Personal communication. Personal communication 15 December 2014. FlodinL , SaafM , CederholmT , Al‐AniAN , AckermannPW , SanegardE , et al. Additive effects of nutritional supplementation, together with bisphosphonates, on bone mineral density after hip fracture: a 12‐month randomized controlled study. Clinical Interventions in Aging2014;9:1043‐50. ">Flodin 2014</a>; <a href="./references#CD001880-bbs2-0019" title="HankinsC . Dietary supplementation with sustagen in elderly patients with fractured neck of femur [MSc dissertation]. Sydney (Australia): University of Sydney, 1996. HankinsC . Personal communication 11 June 1999. ">Hankins 1996</a>; <a href="./references#CD001880-bbs2-0022" title="HouwingR . Personal communication 29 October 2003. HouwingR , RozendaalM , Wouters‐WesselingW , BeulensJ , BuskensE , HaalboomJ . The effect of nutritional supplementation on the prevention of pressure ulcers (PU) in hip‐fracture patients. Clinical Nutrition2002;21(Suppl 1):84. HouwingRH , RozendaalM , Wouters‐WesselingW , BeulensJW , BuskensE , HaalboomJR . A randomised, double‐blind assessment of the effect of nutritional supplementation on the prevention of pressure ulcers in hip‐fracture patients. Clinical Nutrition2003;22(4):401‐5. [MEDLINE: 12880608] ">Houwing 2003</a>; <a href="./references#CD001880-bbs2-0023" title="KangJH , ShinDW , BaikHW , HongJ . Short‐term oral nutritional supplements and nutrition intervention in elderly patients after hip fracture surgery: a randomized controlled clinical trial. Clinical Nutrition, Supplement2012;7(1):280. ">Kang 2012</a>; <a href="./references#CD001880-bbs2-0024" title="LuoM . Personal communication 17 November 2014. LuoM , GolubevG , KlyukvinI , ReznikL , KuropatkinG , OliverJS , et al. Oral nutrition supplement improved nutritional status in malnourished hip fracture patients: a randomized controlled study. Journal of Scientific Research and Reports2015;4(6):480‐9. LuoM , GolybevG , KlyukvinI , ReznikL , KuropatkinG , VossAC . Oral nutritional supplement (ONS) improved nutritional status in malnourished patients receiving hip fracture surgery. Clinical Nutrition Supplements2011;6:151. SwearenginB . Effect of a medical food supplement in hospitalized patients recovering from surgery. clinicaltrials.gov/ct2/show/NCT01011608 (accessed 4 December 2015). ">Luo 2015</a>; <a href="./references#CD001880-bbs2-0025" title="MadiganC . Benefits of dietary supplementation in elderly patients with fractured neck of femur. Sydney (Australia): University of Sydney, 1994. ">Madigan 1994</a>; <a href="./references#CD001880-bbs2-0026" title="CrottyM . Personal communication 20 February 2009. DanielsLA , MillerM , BannermanE , WhiteheadC , CrottyM . Weight loss post lower limb fracture despite an intensive oral nutrition and exercise intervention. Clinical Nutrition2003;22 Suppl:S86. DanielsLA , MillerMD , BannermannE , CrottyM . Adherence to nutritional supplements amongst orthopedic patients: an important clinical and study design issue. Clinical Nutrition2005;24:535. MillerMD , BannermanE , DanielsLA , CrottyM . Lower limb fracture, cognitive impairment and risk of subsequent malnutrition: a prospective evaluation of dietary energy and protein intake on an orthopaedic ward. European Journal of Clinical Nutrition2006;60(7):853‐61. [MEDLINE: 16452913] MillerMD , CrottyM , WhiteheadC , BannermanE , DanielsLA . Nutritional supplementation and resistance training in nutritionally at risk older adults following lower limb fracture: a randomized controlled trial. Clinical Rehabilitation2006;20(4):311‐23. MillerMD , DanielsLA , BannermanE , CrottyM . Adherence to nutrition supplements among patients with a fall‐related lower limb fracture. Nutrition in Clinical Practice2005;20(5):569‐78. [MEDLINE: 16207699] ">Miller 2006</a>; <a href="./references#CD001880-bbs2-0027" title="MyintMW . Personal communication 6 January 2015. MyintMW , WuJ , WongE , ChanSP , ToTS , ChauMW , et al. Clinical benefits of oral nutritional supplementation for elderly hip fracture patients: a single blind randomised controlled trial. Age and Ageing2013;42(1):39‐45. MyintMWW . A randomized controlled study of nutritional intervention for geriatric hip fracture patients and its effect on rehabilitation outcomes. clinicaltrials.gov/ct2/show/NCT01088139 (accessed 4 December 2015). ">Myint 2013</a>; <a href="./references#CD001880-bbs2-0035" title="StableforthPG . Supplement feeds and nitrogen and calorie balance following femoral neck fracture. British Journal of Surgery1986;73:651‐5. ">Stableforth 1986</a>; <a href="./references#CD001880-bbs2-0038" title="CarlssonP , TidermarkJ , PonzerS , SoderqvistA , CederholmT . Food habits and appetite of elderly women at the time of a femoral neck fracture and after nutritional and anabolic support. Journal of Human Nutrition and Dietetics2005;18(2):117‐20. [MEDLINE: 15788020] TengstrandB , CederholmT , SoderqvistA , TidermarkJ . Effects of protein‐rich supplementation and nandrolone on bone tissue after a hip fracture. Clinical Nutrition2007;26(4):460‐5. [MEDLINE: 17498850] TidermarkJ . Personal communication 14 October 2004. TidermarkJ . Quality of life and femoral neck fractures. Acta Orthopaedica Scandinavica. Supplementum2003;74(309):1‐42. TidermarkJ , PonzerS , CarlssonP , SoderqvistA , BrismarK , TengstrandB , et al. Effects of protein‐rich supplementation and nandrolone in lean elderly women with femoral neck fractures. Clinical Nutrition2004;23(4):587‐96. TidermarkJ , PonzerS , TengstrandB , CederholmT . Liquid supplementation and nandrolone to elderly women. Clinical Nutrition2002;21(Suppl 1):40. ">Tidermark 2004</a>; <a href="./references#CD001880-bbs2-0041" title="Breedveld‐PetersJ , ReijvenPL , WyersCE , HendrikxAA , VerburgAD , ScholsJM , et al. Qualitative analysis of barriers and facilitators for nutritional intervention in hip fracture patients. Clinical Nutrition, Supplement2012;7(1):234. Breedveld‐PetersJJ , ReijvenPL , WyersCE , HendrikxAA , VerburgAD , ScholsJM , et al. Barriers and facilitators of nutritional intervention after hip fracture in integrated care as perceived by the different health care professionals: a qualitative interview study. e‐SPEN Journal2012;7(5):e182‐8. Breedveld‐PetersJJ , ReijvenPL , WyersCE , VanHeldenS , ArtsJJ , MeestersB , et al. Integrated nutritional intervention in the elderly after hip fracture. A process evaluation. Clinical Nutrition, Supplement2012;31(1):199‐205. Breedveld‐PetersJJ , ReijvenPL , WyersCE , VanHeldenS , ArtsJJ , MeestersB , et al. Integrated nutritional intervention in the elderly after hip fracture. A process evaluation. Clinical Nutrition, Supplement2012;7(1):43. DagneliePC . Effectiveness and cost‐effectiveness of nutritional screening and intervention in elderly subjects after hip fracture. clinicaltrials.gov/show/NCT00523575 (accessed 8 November 2009). WyersC , ReijvenPL , EversSM , WillemsPC , HeyligersIC , VerburgAD , et al. Cost‐effectiveness of nutritional intervention in hip fracture patients: a multi‐centre randomised controlled trial (RCT). Clinical Nutrition, Supplement2012;7(1):49. WyersCE . PhD thesis. Maastricht, the Netherlands: Maastricht University, 2012. WyersCE , Breedveld‐PetersJJ , ReijvenPL , ArtsC , ThomassenBJ , VerburgAD , et al. Effect of nutritional intervention on nutritional intake and status in hip fracture patients: a multicentre randomised controlled trial (RCT). Clinical Nutrition, Supplement2012;7(1):50‐1. WyersCE , Breedveld‐PetersJJ , ReijvenPL , VanHeldenS , GuldemondNA , SeverensJL , et al. Efficacy and cost‐effectiveness of nutritional intervention in elderly after hip fracture: design of a randomized controlled trial. BMC Public Health2010;10:212. WyersCE , ReijvenPL , EversSM , WillemsPC , HeyligersIC , VerburgAD , et al. Cost‐effectiveness of nutritional intervention in elderly subjects after hip fracture. A randomized controlled trial. Osteoporosis International2013;24(1):151‐62. ">Wyers 2013</a>). <a href="./references#CD001880-bbs2-0001" title="AnbarR , BelooseskyY , CohenJ , MadarZ , WeissA , TheillaM , et al. Tight calorie control in geriatric patients following hip fracture decreases complications: a randomized, controlled study. Clinical Nutrition2014;33:23‐8. AnbarR , BelooseskyY , MadarZ , TheillaM , Koren‐HakimT , WeissA , et al. Tight calorie control (TICACOS) in geriatric hip fracture patients. Clinical Nutrition, Supplement2012;7(1):18. AnbarR , BelooseskyY , MadarZ , TheillaM , Koren‐HakimT , WeissA , et al. Tight calorie control in geriatric hip fracture patients: preliminary results of the geriatric TICACOS study. Clinical Nutrition, Supplement2011;6(1):155. SingerP . Tight caloric balance in geriatric patients (TICACOSiGP). clinicaltrials.gov/show/NCT01735435 (accessed 3 December 2015). ">Anbar 2014</a> undertook three measurements of resting energy expenditure to estimate requirements for the intervention group. <a href="./references#CD001880-bbs2-0041" title="Breedveld‐PetersJ , ReijvenPL , WyersCE , HendrikxAA , VerburgAD , ScholsJM , et al. Qualitative analysis of barriers and facilitators for nutritional intervention in hip fracture patients. Clinical Nutrition, Supplement2012;7(1):234. Breedveld‐PetersJJ , ReijvenPL , WyersCE , HendrikxAA , VerburgAD , ScholsJM , et al. Barriers and facilitators of nutritional intervention after hip fracture in integrated care as perceived by the different health care professionals: a qualitative interview study. e‐SPEN Journal2012;7(5):e182‐8. Breedveld‐PetersJJ , ReijvenPL , WyersCE , VanHeldenS , ArtsJJ , MeestersB , et al. Integrated nutritional intervention in the elderly after hip fracture. A process evaluation. Clinical Nutrition, Supplement2012;31(1):199‐205. Breedveld‐PetersJJ , ReijvenPL , WyersCE , VanHeldenS , ArtsJJ , MeestersB , et al. Integrated nutritional intervention in the elderly after hip fracture. A process evaluation. Clinical Nutrition, Supplement2012;7(1):43. DagneliePC . Effectiveness and cost‐effectiveness of nutritional screening and intervention in elderly subjects after hip fracture. clinicaltrials.gov/show/NCT00523575 (accessed 8 November 2009). WyersC , ReijvenPL , EversSM , WillemsPC , HeyligersIC , VerburgAD , et al. Cost‐effectiveness of nutritional intervention in hip fracture patients: a multi‐centre randomised controlled trial (RCT). Clinical Nutrition, Supplement2012;7(1):49. WyersCE . PhD thesis. Maastricht, the Netherlands: Maastricht University, 2012. WyersCE , Breedveld‐PetersJJ , ReijvenPL , ArtsC , ThomassenBJ , VerburgAD , et al. Effect of nutritional intervention on nutritional intake and status in hip fracture patients: a multicentre randomised controlled trial (RCT). Clinical Nutrition, Supplement2012;7(1):50‐1. WyersCE , Breedveld‐PetersJJ , ReijvenPL , VanHeldenS , GuldemondNA , SeverensJL , et al. Efficacy and cost‐effectiveness of nutritional intervention in elderly after hip fracture: design of a randomized controlled trial. BMC Public Health2010;10:212. WyersCE , ReijvenPL , EversSM , WillemsPC , HeyligersIC , VerburgAD , et al. Cost‐effectiveness of nutritional intervention in elderly subjects after hip fracture. A randomized controlled trial. Osteoporosis International2013;24(1):151‐62. ">Wyers 2013</a> included five dietetic visits and five follow‐up phone calls for the intervention group. Interventions were usually started pre‐operatively or in two days postoperatively and most continued for at least a month. </p> </section> <section id="CD001880-sec-0087"> <p><b>Nasogastric tube feeding</b></p> <p>Four studies involving 377 participants (<a href="./references#CD001880-bbs2-0002" title="AllisonSP . Personal communication 15 February 2000. AllisonSP . Reflections on a study of nutrition support in patients with femur neck fracture. Nutrition1995;11(3):322‐7. BastowMD , RawlingsJ , AllisonSP . Benefits of supplementary tube feeding after fractured neck of femur: a randomised controlled trial. British Medical Journal (Clinical Research Edition)1983;287(6405):1589‐92. [MEDLINE: 6416514] BastowMD , RawlingsJ , AllisonSP . Controlled trial showing clinical benefit of tube feeding in elderly patients with fractured femur. Clinical Nutrition1984;2 Suppl:57. BastowMD , RawlingsJ , AllisonSP . Overnight nasogastric tube feeding. Clinical Nutrition1985;4(1):7‐11. ">Bastow 1983b</a>; <a href="./references#CD001880-bbs2-0017" title="GallagherJ , SchermbeckJ , DixonL , Labbe‐BellM . Aggressive early management of malnutrition in hip fracture patients. Journal of Parenteral and Enteral Nutrition1992;16(1):19S. KoretzR . Personal communication 7 September 1999. ">Gallagher 1992</a>; <a href="./references#CD001880-bbs2-0020" title="HartgrinkHH . Personal communication 23 June 1999. HartgrinkHH , WilleJ , KönigP , HermansJ , BreslauPJ . Pressure sores and tube feeding in patients with a fracture of the hip: a randomized clinical trial. Clinical Nutrition1998;17:287‐92. ">Hartgrink 1998</a>; <a href="./references#CD001880-bbs2-0036" title="SullivanDH . Personal communication 10 February 2000. SullivanDH , NelsonCL , BoppMM , Puskarich‐MayCL , WallsRC . Nightly enteral nutrition support of elderly fracture patients: a phase I trial. Journal of the American College of Nutrition1998;17(1):155‐61. ">Sullivan 1998</a>), examined supplementation starting within five days of surgery and continued usually until oral intake was sufficient, or hospital discharge. </p> </section> <section id="CD001880-sec-0088"> <p><b>Nasogastric tube feeding and oral supplements</b></p> <p>One study involving 57 participants (<a href="./references#CD001880-bbs2-0037" title="SullivanDH . Personal communication 14 April 2006. SullivanDH , NelsonCL , KlimbergVS , BoppMM . Nightly enteral nutrition support of elderly hip fracture patients: a pilot study. Journal of the American College of Nutrition2004;23(6):683‐91. [MEDLINE: 15637216] ">Sullivan 2004</a>), examined supplementation postoperatively until oral intake was sufficient. </p> </section> <section id="CD001880-sec-0089"> <p><b>Intravenous feeding and oral supplements</b></p> <p>One study involving 80 participants (<a href="./references#CD001880-bbs2-0013" title="EnerothM . Personal communication 10 February 2009. EnerothM . Personal communication 17 March 2006. EnerothM , OlssonU‐B , ThorngrenK‐G . Combined parenteral and oral nutritional supplementation decreases fracture‐related complications. A prospective randomised trial of 80 patients with hip fractures. Journal of Bone and Joint Surgery ‐ British Volume2006;88(Suppl 1):44. EnerothM , OlssonU‐B , ThorngrenK‐G . Insufficient fluid and energy intake in hospitalised patients with hip fracture. A prospective randomised study of 80 patients. Clinical Nutrition2005;24:297‐303. [MEDLINE: 15784492] EnerothM , OlssonUB , ThorngrenKG . Nutritional supplementation decreases hip fracture‐related complications. Clinical Orthopaedics and Related Research2006;(451):212‐7. [MEDLINE: 16770284] ">Eneroth 2006</a>) examined supplementation for the first 10 days in hospital. </p> </section> </section> <section id="CD001880-sec-0090"> <h6 class="title">High protein‐containing supplements versus low‐protein or non‐protein‐containing supplements</h6> <p>Protein supplementation was delivered within oral feeds, usually starting within a week of fracture and given for one to six months. This was assessed in four studies involving 371 participants (<a href="./references#CD001880-bbs2-0014" title="EspaulellaJ , GuyerH , Diaz‐EscriuF , Mellado‐NavasJA , CastellsM , PladevallM . Nutritional supplementation of elderly hip fracture patients. A randomized, double‐blind, placebo‐controlled trial. Age and Ageing2000;29(5):425‐31. [MEDLINE: 11108415] GuyerH . Personal communication 13 June 2000. ">Espaulella 2000</a>; <a href="./references#CD001880-bbs2-0028" title="JensenG . Personal communication 6 January 2005. NeumannM , FriedmannJ , RoyMA , JensenGL . Provision of high‐protein supplement for patients recovering from hip fracture. Nutrition2004;20(5):415‐9. [MEDLINE: 15105027] NeumannMM , FriedmannJM , JensenGL . Provision of high protein supplement for patients recovering from hip fracture. Journal of Parenteral and Enteral Nutrition2004;28(Suppl 1):S30. ">Neumann 2004</a>; <a href="./references#CD001880-bbs2-0032" title="BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. RizzoliR , SchürchMA , BonjourJP . Protein supplements after osteoporotic hip fracture. Annals of Internal Medicine1998;129:1076. SchürchM‐A , BonjourJ‐P , SlosmanD , RizzoliR . Protein supplements favourably influence the outcome after hip fracture [Un supplement proteique ameliore les suites d'une fracture du femur proximal]. Medecine et Hygiene1999;57(2271):1876‐8. SchürchMA , RizzoliR , SlosmanD , BonjourJP . Protein supplements increase serum IGF‐1 and decrease proximal femur bone loss in patients with a recent hip fracture. Osteoporosis 1996: Proceedings of the 1996 World Congress on Osteoporosis; 1996 May 18‐23; Amsterdam, The Netherlands. Amsterdam: Elsevier, 1996:327‐9. SchürchMA , RizzoliR , SlosmanD , VadasL , VergnaudP , BonjourJP . Protein supplements increase serum insulin‐like growth factor‐I levels and attenuate proximal femur bone loss in patients with recent hip fracture. A randomized, double‐blind, placebo‐controlled trial. Annals of Internal Medicine1998;128(10):801‐9. ">Schürch 1998</a>; <a href="./references#CD001880-bbs2-0039" title="BonjourJP , RapinCH , RizzoliR , TkatchL , DelmiM , ChevalleyT , et al. Hip fracture, femoral bone mineral density, and protein supply in elderly patients. In: MunroH , SchlierfG editor(s). Nutrition of the elderly. Nestle nutrition workshop series. Vol. 29, New York: Raven Press, 1992:151‐9. BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. BonjourJP , SchürchMA , RizzoliR . Nutritional aspects of hip fractures. Bone1996;18(Suppl 3):139S‐44S. BonjourJP , SchürchMA , RizzoliR . Proteins and bone health. Patholgie‐Biologie1997;45(1):57‐9. TkatchL , RapinCH , RizzoliR , SlosmanD , NydeggerV , VaseyH , et al. Benefits of oral protein supplementation in elderly patients with fracture of the proximal femur. Journal of the American College of Nutrition1992;11(5):519‐25. ">Tkatch 1992</a>). Whereas the protein supplement resulted in extra calories in the intervention group in <a href="./references#CD001880-bbs2-0039" title="BonjourJP , RapinCH , RizzoliR , TkatchL , DelmiM , ChevalleyT , et al. Hip fracture, femoral bone mineral density, and protein supply in elderly patients. In: MunroH , SchlierfG editor(s). Nutrition of the elderly. Nestle nutrition workshop series. Vol. 29, New York: Raven Press, 1992:151‐9. BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. BonjourJP , SchürchMA , RizzoliR . Nutritional aspects of hip fractures. Bone1996;18(Suppl 3):139S‐44S. BonjourJP , SchürchMA , RizzoliR . Proteins and bone health. Patholgie‐Biologie1997;45(1):57‐9. TkatchL , RapinCH , RizzoliR , SlosmanD , NydeggerV , VaseyH , et al. Benefits of oral protein supplementation in elderly patients with fracture of the proximal femur. Journal of the American College of Nutrition1992;11(5):519‐25. ">Tkatch 1992</a>, the energy content of both intervention and placebo groups were equivalent in <a href="./references#CD001880-bbs2-0014" title="EspaulellaJ , GuyerH , Diaz‐EscriuF , Mellado‐NavasJA , CastellsM , PladevallM . Nutritional supplementation of elderly hip fracture patients. A randomized, double‐blind, placebo‐controlled trial. Age and Ageing2000;29(5):425‐31. [MEDLINE: 11108415] GuyerH . Personal communication 13 June 2000. ">Espaulella 2000</a> and <a href="./references#CD001880-bbs2-0032" title="BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. RizzoliR , SchürchMA , BonjourJP . Protein supplements after osteoporotic hip fracture. Annals of Internal Medicine1998;129:1076. SchürchM‐A , BonjourJ‐P , SlosmanD , RizzoliR . Protein supplements favourably influence the outcome after hip fracture [Un supplement proteique ameliore les suites d'une fracture du femur proximal]. Medecine et Hygiene1999;57(2271):1876‐8. SchürchMA , RizzoliR , SlosmanD , BonjourJP . Protein supplements increase serum IGF‐1 and decrease proximal femur bone loss in patients with a recent hip fracture. Osteoporosis 1996: Proceedings of the 1996 World Congress on Osteoporosis; 1996 May 18‐23; Amsterdam, The Netherlands. Amsterdam: Elsevier, 1996:327‐9. SchürchMA , RizzoliR , SlosmanD , VadasL , VergnaudP , BonjourJP . Protein supplements increase serum insulin‐like growth factor‐I levels and attenuate proximal femur bone loss in patients with recent hip fracture. A randomized, double‐blind, placebo‐controlled trial. Annals of Internal Medicine1998;128(10):801‐9. ">Schürch 1998</a>. Moderate quantities of minerals and vitamins were also provided with the protein supplement in <a href="./references#CD001880-bbs2-0014" title="EspaulellaJ , GuyerH , Diaz‐EscriuF , Mellado‐NavasJA , CastellsM , PladevallM . Nutritional supplementation of elderly hip fracture patients. A randomized, double‐blind, placebo‐controlled trial. Age and Ageing2000;29(5):425‐31. [MEDLINE: 11108415] GuyerH . Personal communication 13 June 2000. ">Espaulella 2000</a> and <a href="./references#CD001880-bbs2-0032" title="BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. RizzoliR , SchürchMA , BonjourJP . Protein supplements after osteoporotic hip fracture. Annals of Internal Medicine1998;129:1076. SchürchM‐A , BonjourJ‐P , SlosmanD , RizzoliR . Protein supplements favourably influence the outcome after hip fracture [Un supplement proteique ameliore les suites d'une fracture du femur proximal]. Medecine et Hygiene1999;57(2271):1876‐8. SchürchMA , RizzoliR , SlosmanD , BonjourJP . Protein supplements increase serum IGF‐1 and decrease proximal femur bone loss in patients with a recent hip fracture. Osteoporosis 1996: Proceedings of the 1996 World Congress on Osteoporosis; 1996 May 18‐23; Amsterdam, The Netherlands. Amsterdam: Elsevier, 1996:327‐9. SchürchMA , RizzoliR , SlosmanD , VadasL , VergnaudP , BonjourJP . Protein supplements increase serum insulin‐like growth factor‐I levels and attenuate proximal femur bone loss in patients with recent hip fracture. A randomized, double‐blind, placebo‐controlled trial. Annals of Internal Medicine1998;128(10):801‐9. ">Schürch 1998</a>; none were in sufficient doses to detract from these being predominantly protein supplements. In <a href="./references#CD001880-bbs2-0028" title="JensenG . Personal communication 6 January 2005. NeumannM , FriedmannJ , RoyMA , JensenGL . Provision of high‐protein supplement for patients recovering from hip fracture. Nutrition2004;20(5):415‐9. [MEDLINE: 15105027] NeumannMM , FriedmannJM , JensenGL . Provision of high protein supplement for patients recovering from hip fracture. Journal of Parenteral and Enteral Nutrition2004;28(Suppl 1):S30. ">Neumann 2004</a> there were differences in vitamin and mineral intakes between the high‐ and lower‐protein supplements, and the carbohydrate intake in the lower‐protein supplement resulting in similar energy contents of the two supplements. </p> </section> <section id="CD001880-sec-0091"> <h6 class="title">Comparison of different protein sources</h6> <p>One study with 45 participants compared 20 g daily of oral casein protein versus 20 g of oral whey protein versus 15 g of oral whey protein and 5 g of essential amino acids in a ratio identical to casein, given from a mean of 10 days post‐fracture for a month (<a href="./references#CD001880-bbs2-0009" title="ChevalleyT . Personal communication 14 October 2014. ChevalleyT , HoffmeyerP , BonjourJ‐P , RizzoliR . Early serum IGF‐I response to oral protein supplements in elderly women with a recent hip fracture. Clinical Nutrition2010;29(1):78‐83. ">Chevalley 2010</a>). </p> </section> <section id="CD001880-sec-0092"> <h6 class="title">Vitamin supplementation versus control or lower dose supplementation</h6> <p>This comparison was based on four studies involving 335 participants (<a href="./references#CD001880-bbs2-0004" title="Bischoff‐FerrariH . Early rehabilitation after hip fracture. clinicaltrials.gov/ct2/show/NCT00133640 (accessed 7 September 2015). Bischoff‐FerrariH , Dawson‐HughesB , OravE , WillettW , EgliA , MaetzelA , et al. The economic consequences of hip fractures: impact of home exercise and high dose‐vitamin D. 32nd Annual Meeting of the American Society for Bone and Mineral Research Annual Meeting; 2010 Oct 15‐9; Toronto, Canada. (accessed 3 December 2015); Vol. www.asbmr.org/education/2010‐abstracts. Bischoff‐FerrariHA , Dawson‐HughesB , PlatzA , OravEJ , StahelinHB , WillettWC , et al. Effect of high‐dosage cholecalciferol and extended physiotherapy on complications after hip fracture. A randomized controlled trial. Archives of Internal Medicine2010;170(9):813‐20. ">Bischoff‐Ferrari 2010</a>; <a href="./references#CD001880-bbs2-0010" title="DayJJ . Personal communication 27 May 1999. DayJJ , BayerAJ , McMahonM , PathyMS , SpraggBP , RowlandsDC . Thiamine status, vitamin supplements and postoperative confusion. Age and Ageing1988;17:29‐34. ">Day 1988</a>; <a href="./references#CD001880-bbs2-0021" title="HoikkaV , AlhavaEM , AroA , KarjalainenP , RehnbergV . Treatment of osteoporosis with 1‐alpha‐hydroxycholecalciferol and calcium. Acta Medica Scandinavica1980;207(3):221‐4. [MEDLINE: 6989171] RobertsonJ . Personal communication 2 February 1999. ">Hoikka 1980</a>; <a href="./references#CD001880-bbs2-0029" title="PapaioannouA . A randomised, controlled comparison of vitamin D strategies in acute hip fracture patients. clinicaltrials.gov/show/NCT00424619 (accessed 4 December 2015). PapaioannouA , KennedyCC , GiangregorioL , IoannidisG , PritchardJ , HanleyDA , et al. A randomized controlled trial of vitamin D dosing strategies after acute hip fracture: no advantage of loading doses over daily supplementation. BMC Musculoskeletal Disorders2011;12:135. PapaioannouA , KennedyCC , IoannidisG , AdachiJD , HanleyD , GiangregorioL , et al. High versus low vitamin D in acute hip fracture patients: a randomised, controlled trial. Osteoporosis International2010;21(Suppl 1):S201. ">Papaioannou 2011</a>). <a href="./references#CD001880-bbs2-0010" title="DayJJ . Personal communication 27 May 1999. DayJJ , BayerAJ , McMahonM , PathyMS , SpraggBP , RowlandsDC . Thiamine status, vitamin supplements and postoperative confusion. Age and Ageing1988;17:29‐34. ">Day 1988</a> investigated intravenous thiamin (vitamin B1) and water soluble vitamins versus control. <a href="./references#CD001880-bbs2-0021" title="HoikkaV , AlhavaEM , AroA , KarjalainenP , RehnbergV . Treatment of osteoporosis with 1‐alpha‐hydroxycholecalciferol and calcium. Acta Medica Scandinavica1980;207(3):221‐4. [MEDLINE: 6989171] RobertsonJ . Personal communication 2 February 1999. ">Hoikka 1980</a> investigated the use of oral 1 mcg 1‐alpha‐hydroxycholecalciferol and 1 g calcium as calcium carbonate daily versus placebo and 1 g calcium as calcium carbonate daily for four months. <a href="./references#CD001880-bbs2-0004" title="Bischoff‐FerrariH . Early rehabilitation after hip fracture. clinicaltrials.gov/ct2/show/NCT00133640 (accessed 7 September 2015). Bischoff‐FerrariH , Dawson‐HughesB , OravE , WillettW , EgliA , MaetzelA , et al. The economic consequences of hip fractures: impact of home exercise and high dose‐vitamin D. 32nd Annual Meeting of the American Society for Bone and Mineral Research Annual Meeting; 2010 Oct 15‐9; Toronto, Canada. (accessed 3 December 2015); Vol. www.asbmr.org/education/2010‐abstracts. Bischoff‐FerrariHA , Dawson‐HughesB , PlatzA , OravEJ , StahelinHB , WillettWC , et al. Effect of high‐dosage cholecalciferol and extended physiotherapy on complications after hip fracture. A randomized controlled trial. Archives of Internal Medicine2010;170(9):813‐20. ">Bischoff‐Ferrari 2010</a> investigated daily 2000 IU vitamin D3 compared with daily 800 IU vitamin D3; all participants also received 1 g of calcium as calcium carbonate daily over one year. <a href="./references#CD001880-bbs2-0029" title="PapaioannouA . A randomised, controlled comparison of vitamin D strategies in acute hip fracture patients. clinicaltrials.gov/show/NCT00424619 (accessed 4 December 2015). PapaioannouA , KennedyCC , GiangregorioL , IoannidisG , PritchardJ , HanleyDA , et al. A randomized controlled trial of vitamin D dosing strategies after acute hip fracture: no advantage of loading doses over daily supplementation. BMC Musculoskeletal Disorders2011;12:135. PapaioannouA , KennedyCC , IoannidisG , AdachiJD , HanleyD , GiangregorioL , et al. High versus low vitamin D in acute hip fracture patients: a randomised, controlled trial. Osteoporosis International2010;21(Suppl 1):S201. ">Papaioannou 2011</a> compared an initial oral bolus dose of 100,000 IU vitamin D2 versus 50,000 IU vitamin D2 versus placebo; followed by 1000 IU vitamin D3 for 90 days in all groups. Interventions were commenced pre‐operatively or up to a mean of four days postoperatively and continued for between five days (<a href="./references#CD001880-bbs2-0010" title="DayJJ . Personal communication 27 May 1999. DayJJ , BayerAJ , McMahonM , PathyMS , SpraggBP , RowlandsDC . Thiamine status, vitamin supplements and postoperative confusion. Age and Ageing1988;17:29‐34. ">Day 1988</a>) and 3 to 12 months (<a href="./references#CD001880-bbs2-0004" title="Bischoff‐FerrariH . Early rehabilitation after hip fracture. clinicaltrials.gov/ct2/show/NCT00133640 (accessed 7 September 2015). Bischoff‐FerrariH , Dawson‐HughesB , OravE , WillettW , EgliA , MaetzelA , et al. The economic consequences of hip fractures: impact of home exercise and high dose‐vitamin D. 32nd Annual Meeting of the American Society for Bone and Mineral Research Annual Meeting; 2010 Oct 15‐9; Toronto, Canada. (accessed 3 December 2015); Vol. www.asbmr.org/education/2010‐abstracts. Bischoff‐FerrariHA , Dawson‐HughesB , PlatzA , OravEJ , StahelinHB , WillettWC , et al. Effect of high‐dosage cholecalciferol and extended physiotherapy on complications after hip fracture. A randomized controlled trial. Archives of Internal Medicine2010;170(9):813‐20. ">Bischoff‐Ferrari 2010</a>; <a href="./references#CD001880-bbs2-0021" title="HoikkaV , AlhavaEM , AroA , KarjalainenP , RehnbergV . Treatment of osteoporosis with 1‐alpha‐hydroxycholecalciferol and calcium. Acta Medica Scandinavica1980;207(3):221‐4. [MEDLINE: 6989171] RobertsonJ . Personal communication 2 February 1999. ">Hoikka 1980</a>; <a href="./references#CD001880-bbs2-0029" title="PapaioannouA . A randomised, controlled comparison of vitamin D strategies in acute hip fracture patients. clinicaltrials.gov/show/NCT00424619 (accessed 4 December 2015). PapaioannouA , KennedyCC , GiangregorioL , IoannidisG , PritchardJ , HanleyDA , et al. A randomized controlled trial of vitamin D dosing strategies after acute hip fracture: no advantage of loading doses over daily supplementation. BMC Musculoskeletal Disorders2011;12:135. PapaioannouA , KennedyCC , IoannidisG , AdachiJD , HanleyD , GiangregorioL , et al. High versus low vitamin D in acute hip fracture patients: a randomised, controlled trial. Osteoporosis International2010;21(Suppl 1):S201. ">Papaioannou 2011</a>). </p> </section> <section id="CD001880-sec-0093"> <h6 class="title">Comparison of different vitamin D sources</h6> <p>One study with 95 participants compared oral vitamin D3 1000 IU/d and calcium carbonate equivalent to 600 mg/d to vitamin D2 1000 IU/d and calcium carbonate equivalent to 600 mg/d for three months from the inpatient stay (<a href="./references#CD001880-bbs2-0018" title="ChewG , GlendenningP , TarantoM , InderjeethC . Ergocalciferol and cholecalciferol induce comparable increases in vitamin D binding protein and free 25‐hydroxy‐vitamin D with no significant change in free 1,25‐dihydroxyvitamin D in hip fracture patients. 32nd Annual Meeting of the American Society for Bone and Mineral Research Annual Meeting; Oct 15‐9; Toronto, Canada 2010 (accessed 3 December 2015); Vol. www.asbmr.org/education/2010‐abstracts. GlendenningP , ChewGT , InderjeethCA , TarantoM , FraserWD . Calculated free and bioavailable vitamin D metabolite concentrations in vitamin D‐deficient hip fracture patients after supplementation with cholecalciferol and ergocalciferol. Bone2013;56(2):271‐5. GlendenningP , ChewGT , SeymourHM , GillettMJ , GoldswainPR , InderjeethCA , et al. Serum 25‐hydroxyvitamin D levels in vitamin D‐insufficent hip fracture patients after supplementation with ergocalciferol and cholecalciferol. Bone2009;45(5):870‐5. ">Glendenning 2009</a>). </p> </section> <section id="CD001880-sec-0094"> <h6 class="title">Iron supplementation versus control</h6> <p>Three studies with 568 participants investigated oral or intravenous iron supplementation compared with no intervention or placebo, started pre‐operatively or early postoperatively, for the first month after hip fracture (<a href="./references#CD001880-bbs2-0030" title="ParkerM . Personal communication 16 October 2014. ParkerM . Randomised trial comparing iron supplementation versus placebo in the treatment of anaemia after hip fracture. clinicaltrials.gov/show/NCT00919230 (accessed 4 December 2015). ParkerMJ . Iron supplementation for anemia after hip fracture surgery. A randomized trial of 300 patients. Journal of Bone and Joint Surgery ‐ American Volume2010;92(2):265‐9. ">Parker 2010</a>; <a href="./references#CD001880-bbs2-0031" title="PrasadN . Personal communication 24 October 2014. PrasadN , RajamaniV , HullinD , MurrayJM . Post‐operative anaemia in femoral neck fracture patients: does it need treatment? A single blinded prospective randomised controlled trial. Injury2009;40(10):1073‐6. ">Prasad 2009</a>; <a href="./references#CD001880-bbs2-0034" title="Serrano‐TrenasJA , UgaldePF , CabelloLM , ChoflesLC , LazaroPS , BenitezPC . Role of perioperative intravenous iron therapy in elderly hip fracture patients: a single‐center randomized controlled trial. Transfusion2011;51(1):97‐104. ">Serrano‐Trenas 2011</a>). </p> </section> <section id="CD001880-sec-0095"> <h6 class="title">Vitamin, mineral and amino acid supplementation versus control</h6> <p>One study with 107 participants investigated six weeks of an oral Restorfast supplement daily (L‐carnitine, calcium, magnesium, vitamin D3, L‐leucine) followed by 10 weeks of an oral Riabylex supplement daily (creatine, L‐carnitine, coenzyme Q10, nicotinamide, pantothenic acid, riboflavin) (<a href="./references#CD001880-bbs2-0033" title="DerossiD , BoA , BergonziR , ScivolettoG . Six‐week administration of a mixture of ergogenic and osteotrophic ingredients (RestorfastTM) improves the clinical course of elderly patients after hip fracture surgery [La somministrazione per sei settimane di un composto a base di sostanze osteotrofiche ed ergogene (RestorfastTM) migliora il decorso clinico in anziani sottoposti a chirurgia del femore]. Trends in Medicine2009;9(4):235‐42. ScivolettoG , BoA , DerossiD , BergonziR . Ten week administration of a polynutritional supplement with muscle tone action (RiabylexTM) improves the functional recovery in elderly hip fracture patients during home rehabilitation [In anziani in terapia riabilitativa domiciliare per pregressa frattura del femore, l'assunzione di un polinutriente ad azione muscolotonica (RiabylexTM) per 10 settimane migliora il recupero funzionale]. Trends in Medicine2010;10(2):113‐20. ">Scivoletto 2010</a>). The start time for the intervention was unclear. Creatine, coenzyme Q and L‐carnitine were also included but are not vitamins, minerals or amino acids, and can be manufactured by the body. </p> </section> <section id="CD001880-sec-0096"> <h6 class="title">Isonitrogenous ornithine alpha‐ketoglutarate versus peptide supplement</h6> <p>One study with 59 participants made this comparison (<a href="./references#CD001880-bbs2-0003" title="BeanN , ReddenJ , GoodeH , GrimbleG , AllisonSP . Double‐blind pilot trial, in elderly women with fractured femur, of ornithine alpha‐ketoglutarate v. a defined formula oral supplement. Proceedings of the Nutrition Society1994;53(3):203A. ">Bean 1994</a>). Ornithine alpha‐ketogluturate is metabolised in part to the amino acid glutamine, and is used to improve nitrogen conservation. The interventions were probably delivered orally, and were given for two months, start time unclear. </p> <p><b>Taurine versus placebo</b> </p> <p>One trial with 236 participants compared taurine with a placebo control (<a href="./references#CD001880-bbs2-0040" title="HoudijkAPJ . The effect of taurine on morbidity and mortality in the elderly hip fracture patient. clinicaltrials.gov/ct2/show/NCT00497978 (accessed 15 December 2015). VanStijnMF , BruinsAA , VermeulenMA , WitloxJ , TeerlinkT , SchoorlMG , et al. Effect of oral taurine on morbidity and mortality in elderly hip fracture patients: a randomized trial. International Journal of Molecular Sciences2015;16(6):12288‐306. [DOI: 10.3390/ijms160612288; PUBMED: 26035756] ">Van Stijn 2015</a>). Taurine or placebo capsules were started pre‐operatively and then supplied for six days postoperatively. Taurine, which has been described as a conditionally essential amino acid, is a semi‐essential amino acid with antioxidant action to theoretically reduce oxidative stress which can be induced by surgical tissue injury. Taurine was provided three times a day with a scheme of 2‐1‐2 capsules of 1.2 g taurine to reach 6 g per day daily dose. </p> </section> <section id="CD001880-sec-0097"> <h6 class="title">Dietetic assistants versus usual care</h6> <p>One study, involving 318 participants, tested the provision of extra assistance in the form of dietetic assistants, above that of dietitians and nurses, to help improve people's dietary intake (<a href="./references#CD001880-bbs2-0012" title="DuncanD . Personal communication March 15 2006. DuncanD , MurisonJ , MartinR , BeckS , JohansenA . Adequacy of oral feeding among elderly patients with hip fracture. Age and Ageing2001;30(Suppl 2):22. DuncanDG , BeckSJ . Using dietetic assistants to improve the outcome of hip fracture ‐ a randomised controlled trial of nutritional support in an acute trauma ward. Clinical Nutrition2002;21(Suppl 1):41. DuncanDG , BeckSJ , HoodK , JohansenA . Using dietetic assistants to improve the outcome of hip fracture ‐ a randomised controlled trial of nutritional support in an acute trauma ward. Age and Ageing2006;35(Suppl 3):i43. DuncanDG , BeckSJ , HoodK , JohansenA . Using dietetic assistants to improve the outcome of hip fracture: a randomised controlled trial of nutritional support in an acute trauma ward. Age and Ageing2006;35(2):148‐53. [MEDLINE: 16354710] DuncanDG , BeckSJ , JohansenA . Using dietetic assistants to improve the outcome of hip fracture ‐ a randomised controlled trial of nutritional support in an acute trauma ward. Journal of Human Nutrition and Dietetics2002;15:461. JohansenA . Using dietetic assistants to improve the outcome of hip fracture. In: The National Research Register, Issue 1, 2002. Oxford: Update Software2002. ">Duncan 2006</a>). The dietetic assistants gave support for a median of 16 to 17 days; the start time for this assistance was unclear. </p> </section> </section> </section> <section id="CD001880-sec-0098"> <h4 class="title">Excluded studies</h4> <p>We have given reasons for excluding 43 studies in the <a href="./references#CD001880-sec-0190" title="">Characteristics of excluded studies</a>. Six excluded studies were published in languages other than English, sufficient translation having been obtained to establish non‐eligibility. The major reasons for exclusion included studies not being RCTs (<a href="./references#CD001880-bbs2-0044" title="Bachrach‐LindstromM , UnossonM , EkAC , ArnqvistHJ . Assessment of nutritional status using biochemical and anthropometric variables in a nutritional intervention study of women with hip fracture. Clinical Nutrition2001;20(3):217‐23. ">Bachrach 2001</a>; <a href="./references#CD001880-bbs2-0045" title="BellJJ , BauerJD , CapraS , PulleRC . Multidisciplinary, multi‐modal nutritional care in acute hip fracture inpatients ‐ results of a pragmatic intervention. Clinical Nutrition2014;33(6):1101‐7. [DOI: 10.1016/j.clnu.2013.12.003; PUBMED: 24388594] ">Bell 2014</a>; <a href="./references#CD001880-bbs2-0048" title="BradleyCF , KozakC . Nursing care and management of the elderly hip fractured patient. Journal of Gerontological Nursing1995;21:15‐22. ">Bradley 1995</a>; <a href="./references#CD001880-bbs2-0054" title="GiaccagliaG , MalagùU , AntonelliM , BoschiS , TabarroniI . Nutritional support in hip fracture operations on the elderly. Experience and results [Il supporto nutrizionale negli interventi di frattura dell'anca nell'anziano. Esperienze e risultati]. Minerva Anestesiologica1986;52(11):397‐400. ">Giaccaglia 1986</a>; <a href="./references#CD001880-bbs2-0056" title="GrothF . Effects of wheat bran in the diet of postsurgical orthopaedic patients to prevent constipation. Orthopaedic Nursing1988;7(4):41‐6. ">Groth 1988</a>; <a href="./references#CD001880-bbs2-0057" title="GunnarssonAK , LonnK , GunningbergL . Does nutritional intervention for patients with hip fractures reduce postoperative complications and improve rehabilitation?. Journal of Clinical Nursing2009;18(9):1325‐33. ">Gunnarsson 2009</a>; <a href="./references#CD001880-bbs2-0058" title="HarjuE , PunnonenR , TuimalaR , SalmiJ , ParonenI . Vitamin D and calcitonin treatment in patients with femoral neck fracture: a prospective controlled clinical study. The Journal of International Medical Research1989;17:226‐42. ">Harju 1989</a>; <a href="./references#CD001880-bbs2-0062" title="HoekstraJC , GoosenJH , DeWolfGS , VerheyenCC . Effectiveness of multidisciplinary nutritional care on nutritional intake, nutritional status and quality of life in patients with hip fractures: a controlled prospective cohort study. Clinical Nutrition2011;30(4):455‐61. ">Hoekstra 2011</a>; <a href="./references#CD001880-bbs2-0063" title="HolstM , RasmussenHH , LaursenMB , RasmussenS , PorupL , HaalsDS . Standard plan for nutrition treatment in hip fracture patients: room for improvement. Clinical Nutrition, Supplement2012;7(1):118‐9. ">Holst 2012</a>; <a href="./references#CD001880-bbs2-0065" title="KacmazZ , KasiciM . Effectiveness of bran supplement in older orthopaedic patients with constipation. Journal of Clinical Nursing2007;16(5):928‐36. [MEDLINE: 17462043] ">Kacmaz 2007</a>; <a href="./references#CD001880-bbs2-0069" title="DoshiMK , LawsonR , IngoeLE , ColliganJM , BartonJR , CobdenI . Effect of nutritional supplementation on clinical outcome in post‐operative orthopaedic patients. Clinical Nutrition1998;17 Suppl 1:30. LawsonR , DoshiMK , IngoeLE , ColliganJM , BartonJR , CobdenI . Compliance of orthopaedic patients with nutritional supplementation. Proceedings of the Nutrition Society1998;57:91A. LawsonRM , DoshiMK , BartonJR , CobdenI . The effect of unselected post‐operative nutritional supplementation on nutritional status and clinical outcome of orthopaedic patients. Clinical Nutrition2003;22(1):39‐46. LawsonRM , DoshiMK , IngoeLE , ColliganJM , BartonJR , CobdenI . Compliance of orthopaedic patients with postoperative oral nutritional supplementation. Clinical Nutrition2000;19(3):171‐5. ">Lawson 2003</a>; <a href="./references#CD001880-bbs2-0075" title="RavetzE . The effect of a protein supplement in the nutrition of the aged. Geriatrics1959;14:567‐73. ">Ravetz 1959</a>; <a href="./references#CD001880-bbs2-0078" title="TasslerH . Changes in protein fraction and blood glucose level of aged injured patients with standardized oral nutrition [Veranderungen des proteinstatus und der blutzuckerspiegel beim alteren traumatisierten patienten unter standardisierter peroraler ernahrung]. Unfallheilkunde1981;84(5):213‐5. ">Tassler 1981</a>); studies not recruiting (or presenting separate data for) people who had sustained a hip fracture (<a href="./references#CD001880-bbs2-0049" title="BrockerP , VellasB , AlbaredeJ‐L , PoynardT . A two‐centre, randomized, double‐blind trial of ornithine oxoglutarate in 194 elderly, ambulatory, convalescent subjects. Age and Ageing1994;23:303‐6. VellasB , PoynardP , et al. Effects of ornithine alpha‐ketoglutarate on elderly malnourished patients: a double‐blind study. Journal of Parenteral and Enteral Nutrition1993;17(1):34S. ">Brocker 1994</a>; <a href="./references#CD001880-bbs2-0050" title="AuL , CameronI , KurrleS , UyC . Effectiveness of oral nutritional supplementation for older women with hip and other fractures. Australian Society of Geriatric Medicine Annual Scientific Meeting; 2003 June 16‐18; Melbourne (Australia). 2003. CameronID . Personal communication. 26 November 2014. CameronID , KurrleSE , UyC , LockwoodKA , AuL , SchaafsmaFG . Effectiveness of oral nutritional supplementation for older women after fracture: rationale, design and study of the feasibility of a randomized controlled study. BMC Geriatrics2011;11:32. ">Cameron 2011</a>; <a href="./references#CD001880-bbs2-0055" title="GoldsmithRS , WoodhouseCF , IngbarSH , SegalD . Effect of phosphate supplements in patients with fractures. Lancet1967;i:687‐90. ">Goldsmith 1967</a>; <a href="./references#CD001880-bbs2-0061" title="HitzMF , JensenJE , EskildsenPC . Bone mineral density and bone markers in patients with a recent low‐energy fracture: effect of 1 y of treatment with calcium and vitamin D. American Journal of Clinical Nutrition2007;86(1):251‐9. ">Hitz 2007</a>; <a href="./references#CD001880-bbs2-0067" title="LarssonJ , UnossonM , EkAC , NilssonL , ThorslundS , BjurulfP . Effect of dietary supplement on nutritional status and clinical outcome in 501 geriatric patients ‐ a randomised study. Clinical Nutrition1990;9(4):179‐84. [EMBASE: 1990259199] ">Larsson 1990</a>; <a href="./references#CD001880-bbs2-0068" title="LauqueS , Arnaud‐BattandierF , MansourianR , GuigozY , PaintinM , NourhashemiF , et al. Protein‐energy oral supplementation in malnourished nursing‐home residents. A controlled trial. Age and Ageing2000;29(1):51‐6. [MEDLINE: 10690696] ">Lauque 2000</a>; <a href="./references#CD001880-bbs2-0069" title="DoshiMK , LawsonR , IngoeLE , ColliganJM , BartonJR , CobdenI . Effect of nutritional supplementation on clinical outcome in post‐operative orthopaedic patients. Clinical Nutrition1998;17 Suppl 1:30. LawsonR , DoshiMK , IngoeLE , ColliganJM , BartonJR , CobdenI . Compliance of orthopaedic patients with nutritional supplementation. Proceedings of the Nutrition Society1998;57:91A. LawsonRM , DoshiMK , BartonJR , CobdenI . The effect of unselected post‐operative nutritional supplementation on nutritional status and clinical outcome of orthopaedic patients. Clinical Nutrition2003;22(1):39‐46. LawsonRM , DoshiMK , IngoeLE , ColliganJM , BartonJR , CobdenI . Compliance of orthopaedic patients with postoperative oral nutritional supplementation. Clinical Nutrition2000;19(3):171‐5. ">Lawson 2003</a>; <a href="./references#CD001880-bbs2-0074" title="PedersenPU . Dietary intervention in elderly patients prevents loss of activities of daily living after orthopaedic surgery [Kostintervention forebygger postoperativt aktivitetstab hos aeldre ortopaedkirurgiske patienter]. Videnskab &amp; Sygepleje1999;43:52‐74. PedersenPU . Nutritional care: the effectiveness of actively involving older patients. Journal of Clinical Nursing2005;14:247‐55. [MEDLINE: 15669934] PedersenPU , CameronU , JensenL . Active involvement of elderly surgical orthopaedic patients in their own dietary care increases postoperative energy and protein intake [Aktiv inddragelse af aeldre ortopaedkirurgiske patienter i egen kostforplejning oger energi‐ og proteinindtagelsen postoperativt]. Videnskab &amp; Sygepleje1999;21:28‐44. ">Pedersen 1999</a>; <a href="./references#CD001880-bbs2-0081" title="VolkertD , HübschS , OsterP , SchlierfG . Nutritional support and functional status in undernourished geriatric patients during hospitalization and 6‐month follow‐up. Aging1996;8(6):386‐95. ">Volkert 1996</a>); and studies not presenting the outcomes of interest (<a href="./references#CD001880-bbs2-0046" title="BeringerTR , ArdillJ , TaggartHM . Effect of calcium and stanozolol on calcitonin secretion in patients with femoral neck fracture. Bone and Mineral1986;1(4):289‐95. ">Beringer 1986</a>; <a href="./references#CD001880-bbs2-0047" title="BoudvilleAC , BruceDG , JarmanA , CollinsT . Do nutritional supplements reduce subsequent food intake in hip fracture patients?. Internal Medicine Journal2002;32(Suppl):A33. ">Boudville 2002</a>; <a href="./references#CD001880-bbs2-0053" title="GegerleP , BengoaJM , DelmiM , RapinCH , LoizeauE , VaseyH . Dietary survey on the effect of an oral nutritional supplement after femoral neck fracture [Enquete alimentaire apres fracture du col du femur. Effet d'un supplement dietetique sur les apports nutritionnels]. Schweizerische Rundschau fur Medizin Praxis1986;75:933‐5. ">Gegerle 1986</a>; <a href="./references#CD001880-bbs2-0077" title="StummRE , ThomasMS , CoombesJ , GreenhillJ , HayJ . Managing constipation in elderly orthopaedic patients using either pear juice or a high fibre supplement. Australian Journal of Nutrition and Dietetics2001;58(3):181‐5. ">Stumm 2001</a>; <a href="./references#CD001880-bbs2-0083" title="WongSY , LauEM , LauWW , LynnHS . Is dietary counselling effective in increasing dietary calcium, protein and energy intake in patients with osteoporotic fractures? A randomized controlled clinical trial. Journal of Human Nutrition and Dietetics2004;17:359‐64. [MEDLINE: 15250845] ">Wong 2004</a>; <a href="./references#CD001880-bbs2-0084" title="ZauberNP , ZauberAG , GordonFJ , TillisAC , LeedsHC , BermanE , et al. Iron supplementation after femoral head replacement for patients with normal iron stores. JAMA1992;267(4):525‐7. ">Zauber 1992</a>). </p> <section id="CD001880-sec-0099"> <h5 class="title">Ongoing studies</h5> <p>We have given details of seven ongoing trials in the <a href="./references#CD001880-sec-0192" title="">Characteristics of ongoing studies</a>. Of the ongoing studies, two (<a href="./references#CD001880-bbs2-0093" title="HarperM . Does Intravenous iron therapy reduce the need for blood transfusion and improve post operative blood count following surgery for broken neck of femur. www.anzctr.org.au/TrialSearch.aspx?searchTxt=362379&amp;isBasic=True (accessed 23 September 2016). ">ACTRN12612000448842</a>; <a href="./references#CD001880-bbs2-0097" title="RowlandsM , ForwardDP , SahotaO , MoppettIK . The effect of intravenous iron on postoperative transfusion requirements in hip fracture patients: study protocol for a randomized controlled trial. Trials2013;14(1):288. ">Rowlands</a>) with a total of 350 participants will examine the use of intravenous iron supplementation. The size of the trial by <a href="./references#CD001880-bbs2-0094" title="HoudijkAP . Personal communication 18 September 2014. HoudijkAP . The effect of taurine on morbidity and mortality in the elderly hip fracture patient. clinicaltrials.gov/show/NCT00497978 (accessed 8 November 2009). ">NCT00497978</a>, which will examine the use of taurine supplementation, is unclear. <a href="./references#CD001880-bbs2-0091" title="MillerM . Personal communication 7 September 2014. MillerM . Does a high dose fish oil intervention improve outcomes in older adults recovering from hip fracture?. www.anzctr.org.au/ACTRN12609000241235.aspx (accessed 8 November 2009). ">ACTRN12609000241235</a> will recruit 150 participants to examine the effect of fish oils compared with other oils. In a trial with 340 participants, <a href="./references#CD001880-bbs2-0092" title="MakJ . Replenishment of Vitamin D in hip fractured patients (REVITAHIP) trial. www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=335465&amp;isReview=true (accessed 23 September 2016). MakJC , MasonR , KleinL , CameronID . Improving mobility and reducing disability in older people through early high‐dose vitamin D replacement following hip fracture: a protocol for a randomized controlled trial and economic evaluation. Geriatric Orthopaedic Surgery and Rehabiliation2011;2(3):94‐9. MakJS , KleinLA , FinneganT , MasonRS , CameronID . An initial loading‐dose vitamin D versus placebo after hip fracture surgery: baseline characteristics of a randomized controlled trial (REVITAHIP). BMC Geriatrics2014;14:101. Mak , JC , KleinLA , MasonRS , CameronID . An initial loading‐dose vitamin D versus placebo after hip fracture surgery: gait velocity, falls and mortality in the REVITAHIP study. Fragility Fracture Network Conference, 2014 Sep 4‐6; Madrid. 2014. ">ACTRN12610000392066</a> will examine the use of oral 250,000 IU vitamin D3 compared with placebo. <a href="./references#CD001880-bbs2-0096" title="Bischoff‐FerrariH . Hip fracture surgery and oral nutritional supplements (HIATUS). clinicaltrials.gov/ct2/show/NCT01505985 (accessed 9 December 2015). ">NCT01505985</a> and <a href="./references#CD001880-bbs2-0095" title="MalafarinaV . Hyperprotein nutritional intervention in elderly patients with hip fracture and sarcopenia (HIPERPROT). clinicaltrials.gov/ct2/show/NCT01404195 (accessed 4 December 2015). MalafarinaV , Uriz‐OtanoF , Gil‐GuerreroL , IniestaR , ZuletMA , MartinezJA . Study protocol: high‐protein nutritional intervention based on β‐hydroxy‐β‐methylbutirate, vitamin D3 and calcium on obese and lean aged patients with hip fractures and sarcopenia. The HIPERPROT‐GER study. Maturitas2013;76(2):123‐8. ">NCT01404195</a> will examine the use of oral multinutrient supplements compared with placebo or usual care in a total of 124 participants. </p> </section> <section id="CD001880-sec-0100"> <h5 class="title">Studies awaiting classification</h5> <p>We have given details of the six studies in this category in the <a href="./references#CD001880-sec-0191" title="">Characteristics of studies awaiting classification</a>. We have requested further details from the trial investigators, where required. </p> </section> </section> </section> <section id="CD001880-sec-0101"> <h3 class="title">Risk of bias in included studies</h3> <p>The quality of trial methodology, as reported, was disappointing and we could not rule out risk of bias associated with poor trial methods. Many of the trials failed to report trial methodology in sufficient detail. We obtained additional information on methods for nine trials (<a href="./references#CD001880-bbs2-0007" title="BrownKM . Personal communicationMay 1999. BrownKM , SeabrookNA . Effect of nutrition on recovery after fractured femur. Medical Audit News1992;2(1):10‐2. BrownKM , SeabrookNA . Nutritional influences on recovery and length of hospital stay in elderly women following femoral fracture. Proceedings of the Nutrition Society1992;51(2):132A. ">Brown 1992b</a>; <a href="./references#CD001880-bbs2-0008" title="BruceD . Personal communication. October 2003. BruceD , LauranceI , McGuinessM , RidleyM , GoldswainP . Nutritional supplements after hip fracture: poor compliance limits effectiveness. Clinical Nutrition2003;22(5):497‐500. [MEDLINE: 14512038] ">Bruce 2003</a>; <a href="./references#CD001880-bbs2-0010" title="DayJJ . Personal communication 27 May 1999. DayJJ , BayerAJ , McMahonM , PathyMS , SpraggBP , RowlandsDC . Thiamine status, vitamin supplements and postoperative confusion. Age and Ageing1988;17:29‐34. ">Day 1988</a>; <a href="./references#CD001880-bbs2-0014" title="EspaulellaJ , GuyerH , Diaz‐EscriuF , Mellado‐NavasJA , CastellsM , PladevallM . Nutritional supplementation of elderly hip fracture patients. A randomized, double‐blind, placebo‐controlled trial. Age and Ageing2000;29(5):425‐31. [MEDLINE: 11108415] GuyerH . Personal communication 13 June 2000. ">Espaulella 2000</a>; <a href="./references#CD001880-bbs2-0019" title="HankinsC . Dietary supplementation with sustagen in elderly patients with fractured neck of femur [MSc dissertation]. Sydney (Australia): University of Sydney, 1996. HankinsC . Personal communication 11 June 1999. ">Hankins 1996</a>; <a href="./references#CD001880-bbs2-0020" title="HartgrinkHH . Personal communication 23 June 1999. HartgrinkHH , WilleJ , KönigP , HermansJ , BreslauPJ . Pressure sores and tube feeding in patients with a fracture of the hip: a randomized clinical trial. Clinical Nutrition1998;17:287‐92. ">Hartgrink 1998</a>; <a href="./references#CD001880-bbs2-0022" title="HouwingR . Personal communication 29 October 2003. HouwingR , RozendaalM , Wouters‐WesselingW , BeulensJ , BuskensE , HaalboomJ . The effect of nutritional supplementation on the prevention of pressure ulcers (PU) in hip‐fracture patients. Clinical Nutrition2002;21(Suppl 1):84. HouwingRH , RozendaalM , Wouters‐WesselingW , BeulensJW , BuskensE , HaalboomJR . A randomised, double‐blind assessment of the effect of nutritional supplementation on the prevention of pressure ulcers in hip‐fracture patients. Clinical Nutrition2003;22(4):401‐5. [MEDLINE: 12880608] ">Houwing 2003</a>; <a href="./references#CD001880-bbs2-0024" title="LuoM . Personal communication 17 November 2014. LuoM , GolubevG , KlyukvinI , ReznikL , KuropatkinG , OliverJS , et al. Oral nutrition supplement improved nutritional status in malnourished hip fracture patients: a randomized controlled study. Journal of Scientific Research and Reports2015;4(6):480‐9. LuoM , GolybevG , KlyukvinI , ReznikL , KuropatkinG , VossAC . Oral nutritional supplement (ONS) improved nutritional status in malnourished patients receiving hip fracture surgery. Clinical Nutrition Supplements2011;6:151. SwearenginB . Effect of a medical food supplement in hospitalized patients recovering from surgery. clinicaltrials.gov/ct2/show/NCT01011608 (accessed 4 December 2015). ">Luo 2015</a>; <a href="./references#CD001880-bbs2-0036" title="SullivanDH . Personal communication 10 February 2000. SullivanDH , NelsonCL , BoppMM , Puskarich‐MayCL , WallsRC . Nightly enteral nutrition support of elderly fracture patients: a phase I trial. Journal of the American College of Nutrition1998;17(1):155‐61. ">Sullivan 1998</a>). We have summarised the risk of bias judgements in <a href="#CD001880-fig-0002">Figure 2</a> and <a href="#CD001880-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD001880-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies" data-id="CD001880-fig-0002" src="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies </p> </div> </div> </div> <div class="figure" id="CD001880-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study" data-id="CD001880-fig-0003" src="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study </p> </div> </div> </div> <section id="CD001880-sec-0102"> <h4 class="title">Allocation</h4> <section id="CD001880-sec-0103"> <h5 class="title">Sequence generation</h5> <p>We judged random sequence generation as adequate resulting in low risk of bias in 13 trials (32%) (<a href="./references#CD001880-bbs2-0001" title="AnbarR , BelooseskyY , CohenJ , MadarZ , WeissA , TheillaM , et al. Tight calorie control in geriatric patients following hip fracture decreases complications: a randomized, controlled study. Clinical Nutrition2014;33:23‐8. AnbarR , BelooseskyY , MadarZ , TheillaM , Koren‐HakimT , WeissA , et al. Tight calorie control (TICACOS) in geriatric hip fracture patients. Clinical Nutrition, Supplement2012;7(1):18. AnbarR , BelooseskyY , MadarZ , TheillaM , Koren‐HakimT , WeissA , et al. Tight calorie control in geriatric hip fracture patients: preliminary results of the geriatric TICACOS study. Clinical Nutrition, Supplement2011;6(1):155. SingerP . Tight caloric balance in geriatric patients (TICACOSiGP). clinicaltrials.gov/show/NCT01735435 (accessed 3 December 2015). ">Anbar 2014</a>; <a href="./references#CD001880-bbs2-0004" title="Bischoff‐FerrariH . Early rehabilitation after hip fracture. clinicaltrials.gov/ct2/show/NCT00133640 (accessed 7 September 2015). Bischoff‐FerrariH , Dawson‐HughesB , OravE , WillettW , EgliA , MaetzelA , et al. The economic consequences of hip fractures: impact of home exercise and high dose‐vitamin D. 32nd Annual Meeting of the American Society for Bone and Mineral Research Annual Meeting; 2010 Oct 15‐9; Toronto, Canada. (accessed 3 December 2015); Vol. www.asbmr.org/education/2010‐abstracts. Bischoff‐FerrariHA , Dawson‐HughesB , PlatzA , OravEJ , StahelinHB , WillettWC , et al. Effect of high‐dosage cholecalciferol and extended physiotherapy on complications after hip fracture. A randomized controlled trial. Archives of Internal Medicine2010;170(9):813‐20. ">Bischoff‐Ferrari 2010</a>; <a href="./references#CD001880-bbs2-0009" title="ChevalleyT . Personal communication 14 October 2014. ChevalleyT , HoffmeyerP , BonjourJ‐P , RizzoliR . Early serum IGF‐I response to oral protein supplements in elderly women with a recent hip fracture. Clinical Nutrition2010;29(1):78‐83. ">Chevalley 2010</a>; <a href="./references#CD001880-bbs2-0010" title="DayJJ . Personal communication 27 May 1999. DayJJ , BayerAJ , McMahonM , PathyMS , SpraggBP , RowlandsDC . Thiamine status, vitamin supplements and postoperative confusion. Age and Ageing1988;17:29‐34. ">Day 1988</a>; <a href="./references#CD001880-bbs2-0014" title="EspaulellaJ , GuyerH , Diaz‐EscriuF , Mellado‐NavasJA , CastellsM , PladevallM . Nutritional supplementation of elderly hip fracture patients. A randomized, double‐blind, placebo‐controlled trial. Age and Ageing2000;29(5):425‐31. [MEDLINE: 11108415] GuyerH . Personal communication 13 June 2000. ">Espaulella 2000</a>; <a href="./references#CD001880-bbs2-0022" title="HouwingR . Personal communication 29 October 2003. HouwingR , RozendaalM , Wouters‐WesselingW , BeulensJ , BuskensE , HaalboomJ . The effect of nutritional supplementation on the prevention of pressure ulcers (PU) in hip‐fracture patients. Clinical Nutrition2002;21(Suppl 1):84. HouwingRH , RozendaalM , Wouters‐WesselingW , BeulensJW , BuskensE , HaalboomJR . A randomised, double‐blind assessment of the effect of nutritional supplementation on the prevention of pressure ulcers in hip‐fracture patients. Clinical Nutrition2003;22(4):401‐5. [MEDLINE: 12880608] ">Houwing 2003</a>; <a href="./references#CD001880-bbs2-0024" title="LuoM . Personal communication 17 November 2014. LuoM , GolubevG , KlyukvinI , ReznikL , KuropatkinG , OliverJS , et al. Oral nutrition supplement improved nutritional status in malnourished hip fracture patients: a randomized controlled study. Journal of Scientific Research and Reports2015;4(6):480‐9. LuoM , GolybevG , KlyukvinI , ReznikL , KuropatkinG , VossAC . Oral nutritional supplement (ONS) improved nutritional status in malnourished patients receiving hip fracture surgery. Clinical Nutrition Supplements2011;6:151. SwearenginB . Effect of a medical food supplement in hospitalized patients recovering from surgery. clinicaltrials.gov/ct2/show/NCT01011608 (accessed 4 December 2015). ">Luo 2015</a>; <a href="./references#CD001880-bbs2-0026" title="CrottyM . Personal communication 20 February 2009. DanielsLA , MillerM , BannermanE , WhiteheadC , CrottyM . Weight loss post lower limb fracture despite an intensive oral nutrition and exercise intervention. Clinical Nutrition2003;22 Suppl:S86. DanielsLA , MillerMD , BannermannE , CrottyM . Adherence to nutritional supplements amongst orthopedic patients: an important clinical and study design issue. Clinical Nutrition2005;24:535. MillerMD , BannermanE , DanielsLA , CrottyM . Lower limb fracture, cognitive impairment and risk of subsequent malnutrition: a prospective evaluation of dietary energy and protein intake on an orthopaedic ward. European Journal of Clinical Nutrition2006;60(7):853‐61. [MEDLINE: 16452913] MillerMD , CrottyM , WhiteheadC , BannermanE , DanielsLA . Nutritional supplementation and resistance training in nutritionally at risk older adults following lower limb fracture: a randomized controlled trial. Clinical Rehabilitation2006;20(4):311‐23. MillerMD , DanielsLA , BannermanE , CrottyM . Adherence to nutrition supplements among patients with a fall‐related lower limb fracture. Nutrition in Clinical Practice2005;20(5):569‐78. [MEDLINE: 16207699] ">Miller 2006</a>; <a href="./references#CD001880-bbs2-0029" title="PapaioannouA . A randomised, controlled comparison of vitamin D strategies in acute hip fracture patients. clinicaltrials.gov/show/NCT00424619 (accessed 4 December 2015). PapaioannouA , KennedyCC , GiangregorioL , IoannidisG , PritchardJ , HanleyDA , et al. A randomized controlled trial of vitamin D dosing strategies after acute hip fracture: no advantage of loading doses over daily supplementation. BMC Musculoskeletal Disorders2011;12:135. PapaioannouA , KennedyCC , IoannidisG , AdachiJD , HanleyD , GiangregorioL , et al. High versus low vitamin D in acute hip fracture patients: a randomised, controlled trial. Osteoporosis International2010;21(Suppl 1):S201. ">Papaioannou 2011</a>; <a href="./references#CD001880-bbs2-0031" title="PrasadN . Personal communication 24 October 2014. PrasadN , RajamaniV , HullinD , MurrayJM . Post‐operative anaemia in femoral neck fracture patients: does it need treatment? A single blinded prospective randomised controlled trial. Injury2009;40(10):1073‐6. ">Prasad 2009</a>; <a href="./references#CD001880-bbs2-0037" title="SullivanDH . Personal communication 14 April 2006. SullivanDH , NelsonCL , KlimbergVS , BoppMM . Nightly enteral nutrition support of elderly hip fracture patients: a pilot study. Journal of the American College of Nutrition2004;23(6):683‐91. [MEDLINE: 15637216] ">Sullivan 2004</a>; <a href="./references#CD001880-bbs2-0040" title="HoudijkAPJ . The effect of taurine on morbidity and mortality in the elderly hip fracture patient. clinicaltrials.gov/ct2/show/NCT00497978 (accessed 15 December 2015). VanStijnMF , BruinsAA , VermeulenMA , WitloxJ , TeerlinkT , SchoorlMG , et al. Effect of oral taurine on morbidity and mortality in elderly hip fracture patients: a randomized trial. International Journal of Molecular Sciences2015;16(6):12288‐306. [DOI: 10.3390/ijms160612288; PUBMED: 26035756] ">Van Stijn 2015</a>; <a href="./references#CD001880-bbs2-0041" title="Breedveld‐PetersJ , ReijvenPL , WyersCE , HendrikxAA , VerburgAD , ScholsJM , et al. Qualitative analysis of barriers and facilitators for nutritional intervention in hip fracture patients. Clinical Nutrition, Supplement2012;7(1):234. Breedveld‐PetersJJ , ReijvenPL , WyersCE , HendrikxAA , VerburgAD , ScholsJM , et al. Barriers and facilitators of nutritional intervention after hip fracture in integrated care as perceived by the different health care professionals: a qualitative interview study. e‐SPEN Journal2012;7(5):e182‐8. Breedveld‐PetersJJ , ReijvenPL , WyersCE , VanHeldenS , ArtsJJ , MeestersB , et al. Integrated nutritional intervention in the elderly after hip fracture. A process evaluation. Clinical Nutrition, Supplement2012;31(1):199‐205. Breedveld‐PetersJJ , ReijvenPL , WyersCE , VanHeldenS , ArtsJJ , MeestersB , et al. Integrated nutritional intervention in the elderly after hip fracture. A process evaluation. Clinical Nutrition, Supplement2012;7(1):43. DagneliePC . Effectiveness and cost‐effectiveness of nutritional screening and intervention in elderly subjects after hip fracture. clinicaltrials.gov/show/NCT00523575 (accessed 8 November 2009). WyersC , ReijvenPL , EversSM , WillemsPC , HeyligersIC , VerburgAD , et al. Cost‐effectiveness of nutritional intervention in hip fracture patients: a multi‐centre randomised controlled trial (RCT). Clinical Nutrition, Supplement2012;7(1):49. WyersCE . PhD thesis. Maastricht, the Netherlands: Maastricht University, 2012. WyersCE , Breedveld‐PetersJJ , ReijvenPL , ArtsC , ThomassenBJ , VerburgAD , et al. Effect of nutritional intervention on nutritional intake and status in hip fracture patients: a multicentre randomised controlled trial (RCT). Clinical Nutrition, Supplement2012;7(1):50‐1. WyersCE , Breedveld‐PetersJJ , ReijvenPL , VanHeldenS , GuldemondNA , SeverensJL , et al. Efficacy and cost‐effectiveness of nutritional intervention in elderly after hip fracture: design of a randomized controlled trial. BMC Public Health2010;10:212. WyersCE , ReijvenPL , EversSM , WillemsPC , HeyligersIC , VerburgAD , et al. Cost‐effectiveness of nutritional intervention in elderly subjects after hip fracture. A randomized controlled trial. Osteoporosis International2013;24(1):151‐62. ">Wyers 2013</a>). Four trials (10%) were quasi‐randomised and thus at high risk of bias (<a href="./references#CD001880-bbs2-0002" title="AllisonSP . Personal communication 15 February 2000. AllisonSP . Reflections on a study of nutrition support in patients with femur neck fracture. Nutrition1995;11(3):322‐7. BastowMD , RawlingsJ , AllisonSP . Benefits of supplementary tube feeding after fractured neck of femur: a randomised controlled trial. British Medical Journal (Clinical Research Edition)1983;287(6405):1589‐92. [MEDLINE: 6416514] BastowMD , RawlingsJ , AllisonSP . Controlled trial showing clinical benefit of tube feeding in elderly patients with fractured femur. Clinical Nutrition1984;2 Suppl:57. BastowMD , RawlingsJ , AllisonSP . Overnight nasogastric tube feeding. Clinical Nutrition1985;4(1):7‐11. ">Bastow 1983b</a>; <a href="./references#CD001880-bbs2-0007" title="BrownKM . Personal communicationMay 1999. BrownKM , SeabrookNA . Effect of nutrition on recovery after fractured femur. Medical Audit News1992;2(1):10‐2. BrownKM , SeabrookNA . Nutritional influences on recovery and length of hospital stay in elderly women following femoral fracture. Proceedings of the Nutrition Society1992;51(2):132A. ">Brown 1992b</a>; <a href="./references#CD001880-bbs2-0008" title="BruceD . Personal communication. October 2003. BruceD , LauranceI , McGuinessM , RidleyM , GoldswainP . Nutritional supplements after hip fracture: poor compliance limits effectiveness. Clinical Nutrition2003;22(5):497‐500. [MEDLINE: 14512038] ">Bruce 2003</a>; <a href="./references#CD001880-bbs2-0021" title="HoikkaV , AlhavaEM , AroA , KarjalainenP , RehnbergV . Treatment of osteoporosis with 1‐alpha‐hydroxycholecalciferol and calcium. Acta Medica Scandinavica1980;207(3):221‐4. [MEDLINE: 6989171] RobertsonJ . Personal communication 2 February 1999. ">Hoikka 1980</a>). The remaining trials we judged to be at unclear risk of risk because of insufficient details. </p> </section> <section id="CD001880-sec-0104"> <h5 class="title">Allocation concealment</h5> <p>Concealment of allocation was judged to be adequate resulting in low risk of bias in 19 (46%) trials (<a href="./references#CD001880-bbs2-0001" title="AnbarR , BelooseskyY , CohenJ , MadarZ , WeissA , TheillaM , et al. Tight calorie control in geriatric patients following hip fracture decreases complications: a randomized, controlled study. Clinical Nutrition2014;33:23‐8. AnbarR , BelooseskyY , MadarZ , TheillaM , Koren‐HakimT , WeissA , et al. Tight calorie control (TICACOS) in geriatric hip fracture patients. Clinical Nutrition, Supplement2012;7(1):18. AnbarR , BelooseskyY , MadarZ , TheillaM , Koren‐HakimT , WeissA , et al. Tight calorie control in geriatric hip fracture patients: preliminary results of the geriatric TICACOS study. Clinical Nutrition, Supplement2011;6(1):155. SingerP . Tight caloric balance in geriatric patients (TICACOSiGP). clinicaltrials.gov/show/NCT01735435 (accessed 3 December 2015). ">Anbar 2014</a>; <a href="./references#CD001880-bbs2-0005" title="Botella‐CarreteroJI . Personal communication 23 January 2009. Botella‐CarreteroJI , IglesiasB , BalsaJA , ZamarronI , ArrietaF , VazquezC . Effects of oral nutritional supplements in normally nourished or mildly undernourished geriatric patients after surgery for hip fracture: a randomized clinical trial. Journal of Parenteral and Enteral Nutrition2008;32(2):120‐8. [MEDLINE: 18407904] IglesiasB , Botella‐CarreteroJI , BalsaJA , ArrietaF , ZamarronI , VazquezC . Effects of oral nutritional supplements in geriatric patients after surgery for hip fracture. Clinical Nutrition Supplements2007;2(2):97. ">Botella‐Carretero 2008</a>; <a href="./references#CD001880-bbs2-0006" title="Botella‐CarreteroJI . Personal communication 26 October 2014. Botella‐CarreteroJI , IglesiasB , BalsaJA , ArrietaF , ZamarronI , VazquezC . Perioperative oral nutritional supplements in normally and mildly undernourished geriatric patients submitted to surgery for hip fracture: a randomized clinical trial. Clinical Nutrition2010;29(5):574‐9. ">Botella‐Carretero 2010</a>; <a href="./references#CD001880-bbs2-0009" title="ChevalleyT . Personal communication 14 October 2014. ChevalleyT , HoffmeyerP , BonjourJ‐P , RizzoliR . Early serum IGF‐I response to oral protein supplements in elderly women with a recent hip fracture. Clinical Nutrition2010;29(1):78‐83. ">Chevalley 2010</a>; <a href="./references#CD001880-bbs2-0012" title="DuncanD . Personal communication March 15 2006. DuncanD , MurisonJ , MartinR , BeckS , JohansenA . Adequacy of oral feeding among elderly patients with hip fracture. Age and Ageing2001;30(Suppl 2):22. DuncanDG , BeckSJ . Using dietetic assistants to improve the outcome of hip fracture ‐ a randomised controlled trial of nutritional support in an acute trauma ward. Clinical Nutrition2002;21(Suppl 1):41. DuncanDG , BeckSJ , HoodK , JohansenA . Using dietetic assistants to improve the outcome of hip fracture ‐ a randomised controlled trial of nutritional support in an acute trauma ward. Age and Ageing2006;35(Suppl 3):i43. DuncanDG , BeckSJ , HoodK , JohansenA . Using dietetic assistants to improve the outcome of hip fracture: a randomised controlled trial of nutritional support in an acute trauma ward. Age and Ageing2006;35(2):148‐53. [MEDLINE: 16354710] DuncanDG , BeckSJ , JohansenA . Using dietetic assistants to improve the outcome of hip fracture ‐ a randomised controlled trial of nutritional support in an acute trauma ward. Journal of Human Nutrition and Dietetics2002;15:461. JohansenA . Using dietetic assistants to improve the outcome of hip fracture. In: The National Research Register, Issue 1, 2002. Oxford: Update Software2002. ">Duncan 2006</a>; <a href="./references#CD001880-bbs2-0014" title="EspaulellaJ , GuyerH , Diaz‐EscriuF , Mellado‐NavasJA , CastellsM , PladevallM . Nutritional supplementation of elderly hip fracture patients. A randomized, double‐blind, placebo‐controlled trial. Age and Ageing2000;29(5):425‐31. [MEDLINE: 11108415] GuyerH . Personal communication 13 June 2000. ">Espaulella 2000</a>; <a href="./references#CD001880-bbs2-0016" title="FlodinL . Effects of bisphosphonates and nutritional supplementation after a hip fracture. clinicaltrials.gov/show/NCT01950169 2013 (accessed 3 December 2015). FlodinL . Personal communication. Personal communication 15 December 2014. FlodinL , SaafM , CederholmT , Al‐AniAN , AckermannPW , SanegardE , et al. Additive effects of nutritional supplementation, together with bisphosphonates, on bone mineral density after hip fracture: a 12‐month randomized controlled study. Clinical Interventions in Aging2014;9:1043‐50. ">Flodin 2014</a>; <a href="./references#CD001880-bbs2-0018" title="ChewG , GlendenningP , TarantoM , InderjeethC . Ergocalciferol and cholecalciferol induce comparable increases in vitamin D binding protein and free 25‐hydroxy‐vitamin D with no significant change in free 1,25‐dihydroxyvitamin D in hip fracture patients. 32nd Annual Meeting of the American Society for Bone and Mineral Research Annual Meeting; Oct 15‐9; Toronto, Canada 2010 (accessed 3 December 2015); Vol. www.asbmr.org/education/2010‐abstracts. GlendenningP , ChewGT , InderjeethCA , TarantoM , FraserWD . Calculated free and bioavailable vitamin D metabolite concentrations in vitamin D‐deficient hip fracture patients after supplementation with cholecalciferol and ergocalciferol. Bone2013;56(2):271‐5. GlendenningP , ChewGT , SeymourHM , GillettMJ , GoldswainPR , InderjeethCA , et al. Serum 25‐hydroxyvitamin D levels in vitamin D‐insufficent hip fracture patients after supplementation with ergocalciferol and cholecalciferol. Bone2009;45(5):870‐5. ">Glendenning 2009</a>; <a href="./references#CD001880-bbs2-0019" title="HankinsC . Dietary supplementation with sustagen in elderly patients with fractured neck of femur [MSc dissertation]. Sydney (Australia): University of Sydney, 1996. HankinsC . Personal communication 11 June 1999. ">Hankins 1996</a>; <a href="./references#CD001880-bbs2-0022" title="HouwingR . Personal communication 29 October 2003. HouwingR , RozendaalM , Wouters‐WesselingW , BeulensJ , BuskensE , HaalboomJ . The effect of nutritional supplementation on the prevention of pressure ulcers (PU) in hip‐fracture patients. Clinical Nutrition2002;21(Suppl 1):84. HouwingRH , RozendaalM , Wouters‐WesselingW , BeulensJW , BuskensE , HaalboomJR . A randomised, double‐blind assessment of the effect of nutritional supplementation on the prevention of pressure ulcers in hip‐fracture patients. Clinical Nutrition2003;22(4):401‐5. [MEDLINE: 12880608] ">Houwing 2003</a>; <a href="./references#CD001880-bbs2-0026" title="CrottyM . Personal communication 20 February 2009. DanielsLA , MillerM , BannermanE , WhiteheadC , CrottyM . Weight loss post lower limb fracture despite an intensive oral nutrition and exercise intervention. Clinical Nutrition2003;22 Suppl:S86. DanielsLA , MillerMD , BannermannE , CrottyM . Adherence to nutritional supplements amongst orthopedic patients: an important clinical and study design issue. Clinical Nutrition2005;24:535. MillerMD , BannermanE , DanielsLA , CrottyM . Lower limb fracture, cognitive impairment and risk of subsequent malnutrition: a prospective evaluation of dietary energy and protein intake on an orthopaedic ward. European Journal of Clinical Nutrition2006;60(7):853‐61. [MEDLINE: 16452913] MillerMD , CrottyM , WhiteheadC , BannermanE , DanielsLA . Nutritional supplementation and resistance training in nutritionally at risk older adults following lower limb fracture: a randomized controlled trial. Clinical Rehabilitation2006;20(4):311‐23. MillerMD , DanielsLA , BannermanE , CrottyM . Adherence to nutrition supplements among patients with a fall‐related lower limb fracture. Nutrition in Clinical Practice2005;20(5):569‐78. [MEDLINE: 16207699] ">Miller 2006</a>; <a href="./references#CD001880-bbs2-0027" title="MyintMW . Personal communication 6 January 2015. MyintMW , WuJ , WongE , ChanSP , ToTS , ChauMW , et al. Clinical benefits of oral nutritional supplementation for elderly hip fracture patients: a single blind randomised controlled trial. Age and Ageing2013;42(1):39‐45. MyintMWW . A randomized controlled study of nutritional intervention for geriatric hip fracture patients and its effect on rehabilitation outcomes. clinicaltrials.gov/ct2/show/NCT01088139 (accessed 4 December 2015). ">Myint 2013</a>; <a href="./references#CD001880-bbs2-0029" title="PapaioannouA . A randomised, controlled comparison of vitamin D strategies in acute hip fracture patients. clinicaltrials.gov/show/NCT00424619 (accessed 4 December 2015). PapaioannouA , KennedyCC , GiangregorioL , IoannidisG , PritchardJ , HanleyDA , et al. A randomized controlled trial of vitamin D dosing strategies after acute hip fracture: no advantage of loading doses over daily supplementation. BMC Musculoskeletal Disorders2011;12:135. PapaioannouA , KennedyCC , IoannidisG , AdachiJD , HanleyD , GiangregorioL , et al. High versus low vitamin D in acute hip fracture patients: a randomised, controlled trial. Osteoporosis International2010;21(Suppl 1):S201. ">Papaioannou 2011</a>; <a href="./references#CD001880-bbs2-0030" title="ParkerM . Personal communication 16 October 2014. ParkerM . Randomised trial comparing iron supplementation versus placebo in the treatment of anaemia after hip fracture. clinicaltrials.gov/show/NCT00919230 (accessed 4 December 2015). ParkerMJ . Iron supplementation for anemia after hip fracture surgery. A randomized trial of 300 patients. Journal of Bone and Joint Surgery ‐ American Volume2010;92(2):265‐9. ">Parker 2010</a>; <a href="./references#CD001880-bbs2-0034" title="Serrano‐TrenasJA , UgaldePF , CabelloLM , ChoflesLC , LazaroPS , BenitezPC . Role of perioperative intravenous iron therapy in elderly hip fracture patients: a single‐center randomized controlled trial. Transfusion2011;51(1):97‐104. ">Serrano‐Trenas 2011</a>; <a href="./references#CD001880-bbs2-0036" title="SullivanDH . Personal communication 10 February 2000. SullivanDH , NelsonCL , BoppMM , Puskarich‐MayCL , WallsRC . Nightly enteral nutrition support of elderly fracture patients: a phase I trial. Journal of the American College of Nutrition1998;17(1):155‐61. ">Sullivan 1998</a>; <a href="./references#CD001880-bbs2-0037" title="SullivanDH . Personal communication 14 April 2006. SullivanDH , NelsonCL , KlimbergVS , BoppMM . Nightly enteral nutrition support of elderly hip fracture patients: a pilot study. Journal of the American College of Nutrition2004;23(6):683‐91. [MEDLINE: 15637216] ">Sullivan 2004</a>; <a href="./references#CD001880-bbs2-0040" title="HoudijkAPJ . The effect of taurine on morbidity and mortality in the elderly hip fracture patient. clinicaltrials.gov/ct2/show/NCT00497978 (accessed 15 December 2015). VanStijnMF , BruinsAA , VermeulenMA , WitloxJ , TeerlinkT , SchoorlMG , et al. Effect of oral taurine on morbidity and mortality in elderly hip fracture patients: a randomized trial. International Journal of Molecular Sciences2015;16(6):12288‐306. [DOI: 10.3390/ijms160612288; PUBMED: 26035756] ">Van Stijn 2015</a>; <a href="./references#CD001880-bbs2-0041" title="Breedveld‐PetersJ , ReijvenPL , WyersCE , HendrikxAA , VerburgAD , ScholsJM , et al. Qualitative analysis of barriers and facilitators for nutritional intervention in hip fracture patients. Clinical Nutrition, Supplement2012;7(1):234. Breedveld‐PetersJJ , ReijvenPL , WyersCE , HendrikxAA , VerburgAD , ScholsJM , et al. Barriers and facilitators of nutritional intervention after hip fracture in integrated care as perceived by the different health care professionals: a qualitative interview study. e‐SPEN Journal2012;7(5):e182‐8. Breedveld‐PetersJJ , ReijvenPL , WyersCE , VanHeldenS , ArtsJJ , MeestersB , et al. Integrated nutritional intervention in the elderly after hip fracture. A process evaluation. Clinical Nutrition, Supplement2012;31(1):199‐205. Breedveld‐PetersJJ , ReijvenPL , WyersCE , VanHeldenS , ArtsJJ , MeestersB , et al. Integrated nutritional intervention in the elderly after hip fracture. A process evaluation. Clinical Nutrition, Supplement2012;7(1):43. DagneliePC . Effectiveness and cost‐effectiveness of nutritional screening and intervention in elderly subjects after hip fracture. clinicaltrials.gov/show/NCT00523575 (accessed 8 November 2009). WyersC , ReijvenPL , EversSM , WillemsPC , HeyligersIC , VerburgAD , et al. Cost‐effectiveness of nutritional intervention in hip fracture patients: a multi‐centre randomised controlled trial (RCT). Clinical Nutrition, Supplement2012;7(1):49. WyersCE . PhD thesis. Maastricht, the Netherlands: Maastricht University, 2012. WyersCE , Breedveld‐PetersJJ , ReijvenPL , ArtsC , ThomassenBJ , VerburgAD , et al. Effect of nutritional intervention on nutritional intake and status in hip fracture patients: a multicentre randomised controlled trial (RCT). Clinical Nutrition, Supplement2012;7(1):50‐1. WyersCE , Breedveld‐PetersJJ , ReijvenPL , VanHeldenS , GuldemondNA , SeverensJL , et al. Efficacy and cost‐effectiveness of nutritional intervention in elderly after hip fracture: design of a randomized controlled trial. BMC Public Health2010;10:212. WyersCE , ReijvenPL , EversSM , WillemsPC , HeyligersIC , VerburgAD , et al. Cost‐effectiveness of nutritional intervention in elderly subjects after hip fracture. A randomized controlled trial. Osteoporosis International2013;24(1):151‐62. ">Wyers 2013</a>). Allocation was unlikely to be concealed in three of the quasi‐randomised studies (<a href="./references#CD001880-bbs2-0002" title="AllisonSP . Personal communication 15 February 2000. AllisonSP . Reflections on a study of nutrition support in patients with femur neck fracture. Nutrition1995;11(3):322‐7. BastowMD , RawlingsJ , AllisonSP . Benefits of supplementary tube feeding after fractured neck of femur: a randomised controlled trial. British Medical Journal (Clinical Research Edition)1983;287(6405):1589‐92. [MEDLINE: 6416514] BastowMD , RawlingsJ , AllisonSP . Controlled trial showing clinical benefit of tube feeding in elderly patients with fractured femur. Clinical Nutrition1984;2 Suppl:57. BastowMD , RawlingsJ , AllisonSP . Overnight nasogastric tube feeding. Clinical Nutrition1985;4(1):7‐11. ">Bastow 1983b</a>; <a href="./references#CD001880-bbs2-0007" title="BrownKM . Personal communicationMay 1999. BrownKM , SeabrookNA . Effect of nutrition on recovery after fractured femur. Medical Audit News1992;2(1):10‐2. BrownKM , SeabrookNA . Nutritional influences on recovery and length of hospital stay in elderly women following femoral fracture. Proceedings of the Nutrition Society1992;51(2):132A. ">Brown 1992b</a>; <a href="./references#CD001880-bbs2-0008" title="BruceD . Personal communication. October 2003. BruceD , LauranceI , McGuinessM , RidleyM , GoldswainP . Nutritional supplements after hip fracture: poor compliance limits effectiveness. Clinical Nutrition2003;22(5):497‐500. [MEDLINE: 14512038] ">Bruce 2003</a>), which were judged to be at high risk of bias. The remaining trials were judged to be at unclear risk of risk because of insufficient details. </p> </section> </section> <section id="CD001880-sec-0105"> <h4 class="title">Blinding</h4> <p>We judged eight (20%) trials to be at low risk of performance bias (blinding of participants and personnel) (<a href="./references#CD001880-bbs2-0003" title="BeanN , ReddenJ , GoodeH , GrimbleG , AllisonSP . Double‐blind pilot trial, in elderly women with fractured femur, of ornithine alpha‐ketoglutarate v. a defined formula oral supplement. Proceedings of the Nutrition Society1994;53(3):203A. ">Bean 1994</a>; <a href="./references#CD001880-bbs2-0004" title="Bischoff‐FerrariH . Early rehabilitation after hip fracture. clinicaltrials.gov/ct2/show/NCT00133640 (accessed 7 September 2015). Bischoff‐FerrariH , Dawson‐HughesB , OravE , WillettW , EgliA , MaetzelA , et al. The economic consequences of hip fractures: impact of home exercise and high dose‐vitamin D. 32nd Annual Meeting of the American Society for Bone and Mineral Research Annual Meeting; 2010 Oct 15‐9; Toronto, Canada. (accessed 3 December 2015); Vol. www.asbmr.org/education/2010‐abstracts. Bischoff‐FerrariHA , Dawson‐HughesB , PlatzA , OravEJ , StahelinHB , WillettWC , et al. Effect of high‐dosage cholecalciferol and extended physiotherapy on complications after hip fracture. A randomized controlled trial. Archives of Internal Medicine2010;170(9):813‐20. ">Bischoff‐Ferrari 2010</a>; <a href="./references#CD001880-bbs2-0014" title="EspaulellaJ , GuyerH , Diaz‐EscriuF , Mellado‐NavasJA , CastellsM , PladevallM . Nutritional supplementation of elderly hip fracture patients. A randomized, double‐blind, placebo‐controlled trial. Age and Ageing2000;29(5):425‐31. [MEDLINE: 11108415] GuyerH . Personal communication 13 June 2000. ">Espaulella 2000</a>; <a href="./references#CD001880-bbs2-0018" title="ChewG , GlendenningP , TarantoM , InderjeethC . Ergocalciferol and cholecalciferol induce comparable increases in vitamin D binding protein and free 25‐hydroxy‐vitamin D with no significant change in free 1,25‐dihydroxyvitamin D in hip fracture patients. 32nd Annual Meeting of the American Society for Bone and Mineral Research Annual Meeting; Oct 15‐9; Toronto, Canada 2010 (accessed 3 December 2015); Vol. www.asbmr.org/education/2010‐abstracts. GlendenningP , ChewGT , InderjeethCA , TarantoM , FraserWD . Calculated free and bioavailable vitamin D metabolite concentrations in vitamin D‐deficient hip fracture patients after supplementation with cholecalciferol and ergocalciferol. Bone2013;56(2):271‐5. GlendenningP , ChewGT , SeymourHM , GillettMJ , GoldswainPR , InderjeethCA , et al. Serum 25‐hydroxyvitamin D levels in vitamin D‐insufficent hip fracture patients after supplementation with ergocalciferol and cholecalciferol. Bone2009;45(5):870‐5. ">Glendenning 2009</a>; <a href="./references#CD001880-bbs2-0022" title="HouwingR . Personal communication 29 October 2003. HouwingR , RozendaalM , Wouters‐WesselingW , BeulensJ , BuskensE , HaalboomJ . The effect of nutritional supplementation on the prevention of pressure ulcers (PU) in hip‐fracture patients. Clinical Nutrition2002;21(Suppl 1):84. HouwingRH , RozendaalM , Wouters‐WesselingW , BeulensJW , BuskensE , HaalboomJR . A randomised, double‐blind assessment of the effect of nutritional supplementation on the prevention of pressure ulcers in hip‐fracture patients. Clinical Nutrition2003;22(4):401‐5. [MEDLINE: 12880608] ">Houwing 2003</a>; <a href="./references#CD001880-bbs2-0029" title="PapaioannouA . A randomised, controlled comparison of vitamin D strategies in acute hip fracture patients. clinicaltrials.gov/show/NCT00424619 (accessed 4 December 2015). PapaioannouA , KennedyCC , GiangregorioL , IoannidisG , PritchardJ , HanleyDA , et al. A randomized controlled trial of vitamin D dosing strategies after acute hip fracture: no advantage of loading doses over daily supplementation. BMC Musculoskeletal Disorders2011;12:135. PapaioannouA , KennedyCC , IoannidisG , AdachiJD , HanleyD , GiangregorioL , et al. High versus low vitamin D in acute hip fracture patients: a randomised, controlled trial. Osteoporosis International2010;21(Suppl 1):S201. ">Papaioannou 2011</a>; <a href="./references#CD001880-bbs2-0032" title="BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. RizzoliR , SchürchMA , BonjourJP . Protein supplements after osteoporotic hip fracture. Annals of Internal Medicine1998;129:1076. SchürchM‐A , BonjourJ‐P , SlosmanD , RizzoliR . Protein supplements favourably influence the outcome after hip fracture [Un supplement proteique ameliore les suites d'une fracture du femur proximal]. Medecine et Hygiene1999;57(2271):1876‐8. SchürchMA , RizzoliR , SlosmanD , BonjourJP . Protein supplements increase serum IGF‐1 and decrease proximal femur bone loss in patients with a recent hip fracture. Osteoporosis 1996: Proceedings of the 1996 World Congress on Osteoporosis; 1996 May 18‐23; Amsterdam, The Netherlands. Amsterdam: Elsevier, 1996:327‐9. SchürchMA , RizzoliR , SlosmanD , VadasL , VergnaudP , BonjourJP . Protein supplements increase serum insulin‐like growth factor‐I levels and attenuate proximal femur bone loss in patients with recent hip fracture. A randomized, double‐blind, placebo‐controlled trial. Annals of Internal Medicine1998;128(10):801‐9. ">Schürch 1998</a>; <a href="./references#CD001880-bbs2-0040" title="HoudijkAPJ . The effect of taurine on morbidity and mortality in the elderly hip fracture patient. clinicaltrials.gov/ct2/show/NCT00497978 (accessed 15 December 2015). VanStijnMF , BruinsAA , VermeulenMA , WitloxJ , TeerlinkT , SchoorlMG , et al. Effect of oral taurine on morbidity and mortality in elderly hip fracture patients: a randomized trial. International Journal of Molecular Sciences2015;16(6):12288‐306. [DOI: 10.3390/ijms160612288; PUBMED: 26035756] ">Van Stijn 2015</a>). These trials generally had placebo interventions, or were comparisons of different kinds of supplement. We judged 29 trials at high risk of performance bias and four at unclear risk. </p> <p>We judged almost all trials (95%) to be at low risk of detection bias relating to blinding of outcome assessment for primary outcomes, with the exception of two trials reporting putative side effects of interventions (<a href="./references#CD001880-bbs2-0009" title="ChevalleyT . Personal communication 14 October 2014. ChevalleyT , HoffmeyerP , BonjourJ‐P , RizzoliR . Early serum IGF‐I response to oral protein supplements in elderly women with a recent hip fracture. Clinical Nutrition2010;29(1):78‐83. ">Chevalley 2010</a>; <a href="./references#CD001880-bbs2-0031" title="PrasadN . Personal communication 24 October 2014. PrasadN , RajamaniV , HullinD , MurrayJM . Post‐operative anaemia in femoral neck fracture patients: does it need treatment? A single blinded prospective randomised controlled trial. Injury2009;40(10):1073‐6. ">Prasad 2009</a>). Blinding of secondary or other outcomes was less likely to be judged low risk, with only six trials (15%) judged as being low risk of detection bias (<a href="./references#CD001880-bbs2-0004" title="Bischoff‐FerrariH . Early rehabilitation after hip fracture. clinicaltrials.gov/ct2/show/NCT00133640 (accessed 7 September 2015). Bischoff‐FerrariH , Dawson‐HughesB , OravE , WillettW , EgliA , MaetzelA , et al. The economic consequences of hip fractures: impact of home exercise and high dose‐vitamin D. 32nd Annual Meeting of the American Society for Bone and Mineral Research Annual Meeting; 2010 Oct 15‐9; Toronto, Canada. (accessed 3 December 2015); Vol. www.asbmr.org/education/2010‐abstracts. Bischoff‐FerrariHA , Dawson‐HughesB , PlatzA , OravEJ , StahelinHB , WillettWC , et al. Effect of high‐dosage cholecalciferol and extended physiotherapy on complications after hip fracture. A randomized controlled trial. Archives of Internal Medicine2010;170(9):813‐20. ">Bischoff‐Ferrari 2010</a>; <a href="./references#CD001880-bbs2-0014" title="EspaulellaJ , GuyerH , Diaz‐EscriuF , Mellado‐NavasJA , CastellsM , PladevallM . Nutritional supplementation of elderly hip fracture patients. A randomized, double‐blind, placebo‐controlled trial. Age and Ageing2000;29(5):425‐31. [MEDLINE: 11108415] GuyerH . Personal communication 13 June 2000. ">Espaulella 2000</a>; <a href="./references#CD001880-bbs2-0022" title="HouwingR . Personal communication 29 October 2003. HouwingR , RozendaalM , Wouters‐WesselingW , BeulensJ , BuskensE , HaalboomJ . The effect of nutritional supplementation on the prevention of pressure ulcers (PU) in hip‐fracture patients. Clinical Nutrition2002;21(Suppl 1):84. HouwingRH , RozendaalM , Wouters‐WesselingW , BeulensJW , BuskensE , HaalboomJR . A randomised, double‐blind assessment of the effect of nutritional supplementation on the prevention of pressure ulcers in hip‐fracture patients. Clinical Nutrition2003;22(4):401‐5. [MEDLINE: 12880608] ">Houwing 2003</a>; <a href="./references#CD001880-bbs2-0027" title="MyintMW . Personal communication 6 January 2015. MyintMW , WuJ , WongE , ChanSP , ToTS , ChauMW , et al. Clinical benefits of oral nutritional supplementation for elderly hip fracture patients: a single blind randomised controlled trial. Age and Ageing2013;42(1):39‐45. MyintMWW . A randomized controlled study of nutritional intervention for geriatric hip fracture patients and its effect on rehabilitation outcomes. clinicaltrials.gov/ct2/show/NCT01088139 (accessed 4 December 2015). ">Myint 2013</a>; <a href="./references#CD001880-bbs2-0029" title="PapaioannouA . A randomised, controlled comparison of vitamin D strategies in acute hip fracture patients. clinicaltrials.gov/show/NCT00424619 (accessed 4 December 2015). PapaioannouA , KennedyCC , GiangregorioL , IoannidisG , PritchardJ , HanleyDA , et al. A randomized controlled trial of vitamin D dosing strategies after acute hip fracture: no advantage of loading doses over daily supplementation. BMC Musculoskeletal Disorders2011;12:135. PapaioannouA , KennedyCC , IoannidisG , AdachiJD , HanleyD , GiangregorioL , et al. High versus low vitamin D in acute hip fracture patients: a randomised, controlled trial. Osteoporosis International2010;21(Suppl 1):S201. ">Papaioannou 2011</a>; <a href="./references#CD001880-bbs2-0040" title="HoudijkAPJ . The effect of taurine on morbidity and mortality in the elderly hip fracture patient. clinicaltrials.gov/ct2/show/NCT00497978 (accessed 15 December 2015). VanStijnMF , BruinsAA , VermeulenMA , WitloxJ , TeerlinkT , SchoorlMG , et al. Effect of oral taurine on morbidity and mortality in elderly hip fracture patients: a randomized trial. International Journal of Molecular Sciences2015;16(6):12288‐306. [DOI: 10.3390/ijms160612288; PUBMED: 26035756] ">Van Stijn 2015</a>). The remaining trials we judged to be at unclear risk of detection bias for both domains. </p> </section> <section id="CD001880-sec-0106"> <h4 class="title">Incomplete outcome data</h4> <p>We judged 15 trials to be at low risk of bias for incomplete outcome data (attrition bias) for primary outcomes. Fourteen trials were judged to be at high risk of bias in this category (<a href="./references#CD001880-bbs2-0006" title="Botella‐CarreteroJI . Personal communication 26 October 2014. Botella‐CarreteroJI , IglesiasB , BalsaJA , ArrietaF , ZamarronI , VazquezC . Perioperative oral nutritional supplements in normally and mildly undernourished geriatric patients submitted to surgery for hip fracture: a randomized clinical trial. Clinical Nutrition2010;29(5):574‐9. ">Botella‐Carretero 2010</a>; <a href="./references#CD001880-bbs2-0009" title="ChevalleyT . Personal communication 14 October 2014. ChevalleyT , HoffmeyerP , BonjourJ‐P , RizzoliR . Early serum IGF‐I response to oral protein supplements in elderly women with a recent hip fracture. Clinical Nutrition2010;29(1):78‐83. ">Chevalley 2010</a>; <a href="./references#CD001880-bbs2-0011" title="BonjourJP , RapinCH , RizzoliR , TkatchL , DelmiM , ChevalleyT , et al. Hip fracture, femoral bone mineral density, and protein supply in elderly patients. In: MunroHN , SchlierfG editor(s). Nutrition of the elderly. Nestlé nutrition workshop series. Vol. 29, New York: Raven Press, 1992:151‐9. [ISBN 0881678740 ] BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. BonjourJP , SchürchMA , RizzoliR . Nutritional aspects of hip fractures. Bone1996;18(3 Suppl):139S‐44S. BonjourJP , SchürchMA , RizzoliR . Proteins and bone health. Pathologie‐Biologie1997;45(1):57‐9. DelmiM , RapinC‐H , BengoaJ‐M , DelmasPD , VaseyH , BonjourJ‐P . Dietary supplementation in elderly patients with fractured neck of the femur. Lancet1990;335:1013‐6. [MEDLINE: 1970070] RapinCH , BengoaJM , KahnJM , DelmiM , BonjourJP , VaseyH . A prospective randomised control study of oral dietary supplementation in patients with fractured necks of femur. Journal of Parenteral and Enteral Nutrition1989;13(1):9S. ">Delmi 1990</a>; <a href="./references#CD001880-bbs2-0016" title="FlodinL . Effects of bisphosphonates and nutritional supplementation after a hip fracture. clinicaltrials.gov/show/NCT01950169 2013 (accessed 3 December 2015). FlodinL . Personal communication. Personal communication 15 December 2014. FlodinL , SaafM , CederholmT , Al‐AniAN , AckermannPW , SanegardE , et al. Additive effects of nutritional supplementation, together with bisphosphonates, on bone mineral density after hip fracture: a 12‐month randomized controlled study. Clinical Interventions in Aging2014;9:1043‐50. ">Flodin 2014</a>; <a href="./references#CD001880-bbs2-0018" title="ChewG , GlendenningP , TarantoM , InderjeethC . Ergocalciferol and cholecalciferol induce comparable increases in vitamin D binding protein and free 25‐hydroxy‐vitamin D with no significant change in free 1,25‐dihydroxyvitamin D in hip fracture patients. 32nd Annual Meeting of the American Society for Bone and Mineral Research Annual Meeting; Oct 15‐9; Toronto, Canada 2010 (accessed 3 December 2015); Vol. www.asbmr.org/education/2010‐abstracts. GlendenningP , ChewGT , InderjeethCA , TarantoM , FraserWD . Calculated free and bioavailable vitamin D metabolite concentrations in vitamin D‐deficient hip fracture patients after supplementation with cholecalciferol and ergocalciferol. Bone2013;56(2):271‐5. GlendenningP , ChewGT , SeymourHM , GillettMJ , GoldswainPR , InderjeethCA , et al. Serum 25‐hydroxyvitamin D levels in vitamin D‐insufficent hip fracture patients after supplementation with ergocalciferol and cholecalciferol. Bone2009;45(5):870‐5. ">Glendenning 2009</a>; <a href="./references#CD001880-bbs2-0024" title="LuoM . Personal communication 17 November 2014. LuoM , GolubevG , KlyukvinI , ReznikL , KuropatkinG , OliverJS , et al. Oral nutrition supplement improved nutritional status in malnourished hip fracture patients: a randomized controlled study. Journal of Scientific Research and Reports2015;4(6):480‐9. LuoM , GolybevG , KlyukvinI , ReznikL , KuropatkinG , VossAC . Oral nutritional supplement (ONS) improved nutritional status in malnourished patients receiving hip fracture surgery. Clinical Nutrition Supplements2011;6:151. SwearenginB . Effect of a medical food supplement in hospitalized patients recovering from surgery. clinicaltrials.gov/ct2/show/NCT01011608 (accessed 4 December 2015). ">Luo 2015</a>; <a href="./references#CD001880-bbs2-0025" title="MadiganC . Benefits of dietary supplementation in elderly patients with fractured neck of femur. Sydney (Australia): University of Sydney, 1994. ">Madigan 1994</a>; <a href="./references#CD001880-bbs2-0027" title="MyintMW . Personal communication 6 January 2015. MyintMW , WuJ , WongE , ChanSP , ToTS , ChauMW , et al. Clinical benefits of oral nutritional supplementation for elderly hip fracture patients: a single blind randomised controlled trial. Age and Ageing2013;42(1):39‐45. MyintMWW . A randomized controlled study of nutritional intervention for geriatric hip fracture patients and its effect on rehabilitation outcomes. clinicaltrials.gov/ct2/show/NCT01088139 (accessed 4 December 2015). ">Myint 2013</a>; <a href="./references#CD001880-bbs2-0029" title="PapaioannouA . A randomised, controlled comparison of vitamin D strategies in acute hip fracture patients. clinicaltrials.gov/show/NCT00424619 (accessed 4 December 2015). PapaioannouA , KennedyCC , GiangregorioL , IoannidisG , PritchardJ , HanleyDA , et al. A randomized controlled trial of vitamin D dosing strategies after acute hip fracture: no advantage of loading doses over daily supplementation. BMC Musculoskeletal Disorders2011;12:135. PapaioannouA , KennedyCC , IoannidisG , AdachiJD , HanleyD , GiangregorioL , et al. High versus low vitamin D in acute hip fracture patients: a randomised, controlled trial. Osteoporosis International2010;21(Suppl 1):S201. ">Papaioannou 2011</a>; <a href="./references#CD001880-bbs2-0031" title="PrasadN . Personal communication 24 October 2014. PrasadN , RajamaniV , HullinD , MurrayJM . Post‐operative anaemia in femoral neck fracture patients: does it need treatment? A single blinded prospective randomised controlled trial. Injury2009;40(10):1073‐6. ">Prasad 2009</a>; <a href="./references#CD001880-bbs2-0033" title="DerossiD , BoA , BergonziR , ScivolettoG . Six‐week administration of a mixture of ergogenic and osteotrophic ingredients (RestorfastTM) improves the clinical course of elderly patients after hip fracture surgery [La somministrazione per sei settimane di un composto a base di sostanze osteotrofiche ed ergogene (RestorfastTM) migliora il decorso clinico in anziani sottoposti a chirurgia del femore]. Trends in Medicine2009;9(4):235‐42. ScivolettoG , BoA , DerossiD , BergonziR . Ten week administration of a polynutritional supplement with muscle tone action (RiabylexTM) improves the functional recovery in elderly hip fracture patients during home rehabilitation [In anziani in terapia riabilitativa domiciliare per pregressa frattura del femore, l'assunzione di un polinutriente ad azione muscolotonica (RiabylexTM) per 10 settimane migliora il recupero funzionale]. Trends in Medicine2010;10(2):113‐20. ">Scivoletto 2010</a>; <a href="./references#CD001880-bbs2-0034" title="Serrano‐TrenasJA , UgaldePF , CabelloLM , ChoflesLC , LazaroPS , BenitezPC . Role of perioperative intravenous iron therapy in elderly hip fracture patients: a single‐center randomized controlled trial. Transfusion2011;51(1):97‐104. ">Serrano‐Trenas 2011</a>; <a href="./references#CD001880-bbs2-0039" title="BonjourJP , RapinCH , RizzoliR , TkatchL , DelmiM , ChevalleyT , et al. Hip fracture, femoral bone mineral density, and protein supply in elderly patients. In: MunroH , SchlierfG editor(s). Nutrition of the elderly. Nestle nutrition workshop series. Vol. 29, New York: Raven Press, 1992:151‐9. BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. BonjourJP , SchürchMA , RizzoliR . Nutritional aspects of hip fractures. Bone1996;18(Suppl 3):139S‐44S. BonjourJP , SchürchMA , RizzoliR . Proteins and bone health. Patholgie‐Biologie1997;45(1):57‐9. TkatchL , RapinCH , RizzoliR , SlosmanD , NydeggerV , VaseyH , et al. Benefits of oral protein supplementation in elderly patients with fracture of the proximal femur. Journal of the American College of Nutrition1992;11(5):519‐25. ">Tkatch 1992</a>; <a href="./references#CD001880-bbs2-0040" title="HoudijkAPJ . The effect of taurine on morbidity and mortality in the elderly hip fracture patient. clinicaltrials.gov/ct2/show/NCT00497978 (accessed 15 December 2015). VanStijnMF , BruinsAA , VermeulenMA , WitloxJ , TeerlinkT , SchoorlMG , et al. Effect of oral taurine on morbidity and mortality in elderly hip fracture patients: a randomized trial. International Journal of Molecular Sciences2015;16(6):12288‐306. [DOI: 10.3390/ijms160612288; PUBMED: 26035756] ">Van Stijn 2015</a>). The remainder were judged at unclear risk of attrition bias for primary outcomes, where reported. </p> <p>Incomplete outcome data were more problematic for secondary outcome data, and we judged only 10 trials to be at low risk of attrition bias. Thirteen trials were judged to be at high risk of bias and the remainder, where secondary outcomes were reported, at unclear risk of attrition bias. </p> </section> <section id="CD001880-sec-0107"> <h4 class="title">Selective reporting</h4> <p>We judged 14 trials (34%) to be at low risk of bias for selective reporting of outcomes. However, we judged seven trials to be at high risk of bias (<a href="./references#CD001880-bbs2-0004" title="Bischoff‐FerrariH . Early rehabilitation after hip fracture. clinicaltrials.gov/ct2/show/NCT00133640 (accessed 7 September 2015). Bischoff‐FerrariH , Dawson‐HughesB , OravE , WillettW , EgliA , MaetzelA , et al. The economic consequences of hip fractures: impact of home exercise and high dose‐vitamin D. 32nd Annual Meeting of the American Society for Bone and Mineral Research Annual Meeting; 2010 Oct 15‐9; Toronto, Canada. (accessed 3 December 2015); Vol. www.asbmr.org/education/2010‐abstracts. Bischoff‐FerrariHA , Dawson‐HughesB , PlatzA , OravEJ , StahelinHB , WillettWC , et al. Effect of high‐dosage cholecalciferol and extended physiotherapy on complications after hip fracture. A randomized controlled trial. Archives of Internal Medicine2010;170(9):813‐20. ">Bischoff‐Ferrari 2010</a>; <a href="./references#CD001880-bbs2-0008" title="BruceD . Personal communication. October 2003. BruceD , LauranceI , McGuinessM , RidleyM , GoldswainP . Nutritional supplements after hip fracture: poor compliance limits effectiveness. Clinical Nutrition2003;22(5):497‐500. [MEDLINE: 14512038] ">Bruce 2003</a>; <a href="./references#CD001880-bbs2-0009" title="ChevalleyT . Personal communication 14 October 2014. ChevalleyT , HoffmeyerP , BonjourJ‐P , RizzoliR . Early serum IGF‐I response to oral protein supplements in elderly women with a recent hip fracture. Clinical Nutrition2010;29(1):78‐83. ">Chevalley 2010</a>; <a href="./references#CD001880-bbs2-0010" title="DayJJ . Personal communication 27 May 1999. DayJJ , BayerAJ , McMahonM , PathyMS , SpraggBP , RowlandsDC . Thiamine status, vitamin supplements and postoperative confusion. Age and Ageing1988;17:29‐34. ">Day 1988</a>; <a href="./references#CD001880-bbs2-0015" title="FabianE , GerstorferI , ThalerHW , StundnerH , BiswasP , ElmadfaI . Nutritional supplementation affects postoperative oxidative stress and duration of hospitalization in patients with hip fracture. Wiener Klinische Wochenschrift2011;123(3‐4):88‐93. ">Fabian 2011</a>; <a href="./references#CD001880-bbs2-0017" title="GallagherJ , SchermbeckJ , DixonL , Labbe‐BellM . Aggressive early management of malnutrition in hip fracture patients. Journal of Parenteral and Enteral Nutrition1992;16(1):19S. KoretzR . Personal communication 7 September 1999. ">Gallagher 1992</a>; <a href="./references#CD001880-bbs2-0024" title="LuoM . Personal communication 17 November 2014. LuoM , GolubevG , KlyukvinI , ReznikL , KuropatkinG , OliverJS , et al. Oral nutrition supplement improved nutritional status in malnourished hip fracture patients: a randomized controlled study. Journal of Scientific Research and Reports2015;4(6):480‐9. LuoM , GolybevG , KlyukvinI , ReznikL , KuropatkinG , VossAC . Oral nutritional supplement (ONS) improved nutritional status in malnourished patients receiving hip fracture surgery. Clinical Nutrition Supplements2011;6:151. SwearenginB . Effect of a medical food supplement in hospitalized patients recovering from surgery. clinicaltrials.gov/ct2/show/NCT01011608 (accessed 4 December 2015). ">Luo 2015</a>), usually as a result of data not presented that would be expected from their methods, or data that were provided not mentioned in methods, for example, length of stay, mortality, functional status. The remainder were at unclear risk of selective reporting bias. </p> </section> <section id="CD001880-sec-0108"> <h4 class="title">Other potential sources of bias</h4> <p>For other potential sources of bias, we assessed adequacy of the length of follow‐up, adequacy of information on nutritional status, whether there were major between‐group imbalances in key baseline characteristics, and whether there was drug company involvement. </p> <p>Recovery from hip fracture in older people takes time, with long‐term implications for morbidity and functional status. Sixteen studies followed up participants for six months or over; with six of these extending follow‐up to one year (<a href="./references#CD001880-bbs2-0004" title="Bischoff‐FerrariH . Early rehabilitation after hip fracture. clinicaltrials.gov/ct2/show/NCT00133640 (accessed 7 September 2015). Bischoff‐FerrariH , Dawson‐HughesB , OravE , WillettW , EgliA , MaetzelA , et al. The economic consequences of hip fractures: impact of home exercise and high dose‐vitamin D. 32nd Annual Meeting of the American Society for Bone and Mineral Research Annual Meeting; 2010 Oct 15‐9; Toronto, Canada. (accessed 3 December 2015); Vol. www.asbmr.org/education/2010‐abstracts. Bischoff‐FerrariHA , Dawson‐HughesB , PlatzA , OravEJ , StahelinHB , WillettWC , et al. Effect of high‐dosage cholecalciferol and extended physiotherapy on complications after hip fracture. A randomized controlled trial. Archives of Internal Medicine2010;170(9):813‐20. ">Bischoff‐Ferrari 2010</a>; <a href="./references#CD001880-bbs2-0016" title="FlodinL . Effects of bisphosphonates and nutritional supplementation after a hip fracture. clinicaltrials.gov/show/NCT01950169 2013 (accessed 3 December 2015). FlodinL . Personal communication. Personal communication 15 December 2014. FlodinL , SaafM , CederholmT , Al‐AniAN , AckermannPW , SanegardE , et al. Additive effects of nutritional supplementation, together with bisphosphonates, on bone mineral density after hip fracture: a 12‐month randomized controlled study. Clinical Interventions in Aging2014;9:1043‐50. ">Flodin 2014</a>; <a href="./references#CD001880-bbs2-0026" title="CrottyM . Personal communication 20 February 2009. DanielsLA , MillerM , BannermanE , WhiteheadC , CrottyM . Weight loss post lower limb fracture despite an intensive oral nutrition and exercise intervention. Clinical Nutrition2003;22 Suppl:S86. DanielsLA , MillerMD , BannermannE , CrottyM . Adherence to nutritional supplements amongst orthopedic patients: an important clinical and study design issue. Clinical Nutrition2005;24:535. MillerMD , BannermanE , DanielsLA , CrottyM . Lower limb fracture, cognitive impairment and risk of subsequent malnutrition: a prospective evaluation of dietary energy and protein intake on an orthopaedic ward. European Journal of Clinical Nutrition2006;60(7):853‐61. [MEDLINE: 16452913] MillerMD , CrottyM , WhiteheadC , BannermanE , DanielsLA . Nutritional supplementation and resistance training in nutritionally at risk older adults following lower limb fracture: a randomized controlled trial. Clinical Rehabilitation2006;20(4):311‐23. MillerMD , DanielsLA , BannermanE , CrottyM . Adherence to nutrition supplements among patients with a fall‐related lower limb fracture. Nutrition in Clinical Practice2005;20(5):569‐78. [MEDLINE: 16207699] ">Miller 2006</a>; <a href="./references#CD001880-bbs2-0032" title="BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. RizzoliR , SchürchMA , BonjourJP . Protein supplements after osteoporotic hip fracture. Annals of Internal Medicine1998;129:1076. SchürchM‐A , BonjourJ‐P , SlosmanD , RizzoliR . Protein supplements favourably influence the outcome after hip fracture [Un supplement proteique ameliore les suites d'une fracture du femur proximal]. Medecine et Hygiene1999;57(2271):1876‐8. SchürchMA , RizzoliR , SlosmanD , BonjourJP . Protein supplements increase serum IGF‐1 and decrease proximal femur bone loss in patients with a recent hip fracture. Osteoporosis 1996: Proceedings of the 1996 World Congress on Osteoporosis; 1996 May 18‐23; Amsterdam, The Netherlands. Amsterdam: Elsevier, 1996:327‐9. SchürchMA , RizzoliR , SlosmanD , VadasL , VergnaudP , BonjourJP . Protein supplements increase serum insulin‐like growth factor‐I levels and attenuate proximal femur bone loss in patients with recent hip fracture. A randomized, double‐blind, placebo‐controlled trial. Annals of Internal Medicine1998;128(10):801‐9. ">Schürch 1998</a>; <a href="./references#CD001880-bbs2-0040" title="HoudijkAPJ . The effect of taurine on morbidity and mortality in the elderly hip fracture patient. clinicaltrials.gov/ct2/show/NCT00497978 (accessed 15 December 2015). VanStijnMF , BruinsAA , VermeulenMA , WitloxJ , TeerlinkT , SchoorlMG , et al. Effect of oral taurine on morbidity and mortality in elderly hip fracture patients: a randomized trial. International Journal of Molecular Sciences2015;16(6):12288‐306. [DOI: 10.3390/ijms160612288; PUBMED: 26035756] ">Van Stijn 2015</a>; <a href="./references#CD001880-bbs2-0041" title="Breedveld‐PetersJ , ReijvenPL , WyersCE , HendrikxAA , VerburgAD , ScholsJM , et al. Qualitative analysis of barriers and facilitators for nutritional intervention in hip fracture patients. Clinical Nutrition, Supplement2012;7(1):234. Breedveld‐PetersJJ , ReijvenPL , WyersCE , HendrikxAA , VerburgAD , ScholsJM , et al. Barriers and facilitators of nutritional intervention after hip fracture in integrated care as perceived by the different health care professionals: a qualitative interview study. e‐SPEN Journal2012;7(5):e182‐8. Breedveld‐PetersJJ , ReijvenPL , WyersCE , VanHeldenS , ArtsJJ , MeestersB , et al. Integrated nutritional intervention in the elderly after hip fracture. A process evaluation. Clinical Nutrition, Supplement2012;31(1):199‐205. Breedveld‐PetersJJ , ReijvenPL , WyersCE , VanHeldenS , ArtsJJ , MeestersB , et al. Integrated nutritional intervention in the elderly after hip fracture. A process evaluation. Clinical Nutrition, Supplement2012;7(1):43. DagneliePC . Effectiveness and cost‐effectiveness of nutritional screening and intervention in elderly subjects after hip fracture. clinicaltrials.gov/show/NCT00523575 (accessed 8 November 2009). WyersC , ReijvenPL , EversSM , WillemsPC , HeyligersIC , VerburgAD , et al. Cost‐effectiveness of nutritional intervention in hip fracture patients: a multi‐centre randomised controlled trial (RCT). Clinical Nutrition, Supplement2012;7(1):49. WyersCE . PhD thesis. Maastricht, the Netherlands: Maastricht University, 2012. WyersCE , Breedveld‐PetersJJ , ReijvenPL , ArtsC , ThomassenBJ , VerburgAD , et al. Effect of nutritional intervention on nutritional intake and status in hip fracture patients: a multicentre randomised controlled trial (RCT). Clinical Nutrition, Supplement2012;7(1):50‐1. WyersCE , Breedveld‐PetersJJ , ReijvenPL , VanHeldenS , GuldemondNA , SeverensJL , et al. Efficacy and cost‐effectiveness of nutritional intervention in elderly after hip fracture: design of a randomized controlled trial. BMC Public Health2010;10:212. WyersCE , ReijvenPL , EversSM , WillemsPC , HeyligersIC , VerburgAD , et al. Cost‐effectiveness of nutritional intervention in elderly subjects after hip fracture. A randomized controlled trial. Osteoporosis International2013;24(1):151‐62. ">Wyers 2013</a>). </p> <p>Details of the nutritional status of the groups were often missing. Related to this was the lack of information on anthropometric parameters. While it is difficult to measure height and weight in people with hip fracture, 11 trials (27%) failed to provide any information on baseline anthropometry (e.g. mid‐upper arm circumference or weight) or an anthropometry‐derived nutrition risk score. </p> <p>An appraisal of the trials for baseline imbalances found important differences between the two groups for age in two trials (<a href="./references#CD001880-bbs2-0029" title="PapaioannouA . A randomised, controlled comparison of vitamin D strategies in acute hip fracture patients. clinicaltrials.gov/show/NCT00424619 (accessed 4 December 2015). PapaioannouA , KennedyCC , GiangregorioL , IoannidisG , PritchardJ , HanleyDA , et al. A randomized controlled trial of vitamin D dosing strategies after acute hip fracture: no advantage of loading doses over daily supplementation. BMC Musculoskeletal Disorders2011;12:135. PapaioannouA , KennedyCC , IoannidisG , AdachiJD , HanleyD , GiangregorioL , et al. High versus low vitamin D in acute hip fracture patients: a randomised, controlled trial. Osteoporosis International2010;21(Suppl 1):S201. ">Papaioannou 2011</a>; <a href="./references#CD001880-bbs2-0037" title="SullivanDH . Personal communication 14 April 2006. SullivanDH , NelsonCL , KlimbergVS , BoppMM . Nightly enteral nutrition support of elderly hip fracture patients: a pilot study. Journal of the American College of Nutrition2004;23(6):683‐91. [MEDLINE: 15637216] ">Sullivan 2004</a>), for type of hip fracture in <a href="./references#CD001880-bbs2-0038" title="CarlssonP , TidermarkJ , PonzerS , SoderqvistA , CederholmT . Food habits and appetite of elderly women at the time of a femoral neck fracture and after nutritional and anabolic support. Journal of Human Nutrition and Dietetics2005;18(2):117‐20. [MEDLINE: 15788020] TengstrandB , CederholmT , SoderqvistA , TidermarkJ . Effects of protein‐rich supplementation and nandrolone on bone tissue after a hip fracture. Clinical Nutrition2007;26(4):460‐5. [MEDLINE: 17498850] TidermarkJ . Personal communication 14 October 2004. TidermarkJ . Quality of life and femoral neck fractures. Acta Orthopaedica Scandinavica. Supplementum2003;74(309):1‐42. TidermarkJ , PonzerS , CarlssonP , SoderqvistA , BrismarK , TengstrandB , et al. Effects of protein‐rich supplementation and nandrolone in lean elderly women with femoral neck fractures. Clinical Nutrition2004;23(4):587‐96. TidermarkJ , PonzerS , TengstrandB , CederholmT . Liquid supplementation and nandrolone to elderly women. Clinical Nutrition2002;21(Suppl 1):40. ">Tidermark 2004</a>; and for body weight in <a href="./references#CD001880-bbs2-0035" title="StableforthPG . Supplement feeds and nitrogen and calorie balance following femoral neck fracture. British Journal of Surgery1986;73:651‐5. ">Stableforth 1986</a>. </p> <p>Twenty trials reported receiving some drug company sponsorship or provision of supplements, and were judged to be at high risk of bias. One trial (<a href="./references#CD001880-bbs2-0001" title="AnbarR , BelooseskyY , CohenJ , MadarZ , WeissA , TheillaM , et al. Tight calorie control in geriatric patients following hip fracture decreases complications: a randomized, controlled study. Clinical Nutrition2014;33:23‐8. AnbarR , BelooseskyY , MadarZ , TheillaM , Koren‐HakimT , WeissA , et al. Tight calorie control (TICACOS) in geriatric hip fracture patients. Clinical Nutrition, Supplement2012;7(1):18. AnbarR , BelooseskyY , MadarZ , TheillaM , Koren‐HakimT , WeissA , et al. Tight calorie control in geriatric hip fracture patients: preliminary results of the geriatric TICACOS study. Clinical Nutrition, Supplement2011;6(1):155. SingerP . Tight caloric balance in geriatric patients (TICACOSiGP). clinicaltrials.gov/show/NCT01735435 (accessed 3 December 2015). ">Anbar 2014</a>) was judged to be at high risk of bias as a result of stopping early due to poor recruitment, when the interim analysis showed a 'positive result'. Another trial (<a href="./references#CD001880-bbs2-0040" title="HoudijkAPJ . The effect of taurine on morbidity and mortality in the elderly hip fracture patient. clinicaltrials.gov/ct2/show/NCT00497978 (accessed 15 December 2015). VanStijnMF , BruinsAA , VermeulenMA , WitloxJ , TeerlinkT , SchoorlMG , et al. Effect of oral taurine on morbidity and mortality in elderly hip fracture patients: a randomized trial. International Journal of Molecular Sciences2015;16(6):12288‐306. [DOI: 10.3390/ijms160612288; PUBMED: 26035756] ">Van Stijn 2015</a>) was judged to be at high risk of bias because the power calculation was based on a very unlikely 50% reduction in mortality. </p> </section> </section> <section id="CD001880-sec-0109"> <h3 class="title" id="CD001880-sec-0109">Effects of interventions</h3> <p>See: <a href="./full#CD001880-tbl-0001"><b>Summary of findings for the main comparison</b> Multinutrient supplements (oral) versus control for hip fracture aftercare in older people</a>; <a href="./full#CD001880-tbl-0002"><b>Summary of findings 2</b> Multinutrient supplements (nasogastric) versus control for hip fracture aftercare in older people</a> </p> <p>We have listed the outcomes reported in the included studies in the <a href="./references#CD001880-sec-0189" title="">Characteristics of included studies</a>. These are grouped by 'main' (primary and secondary) outcomes and 'other' outcomes, as defined in the <a href="#CD001880-sec-0055">Types of outcome measures</a>. The results presented concentrate on main outcomes. </p> <p>The included studies often failed to report main outcomes. For example, only two trials reported participants' perceived quality of life after discharge (<a href="./references#CD001880-bbs2-0038" title="CarlssonP , TidermarkJ , PonzerS , SoderqvistA , CederholmT . Food habits and appetite of elderly women at the time of a femoral neck fracture and after nutritional and anabolic support. Journal of Human Nutrition and Dietetics2005;18(2):117‐20. [MEDLINE: 15788020] TengstrandB , CederholmT , SoderqvistA , TidermarkJ . Effects of protein‐rich supplementation and nandrolone on bone tissue after a hip fracture. Clinical Nutrition2007;26(4):460‐5. [MEDLINE: 17498850] TidermarkJ . Personal communication 14 October 2004. TidermarkJ . Quality of life and femoral neck fractures. Acta Orthopaedica Scandinavica. Supplementum2003;74(309):1‐42. TidermarkJ , PonzerS , CarlssonP , SoderqvistA , BrismarK , TengstrandB , et al. Effects of protein‐rich supplementation and nandrolone in lean elderly women with femoral neck fractures. Clinical Nutrition2004;23(4):587‐96. TidermarkJ , PonzerS , TengstrandB , CederholmT . Liquid supplementation and nandrolone to elderly women. Clinical Nutrition2002;21(Suppl 1):40. ">Tidermark 2004</a>; <a href="./references#CD001880-bbs2-0041" title="Breedveld‐PetersJ , ReijvenPL , WyersCE , HendrikxAA , VerburgAD , ScholsJM , et al. Qualitative analysis of barriers and facilitators for nutritional intervention in hip fracture patients. Clinical Nutrition, Supplement2012;7(1):234. Breedveld‐PetersJJ , ReijvenPL , WyersCE , HendrikxAA , VerburgAD , ScholsJM , et al. Barriers and facilitators of nutritional intervention after hip fracture in integrated care as perceived by the different health care professionals: a qualitative interview study. e‐SPEN Journal2012;7(5):e182‐8. Breedveld‐PetersJJ , ReijvenPL , WyersCE , VanHeldenS , ArtsJJ , MeestersB , et al. Integrated nutritional intervention in the elderly after hip fracture. A process evaluation. Clinical Nutrition, Supplement2012;31(1):199‐205. Breedveld‐PetersJJ , ReijvenPL , WyersCE , VanHeldenS , ArtsJJ , MeestersB , et al. Integrated nutritional intervention in the elderly after hip fracture. A process evaluation. Clinical Nutrition, Supplement2012;7(1):43. DagneliePC . Effectiveness and cost‐effectiveness of nutritional screening and intervention in elderly subjects after hip fracture. clinicaltrials.gov/show/NCT00523575 (accessed 8 November 2009). WyersC , ReijvenPL , EversSM , WillemsPC , HeyligersIC , VerburgAD , et al. Cost‐effectiveness of nutritional intervention in hip fracture patients: a multi‐centre randomised controlled trial (RCT). Clinical Nutrition, Supplement2012;7(1):49. WyersCE . PhD thesis. Maastricht, the Netherlands: Maastricht University, 2012. WyersCE , Breedveld‐PetersJJ , ReijvenPL , ArtsC , ThomassenBJ , VerburgAD , et al. Effect of nutritional intervention on nutritional intake and status in hip fracture patients: a multicentre randomised controlled trial (RCT). Clinical Nutrition, Supplement2012;7(1):50‐1. WyersCE , Breedveld‐PetersJJ , ReijvenPL , VanHeldenS , GuldemondNA , SeverensJL , et al. Efficacy and cost‐effectiveness of nutritional intervention in elderly after hip fracture: design of a randomized controlled trial. BMC Public Health2010;10:212. WyersCE , ReijvenPL , EversSM , WillemsPC , HeyligersIC , VerburgAD , et al. Cost‐effectiveness of nutritional intervention in elderly subjects after hip fracture. A randomized controlled trial. Osteoporosis International2013;24(1):151‐62. ">Wyers 2013</a>), though in the 'other' outcomes category, it was notable that carer burden and stress were also not reported. </p> <p>Postoperative complications were reported as a very wide variety of individual conditions (including aspiration pneumonia, gastrointestinal ulcer, pressure sore, face flushing, deep hip joint infection, chest infection, urinary tract infection, deep venous thrombosis, pulmonary embolism, stroke, thrombophlebitis, ischaemic heart disease, cardiac failure, anaemia, hyponatraemia, confusion, anaphylaxis, and acute renal failure) and generic complications (gastrointestinal, surgical, infection, postoperative, life‐threatening). It was not possible to undertake analyses according to the severity or type of complication. Putative side‐effects of supplementation are also presented separately. Those presented for individual studies are noted in the <a href="./references#CD001880-sec-0189" title="">Characteristics of included studies</a>. In order to give a more complete picture of morbidity, we opted to present the number of participants with complications at the end of individual studies. Results were not used from those studies, such as <a href="./references#CD001880-bbs2-0039" title="BonjourJP , RapinCH , RizzoliR , TkatchL , DelmiM , ChevalleyT , et al. Hip fracture, femoral bone mineral density, and protein supply in elderly patients. In: MunroH , SchlierfG editor(s). Nutrition of the elderly. Nestle nutrition workshop series. Vol. 29, New York: Raven Press, 1992:151‐9. BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. BonjourJP , SchürchMA , RizzoliR . Nutritional aspects of hip fractures. Bone1996;18(Suppl 3):139S‐44S. BonjourJP , SchürchMA , RizzoliR . Proteins and bone health. Patholgie‐Biologie1997;45(1):57‐9. TkatchL , RapinCH , RizzoliR , SlosmanD , NydeggerV , VaseyH , et al. Benefits of oral protein supplementation in elderly patients with fracture of the proximal femur. Journal of the American College of Nutrition1992;11(5):519‐25. ">Tkatch 1992</a>, which provided the numbers of complications but not the numbers of participants with complications. Results from <a href="./references#CD001880-bbs2-0022" title="HouwingR . Personal communication 29 October 2003. HouwingR , RozendaalM , Wouters‐WesselingW , BeulensJ , BuskensE , HaalboomJ . The effect of nutritional supplementation on the prevention of pressure ulcers (PU) in hip‐fracture patients. Clinical Nutrition2002;21(Suppl 1):84. HouwingRH , RozendaalM , Wouters‐WesselingW , BeulensJW , BuskensE , HaalboomJR . A randomised, double‐blind assessment of the effect of nutritional supplementation on the prevention of pressure ulcers in hip‐fracture patients. Clinical Nutrition2003;22(4):401‐5. [MEDLINE: 12880608] ">Houwing 2003</a> were also not pooled since this trial only recorded pressure sores. </p> <p>For some trials we have presented the numbers of trial participants with 'unfavourable outcome'. As defined above, this is the sum of the participants who had died plus the survivors with complications. For most studies, we could not deduce this result from the available data. Results for 'unfavourable outcome' based on a slightly different definition (mortality or survivors with a major complication or two or more minor complications) originally presented in <a href="./references#CD001880-bbs2-0011" title="BonjourJP , RapinCH , RizzoliR , TkatchL , DelmiM , ChevalleyT , et al. Hip fracture, femoral bone mineral density, and protein supply in elderly patients. In: MunroHN , SchlierfG editor(s). Nutrition of the elderly. Nestlé nutrition workshop series. Vol. 29, New York: Raven Press, 1992:151‐9. [ISBN 0881678740 ] BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. BonjourJP , SchürchMA , RizzoliR . Nutritional aspects of hip fractures. Bone1996;18(3 Suppl):139S‐44S. BonjourJP , SchürchMA , RizzoliR . Proteins and bone health. Pathologie‐Biologie1997;45(1):57‐9. DelmiM , RapinC‐H , BengoaJ‐M , DelmasPD , VaseyH , BonjourJ‐P . Dietary supplementation in elderly patients with fractured neck of the femur. Lancet1990;335:1013‐6. [MEDLINE: 1970070] RapinCH , BengoaJM , KahnJM , DelmiM , BonjourJP , VaseyH . A prospective randomised control study of oral dietary supplementation in patients with fractured necks of femur. Journal of Parenteral and Enteral Nutrition1989;13(1):9S. ">Delmi 1990</a>, were available for three studies (<a href="./references#CD001880-bbs2-0011" title="BonjourJP , RapinCH , RizzoliR , TkatchL , DelmiM , ChevalleyT , et al. Hip fracture, femoral bone mineral density, and protein supply in elderly patients. In: MunroHN , SchlierfG editor(s). Nutrition of the elderly. Nestlé nutrition workshop series. Vol. 29, New York: Raven Press, 1992:151‐9. [ISBN 0881678740 ] BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. BonjourJP , SchürchMA , RizzoliR . Nutritional aspects of hip fractures. Bone1996;18(3 Suppl):139S‐44S. BonjourJP , SchürchMA , RizzoliR . Proteins and bone health. Pathologie‐Biologie1997;45(1):57‐9. DelmiM , RapinC‐H , BengoaJ‐M , DelmasPD , VaseyH , BonjourJ‐P . Dietary supplementation in elderly patients with fractured neck of the femur. Lancet1990;335:1013‐6. [MEDLINE: 1970070] RapinCH , BengoaJM , KahnJM , DelmiM , BonjourJP , VaseyH . A prospective randomised control study of oral dietary supplementation in patients with fractured necks of femur. Journal of Parenteral and Enteral Nutrition1989;13(1):9S. ">Delmi 1990</a>; <a href="./references#CD001880-bbs2-0019" title="HankinsC . Dietary supplementation with sustagen in elderly patients with fractured neck of femur [MSc dissertation]. Sydney (Australia): University of Sydney, 1996. HankinsC . Personal communication 11 June 1999. ">Hankins 1996</a>; <a href="./references#CD001880-bbs2-0039" title="BonjourJP , RapinCH , RizzoliR , TkatchL , DelmiM , ChevalleyT , et al. Hip fracture, femoral bone mineral density, and protein supply in elderly patients. In: MunroH , SchlierfG editor(s). Nutrition of the elderly. Nestle nutrition workshop series. Vol. 29, New York: Raven Press, 1992:151‐9. BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. BonjourJP , SchürchMA , RizzoliR . Nutritional aspects of hip fractures. Bone1996;18(Suppl 3):139S‐44S. BonjourJP , SchürchMA , RizzoliR . Proteins and bone health. Patholgie‐Biologie1997;45(1):57‐9. TkatchL , RapinCH , RizzoliR , SlosmanD , NydeggerV , VaseyH , et al. Benefits of oral protein supplementation in elderly patients with fracture of the proximal femur. Journal of the American College of Nutrition1992;11(5):519‐25. ">Tkatch 1992</a>) and we have used in them this review. </p> <p>We have presented mortality results using denominators based on the numbers of participants at randomisation (intention‐to‐treat analysis). Generally, we have presented the results for other outcomes using denominators based on the numbers of participants available at follow‐up. Exceptions to this are noted below. </p> <p>Lengths of hospital stay in the acute hospital and rehabilitation hospital were often reported but we have not presented them in the analyses, or pooled them. This is because, even when means and standard deviations (SD) for these outcomes were reported, it was unlikely that lengths of stay were normally distributed. </p> <p>In the following,we have presented results for the fixed‐effect model. Where the conclusions reached by combining comparable groups of trials differed noticeably between the fixed‐effect and random‐effects models, we have also presented the results for the random‐effects models. </p> <section id="CD001880-sec-0110"> <h4 class="title">Multinutrient supplements (oral or nasogastric routes, or both) versus control</h4> <p>Below we present the separate results by the route (oral, nasogastric or both) used for multinutrient supplementation, and then discuss the overall results for multinutrient supplementation. Finally, we investigate whether the results varied, according to whether the trials specifically targeted people who were malnourished, or according to trial quality (represented by whether allocation was concealed or not). </p> <section id="CD001880-sec-0111"> <h5 class="title">Oral supplements</h5> <p>Eighteen studies evaluated the effect of oral multinutrient supplementation (<a href="./references#CD001880-bbs2-0001" title="AnbarR , BelooseskyY , CohenJ , MadarZ , WeissA , TheillaM , et al. Tight calorie control in geriatric patients following hip fracture decreases complications: a randomized, controlled study. Clinical Nutrition2014;33:23‐8. AnbarR , BelooseskyY , MadarZ , TheillaM , Koren‐HakimT , WeissA , et al. Tight calorie control (TICACOS) in geriatric hip fracture patients. Clinical Nutrition, Supplement2012;7(1):18. AnbarR , BelooseskyY , MadarZ , TheillaM , Koren‐HakimT , WeissA , et al. Tight calorie control in geriatric hip fracture patients: preliminary results of the geriatric TICACOS study. Clinical Nutrition, Supplement2011;6(1):155. SingerP . Tight caloric balance in geriatric patients (TICACOSiGP). clinicaltrials.gov/show/NCT01735435 (accessed 3 December 2015). ">Anbar 2014</a>; <a href="./references#CD001880-bbs2-0005" title="Botella‐CarreteroJI . Personal communication 23 January 2009. Botella‐CarreteroJI , IglesiasB , BalsaJA , ZamarronI , ArrietaF , VazquezC . Effects of oral nutritional supplements in normally nourished or mildly undernourished geriatric patients after surgery for hip fracture: a randomized clinical trial. Journal of Parenteral and Enteral Nutrition2008;32(2):120‐8. [MEDLINE: 18407904] IglesiasB , Botella‐CarreteroJI , BalsaJA , ArrietaF , ZamarronI , VazquezC . Effects of oral nutritional supplements in geriatric patients after surgery for hip fracture. Clinical Nutrition Supplements2007;2(2):97. ">Botella‐Carretero 2008</a>; <a href="./references#CD001880-bbs2-0006" title="Botella‐CarreteroJI . Personal communication 26 October 2014. Botella‐CarreteroJI , IglesiasB , BalsaJA , ArrietaF , ZamarronI , VazquezC . Perioperative oral nutritional supplements in normally and mildly undernourished geriatric patients submitted to surgery for hip fracture: a randomized clinical trial. Clinical Nutrition2010;29(5):574‐9. ">Botella‐Carretero 2010</a>; <a href="./references#CD001880-bbs2-0007" title="BrownKM . Personal communicationMay 1999. BrownKM , SeabrookNA . Effect of nutrition on recovery after fractured femur. Medical Audit News1992;2(1):10‐2. BrownKM , SeabrookNA . Nutritional influences on recovery and length of hospital stay in elderly women following femoral fracture. Proceedings of the Nutrition Society1992;51(2):132A. ">Brown 1992b</a>; <a href="./references#CD001880-bbs2-0008" title="BruceD . Personal communication. October 2003. BruceD , LauranceI , McGuinessM , RidleyM , GoldswainP . Nutritional supplements after hip fracture: poor compliance limits effectiveness. Clinical Nutrition2003;22(5):497‐500. [MEDLINE: 14512038] ">Bruce 2003</a>; <a href="./references#CD001880-bbs2-0011" title="BonjourJP , RapinCH , RizzoliR , TkatchL , DelmiM , ChevalleyT , et al. Hip fracture, femoral bone mineral density, and protein supply in elderly patients. In: MunroHN , SchlierfG editor(s). Nutrition of the elderly. Nestlé nutrition workshop series. Vol. 29, New York: Raven Press, 1992:151‐9. [ISBN 0881678740 ] BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. BonjourJP , SchürchMA , RizzoliR . Nutritional aspects of hip fractures. Bone1996;18(3 Suppl):139S‐44S. BonjourJP , SchürchMA , RizzoliR . Proteins and bone health. Pathologie‐Biologie1997;45(1):57‐9. DelmiM , RapinC‐H , BengoaJ‐M , DelmasPD , VaseyH , BonjourJ‐P . Dietary supplementation in elderly patients with fractured neck of the femur. Lancet1990;335:1013‐6. [MEDLINE: 1970070] RapinCH , BengoaJM , KahnJM , DelmiM , BonjourJP , VaseyH . A prospective randomised control study of oral dietary supplementation in patients with fractured necks of femur. Journal of Parenteral and Enteral Nutrition1989;13(1):9S. ">Delmi 1990</a>; <a href="./references#CD001880-bbs2-0015" title="FabianE , GerstorferI , ThalerHW , StundnerH , BiswasP , ElmadfaI . Nutritional supplementation affects postoperative oxidative stress and duration of hospitalization in patients with hip fracture. Wiener Klinische Wochenschrift2011;123(3‐4):88‐93. ">Fabian 2011</a>; <a href="./references#CD001880-bbs2-0016" title="FlodinL . Effects of bisphosphonates and nutritional supplementation after a hip fracture. clinicaltrials.gov/show/NCT01950169 2013 (accessed 3 December 2015). FlodinL . Personal communication. Personal communication 15 December 2014. FlodinL , SaafM , CederholmT , Al‐AniAN , AckermannPW , SanegardE , et al. Additive effects of nutritional supplementation, together with bisphosphonates, on bone mineral density after hip fracture: a 12‐month randomized controlled study. Clinical Interventions in Aging2014;9:1043‐50. ">Flodin 2014</a>; <a href="./references#CD001880-bbs2-0019" title="HankinsC . Dietary supplementation with sustagen in elderly patients with fractured neck of femur [MSc dissertation]. Sydney (Australia): University of Sydney, 1996. HankinsC . Personal communication 11 June 1999. ">Hankins 1996</a>; <a href="./references#CD001880-bbs2-0022" title="HouwingR . Personal communication 29 October 2003. HouwingR , RozendaalM , Wouters‐WesselingW , BeulensJ , BuskensE , HaalboomJ . The effect of nutritional supplementation on the prevention of pressure ulcers (PU) in hip‐fracture patients. Clinical Nutrition2002;21(Suppl 1):84. HouwingRH , RozendaalM , Wouters‐WesselingW , BeulensJW , BuskensE , HaalboomJR . A randomised, double‐blind assessment of the effect of nutritional supplementation on the prevention of pressure ulcers in hip‐fracture patients. Clinical Nutrition2003;22(4):401‐5. [MEDLINE: 12880608] ">Houwing 2003</a>; <a href="./references#CD001880-bbs2-0023" title="KangJH , ShinDW , BaikHW , HongJ . Short‐term oral nutritional supplements and nutrition intervention in elderly patients after hip fracture surgery: a randomized controlled clinical trial. Clinical Nutrition, Supplement2012;7(1):280. ">Kang 2012</a>; <a href="./references#CD001880-bbs2-0024" title="LuoM . Personal communication 17 November 2014. LuoM , GolubevG , KlyukvinI , ReznikL , KuropatkinG , OliverJS , et al. Oral nutrition supplement improved nutritional status in malnourished hip fracture patients: a randomized controlled study. Journal of Scientific Research and Reports2015;4(6):480‐9. LuoM , GolybevG , KlyukvinI , ReznikL , KuropatkinG , VossAC . Oral nutritional supplement (ONS) improved nutritional status in malnourished patients receiving hip fracture surgery. Clinical Nutrition Supplements2011;6:151. SwearenginB . Effect of a medical food supplement in hospitalized patients recovering from surgery. clinicaltrials.gov/ct2/show/NCT01011608 (accessed 4 December 2015). ">Luo 2015</a>; <a href="./references#CD001880-bbs2-0025" title="MadiganC . Benefits of dietary supplementation in elderly patients with fractured neck of femur. Sydney (Australia): University of Sydney, 1994. ">Madigan 1994</a>; <a href="./references#CD001880-bbs2-0026" title="CrottyM . Personal communication 20 February 2009. DanielsLA , MillerM , BannermanE , WhiteheadC , CrottyM . Weight loss post lower limb fracture despite an intensive oral nutrition and exercise intervention. Clinical Nutrition2003;22 Suppl:S86. DanielsLA , MillerMD , BannermannE , CrottyM . Adherence to nutritional supplements amongst orthopedic patients: an important clinical and study design issue. Clinical Nutrition2005;24:535. MillerMD , BannermanE , DanielsLA , CrottyM . Lower limb fracture, cognitive impairment and risk of subsequent malnutrition: a prospective evaluation of dietary energy and protein intake on an orthopaedic ward. European Journal of Clinical Nutrition2006;60(7):853‐61. [MEDLINE: 16452913] MillerMD , CrottyM , WhiteheadC , BannermanE , DanielsLA . Nutritional supplementation and resistance training in nutritionally at risk older adults following lower limb fracture: a randomized controlled trial. Clinical Rehabilitation2006;20(4):311‐23. MillerMD , DanielsLA , BannermanE , CrottyM . Adherence to nutrition supplements among patients with a fall‐related lower limb fracture. Nutrition in Clinical Practice2005;20(5):569‐78. [MEDLINE: 16207699] ">Miller 2006</a>; <a href="./references#CD001880-bbs2-0027" title="MyintMW . Personal communication 6 January 2015. MyintMW , WuJ , WongE , ChanSP , ToTS , ChauMW , et al. Clinical benefits of oral nutritional supplementation for elderly hip fracture patients: a single blind randomised controlled trial. Age and Ageing2013;42(1):39‐45. MyintMWW . A randomized controlled study of nutritional intervention for geriatric hip fracture patients and its effect on rehabilitation outcomes. clinicaltrials.gov/ct2/show/NCT01088139 (accessed 4 December 2015). ">Myint 2013</a>; <a href="./references#CD001880-bbs2-0035" title="StableforthPG . Supplement feeds and nitrogen and calorie balance following femoral neck fracture. British Journal of Surgery1986;73:651‐5. ">Stableforth 1986</a>; <a href="./references#CD001880-bbs2-0038" title="CarlssonP , TidermarkJ , PonzerS , SoderqvistA , CederholmT . Food habits and appetite of elderly women at the time of a femoral neck fracture and after nutritional and anabolic support. Journal of Human Nutrition and Dietetics2005;18(2):117‐20. [MEDLINE: 15788020] TengstrandB , CederholmT , SoderqvistA , TidermarkJ . Effects of protein‐rich supplementation and nandrolone on bone tissue after a hip fracture. Clinical Nutrition2007;26(4):460‐5. [MEDLINE: 17498850] TidermarkJ . Personal communication 14 October 2004. TidermarkJ . Quality of life and femoral neck fractures. Acta Orthopaedica Scandinavica. Supplementum2003;74(309):1‐42. TidermarkJ , PonzerS , CarlssonP , SoderqvistA , BrismarK , TengstrandB , et al. Effects of protein‐rich supplementation and nandrolone in lean elderly women with femoral neck fractures. Clinical Nutrition2004;23(4):587‐96. TidermarkJ , PonzerS , TengstrandB , CederholmT . Liquid supplementation and nandrolone to elderly women. Clinical Nutrition2002;21(Suppl 1):40. ">Tidermark 2004</a>; <a href="./references#CD001880-bbs2-0041" title="Breedveld‐PetersJ , ReijvenPL , WyersCE , HendrikxAA , VerburgAD , ScholsJM , et al. Qualitative analysis of barriers and facilitators for nutritional intervention in hip fracture patients. Clinical Nutrition, Supplement2012;7(1):234. Breedveld‐PetersJJ , ReijvenPL , WyersCE , HendrikxAA , VerburgAD , ScholsJM , et al. Barriers and facilitators of nutritional intervention after hip fracture in integrated care as perceived by the different health care professionals: a qualitative interview study. e‐SPEN Journal2012;7(5):e182‐8. Breedveld‐PetersJJ , ReijvenPL , WyersCE , VanHeldenS , ArtsJJ , MeestersB , et al. Integrated nutritional intervention in the elderly after hip fracture. A process evaluation. Clinical Nutrition, Supplement2012;31(1):199‐205. Breedveld‐PetersJJ , ReijvenPL , WyersCE , VanHeldenS , ArtsJJ , MeestersB , et al. Integrated nutritional intervention in the elderly after hip fracture. A process evaluation. Clinical Nutrition, Supplement2012;7(1):43. DagneliePC . Effectiveness and cost‐effectiveness of nutritional screening and intervention in elderly subjects after hip fracture. clinicaltrials.gov/show/NCT00523575 (accessed 8 November 2009). WyersC , ReijvenPL , EversSM , WillemsPC , HeyligersIC , VerburgAD , et al. Cost‐effectiveness of nutritional intervention in hip fracture patients: a multi‐centre randomised controlled trial (RCT). Clinical Nutrition, Supplement2012;7(1):49. WyersCE . PhD thesis. Maastricht, the Netherlands: Maastricht University, 2012. WyersCE , Breedveld‐PetersJJ , ReijvenPL , ArtsC , ThomassenBJ , VerburgAD , et al. Effect of nutritional intervention on nutritional intake and status in hip fracture patients: a multicentre randomised controlled trial (RCT). Clinical Nutrition, Supplement2012;7(1):50‐1. WyersCE , Breedveld‐PetersJJ , ReijvenPL , VanHeldenS , GuldemondNA , SeverensJL , et al. Efficacy and cost‐effectiveness of nutritional intervention in elderly after hip fracture: design of a randomized controlled trial. BMC Public Health2010;10:212. WyersCE , ReijvenPL , EversSM , WillemsPC , HeyligersIC , VerburgAD , et al. Cost‐effectiveness of nutritional intervention in elderly subjects after hip fracture. A randomized controlled trial. Osteoporosis International2013;24(1):151‐62. ">Wyers 2013</a>) of which five (<a href="./references#CD001880-bbs2-0007" title="BrownKM . Personal communicationMay 1999. BrownKM , SeabrookNA . Effect of nutrition on recovery after fractured femur. Medical Audit News1992;2(1):10‐2. BrownKM , SeabrookNA . Nutritional influences on recovery and length of hospital stay in elderly women following femoral fracture. Proceedings of the Nutrition Society1992;51(2):132A. ">Brown 1992b</a>; <a href="./references#CD001880-bbs2-0019" title="HankinsC . Dietary supplementation with sustagen in elderly patients with fractured neck of femur [MSc dissertation]. Sydney (Australia): University of Sydney, 1996. HankinsC . Personal communication 11 June 1999. ">Hankins 1996</a>; <a href="./references#CD001880-bbs2-0024" title="LuoM . Personal communication 17 November 2014. LuoM , GolubevG , KlyukvinI , ReznikL , KuropatkinG , OliverJS , et al. Oral nutrition supplement improved nutritional status in malnourished hip fracture patients: a randomized controlled study. Journal of Scientific Research and Reports2015;4(6):480‐9. LuoM , GolybevG , KlyukvinI , ReznikL , KuropatkinG , VossAC . Oral nutritional supplement (ONS) improved nutritional status in malnourished patients receiving hip fracture surgery. Clinical Nutrition Supplements2011;6:151. SwearenginB . Effect of a medical food supplement in hospitalized patients recovering from surgery. clinicaltrials.gov/ct2/show/NCT01011608 (accessed 4 December 2015). ">Luo 2015</a>; <a href="./references#CD001880-bbs2-0026" title="CrottyM . Personal communication 20 February 2009. DanielsLA , MillerM , BannermanE , WhiteheadC , CrottyM . Weight loss post lower limb fracture despite an intensive oral nutrition and exercise intervention. Clinical Nutrition2003;22 Suppl:S86. DanielsLA , MillerMD , BannermannE , CrottyM . Adherence to nutritional supplements amongst orthopedic patients: an important clinical and study design issue. Clinical Nutrition2005;24:535. MillerMD , BannermanE , DanielsLA , CrottyM . Lower limb fracture, cognitive impairment and risk of subsequent malnutrition: a prospective evaluation of dietary energy and protein intake on an orthopaedic ward. European Journal of Clinical Nutrition2006;60(7):853‐61. [MEDLINE: 16452913] MillerMD , CrottyM , WhiteheadC , BannermanE , DanielsLA . Nutritional supplementation and resistance training in nutritionally at risk older adults following lower limb fracture: a randomized controlled trial. Clinical Rehabilitation2006;20(4):311‐23. MillerMD , DanielsLA , BannermanE , CrottyM . Adherence to nutrition supplements among patients with a fall‐related lower limb fracture. Nutrition in Clinical Practice2005;20(5):569‐78. [MEDLINE: 16207699] ">Miller 2006</a>; <a href="./references#CD001880-bbs2-0027" title="MyintMW . Personal communication 6 January 2015. MyintMW , WuJ , WongE , ChanSP , ToTS , ChauMW , et al. Clinical benefits of oral nutritional supplementation for elderly hip fracture patients: a single blind randomised controlled trial. Age and Ageing2013;42(1):39‐45. MyintMWW . A randomized controlled study of nutritional intervention for geriatric hip fracture patients and its effect on rehabilitation outcomes. clinicaltrials.gov/ct2/show/NCT01088139 (accessed 4 December 2015). ">Myint 2013</a>) targeted people who were malnourished. Follow‐up was usually until discharge or for one month; three trials followed up for six months (<a href="./references#CD001880-bbs2-0008" title="BruceD . Personal communication. October 2003. BruceD , LauranceI , McGuinessM , RidleyM , GoldswainP . Nutritional supplements after hip fracture: poor compliance limits effectiveness. Clinical Nutrition2003;22(5):497‐500. [MEDLINE: 14512038] ">Bruce 2003</a>; <a href="./references#CD001880-bbs2-0011" title="BonjourJP , RapinCH , RizzoliR , TkatchL , DelmiM , ChevalleyT , et al. Hip fracture, femoral bone mineral density, and protein supply in elderly patients. In: MunroHN , SchlierfG editor(s). Nutrition of the elderly. Nestlé nutrition workshop series. Vol. 29, New York: Raven Press, 1992:151‐9. [ISBN 0881678740 ] BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. BonjourJP , SchürchMA , RizzoliR . Nutritional aspects of hip fractures. Bone1996;18(3 Suppl):139S‐44S. BonjourJP , SchürchMA , RizzoliR . Proteins and bone health. Pathologie‐Biologie1997;45(1):57‐9. DelmiM , RapinC‐H , BengoaJ‐M , DelmasPD , VaseyH , BonjourJ‐P . Dietary supplementation in elderly patients with fractured neck of the femur. Lancet1990;335:1013‐6. [MEDLINE: 1970070] RapinCH , BengoaJM , KahnJM , DelmiM , BonjourJP , VaseyH . A prospective randomised control study of oral dietary supplementation in patients with fractured necks of femur. Journal of Parenteral and Enteral Nutrition1989;13(1):9S. ">Delmi 1990</a>; <a href="./references#CD001880-bbs2-0027" title="MyintMW . Personal communication 6 January 2015. MyintMW , WuJ , WongE , ChanSP , ToTS , ChauMW , et al. Clinical benefits of oral nutritional supplementation for elderly hip fracture patients: a single blind randomised controlled trial. Age and Ageing2013;42(1):39‐45. MyintMWW . A randomized controlled study of nutritional intervention for geriatric hip fracture patients and its effect on rehabilitation outcomes. clinicaltrials.gov/ct2/show/NCT01088139 (accessed 4 December 2015). ">Myint 2013</a>) and four trials followed up for 12 months (<a href="./references#CD001880-bbs2-0016" title="FlodinL . Effects of bisphosphonates and nutritional supplementation after a hip fracture. clinicaltrials.gov/show/NCT01950169 2013 (accessed 3 December 2015). FlodinL . Personal communication. Personal communication 15 December 2014. FlodinL , SaafM , CederholmT , Al‐AniAN , AckermannPW , SanegardE , et al. Additive effects of nutritional supplementation, together with bisphosphonates, on bone mineral density after hip fracture: a 12‐month randomized controlled study. Clinical Interventions in Aging2014;9:1043‐50. ">Flodin 2014</a>; <a href="./references#CD001880-bbs2-0026" title="CrottyM . Personal communication 20 February 2009. DanielsLA , MillerM , BannermanE , WhiteheadC , CrottyM . Weight loss post lower limb fracture despite an intensive oral nutrition and exercise intervention. Clinical Nutrition2003;22 Suppl:S86. DanielsLA , MillerMD , BannermannE , CrottyM . Adherence to nutritional supplements amongst orthopedic patients: an important clinical and study design issue. Clinical Nutrition2005;24:535. MillerMD , BannermanE , DanielsLA , CrottyM . Lower limb fracture, cognitive impairment and risk of subsequent malnutrition: a prospective evaluation of dietary energy and protein intake on an orthopaedic ward. European Journal of Clinical Nutrition2006;60(7):853‐61. [MEDLINE: 16452913] MillerMD , CrottyM , WhiteheadC , BannermanE , DanielsLA . Nutritional supplementation and resistance training in nutritionally at risk older adults following lower limb fracture: a randomized controlled trial. Clinical Rehabilitation2006;20(4):311‐23. MillerMD , DanielsLA , BannermanE , CrottyM . Adherence to nutrition supplements among patients with a fall‐related lower limb fracture. Nutrition in Clinical Practice2005;20(5):569‐78. [MEDLINE: 16207699] ">Miller 2006</a>; <a href="./references#CD001880-bbs2-0038" title="CarlssonP , TidermarkJ , PonzerS , SoderqvistA , CederholmT . Food habits and appetite of elderly women at the time of a femoral neck fracture and after nutritional and anabolic support. Journal of Human Nutrition and Dietetics2005;18(2):117‐20. [MEDLINE: 15788020] TengstrandB , CederholmT , SoderqvistA , TidermarkJ . Effects of protein‐rich supplementation and nandrolone on bone tissue after a hip fracture. Clinical Nutrition2007;26(4):460‐5. [MEDLINE: 17498850] TidermarkJ . Personal communication 14 October 2004. TidermarkJ . Quality of life and femoral neck fractures. Acta Orthopaedica Scandinavica. Supplementum2003;74(309):1‐42. TidermarkJ , PonzerS , CarlssonP , SoderqvistA , BrismarK , TengstrandB , et al. Effects of protein‐rich supplementation and nandrolone in lean elderly women with femoral neck fractures. Clinical Nutrition2004;23(4):587‐96. TidermarkJ , PonzerS , TengstrandB , CederholmT . Liquid supplementation and nandrolone to elderly women. Clinical Nutrition2002;21(Suppl 1):40. ">Tidermark 2004</a>; <a href="./references#CD001880-bbs2-0041" title="Breedveld‐PetersJ , ReijvenPL , WyersCE , HendrikxAA , VerburgAD , ScholsJM , et al. Qualitative analysis of barriers and facilitators for nutritional intervention in hip fracture patients. Clinical Nutrition, Supplement2012;7(1):234. Breedveld‐PetersJJ , ReijvenPL , WyersCE , HendrikxAA , VerburgAD , ScholsJM , et al. Barriers and facilitators of nutritional intervention after hip fracture in integrated care as perceived by the different health care professionals: a qualitative interview study. e‐SPEN Journal2012;7(5):e182‐8. Breedveld‐PetersJJ , ReijvenPL , WyersCE , VanHeldenS , ArtsJJ , MeestersB , et al. Integrated nutritional intervention in the elderly after hip fracture. A process evaluation. Clinical Nutrition, Supplement2012;31(1):199‐205. Breedveld‐PetersJJ , ReijvenPL , WyersCE , VanHeldenS , ArtsJJ , MeestersB , et al. Integrated nutritional intervention in the elderly after hip fracture. A process evaluation. Clinical Nutrition, Supplement2012;7(1):43. DagneliePC . Effectiveness and cost‐effectiveness of nutritional screening and intervention in elderly subjects after hip fracture. clinicaltrials.gov/show/NCT00523575 (accessed 8 November 2009). WyersC , ReijvenPL , EversSM , WillemsPC , HeyligersIC , VerburgAD , et al. Cost‐effectiveness of nutritional intervention in hip fracture patients: a multi‐centre randomised controlled trial (RCT). Clinical Nutrition, Supplement2012;7(1):49. WyersCE . PhD thesis. Maastricht, the Netherlands: Maastricht University, 2012. WyersCE , Breedveld‐PetersJJ , ReijvenPL , ArtsC , ThomassenBJ , VerburgAD , et al. Effect of nutritional intervention on nutritional intake and status in hip fracture patients: a multicentre randomised controlled trial (RCT). Clinical Nutrition, Supplement2012;7(1):50‐1. WyersCE , Breedveld‐PetersJJ , ReijvenPL , VanHeldenS , GuldemondNA , SeverensJL , et al. Efficacy and cost‐effectiveness of nutritional intervention in elderly after hip fracture: design of a randomized controlled trial. BMC Public Health2010;10:212. WyersCE , ReijvenPL , EversSM , WillemsPC , HeyligersIC , VerburgAD , et al. Cost‐effectiveness of nutritional intervention in elderly subjects after hip fracture. A randomized controlled trial. Osteoporosis International2013;24(1):151‐62. ">Wyers 2013</a>). </p> <section id="CD001880-sec-0112"> <h6 class="title">Mortality</h6> <p>Pooled mortality data from 15 studies showed no clear difference between the two groups in mortality at follow‐up ranging from until hospital discharge to one year (24/486 versus 31/481; risk ratio (RR) 0.81, 95% confidence interval (CI) 0.49 to 1.32; low‐quality evidence downgraded two levels due to risk of bias and imprecision; <a href="./references#CD001880-fig-0008" title="">Analysis 1.1</a>, <a href="#CD001880-fig-0004">Figure 4</a>). Five of these 15 studies reported no deaths in either group; all had short‐term follow‐up of up to discharge or for one month (<a href="./references#CD001880-bbs2-0005" title="Botella‐CarreteroJI . Personal communication 23 January 2009. Botella‐CarreteroJI , IglesiasB , BalsaJA , ZamarronI , ArrietaF , VazquezC . Effects of oral nutritional supplements in normally nourished or mildly undernourished geriatric patients after surgery for hip fracture: a randomized clinical trial. Journal of Parenteral and Enteral Nutrition2008;32(2):120‐8. [MEDLINE: 18407904] IglesiasB , Botella‐CarreteroJI , BalsaJA , ArrietaF , ZamarronI , VazquezC . Effects of oral nutritional supplements in geriatric patients after surgery for hip fracture. Clinical Nutrition Supplements2007;2(2):97. ">Botella‐Carretero 2008</a>; <a href="./references#CD001880-bbs2-0006" title="Botella‐CarreteroJI . Personal communication 26 October 2014. Botella‐CarreteroJI , IglesiasB , BalsaJA , ArrietaF , ZamarronI , VazquezC . Perioperative oral nutritional supplements in normally and mildly undernourished geriatric patients submitted to surgery for hip fracture: a randomized clinical trial. Clinical Nutrition2010;29(5):574‐9. ">Botella‐Carretero 2010</a>; <a href="./references#CD001880-bbs2-0007" title="BrownKM . Personal communicationMay 1999. BrownKM , SeabrookNA . Effect of nutrition on recovery after fractured femur. Medical Audit News1992;2(1):10‐2. BrownKM , SeabrookNA . Nutritional influences on recovery and length of hospital stay in elderly women following femoral fracture. Proceedings of the Nutrition Society1992;51(2):132A. ">Brown 1992b</a>; <a href="./references#CD001880-bbs2-0024" title="LuoM . Personal communication 17 November 2014. LuoM , GolubevG , KlyukvinI , ReznikL , KuropatkinG , OliverJS , et al. Oral nutrition supplement improved nutritional status in malnourished hip fracture patients: a randomized controlled study. Journal of Scientific Research and Reports2015;4(6):480‐9. LuoM , GolybevG , KlyukvinI , ReznikL , KuropatkinG , VossAC . Oral nutritional supplement (ONS) improved nutritional status in malnourished patients receiving hip fracture surgery. Clinical Nutrition Supplements2011;6:151. SwearenginB . Effect of a medical food supplement in hospitalized patients recovering from surgery. clinicaltrials.gov/ct2/show/NCT01011608 (accessed 4 December 2015). ">Luo 2015</a>; <a href="./references#CD001880-bbs2-0035" title="StableforthPG . Supplement feeds and nitrogen and calorie balance following femoral neck fracture. British Journal of Surgery1986;73:651‐5. ">Stableforth 1986</a>). <a href="./references#CD001880-bbs2-0008" title="BruceD . Personal communication. October 2003. BruceD , LauranceI , McGuinessM , RidleyM , GoldswainP . Nutritional supplements after hip fracture: poor compliance limits effectiveness. Clinical Nutrition2003;22(5):497‐500. [MEDLINE: 14512038] ">Bruce 2003</a> reported similar percentages of participants in the two groups who had died or were in a nursing home at six months (23.4% versus 24.6%). <a href="./references#CD001880-bbs2-0023" title="KangJH , ShinDW , BaikHW , HongJ . Short‐term oral nutritional supplements and nutrition intervention in elderly patients after hip fracture surgery: a randomized controlled clinical trial. Clinical Nutrition, Supplement2012;7(1):280. ">Kang 2012</a> reported that supplementation reduced mortality but provided no data to support this. </p> <div class="figure" id="CD001880-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Multinutrient supplements (oral, nasogastric, intravenous) versus control, outcome: 1.1 Mortality by end of study" data-id="CD001880-fig-0004" src="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Multinutrient supplements (oral, nasogastric, intravenous) versus control, outcome: 1.1 Mortality by end of study </p> </div> </div> </div> </section> <section id="CD001880-sec-0113"> <h6 class="title">Complications</h6> <p>Thirteen studies reported the numbers of participants with complications at the end of the study (<a href="./references#CD001880-bbs2-0001" title="AnbarR , BelooseskyY , CohenJ , MadarZ , WeissA , TheillaM , et al. Tight calorie control in geriatric patients following hip fracture decreases complications: a randomized, controlled study. Clinical Nutrition2014;33:23‐8. AnbarR , BelooseskyY , MadarZ , TheillaM , Koren‐HakimT , WeissA , et al. Tight calorie control (TICACOS) in geriatric hip fracture patients. Clinical Nutrition, Supplement2012;7(1):18. AnbarR , BelooseskyY , MadarZ , TheillaM , Koren‐HakimT , WeissA , et al. Tight calorie control in geriatric hip fracture patients: preliminary results of the geriatric TICACOS study. Clinical Nutrition, Supplement2011;6(1):155. SingerP . Tight caloric balance in geriatric patients (TICACOSiGP). clinicaltrials.gov/show/NCT01735435 (accessed 3 December 2015). ">Anbar 2014</a>; <a href="./references#CD001880-bbs2-0005" title="Botella‐CarreteroJI . Personal communication 23 January 2009. Botella‐CarreteroJI , IglesiasB , BalsaJA , ZamarronI , ArrietaF , VazquezC . Effects of oral nutritional supplements in normally nourished or mildly undernourished geriatric patients after surgery for hip fracture: a randomized clinical trial. Journal of Parenteral and Enteral Nutrition2008;32(2):120‐8. [MEDLINE: 18407904] IglesiasB , Botella‐CarreteroJI , BalsaJA , ArrietaF , ZamarronI , VazquezC . Effects of oral nutritional supplements in geriatric patients after surgery for hip fracture. Clinical Nutrition Supplements2007;2(2):97. ">Botella‐Carretero 2008</a>; <a href="./references#CD001880-bbs2-0006" title="Botella‐CarreteroJI . Personal communication 26 October 2014. Botella‐CarreteroJI , IglesiasB , BalsaJA , ArrietaF , ZamarronI , VazquezC . Perioperative oral nutritional supplements in normally and mildly undernourished geriatric patients submitted to surgery for hip fracture: a randomized clinical trial. Clinical Nutrition2010;29(5):574‐9. ">Botella‐Carretero 2010</a>; <a href="./references#CD001880-bbs2-0011" title="BonjourJP , RapinCH , RizzoliR , TkatchL , DelmiM , ChevalleyT , et al. Hip fracture, femoral bone mineral density, and protein supply in elderly patients. In: MunroHN , SchlierfG editor(s). Nutrition of the elderly. Nestlé nutrition workshop series. Vol. 29, New York: Raven Press, 1992:151‐9. [ISBN 0881678740 ] BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. BonjourJP , SchürchMA , RizzoliR . Nutritional aspects of hip fractures. Bone1996;18(3 Suppl):139S‐44S. BonjourJP , SchürchMA , RizzoliR . Proteins and bone health. Pathologie‐Biologie1997;45(1):57‐9. DelmiM , RapinC‐H , BengoaJ‐M , DelmasPD , VaseyH , BonjourJ‐P . Dietary supplementation in elderly patients with fractured neck of the femur. Lancet1990;335:1013‐6. [MEDLINE: 1970070] RapinCH , BengoaJM , KahnJM , DelmiM , BonjourJP , VaseyH . A prospective randomised control study of oral dietary supplementation in patients with fractured necks of femur. Journal of Parenteral and Enteral Nutrition1989;13(1):9S. ">Delmi 1990</a>; <a href="./references#CD001880-bbs2-0016" title="FlodinL . Effects of bisphosphonates and nutritional supplementation after a hip fracture. clinicaltrials.gov/show/NCT01950169 2013 (accessed 3 December 2015). FlodinL . Personal communication. Personal communication 15 December 2014. FlodinL , SaafM , CederholmT , Al‐AniAN , AckermannPW , SanegardE , et al. Additive effects of nutritional supplementation, together with bisphosphonates, on bone mineral density after hip fracture: a 12‐month randomized controlled study. Clinical Interventions in Aging2014;9:1043‐50. ">Flodin 2014</a>; <a href="./references#CD001880-bbs2-0019" title="HankinsC . Dietary supplementation with sustagen in elderly patients with fractured neck of femur [MSc dissertation]. Sydney (Australia): University of Sydney, 1996. HankinsC . Personal communication 11 June 1999. ">Hankins 1996</a>; <a href="./references#CD001880-bbs2-0023" title="KangJH , ShinDW , BaikHW , HongJ . Short‐term oral nutritional supplements and nutrition intervention in elderly patients after hip fracture surgery: a randomized controlled clinical trial. Clinical Nutrition, Supplement2012;7(1):280. ">Kang 2012</a>; <a href="./references#CD001880-bbs2-0024" title="LuoM . Personal communication 17 November 2014. LuoM , GolubevG , KlyukvinI , ReznikL , KuropatkinG , OliverJS , et al. Oral nutrition supplement improved nutritional status in malnourished hip fracture patients: a randomized controlled study. Journal of Scientific Research and Reports2015;4(6):480‐9. LuoM , GolybevG , KlyukvinI , ReznikL , KuropatkinG , VossAC . Oral nutritional supplement (ONS) improved nutritional status in malnourished patients receiving hip fracture surgery. Clinical Nutrition Supplements2011;6:151. SwearenginB . Effect of a medical food supplement in hospitalized patients recovering from surgery. clinicaltrials.gov/ct2/show/NCT01011608 (accessed 4 December 2015). ">Luo 2015</a>; <a href="./references#CD001880-bbs2-0025" title="MadiganC . Benefits of dietary supplementation in elderly patients with fractured neck of femur. Sydney (Australia): University of Sydney, 1994. ">Madigan 1994</a>; <a href="./references#CD001880-bbs2-0027" title="MyintMW . Personal communication 6 January 2015. MyintMW , WuJ , WongE , ChanSP , ToTS , ChauMW , et al. Clinical benefits of oral nutritional supplementation for elderly hip fracture patients: a single blind randomised controlled trial. Age and Ageing2013;42(1):39‐45. MyintMWW . A randomized controlled study of nutritional intervention for geriatric hip fracture patients and its effect on rehabilitation outcomes. clinicaltrials.gov/ct2/show/NCT01088139 (accessed 4 December 2015). ">Myint 2013</a>; <a href="./references#CD001880-bbs2-0035" title="StableforthPG . Supplement feeds and nitrogen and calorie balance following femoral neck fracture. British Journal of Surgery1986;73:651‐5. ">Stableforth 1986</a>; <a href="./references#CD001880-bbs2-0038" title="CarlssonP , TidermarkJ , PonzerS , SoderqvistA , CederholmT . Food habits and appetite of elderly women at the time of a femoral neck fracture and after nutritional and anabolic support. Journal of Human Nutrition and Dietetics2005;18(2):117‐20. [MEDLINE: 15788020] TengstrandB , CederholmT , SoderqvistA , TidermarkJ . Effects of protein‐rich supplementation and nandrolone on bone tissue after a hip fracture. Clinical Nutrition2007;26(4):460‐5. [MEDLINE: 17498850] TidermarkJ . Personal communication 14 October 2004. TidermarkJ . Quality of life and femoral neck fractures. Acta Orthopaedica Scandinavica. Supplementum2003;74(309):1‐42. TidermarkJ , PonzerS , CarlssonP , SoderqvistA , BrismarK , TengstrandB , et al. Effects of protein‐rich supplementation and nandrolone in lean elderly women with femoral neck fractures. Clinical Nutrition2004;23(4):587‐96. TidermarkJ , PonzerS , TengstrandB , CederholmT . Liquid supplementation and nandrolone to elderly women. Clinical Nutrition2002;21(Suppl 1):40. ">Tidermark 2004</a>; <a href="./references#CD001880-bbs2-0041" title="Breedveld‐PetersJ , ReijvenPL , WyersCE , HendrikxAA , VerburgAD , ScholsJM , et al. Qualitative analysis of barriers and facilitators for nutritional intervention in hip fracture patients. Clinical Nutrition, Supplement2012;7(1):234. Breedveld‐PetersJJ , ReijvenPL , WyersCE , HendrikxAA , VerburgAD , ScholsJM , et al. Barriers and facilitators of nutritional intervention after hip fracture in integrated care as perceived by the different health care professionals: a qualitative interview study. e‐SPEN Journal2012;7(5):e182‐8. Breedveld‐PetersJJ , ReijvenPL , WyersCE , VanHeldenS , ArtsJJ , MeestersB , et al. Integrated nutritional intervention in the elderly after hip fracture. A process evaluation. Clinical Nutrition, Supplement2012;31(1):199‐205. Breedveld‐PetersJJ , ReijvenPL , WyersCE , VanHeldenS , ArtsJJ , MeestersB , et al. Integrated nutritional intervention in the elderly after hip fracture. A process evaluation. Clinical Nutrition, Supplement2012;7(1):43. DagneliePC . Effectiveness and cost‐effectiveness of nutritional screening and intervention in elderly subjects after hip fracture. clinicaltrials.gov/show/NCT00523575 (accessed 8 November 2009). WyersC , ReijvenPL , EversSM , WillemsPC , HeyligersIC , VerburgAD , et al. Cost‐effectiveness of nutritional intervention in hip fracture patients: a multi‐centre randomised controlled trial (RCT). Clinical Nutrition, Supplement2012;7(1):49. WyersCE . PhD thesis. Maastricht, the Netherlands: Maastricht University, 2012. WyersCE , Breedveld‐PetersJJ , ReijvenPL , ArtsC , ThomassenBJ , VerburgAD , et al. Effect of nutritional intervention on nutritional intake and status in hip fracture patients: a multicentre randomised controlled trial (RCT). Clinical Nutrition, Supplement2012;7(1):50‐1. WyersCE , Breedveld‐PetersJJ , ReijvenPL , VanHeldenS , GuldemondNA , SeverensJL , et al. Efficacy and cost‐effectiveness of nutritional intervention in elderly after hip fracture: design of a randomized controlled trial. BMC Public Health2010;10:212. WyersCE , ReijvenPL , EversSM , WillemsPC , HeyligersIC , VerburgAD , et al. Cost‐effectiveness of nutritional intervention in elderly subjects after hip fracture. A randomized controlled trial. Osteoporosis International2013;24(1):151‐62. ">Wyers 2013</a>). Follow‐up was usually until discharge or for one month but two trials followed up for six months (<a href="./references#CD001880-bbs2-0011" title="BonjourJP , RapinCH , RizzoliR , TkatchL , DelmiM , ChevalleyT , et al. Hip fracture, femoral bone mineral density, and protein supply in elderly patients. In: MunroHN , SchlierfG editor(s). Nutrition of the elderly. Nestlé nutrition workshop series. Vol. 29, New York: Raven Press, 1992:151‐9. [ISBN 0881678740 ] BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. BonjourJP , SchürchMA , RizzoliR . Nutritional aspects of hip fractures. Bone1996;18(3 Suppl):139S‐44S. BonjourJP , SchürchMA , RizzoliR . Proteins and bone health. Pathologie‐Biologie1997;45(1):57‐9. DelmiM , RapinC‐H , BengoaJ‐M , DelmasPD , VaseyH , BonjourJ‐P . Dietary supplementation in elderly patients with fractured neck of the femur. Lancet1990;335:1013‐6. [MEDLINE: 1970070] RapinCH , BengoaJM , KahnJM , DelmiM , BonjourJP , VaseyH . A prospective randomised control study of oral dietary supplementation in patients with fractured necks of femur. Journal of Parenteral and Enteral Nutrition1989;13(1):9S. ">Delmi 1990</a>; <a href="./references#CD001880-bbs2-0027" title="MyintMW . Personal communication 6 January 2015. MyintMW , WuJ , WongE , ChanSP , ToTS , ChauMW , et al. Clinical benefits of oral nutritional supplementation for elderly hip fracture patients: a single blind randomised controlled trial. Age and Ageing2013;42(1):39‐45. MyintMWW . A randomized controlled study of nutritional intervention for geriatric hip fracture patients and its effect on rehabilitation outcomes. clinicaltrials.gov/ct2/show/NCT01088139 (accessed 4 December 2015). ">Myint 2013</a>) and three trials followed up for 12 months (<a href="./references#CD001880-bbs2-0016" title="FlodinL . Effects of bisphosphonates and nutritional supplementation after a hip fracture. clinicaltrials.gov/show/NCT01950169 2013 (accessed 3 December 2015). FlodinL . Personal communication. Personal communication 15 December 2014. FlodinL , SaafM , CederholmT , Al‐AniAN , AckermannPW , SanegardE , et al. Additive effects of nutritional supplementation, together with bisphosphonates, on bone mineral density after hip fracture: a 12‐month randomized controlled study. Clinical Interventions in Aging2014;9:1043‐50. ">Flodin 2014</a>; <a href="./references#CD001880-bbs2-0038" title="CarlssonP , TidermarkJ , PonzerS , SoderqvistA , CederholmT . Food habits and appetite of elderly women at the time of a femoral neck fracture and after nutritional and anabolic support. Journal of Human Nutrition and Dietetics2005;18(2):117‐20. [MEDLINE: 15788020] TengstrandB , CederholmT , SoderqvistA , TidermarkJ . Effects of protein‐rich supplementation and nandrolone on bone tissue after a hip fracture. Clinical Nutrition2007;26(4):460‐5. [MEDLINE: 17498850] TidermarkJ . Personal communication 14 October 2004. TidermarkJ . Quality of life and femoral neck fractures. Acta Orthopaedica Scandinavica. Supplementum2003;74(309):1‐42. TidermarkJ , PonzerS , CarlssonP , SoderqvistA , BrismarK , TengstrandB , et al. Effects of protein‐rich supplementation and nandrolone in lean elderly women with femoral neck fractures. Clinical Nutrition2004;23(4):587‐96. TidermarkJ , PonzerS , TengstrandB , CederholmT . Liquid supplementation and nandrolone to elderly women. Clinical Nutrition2002;21(Suppl 1):40. ">Tidermark 2004</a>; <a href="./references#CD001880-bbs2-0041" title="Breedveld‐PetersJ , ReijvenPL , WyersCE , HendrikxAA , VerburgAD , ScholsJM , et al. Qualitative analysis of barriers and facilitators for nutritional intervention in hip fracture patients. Clinical Nutrition, Supplement2012;7(1):234. Breedveld‐PetersJJ , ReijvenPL , WyersCE , HendrikxAA , VerburgAD , ScholsJM , et al. Barriers and facilitators of nutritional intervention after hip fracture in integrated care as perceived by the different health care professionals: a qualitative interview study. e‐SPEN Journal2012;7(5):e182‐8. Breedveld‐PetersJJ , ReijvenPL , WyersCE , VanHeldenS , ArtsJJ , MeestersB , et al. Integrated nutritional intervention in the elderly after hip fracture. A process evaluation. Clinical Nutrition, Supplement2012;31(1):199‐205. Breedveld‐PetersJJ , ReijvenPL , WyersCE , VanHeldenS , ArtsJJ , MeestersB , et al. Integrated nutritional intervention in the elderly after hip fracture. A process evaluation. Clinical Nutrition, Supplement2012;7(1):43. DagneliePC . Effectiveness and cost‐effectiveness of nutritional screening and intervention in elderly subjects after hip fracture. clinicaltrials.gov/show/NCT00523575 (accessed 8 November 2009). WyersC , ReijvenPL , EversSM , WillemsPC , HeyligersIC , VerburgAD , et al. Cost‐effectiveness of nutritional intervention in hip fracture patients: a multi‐centre randomised controlled trial (RCT). Clinical Nutrition, Supplement2012;7(1):49. WyersCE . PhD thesis. Maastricht, the Netherlands: Maastricht University, 2012. WyersCE , Breedveld‐PetersJJ , ReijvenPL , ArtsC , ThomassenBJ , VerburgAD , et al. Effect of nutritional intervention on nutritional intake and status in hip fracture patients: a multicentre randomised controlled trial (RCT). Clinical Nutrition, Supplement2012;7(1):50‐1. WyersCE , Breedveld‐PetersJJ , ReijvenPL , VanHeldenS , GuldemondNA , SeverensJL , et al. Efficacy and cost‐effectiveness of nutritional intervention in elderly after hip fracture: design of a randomized controlled trial. BMC Public Health2010;10:212. WyersCE , ReijvenPL , EversSM , WillemsPC , HeyligersIC , VerburgAD , et al. Cost‐effectiveness of nutritional intervention in elderly subjects after hip fracture. A randomized controlled trial. Osteoporosis International2013;24(1):151‐62. ">Wyers 2013</a>). Results from <a href="./references#CD001880-bbs2-0022" title="HouwingR . Personal communication 29 October 2003. HouwingR , RozendaalM , Wouters‐WesselingW , BeulensJ , BuskensE , HaalboomJ . The effect of nutritional supplementation on the prevention of pressure ulcers (PU) in hip‐fracture patients. Clinical Nutrition2002;21(Suppl 1):84. HouwingRH , RozendaalM , Wouters‐WesselingW , BeulensJW , BuskensE , HaalboomJR . A randomised, double‐blind assessment of the effect of nutritional supplementation on the prevention of pressure ulcers in hip‐fracture patients. Clinical Nutrition2003;22(4):401‐5. [MEDLINE: 12880608] ">Houwing 2003</a> were not included since these were only for pressure sores: there was no difference between the two groups in the numbers of participants with this complication. <a href="./references#CD001880-bbs2-0023" title="KangJH , ShinDW , BaikHW , HongJ . Short‐term oral nutritional supplements and nutrition intervention in elderly patients after hip fracture surgery: a randomized controlled clinical trial. Clinical Nutrition, Supplement2012;7(1):280. ">Kang 2012</a> reported that supplementation reduced the rate of postoperative complications but did not provide any data to support this statement. <a href="./references#CD001880-bbs2-0024" title="LuoM . Personal communication 17 November 2014. LuoM , GolubevG , KlyukvinI , ReznikL , KuropatkinG , OliverJS , et al. Oral nutrition supplement improved nutritional status in malnourished hip fracture patients: a randomized controlled study. Journal of Scientific Research and Reports2015;4(6):480‐9. LuoM , GolybevG , KlyukvinI , ReznikL , KuropatkinG , VossAC . Oral nutritional supplement (ONS) improved nutritional status in malnourished patients receiving hip fracture surgery. Clinical Nutrition Supplements2011;6:151. SwearenginB . Effect of a medical food supplement in hospitalized patients recovering from surgery. clinicaltrials.gov/ct2/show/NCT01011608 (accessed 4 December 2015). ">Luo 2015</a> reported 20 adverse events in the supplemented group and 24 in the control group, with two events in the intervention group assessed as being possibly related to the supplement (nausea, pruritus); denominators were unclear. Pooled results from 11 studies showed a reduction in the participants with complications in the supplemented group (123/370 versus 157/367; RR 0.71 favouring supplementation, 95% CI 0.59 to 0.86; low‐quality evidence downgraded two levels due to serious risk of bias; <a href="./references#CD001880-fig-0009" title="">Analysis 1.2</a>, <a href="#CD001880-fig-0005">Figure 5</a>). </p> <div class="figure" id="CD001880-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Multinutrient supplements (oral, nasogastric, intravenous) versus control, outcome: 1.2 Participants with complications at end of study" data-id="CD001880-fig-0005" src="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Multinutrient supplements (oral, nasogastric, intravenous) versus control, outcome: 1.2 Participants with complications at end of study </p> </div> </div> </div> </section> <section id="CD001880-sec-0114"> <h6 class="title">Unfavourable outcome</h6> <p>Six studies reported data for 'unfavourable outcome' (<a href="./references#CD001880-bbs2-0005" title="Botella‐CarreteroJI . Personal communication 23 January 2009. Botella‐CarreteroJI , IglesiasB , BalsaJA , ZamarronI , ArrietaF , VazquezC . Effects of oral nutritional supplements in normally nourished or mildly undernourished geriatric patients after surgery for hip fracture: a randomized clinical trial. Journal of Parenteral and Enteral Nutrition2008;32(2):120‐8. [MEDLINE: 18407904] IglesiasB , Botella‐CarreteroJI , BalsaJA , ArrietaF , ZamarronI , VazquezC . Effects of oral nutritional supplements in geriatric patients after surgery for hip fracture. Clinical Nutrition Supplements2007;2(2):97. ">Botella‐Carretero 2008</a>; <a href="./references#CD001880-bbs2-0006" title="Botella‐CarreteroJI . Personal communication 26 October 2014. Botella‐CarreteroJI , IglesiasB , BalsaJA , ArrietaF , ZamarronI , VazquezC . Perioperative oral nutritional supplements in normally and mildly undernourished geriatric patients submitted to surgery for hip fracture: a randomized clinical trial. Clinical Nutrition2010;29(5):574‐9. ">Botella‐Carretero 2010</a>; <a href="./references#CD001880-bbs2-0011" title="BonjourJP , RapinCH , RizzoliR , TkatchL , DelmiM , ChevalleyT , et al. Hip fracture, femoral bone mineral density, and protein supply in elderly patients. In: MunroHN , SchlierfG editor(s). Nutrition of the elderly. Nestlé nutrition workshop series. Vol. 29, New York: Raven Press, 1992:151‐9. [ISBN 0881678740 ] BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. BonjourJP , SchürchMA , RizzoliR . Nutritional aspects of hip fractures. Bone1996;18(3 Suppl):139S‐44S. BonjourJP , SchürchMA , RizzoliR . Proteins and bone health. Pathologie‐Biologie1997;45(1):57‐9. DelmiM , RapinC‐H , BengoaJ‐M , DelmasPD , VaseyH , BonjourJ‐P . Dietary supplementation in elderly patients with fractured neck of the femur. Lancet1990;335:1013‐6. [MEDLINE: 1970070] RapinCH , BengoaJM , KahnJM , DelmiM , BonjourJP , VaseyH . A prospective randomised control study of oral dietary supplementation in patients with fractured necks of femur. Journal of Parenteral and Enteral Nutrition1989;13(1):9S. ">Delmi 1990</a>; <a href="./references#CD001880-bbs2-0016" title="FlodinL . Effects of bisphosphonates and nutritional supplementation after a hip fracture. clinicaltrials.gov/show/NCT01950169 2013 (accessed 3 December 2015). FlodinL . Personal communication. Personal communication 15 December 2014. FlodinL , SaafM , CederholmT , Al‐AniAN , AckermannPW , SanegardE , et al. Additive effects of nutritional supplementation, together with bisphosphonates, on bone mineral density after hip fracture: a 12‐month randomized controlled study. Clinical Interventions in Aging2014;9:1043‐50. ">Flodin 2014</a>; <a href="./references#CD001880-bbs2-0019" title="HankinsC . Dietary supplementation with sustagen in elderly patients with fractured neck of femur [MSc dissertation]. Sydney (Australia): University of Sydney, 1996. HankinsC . Personal communication 11 June 1999. ">Hankins 1996</a>; <a href="./references#CD001880-bbs2-0035" title="StableforthPG . Supplement feeds and nitrogen and calorie balance following femoral neck fracture. British Journal of Surgery1986;73:651‐5. ">Stableforth 1986</a>). However, three of these did not report any deaths. Data pooled using the fixed‐effect model from these six trials for the combined outcome for mortality or complications ('unfavourable outcome') at final follow‐up favoured the supplemented group (58/176 versus 67/158; RR 0.67, 95% CI 0.51 to 0.89; very low‐quality evidence downgraded two levels for serious risk of bias and one for indirectness reflecting the mixed definition of the outcome measure; <a href="./references#CD001880-fig-0011" title="">Analysis 1.4</a>; Figure 6). The pooled results using the random‐effects model showed similar results (RR 0.65, 95% CI 0.45 to 0.95; data not shown). <a href="./references#CD001880-bbs2-0011" title="BonjourJP , RapinCH , RizzoliR , TkatchL , DelmiM , ChevalleyT , et al. Hip fracture, femoral bone mineral density, and protein supply in elderly patients. In: MunroHN , SchlierfG editor(s). Nutrition of the elderly. Nestlé nutrition workshop series. Vol. 29, New York: Raven Press, 1992:151‐9. [ISBN 0881678740 ] BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. BonjourJP , SchürchMA , RizzoliR . Nutritional aspects of hip fractures. Bone1996;18(3 Suppl):139S‐44S. BonjourJP , SchürchMA , RizzoliR . Proteins and bone health. Pathologie‐Biologie1997;45(1):57‐9. DelmiM , RapinC‐H , BengoaJ‐M , DelmasPD , VaseyH , BonjourJ‐P . Dietary supplementation in elderly patients with fractured neck of the femur. Lancet1990;335:1013‐6. [MEDLINE: 1970070] RapinCH , BengoaJM , KahnJM , DelmiM , BonjourJP , VaseyH . A prospective randomised control study of oral dietary supplementation in patients with fractured necks of femur. Journal of Parenteral and Enteral Nutrition1989;13(1):9S. ">Delmi 1990</a> presented results, without explanation of the missing participants, for only 52 participants out of the 59 originally randomised. Exploratory analysis for 'unfavourable outcome' based on numbers randomised (in all trials where available) in which it was assumed that all excluded participants in the supplemented group had complications at follow‐up (66/184 versus 67/169; RR 0.81, 95% CI 0.62 to 1.04; <a href="./references#CD001880-fig-0012" title="">Analysis 1.5</a>) shows these findings are not robust. </p> <p><a href="./references#CD001880-bbs2-0019" title="HankinsC . Dietary supplementation with sustagen in elderly patients with fractured neck of femur [MSc dissertation]. Sydney (Australia): University of Sydney, 1996. HankinsC . Personal communication 11 June 1999. ">Hankins 1996</a> also presented data for 'unfavourable outcome' in the acute hospital (14/17 versus 12/14; RR 0.96, 99% CI 0.64 to 1.44) and post‐discharge (8/17 versus 6/14; RR 1.10, 99% CI 0.39 to 3.09); <a href="./references#CD001880-fig-0012" title="">Analysis 1.5</a>. <a href="./references#CD001880-bbs2-0011" title="BonjourJP , RapinCH , RizzoliR , TkatchL , DelmiM , ChevalleyT , et al. Hip fracture, femoral bone mineral density, and protein supply in elderly patients. In: MunroHN , SchlierfG editor(s). Nutrition of the elderly. Nestlé nutrition workshop series. Vol. 29, New York: Raven Press, 1992:151‐9. [ISBN 0881678740 ] BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. BonjourJP , SchürchMA , RizzoliR . Nutritional aspects of hip fractures. Bone1996;18(3 Suppl):139S‐44S. BonjourJP , SchürchMA , RizzoliR . Proteins and bone health. Pathologie‐Biologie1997;45(1):57‐9. DelmiM , RapinC‐H , BengoaJ‐M , DelmasPD , VaseyH , BonjourJ‐P . Dietary supplementation in elderly patients with fractured neck of the femur. Lancet1990;335:1013‐6. [MEDLINE: 1970070] RapinCH , BengoaJM , KahnJM , DelmiM , BonjourJP , VaseyH . A prospective randomised control study of oral dietary supplementation in patients with fractured necks of femur. Journal of Parenteral and Enteral Nutrition1989;13(1):9S. ">Delmi 1990</a> presented data for similar outcomes but gave insufficient explanation of the denominators used in their report. </p> </section> <section id="CD001880-sec-0115"> <h6 class="title">Secondary outcomes</h6> <section id="CD001880-sec-0116"> <p><b>Length of stay</b></p> <p>The duration of hospital stay was reported in 13 studies (<a href="./references#CD001880-bbs2-0001" title="AnbarR , BelooseskyY , CohenJ , MadarZ , WeissA , TheillaM , et al. Tight calorie control in geriatric patients following hip fracture decreases complications: a randomized, controlled study. Clinical Nutrition2014;33:23‐8. AnbarR , BelooseskyY , MadarZ , TheillaM , Koren‐HakimT , WeissA , et al. Tight calorie control (TICACOS) in geriatric hip fracture patients. Clinical Nutrition, Supplement2012;7(1):18. AnbarR , BelooseskyY , MadarZ , TheillaM , Koren‐HakimT , WeissA , et al. Tight calorie control in geriatric hip fracture patients: preliminary results of the geriatric TICACOS study. Clinical Nutrition, Supplement2011;6(1):155. SingerP . Tight caloric balance in geriatric patients (TICACOSiGP). clinicaltrials.gov/show/NCT01735435 (accessed 3 December 2015). ">Anbar 2014</a>; <a href="./references#CD001880-bbs2-0006" title="Botella‐CarreteroJI . Personal communication 26 October 2014. Botella‐CarreteroJI , IglesiasB , BalsaJA , ArrietaF , ZamarronI , VazquezC . Perioperative oral nutritional supplements in normally and mildly undernourished geriatric patients submitted to surgery for hip fracture: a randomized clinical trial. Clinical Nutrition2010;29(5):574‐9. ">Botella‐Carretero 2010</a>; <a href="./references#CD001880-bbs2-0007" title="BrownKM . Personal communicationMay 1999. BrownKM , SeabrookNA . Effect of nutrition on recovery after fractured femur. Medical Audit News1992;2(1):10‐2. BrownKM , SeabrookNA . Nutritional influences on recovery and length of hospital stay in elderly women following femoral fracture. Proceedings of the Nutrition Society1992;51(2):132A. ">Brown 1992b</a>; <a href="./references#CD001880-bbs2-0008" title="BruceD . Personal communication. October 2003. BruceD , LauranceI , McGuinessM , RidleyM , GoldswainP . Nutritional supplements after hip fracture: poor compliance limits effectiveness. Clinical Nutrition2003;22(5):497‐500. [MEDLINE: 14512038] ">Bruce 2003</a>; <a href="./references#CD001880-bbs2-0025" title="MadiganC . Benefits of dietary supplementation in elderly patients with fractured neck of femur. Sydney (Australia): University of Sydney, 1994. ">Madigan 1994</a>; <a href="./references#CD001880-bbs2-0027" title="MyintMW . Personal communication 6 January 2015. MyintMW , WuJ , WongE , ChanSP , ToTS , ChauMW , et al. Clinical benefits of oral nutritional supplementation for elderly hip fracture patients: a single blind randomised controlled trial. Age and Ageing2013;42(1):39‐45. MyintMWW . A randomized controlled study of nutritional intervention for geriatric hip fracture patients and its effect on rehabilitation outcomes. clinicaltrials.gov/ct2/show/NCT01088139 (accessed 4 December 2015). ">Myint 2013</a>; <a href="./references#CD001880-bbs2-0036" title="SullivanDH . Personal communication 10 February 2000. SullivanDH , NelsonCL , BoppMM , Puskarich‐MayCL , WallsRC . Nightly enteral nutrition support of elderly fracture patients: a phase I trial. Journal of the American College of Nutrition1998;17(1):155‐61. ">Sullivan 1998</a>; <a href="./references#CD001880-bbs2-0014" title="EspaulellaJ , GuyerH , Diaz‐EscriuF , Mellado‐NavasJA , CastellsM , PladevallM . Nutritional supplementation of elderly hip fracture patients. A randomized, double‐blind, placebo‐controlled trial. Age and Ageing2000;29(5):425‐31. [MEDLINE: 11108415] GuyerH . Personal communication 13 June 2000. ">Espaulella 2000</a>; <a href="./references#CD001880-bbs2-0028" title="JensenG . Personal communication 6 January 2005. NeumannM , FriedmannJ , RoyMA , JensenGL . Provision of high‐protein supplement for patients recovering from hip fracture. Nutrition2004;20(5):415‐9. [MEDLINE: 15105027] NeumannMM , FriedmannJM , JensenGL . Provision of high protein supplement for patients recovering from hip fracture. Journal of Parenteral and Enteral Nutrition2004;28(Suppl 1):S30. ">Neumann 2004</a>; <a href="./references#CD001880-bbs2-0030" title="ParkerM . Personal communication 16 October 2014. ParkerM . Randomised trial comparing iron supplementation versus placebo in the treatment of anaemia after hip fracture. clinicaltrials.gov/show/NCT00919230 (accessed 4 December 2015). ParkerMJ . Iron supplementation for anemia after hip fracture surgery. A randomized trial of 300 patients. Journal of Bone and Joint Surgery ‐ American Volume2010;92(2):265‐9. ">Parker 2010</a>; <a href="./references#CD001880-bbs2-0034" title="Serrano‐TrenasJA , UgaldePF , CabelloLM , ChoflesLC , LazaroPS , BenitezPC . Role of perioperative intravenous iron therapy in elderly hip fracture patients: a single‐center randomized controlled trial. Transfusion2011;51(1):97‐104. ">Serrano‐Trenas 2011</a>; <a href="./references#CD001880-bbs2-0010" title="DayJJ . Personal communication 27 May 1999. DayJJ , BayerAJ , McMahonM , PathyMS , SpraggBP , RowlandsDC . Thiamine status, vitamin supplements and postoperative confusion. Age and Ageing1988;17:29‐34. ">Day 1988</a>; <a href="./references#CD001880-bbs2-0033" title="DerossiD , BoA , BergonziR , ScivolettoG . Six‐week administration of a mixture of ergogenic and osteotrophic ingredients (RestorfastTM) improves the clinical course of elderly patients after hip fracture surgery [La somministrazione per sei settimane di un composto a base di sostanze osteotrofiche ed ergogene (RestorfastTM) migliora il decorso clinico in anziani sottoposti a chirurgia del femore]. Trends in Medicine2009;9(4):235‐42. ScivolettoG , BoA , DerossiD , BergonziR . Ten week administration of a polynutritional supplement with muscle tone action (RiabylexTM) improves the functional recovery in elderly hip fracture patients during home rehabilitation [In anziani in terapia riabilitativa domiciliare per pregressa frattura del femore, l'assunzione di un polinutriente ad azione muscolotonica (RiabylexTM) per 10 settimane migliora il recupero funzionale]. Trends in Medicine2010;10(2):113‐20. ">Scivoletto 2010</a>), with variable effects for the interventions. We have presented data for those trials that allowed significance testing in <a href="#CD001880-tbl-0003">Table 1</a>. <a href="./references#CD001880-bbs2-0001" title="AnbarR , BelooseskyY , CohenJ , MadarZ , WeissA , TheillaM , et al. Tight calorie control in geriatric patients following hip fracture decreases complications: a randomized, controlled study. Clinical Nutrition2014;33:23‐8. AnbarR , BelooseskyY , MadarZ , TheillaM , Koren‐HakimT , WeissA , et al. Tight calorie control (TICACOS) in geriatric hip fracture patients. Clinical Nutrition, Supplement2012;7(1):18. AnbarR , BelooseskyY , MadarZ , TheillaM , Koren‐HakimT , WeissA , et al. Tight calorie control in geriatric hip fracture patients: preliminary results of the geriatric TICACOS study. Clinical Nutrition, Supplement2011;6(1):155. SingerP . Tight caloric balance in geriatric patients (TICACOSiGP). clinicaltrials.gov/show/NCT01735435 (accessed 3 December 2015). ">Anbar 2014</a> reported that hospitalisation was shorter in the intervention group (10.1 days versus 12.5 days: mean difference (MD) ‐2.40 days, 99% CI ‐5.60 to 0.80 days). <a href="./references#CD001880-bbs2-0005" title="Botella‐CarreteroJI . Personal communication 23 January 2009. Botella‐CarreteroJI , IglesiasB , BalsaJA , ZamarronI , ArrietaF , VazquezC . Effects of oral nutritional supplements in normally nourished or mildly undernourished geriatric patients after surgery for hip fracture: a randomized clinical trial. Journal of Parenteral and Enteral Nutrition2008;32(2):120‐8. [MEDLINE: 18407904] IglesiasB , Botella‐CarreteroJI , BalsaJA , ArrietaF , ZamarronI , VazquezC . Effects of oral nutritional supplements in geriatric patients after surgery for hip fracture. Clinical Nutrition Supplements2007;2(2):97. ">Botella‐Carretero 2008</a> reported that hospital stay was similar for all three groups (the graph of these data clearly showed no differences). <a href="./references#CD001880-bbs2-0006" title="Botella‐CarreteroJI . Personal communication 26 October 2014. Botella‐CarreteroJI , IglesiasB , BalsaJA , ArrietaF , ZamarronI , VazquezC . Perioperative oral nutritional supplements in normally and mildly undernourished geriatric patients submitted to surgery for hip fracture: a randomized clinical trial. Clinical Nutrition2010;29(5):574‐9. ">Botella‐Carretero 2010</a> found that the length of acute hospital stay was similar in intervention and control groups (13.3 days versus 12.8 days: MD 0.50 days, 99% CI ‐2.26 to 3.26 days). <a href="./references#CD001880-bbs2-0006" title="Botella‐CarreteroJI . Personal communication 26 October 2014. Botella‐CarreteroJI , IglesiasB , BalsaJA , ArrietaF , ZamarronI , VazquezC . Perioperative oral nutritional supplements in normally and mildly undernourished geriatric patients submitted to surgery for hip fracture: a randomized clinical trial. Clinical Nutrition2010;29(5):574‐9. ">Botella‐Carretero 2010</a> also reported that total length of hospital stay (including rehabilitation) was similar in intervention and control groups (19.0 (SD 4.2) days versus 18.9 (SD 4.4) days, denominators unclear). <a href="./references#CD001880-bbs2-0007" title="BrownKM . Personal communicationMay 1999. BrownKM , SeabrookNA . Effect of nutrition on recovery after fractured femur. Medical Audit News1992;2(1):10‐2. BrownKM , SeabrookNA . Nutritional influences on recovery and length of hospital stay in elderly women following femoral fracture. Proceedings of the Nutrition Society1992;51(2):132A. ">Brown 1992b</a>, which included 10 participants only, reported a lower acute hospital stay for the supplementation group (27 days versus 48 days: MD ‐21.00 days, 99% CI ‐65.15 to 23.15 days). <a href="./references#CD001880-bbs2-0008" title="BruceD . Personal communication. October 2003. BruceD , LauranceI , McGuinessM , RidleyM , GoldswainP . Nutritional supplements after hip fracture: poor compliance limits effectiveness. Clinical Nutrition2003;22(5):497‐500. [MEDLINE: 14512038] ">Bruce 2003</a> reported no significant difference between the two groups in the mean length of hospital stay (17.7 days versus 16.6 days: MD 1.10 days, 99% CI ‐3.53 to 5.73 days). <a href="./references#CD001880-bbs2-0011" title="BonjourJP , RapinCH , RizzoliR , TkatchL , DelmiM , ChevalleyT , et al. Hip fracture, femoral bone mineral density, and protein supply in elderly patients. In: MunroHN , SchlierfG editor(s). Nutrition of the elderly. Nestlé nutrition workshop series. Vol. 29, New York: Raven Press, 1992:151‐9. [ISBN 0881678740 ] BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. BonjourJP , SchürchMA , RizzoliR . Nutritional aspects of hip fractures. Bone1996;18(3 Suppl):139S‐44S. BonjourJP , SchürchMA , RizzoliR . Proteins and bone health. Pathologie‐Biologie1997;45(1):57‐9. DelmiM , RapinC‐H , BengoaJ‐M , DelmasPD , VaseyH , BonjourJ‐P . Dietary supplementation in elderly patients with fractured neck of the femur. Lancet1990;335:1013‐6. [MEDLINE: 1970070] RapinCH , BengoaJM , KahnJM , DelmiM , BonjourJP , VaseyH . A prospective randomised control study of oral dietary supplementation in patients with fractured necks of femur. Journal of Parenteral and Enteral Nutrition1989;13(1):9S. ">Delmi 1990</a> reported a statistically significantly lower median length of stay in acute and rehabilitation wards for the supplementation group (24 days (range 13 to 157) versus 40 days (range 10 to 259); reported P &lt; 0.02). <a href="./references#CD001880-bbs2-0015" title="FabianE , GerstorferI , ThalerHW , StundnerH , BiswasP , ElmadfaI . Nutritional supplementation affects postoperative oxidative stress and duration of hospitalization in patients with hip fracture. Wiener Klinische Wochenschrift2011;123(3‐4):88‐93. ">Fabian 2011</a> reported that the duration of hospitalisation was shorter in supplemented participants (17(SD 4) versus 19 (SD 9) days, denominators unclear). </p> <div class="table" id="CD001880-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Length of hospital stay data used for significance testing</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p><b>Intervention<br/> (n, mean days, SD)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p><b>Control<br/> (n, mean days, SD)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean difference (99% confidence intervaI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>Multinutritional oral supplements</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001880-bbs2-0001" title="AnbarR , BelooseskyY , CohenJ , MadarZ , WeissA , TheillaM , et al. Tight calorie control in geriatric patients following hip fracture decreases complications: a randomized, controlled study. Clinical Nutrition2014;33:23‐8. AnbarR , BelooseskyY , MadarZ , TheillaM , Koren‐HakimT , WeissA , et al. Tight calorie control (TICACOS) in geriatric hip fracture patients. Clinical Nutrition, Supplement2012;7(1):18. AnbarR , BelooseskyY , MadarZ , TheillaM , Koren‐HakimT , WeissA , et al. Tight calorie control in geriatric hip fracture patients: preliminary results of the geriatric TICACOS study. Clinical Nutrition, Supplement2011;6(1):155. SingerP . Tight caloric balance in geriatric patients (TICACOSiGP). clinicaltrials.gov/show/NCT01735435 (accessed 3 December 2015). ">Anbar 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐2.40 days (‐5.60 to 0.80)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001880-bbs2-0006" title="Botella‐CarreteroJI . Personal communication 26 October 2014. Botella‐CarreteroJI , IglesiasB , BalsaJA , ArrietaF , ZamarronI , VazquezC . Perioperative oral nutritional supplements in normally and mildly undernourished geriatric patients submitted to surgery for hip fracture: a randomized clinical trial. Clinical Nutrition2010;29(5):574‐9. ">Botella‐Carretero 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.50 days (‐2.26 to 3.26)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001880-bbs2-0007" title="BrownKM . Personal communicationMay 1999. BrownKM , SeabrookNA . Effect of nutrition on recovery after fractured femur. Medical Audit News1992;2(1):10‐2. BrownKM , SeabrookNA . Nutritional influences on recovery and length of hospital stay in elderly women following femoral fracture. Proceedings of the Nutrition Society1992;51(2):132A. ">Brown 1992b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>37.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐21.00 days (‐65.15 to 23.15)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001880-bbs2-0008" title="BruceD . Personal communication. October 2003. BruceD , LauranceI , McGuinessM , RidleyM , GoldswainP . Nutritional supplements after hip fracture: poor compliance limits effectiveness. Clinical Nutrition2003;22(5):497‐500. [MEDLINE: 14512038] ">Bruce 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.10 days (‐3.53 to 5.73)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001880-bbs2-0025" title="MadiganC . Benefits of dietary supplementation in elderly patients with fractured neck of femur. Sydney (Australia): University of Sydney, 1994. ">Madigan 1994</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 day (‐8.51 to 10.51)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001880-bbs2-0027" title="MyintMW . Personal communication 6 January 2015. MyintMW , WuJ , WongE , ChanSP , ToTS , ChauMW , et al. Clinical benefits of oral nutritional supplementation for elderly hip fracture patients: a single blind randomised controlled trial. Age and Ageing2013;42(1):39‐45. MyintMWW . A randomized controlled study of nutritional intervention for geriatric hip fracture patients and its effect on rehabilitation outcomes. clinicaltrials.gov/ct2/show/NCT01088139 (accessed 4 December 2015). ">Myint 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐3.70 days (‐8.30 to 0.90)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>Nasogastric tube feeding</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001880-bbs2-0036" title="SullivanDH . Personal communication 10 February 2000. SullivanDH , NelsonCL , BoppMM , Puskarich‐MayCL , WallsRC . Nightly enteral nutrition support of elderly fracture patients: a phase I trial. Journal of the American College of Nutrition1998;17(1):155‐61. ">Sullivan 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36.90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23.70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14.50 days (‐24.34 to 53.34)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>High protein supplements</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001880-bbs2-0014" title="EspaulellaJ , GuyerH , Diaz‐EscriuF , Mellado‐NavasJA , CastellsM , PladevallM . Nutritional supplementation of elderly hip fracture patients. A randomized, double‐blind, placebo‐controlled trial. Age and Ageing2000;29(5):425‐31. [MEDLINE: 11108415] GuyerH . Personal communication 13 June 2000. ">Espaulella 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.80 days (‐3.62 to 2.02)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001880-bbs2-0028" title="JensenG . Personal communication 6 January 2005. NeumannM , FriedmannJ , RoyMA , JensenGL . Provision of high‐protein supplement for patients recovering from hip fracture. Nutrition2004;20(5):415‐9. [MEDLINE: 15105027] NeumannMM , FriedmannJM , JensenGL . Provision of high protein supplement for patients recovering from hip fracture. Journal of Parenteral and Enteral Nutrition2004;28(Suppl 1):S30. ">Neumann 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐4.80 days (‐12.29 to 2.69)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>Iron supplementation versus control</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001880-bbs2-0030" title="ParkerM . Personal communication 16 October 2014. ParkerM . Randomised trial comparing iron supplementation versus placebo in the treatment of anaemia after hip fracture. clinicaltrials.gov/show/NCT00919230 (accessed 4 December 2015). ParkerMJ . Iron supplementation for anemia after hip fracture surgery. A randomized trial of 300 patients. Journal of Bone and Joint Surgery ‐ American Volume2010;92(2):265‐9. ">Parker 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐2.50 days (‐8.17 to 3.17)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001880-bbs2-0034" title="Serrano‐TrenasJA , UgaldePF , CabelloLM , ChoflesLC , LazaroPS , BenitezPC . Role of perioperative intravenous iron therapy in elderly hip fracture patients: a single‐center randomized controlled trial. Transfusion2011;51(1):97‐104. ">Serrano‐Trenas 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.40 days (‐2.18 to 2.98)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>Vitamin B1</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001880-bbs2-0010" title="DayJJ . Personal communication 27 May 1999. DayJJ , BayerAJ , McMahonM , PathyMS , SpraggBP , RowlandsDC . Thiamine status, vitamin supplements and postoperative confusion. Age and Ageing1988;17:29‐34. ">Day 1988</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>35.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.00 days (‐15.75 to 27.75)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>Vitamin, mineral and amino acid supplementation versus control</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001880-bbs2-0033" title="DerossiD , BoA , BergonziR , ScivolettoG . Six‐week administration of a mixture of ergogenic and osteotrophic ingredients (RestorfastTM) improves the clinical course of elderly patients after hip fracture surgery [La somministrazione per sei settimane di un composto a base di sostanze osteotrofiche ed ergogene (RestorfastTM) migliora il decorso clinico in anziani sottoposti a chirurgia del femore]. Trends in Medicine2009;9(4):235‐42. ScivolettoG , BoA , DerossiD , BergonziR . Ten week administration of a polynutritional supplement with muscle tone action (RiabylexTM) improves the functional recovery in elderly hip fracture patients during home rehabilitation [In anziani in terapia riabilitativa domiciliare per pregressa frattura del femore, l'assunzione di un polinutriente ad azione muscolotonica (RiabylexTM) per 10 settimane migliora il recupero funzionale]. Trends in Medicine2010;10(2):113‐20. ">Scivoletto 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐2.50 days (‐6.21 to 1.21)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>Semi‐essential amino acid</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001880-bbs2-0040" title="HoudijkAPJ . The effect of taurine on morbidity and mortality in the elderly hip fracture patient. clinicaltrials.gov/ct2/show/NCT00497978 (accessed 15 December 2015). VanStijnMF , BruinsAA , VermeulenMA , WitloxJ , TeerlinkT , SchoorlMG , et al. Effect of oral taurine on morbidity and mortality in elderly hip fracture patients: a randomized trial. International Journal of Molecular Sciences2015;16(6):12288‐306. [DOI: 10.3390/ijms160612288; PUBMED: 26035756] ">Van Stijn 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>111</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>123</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.00 days (‐3.54 to 3.54)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>SD: standard deviation</p> </div> </div> <p><a href="./references#CD001880-bbs2-0019" title="HankinsC . Dietary supplementation with sustagen in elderly patients with fractured neck of femur [MSc dissertation]. Sydney (Australia): University of Sydney, 1996. HankinsC . Personal communication 11 June 1999. ">Hankins 1996</a> found that supplemented participants had a median acute and rehabilitation stay of 26 days (range 6 to 60) versus 21 days (range 3 to 60) for participants in the control group (reported P = not significant). <a href="./references#CD001880-bbs2-0025" title="MadiganC . Benefits of dietary supplementation in elderly patients with fractured neck of femur. Sydney (Australia): University of Sydney, 1994. ">Madigan 1994</a> found that the acute hospital stay was 16 days in the combined intervention group and 15 days in the control group (MD 1.00 day, 99% CI ‐8.51 to 10.51 days). Both groups, including several patients with other lower‐limb fractures, in <a href="./references#CD001880-bbs2-0026" title="CrottyM . Personal communication 20 February 2009. DanielsLA , MillerM , BannermanE , WhiteheadC , CrottyM . Weight loss post lower limb fracture despite an intensive oral nutrition and exercise intervention. Clinical Nutrition2003;22 Suppl:S86. DanielsLA , MillerMD , BannermannE , CrottyM . Adherence to nutritional supplements amongst orthopedic patients: an important clinical and study design issue. Clinical Nutrition2005;24:535. MillerMD , BannermanE , DanielsLA , CrottyM . Lower limb fracture, cognitive impairment and risk of subsequent malnutrition: a prospective evaluation of dietary energy and protein intake on an orthopaedic ward. European Journal of Clinical Nutrition2006;60(7):853‐61. [MEDLINE: 16452913] MillerMD , CrottyM , WhiteheadC , BannermanE , DanielsLA . Nutritional supplementation and resistance training in nutritionally at risk older adults following lower limb fracture: a randomized controlled trial. Clinical Rehabilitation2006;20(4):311‐23. MillerMD , DanielsLA , BannermanE , CrottyM . Adherence to nutrition supplements among patients with a fall‐related lower limb fracture. Nutrition in Clinical Practice2005;20(5):569‐78. [MEDLINE: 16207699] ">Miller 2006</a> stayed a median of 24 days in hospital. <a href="./references#CD001880-bbs2-0027" title="MyintMW . Personal communication 6 January 2015. MyintMW , WuJ , WongE , ChanSP , ToTS , ChauMW , et al. Clinical benefits of oral nutritional supplementation for elderly hip fracture patients: a single blind randomised controlled trial. Age and Ageing2013;42(1):39‐45. MyintMWW . A randomized controlled study of nutritional intervention for geriatric hip fracture patients and its effect on rehabilitation outcomes. clinicaltrials.gov/ct2/show/NCT01088139 (accessed 4 December 2015). ">Myint 2013</a> found the length of stay in the rehabilitation ward was shorter in the intervention group (26.2 days versus 29.9 days: MD ‐3.70 days, 99% CI ‐8.30 to 0.90 days). <a href="./references#CD001880-bbs2-0038" title="CarlssonP , TidermarkJ , PonzerS , SoderqvistA , CederholmT . Food habits and appetite of elderly women at the time of a femoral neck fracture and after nutritional and anabolic support. Journal of Human Nutrition and Dietetics2005;18(2):117‐20. [MEDLINE: 15788020] TengstrandB , CederholmT , SoderqvistA , TidermarkJ . Effects of protein‐rich supplementation and nandrolone on bone tissue after a hip fracture. Clinical Nutrition2007;26(4):460‐5. [MEDLINE: 17498850] TidermarkJ . Personal communication 14 October 2004. TidermarkJ . Quality of life and femoral neck fractures. Acta Orthopaedica Scandinavica. Supplementum2003;74(309):1‐42. TidermarkJ , PonzerS , CarlssonP , SoderqvistA , BrismarK , TengstrandB , et al. Effects of protein‐rich supplementation and nandrolone in lean elderly women with femoral neck fractures. Clinical Nutrition2004;23(4):587‐96. TidermarkJ , PonzerS , TengstrandB , CederholmT . Liquid supplementation and nandrolone to elderly women. Clinical Nutrition2002;21(Suppl 1):40. ">Tidermark 2004</a> reported no significant difference in median hospital stay during the first year after surgery in intervention and control groups (20 days (range 5 to 356 days) versus 27 days (range 5 to 197 days)). <a href="./references#CD001880-bbs2-0041" title="Breedveld‐PetersJ , ReijvenPL , WyersCE , HendrikxAA , VerburgAD , ScholsJM , et al. Qualitative analysis of barriers and facilitators for nutritional intervention in hip fracture patients. Clinical Nutrition, Supplement2012;7(1):234. Breedveld‐PetersJJ , ReijvenPL , WyersCE , HendrikxAA , VerburgAD , ScholsJM , et al. Barriers and facilitators of nutritional intervention after hip fracture in integrated care as perceived by the different health care professionals: a qualitative interview study. e‐SPEN Journal2012;7(5):e182‐8. Breedveld‐PetersJJ , ReijvenPL , WyersCE , VanHeldenS , ArtsJJ , MeestersB , et al. Integrated nutritional intervention in the elderly after hip fracture. A process evaluation. Clinical Nutrition, Supplement2012;31(1):199‐205. Breedveld‐PetersJJ , ReijvenPL , WyersCE , VanHeldenS , ArtsJJ , MeestersB , et al. Integrated nutritional intervention in the elderly after hip fracture. A process evaluation. Clinical Nutrition, Supplement2012;7(1):43. DagneliePC . Effectiveness and cost‐effectiveness of nutritional screening and intervention in elderly subjects after hip fracture. clinicaltrials.gov/show/NCT00523575 (accessed 8 November 2009). WyersC , ReijvenPL , EversSM , WillemsPC , HeyligersIC , VerburgAD , et al. Cost‐effectiveness of nutritional intervention in hip fracture patients: a multi‐centre randomised controlled trial (RCT). Clinical Nutrition, Supplement2012;7(1):49. WyersCE . PhD thesis. Maastricht, the Netherlands: Maastricht University, 2012. WyersCE , Breedveld‐PetersJJ , ReijvenPL , ArtsC , ThomassenBJ , VerburgAD , et al. Effect of nutritional intervention on nutritional intake and status in hip fracture patients: a multicentre randomised controlled trial (RCT). Clinical Nutrition, Supplement2012;7(1):50‐1. WyersCE , Breedveld‐PetersJJ , ReijvenPL , VanHeldenS , GuldemondNA , SeverensJL , et al. Efficacy and cost‐effectiveness of nutritional intervention in elderly after hip fracture: design of a randomized controlled trial. BMC Public Health2010;10:212. WyersCE , ReijvenPL , EversSM , WillemsPC , HeyligersIC , VerburgAD , et al. Cost‐effectiveness of nutritional intervention in elderly subjects after hip fracture. A randomized controlled trial. Osteoporosis International2013;24(1):151‐62. ">Wyers 2013</a> found the length of stay in acute and rehabilitation hospital to be similar for intervention and control groups (36 days, range 4 to 185 days, versus 38 days, range 3 to 183 days, reported P = 0.85). </p> </section> <section id="CD001880-sec-0117"> <p><b>Functional status and level of care required</b></p> <p>Trials reported a variety of functional outcomes in various ways; pooling was either not possible or not appropriate. <a href="./references#CD001880-bbs2-0008" title="BruceD . Personal communication. October 2003. BruceD , LauranceI , McGuinessM , RidleyM , GoldswainP . Nutritional supplements after hip fracture: poor compliance limits effectiveness. Clinical Nutrition2003;22(5):497‐500. [MEDLINE: 14512038] ">Bruce 2003</a> reported no significant differences between the two groups in functional outcomes (fall in the Katz activities of daily living score: 41.7% versus 33.9%) or living at home at six months (63.8% versus 63.2%). <a href="./references#CD001880-bbs2-0019" title="HankinsC . Dietary supplementation with sustagen in elderly patients with fractured neck of femur [MSc dissertation]. Sydney (Australia): University of Sydney, 1996. HankinsC . Personal communication 11 June 1999. ">Hankins 1996</a> found no statistically significant effect of the supplement at two months on the Barthel Index of functional ability; median 56 (range 0 to 100) versus 40 (range 0 to 92). <a href="./references#CD001880-bbs2-0024" title="LuoM . Personal communication 17 November 2014. LuoM , GolubevG , KlyukvinI , ReznikL , KuropatkinG , OliverJS , et al. Oral nutrition supplement improved nutritional status in malnourished hip fracture patients: a randomized controlled study. Journal of Scientific Research and Reports2015;4(6):480‐9. LuoM , GolybevG , KlyukvinI , ReznikL , KuropatkinG , VossAC . Oral nutritional supplement (ONS) improved nutritional status in malnourished patients receiving hip fracture surgery. Clinical Nutrition Supplements2011;6:151. SwearenginB . Effect of a medical food supplement in hospitalized patients recovering from surgery. clinicaltrials.gov/ct2/show/NCT01011608 (accessed 4 December 2015). ">Luo 2015</a> reported no significant difference between study groups in gait speed or modified Barthel Index at 14 or 28 days. <a href="./references#CD001880-bbs2-0025" title="MadiganC . Benefits of dietary supplementation in elderly patients with fractured neck of femur. Sydney (Australia): University of Sydney, 1994. ">Madigan 1994</a> found that the combined intervention group were more likely to return to their premorbid mobility (non‐return: 9/18 versus 7/12; RR 0.86, 99% CI 0.36 to 2.05; analysis not shown), but this may have reflected that significantly more supplemented participants were sent to a rehabilitation hospital. <a href="./references#CD001880-bbs2-0027" title="MyintMW . Personal communication 6 January 2015. MyintMW , WuJ , WongE , ChanSP , ToTS , ChauMW , et al. Clinical benefits of oral nutritional supplementation for elderly hip fracture patients: a single blind randomised controlled trial. Age and Ageing2013;42(1):39‐45. MyintMWW . A randomized controlled study of nutritional intervention for geriatric hip fracture patients and its effect on rehabilitation outcomes. clinicaltrials.gov/ct2/show/NCT01088139 (accessed 4 December 2015). ">Myint 2013</a> reported no statistically significant difference between groups for the Elderly Mobility Scale or Functional Independence Measure. A higher proportion of participants in the intervention group were discharged to nursing homes (19/61 versus 15/60; RR 1.25, 99% CI 0.70 to 2.22). </p> <p>Activities of daily living, assessed by the Katz score, in <a href="./references#CD001880-bbs2-0038" title="CarlssonP , TidermarkJ , PonzerS , SoderqvistA , CederholmT . Food habits and appetite of elderly women at the time of a femoral neck fracture and after nutritional and anabolic support. Journal of Human Nutrition and Dietetics2005;18(2):117‐20. [MEDLINE: 15788020] TengstrandB , CederholmT , SoderqvistA , TidermarkJ . Effects of protein‐rich supplementation and nandrolone on bone tissue after a hip fracture. Clinical Nutrition2007;26(4):460‐5. [MEDLINE: 17498850] TidermarkJ . Personal communication 14 October 2004. TidermarkJ . Quality of life and femoral neck fractures. Acta Orthopaedica Scandinavica. Supplementum2003;74(309):1‐42. TidermarkJ , PonzerS , CarlssonP , SoderqvistA , BrismarK , TengstrandB , et al. Effects of protein‐rich supplementation and nandrolone in lean elderly women with femoral neck fractures. Clinical Nutrition2004;23(4):587‐96. TidermarkJ , PonzerS , TengstrandB , CederholmT . Liquid supplementation and nandrolone to elderly women. Clinical Nutrition2002;21(Suppl 1):40. ">Tidermark 2004</a>, were better maintained in the supplemented group at six months (dependence in bathing and one other function: 2/18 versus 8/16; RR 0.22, 99% CI 0.04 to 1.39; analysis not shown) but less so at 12 months (4/18 versus 6/16; RR 0.63, 99% CI 0.15 to 2.59; analysis not shown), compared with the control group. <a href="./references#CD001880-bbs2-0038" title="CarlssonP , TidermarkJ , PonzerS , SoderqvistA , CederholmT . Food habits and appetite of elderly women at the time of a femoral neck fracture and after nutritional and anabolic support. Journal of Human Nutrition and Dietetics2005;18(2):117‐20. [MEDLINE: 15788020] TengstrandB , CederholmT , SoderqvistA , TidermarkJ . Effects of protein‐rich supplementation and nandrolone on bone tissue after a hip fracture. Clinical Nutrition2007;26(4):460‐5. [MEDLINE: 17498850] TidermarkJ . Personal communication 14 October 2004. TidermarkJ . Quality of life and femoral neck fractures. Acta Orthopaedica Scandinavica. Supplementum2003;74(309):1‐42. TidermarkJ , PonzerS , CarlssonP , SoderqvistA , BrismarK , TengstrandB , et al. Effects of protein‐rich supplementation and nandrolone in lean elderly women with femoral neck fractures. Clinical Nutrition2004;23(4):587‐96. TidermarkJ , PonzerS , TengstrandB , CederholmT . Liquid supplementation and nandrolone to elderly women. Clinical Nutrition2002;21(Suppl 1):40. ">Tidermark 2004</a> also found that mobility data were not significantly different between the two groups. </p> <p>At six months postoperatively, <a href="./references#CD001880-bbs2-0041" title="Breedveld‐PetersJ , ReijvenPL , WyersCE , HendrikxAA , VerburgAD , ScholsJM , et al. Qualitative analysis of barriers and facilitators for nutritional intervention in hip fracture patients. Clinical Nutrition, Supplement2012;7(1):234. Breedveld‐PetersJJ , ReijvenPL , WyersCE , HendrikxAA , VerburgAD , ScholsJM , et al. Barriers and facilitators of nutritional intervention after hip fracture in integrated care as perceived by the different health care professionals: a qualitative interview study. e‐SPEN Journal2012;7(5):e182‐8. Breedveld‐PetersJJ , ReijvenPL , WyersCE , VanHeldenS , ArtsJJ , MeestersB , et al. Integrated nutritional intervention in the elderly after hip fracture. A process evaluation. Clinical Nutrition, Supplement2012;31(1):199‐205. Breedveld‐PetersJJ , ReijvenPL , WyersCE , VanHeldenS , ArtsJJ , MeestersB , et al. Integrated nutritional intervention in the elderly after hip fracture. A process evaluation. Clinical Nutrition, Supplement2012;7(1):43. DagneliePC . Effectiveness and cost‐effectiveness of nutritional screening and intervention in elderly subjects after hip fracture. clinicaltrials.gov/show/NCT00523575 (accessed 8 November 2009). WyersC , ReijvenPL , EversSM , WillemsPC , HeyligersIC , VerburgAD , et al. Cost‐effectiveness of nutritional intervention in hip fracture patients: a multi‐centre randomised controlled trial (RCT). Clinical Nutrition, Supplement2012;7(1):49. WyersCE . PhD thesis. Maastricht, the Netherlands: Maastricht University, 2012. WyersCE , Breedveld‐PetersJJ , ReijvenPL , ArtsC , ThomassenBJ , VerburgAD , et al. Effect of nutritional intervention on nutritional intake and status in hip fracture patients: a multicentre randomised controlled trial (RCT). Clinical Nutrition, Supplement2012;7(1):50‐1. WyersCE , Breedveld‐PetersJJ , ReijvenPL , VanHeldenS , GuldemondNA , SeverensJL , et al. Efficacy and cost‐effectiveness of nutritional intervention in elderly after hip fracture: design of a randomized controlled trial. BMC Public Health2010;10:212. WyersCE , ReijvenPL , EversSM , WillemsPC , HeyligersIC , VerburgAD , et al. Cost‐effectiveness of nutritional intervention in elderly subjects after hip fracture. A randomized controlled trial. Osteoporosis International2013;24(1):151‐62. ">Wyers 2013</a> found no significant effect from the intervention on functional status, activities of daily living or household activities of daily living. The frequency of hospital readmissions did not differ between groups. </p> </section> <section id="CD001880-sec-0118"> <p><b>Quality of life</b></p> <p><a href="./references#CD001880-bbs2-0038" title="CarlssonP , TidermarkJ , PonzerS , SoderqvistA , CederholmT . Food habits and appetite of elderly women at the time of a femoral neck fracture and after nutritional and anabolic support. Journal of Human Nutrition and Dietetics2005;18(2):117‐20. [MEDLINE: 15788020] TengstrandB , CederholmT , SoderqvistA , TidermarkJ . Effects of protein‐rich supplementation and nandrolone on bone tissue after a hip fracture. Clinical Nutrition2007;26(4):460‐5. [MEDLINE: 17498850] TidermarkJ . Personal communication 14 October 2004. TidermarkJ . Quality of life and femoral neck fractures. Acta Orthopaedica Scandinavica. Supplementum2003;74(309):1‐42. TidermarkJ , PonzerS , CarlssonP , SoderqvistA , BrismarK , TengstrandB , et al. Effects of protein‐rich supplementation and nandrolone in lean elderly women with femoral neck fractures. Clinical Nutrition2004;23(4):587‐96. TidermarkJ , PonzerS , TengstrandB , CederholmT . Liquid supplementation and nandrolone to elderly women. Clinical Nutrition2002;21(Suppl 1):40. ">Tidermark 2004</a> reported no significant difference between the two groups for health‐related quality of life at six and 12 months, as assessed by the EuroQol questionnaire. At six months postoperation <a href="./references#CD001880-bbs2-0041" title="Breedveld‐PetersJ , ReijvenPL , WyersCE , HendrikxAA , VerburgAD , ScholsJM , et al. Qualitative analysis of barriers and facilitators for nutritional intervention in hip fracture patients. Clinical Nutrition, Supplement2012;7(1):234. Breedveld‐PetersJJ , ReijvenPL , WyersCE , HendrikxAA , VerburgAD , ScholsJM , et al. Barriers and facilitators of nutritional intervention after hip fracture in integrated care as perceived by the different health care professionals: a qualitative interview study. e‐SPEN Journal2012;7(5):e182‐8. Breedveld‐PetersJJ , ReijvenPL , WyersCE , VanHeldenS , ArtsJJ , MeestersB , et al. Integrated nutritional intervention in the elderly after hip fracture. A process evaluation. Clinical Nutrition, Supplement2012;31(1):199‐205. Breedveld‐PetersJJ , ReijvenPL , WyersCE , VanHeldenS , ArtsJJ , MeestersB , et al. Integrated nutritional intervention in the elderly after hip fracture. A process evaluation. Clinical Nutrition, Supplement2012;7(1):43. DagneliePC . Effectiveness and cost‐effectiveness of nutritional screening and intervention in elderly subjects after hip fracture. clinicaltrials.gov/show/NCT00523575 (accessed 8 November 2009). WyersC , ReijvenPL , EversSM , WillemsPC , HeyligersIC , VerburgAD , et al. Cost‐effectiveness of nutritional intervention in hip fracture patients: a multi‐centre randomised controlled trial (RCT). Clinical Nutrition, Supplement2012;7(1):49. WyersCE . PhD thesis. Maastricht, the Netherlands: Maastricht University, 2012. WyersCE , Breedveld‐PetersJJ , ReijvenPL , ArtsC , ThomassenBJ , VerburgAD , et al. Effect of nutritional intervention on nutritional intake and status in hip fracture patients: a multicentre randomised controlled trial (RCT). Clinical Nutrition, Supplement2012;7(1):50‐1. WyersCE , Breedveld‐PetersJJ , ReijvenPL , VanHeldenS , GuldemondNA , SeverensJL , et al. Efficacy and cost‐effectiveness of nutritional intervention in elderly after hip fracture: design of a randomized controlled trial. BMC Public Health2010;10:212. WyersCE , ReijvenPL , EversSM , WillemsPC , HeyligersIC , VerburgAD , et al. Cost‐effectiveness of nutritional intervention in elderly subjects after hip fracture. A randomized controlled trial. Osteoporosis International2013;24(1):151‐62. ">Wyers 2013</a> found no significant difference for Quality Adjusted Life Years (QALYs) (MD ‐0.02, 95% CI ‐0.12 to 0.08). </p> </section> <section id="CD001880-sec-0119"> <p><b>Fracture healing</b></p> <p><a href="./references#CD001880-bbs2-0038" title="CarlssonP , TidermarkJ , PonzerS , SoderqvistA , CederholmT . Food habits and appetite of elderly women at the time of a femoral neck fracture and after nutritional and anabolic support. Journal of Human Nutrition and Dietetics2005;18(2):117‐20. [MEDLINE: 15788020] TengstrandB , CederholmT , SoderqvistA , TidermarkJ . Effects of protein‐rich supplementation and nandrolone on bone tissue after a hip fracture. Clinical Nutrition2007;26(4):460‐5. [MEDLINE: 17498850] TidermarkJ . Personal communication 14 October 2004. TidermarkJ . Quality of life and femoral neck fractures. Acta Orthopaedica Scandinavica. Supplementum2003;74(309):1‐42. TidermarkJ , PonzerS , CarlssonP , SoderqvistA , BrismarK , TengstrandB , et al. Effects of protein‐rich supplementation and nandrolone in lean elderly women with femoral neck fractures. Clinical Nutrition2004;23(4):587‐96. TidermarkJ , PonzerS , TengstrandB , CederholmT . Liquid supplementation and nandrolone to elderly women. Clinical Nutrition2002;21(Suppl 1):40. ">Tidermark 2004</a> found no significant difference between the two groups in fracture healing complications (4/18 versus 7/17; RR 0.54, 99% CI 0.14 to 2.10; analysis not shown). </p> </section> <section id="CD001880-sec-0120"> <p><b>Putative side effects of treatment (e.g. vomiting and diarrhoea)</b></p> <p><a href="./references#CD001880-bbs2-0005" title="Botella‐CarreteroJI . Personal communication 23 January 2009. Botella‐CarreteroJI , IglesiasB , BalsaJA , ZamarronI , ArrietaF , VazquezC . Effects of oral nutritional supplements in normally nourished or mildly undernourished geriatric patients after surgery for hip fracture: a randomized clinical trial. Journal of Parenteral and Enteral Nutrition2008;32(2):120‐8. [MEDLINE: 18407904] IglesiasB , Botella‐CarreteroJI , BalsaJA , ArrietaF , ZamarronI , VazquezC . Effects of oral nutritional supplements in geriatric patients after surgery for hip fracture. Clinical Nutrition Supplements2007;2(2):97. ">Botella‐Carretero 2008</a> reported vomiting, diarrhoea or both in 23% of participants taking the protein supplement, 30% of participants taking the protein and energy supplement, and 17% of controls. <a href="./references#CD001880-bbs2-0006" title="Botella‐CarreteroJI . Personal communication 26 October 2014. Botella‐CarreteroJI , IglesiasB , BalsaJA , ArrietaF , ZamarronI , VazquezC . Perioperative oral nutritional supplements in normally and mildly undernourished geriatric patients submitted to surgery for hip fracture: a randomized clinical trial. Clinical Nutrition2010;29(5):574‐9. ">Botella‐Carretero 2010</a> found that 3% of the intervention group and 10% of controls had vomiting, diarrhoea or both. <a href="./references#CD001880-bbs2-0016" title="FlodinL . Effects of bisphosphonates and nutritional supplementation after a hip fracture. clinicaltrials.gov/show/NCT01950169 2013 (accessed 3 December 2015). FlodinL . Personal communication. Personal communication 15 December 2014. FlodinL , SaafM , CederholmT , Al‐AniAN , AckermannPW , SanegardE , et al. Additive effects of nutritional supplementation, together with bisphosphonates, on bone mineral density after hip fracture: a 12‐month randomized controlled study. Clinical Interventions in Aging2014;9:1043‐50. ">Flodin 2014</a> reported that three participants in the control group and none in the intervention group had constipation or diarrhoea (denominators unclear). <a href="./references#CD001880-bbs2-0019" title="HankinsC . Dietary supplementation with sustagen in elderly patients with fractured neck of femur [MSc dissertation]. Sydney (Australia): University of Sydney, 1996. HankinsC . Personal communication 11 June 1999. ">Hankins 1996</a> found that 12% of participants stopped the supplement as a result of nausea or diarrhoea. <a href="./references#CD001880-bbs2-0024" title="LuoM . Personal communication 17 November 2014. LuoM , GolubevG , KlyukvinI , ReznikL , KuropatkinG , OliverJS , et al. Oral nutrition supplement improved nutritional status in malnourished hip fracture patients: a randomized controlled study. Journal of Scientific Research and Reports2015;4(6):480‐9. LuoM , GolybevG , KlyukvinI , ReznikL , KuropatkinG , VossAC . Oral nutritional supplement (ONS) improved nutritional status in malnourished patients receiving hip fracture surgery. Clinical Nutrition Supplements2011;6:151. SwearenginB . Effect of a medical food supplement in hospitalized patients recovering from surgery. clinicaltrials.gov/ct2/show/NCT01011608 (accessed 4 December 2015). ">Luo 2015</a> reported two adverse events possibly related to supplements (nausea and pruritus). <a href="./references#CD001880-bbs2-0027" title="MyintMW . Personal communication 6 January 2015. MyintMW , WuJ , WongE , ChanSP , ToTS , ChauMW , et al. Clinical benefits of oral nutritional supplementation for elderly hip fracture patients: a single blind randomised controlled trial. Age and Ageing2013;42(1):39‐45. MyintMWW . A randomized controlled study of nutritional intervention for geriatric hip fracture patients and its effect on rehabilitation outcomes. clinicaltrials.gov/ct2/show/NCT01088139 (accessed 4 December 2015). ">Myint 2013</a> found that six participants (10%) reported intolerance of the supplements (including dislike of the taste, nausea, abdominal bloating and diarrhoea). <a href="./references#CD001880-bbs2-0028" title="JensenG . Personal communication 6 January 2005. NeumannM , FriedmannJ , RoyMA , JensenGL . Provision of high‐protein supplement for patients recovering from hip fracture. Nutrition2004;20(5):415‐9. [MEDLINE: 15105027] NeumannMM , FriedmannJM , JensenGL . Provision of high protein supplement for patients recovering from hip fracture. Journal of Parenteral and Enteral Nutrition2004;28(Suppl 1):S30. ">Neumann 2004</a>, <a href="./references#CD001880-bbs2-0038" title="CarlssonP , TidermarkJ , PonzerS , SoderqvistA , CederholmT . Food habits and appetite of elderly women at the time of a femoral neck fracture and after nutritional and anabolic support. Journal of Human Nutrition and Dietetics2005;18(2):117‐20. [MEDLINE: 15788020] TengstrandB , CederholmT , SoderqvistA , TidermarkJ . Effects of protein‐rich supplementation and nandrolone on bone tissue after a hip fracture. Clinical Nutrition2007;26(4):460‐5. [MEDLINE: 17498850] TidermarkJ . Personal communication 14 October 2004. TidermarkJ . Quality of life and femoral neck fractures. Acta Orthopaedica Scandinavica. Supplementum2003;74(309):1‐42. TidermarkJ , PonzerS , CarlssonP , SoderqvistA , BrismarK , TengstrandB , et al. Effects of protein‐rich supplementation and nandrolone in lean elderly women with femoral neck fractures. Clinical Nutrition2004;23(4):587‐96. TidermarkJ , PonzerS , TengstrandB , CederholmT . Liquid supplementation and nandrolone to elderly women. Clinical Nutrition2002;21(Suppl 1):40. ">Tidermark 2004</a> and <a href="./references#CD001880-bbs2-0041" title="Breedveld‐PetersJ , ReijvenPL , WyersCE , HendrikxAA , VerburgAD , ScholsJM , et al. Qualitative analysis of barriers and facilitators for nutritional intervention in hip fracture patients. Clinical Nutrition, Supplement2012;7(1):234. Breedveld‐PetersJJ , ReijvenPL , WyersCE , HendrikxAA , VerburgAD , ScholsJM , et al. Barriers and facilitators of nutritional intervention after hip fracture in integrated care as perceived by the different health care professionals: a qualitative interview study. e‐SPEN Journal2012;7(5):e182‐8. Breedveld‐PetersJJ , ReijvenPL , WyersCE , VanHeldenS , ArtsJJ , MeestersB , et al. Integrated nutritional intervention in the elderly after hip fracture. A process evaluation. Clinical Nutrition, Supplement2012;31(1):199‐205. Breedveld‐PetersJJ , ReijvenPL , WyersCE , VanHeldenS , ArtsJJ , MeestersB , et al. Integrated nutritional intervention in the elderly after hip fracture. A process evaluation. Clinical Nutrition, Supplement2012;7(1):43. DagneliePC . Effectiveness and cost‐effectiveness of nutritional screening and intervention in elderly subjects after hip fracture. clinicaltrials.gov/show/NCT00523575 (accessed 8 November 2009). WyersC , ReijvenPL , EversSM , WillemsPC , HeyligersIC , VerburgAD , et al. Cost‐effectiveness of nutritional intervention in hip fracture patients: a multi‐centre randomised controlled trial (RCT). Clinical Nutrition, Supplement2012;7(1):49. WyersCE . PhD thesis. Maastricht, the Netherlands: Maastricht University, 2012. WyersCE , Breedveld‐PetersJJ , ReijvenPL , ArtsC , ThomassenBJ , VerburgAD , et al. Effect of nutritional intervention on nutritional intake and status in hip fracture patients: a multicentre randomised controlled trial (RCT). Clinical Nutrition, Supplement2012;7(1):50‐1. WyersCE , Breedveld‐PetersJJ , ReijvenPL , VanHeldenS , GuldemondNA , SeverensJL , et al. Efficacy and cost‐effectiveness of nutritional intervention in elderly after hip fracture: design of a randomized controlled trial. BMC Public Health2010;10:212. WyersCE , ReijvenPL , EversSM , WillemsPC , HeyligersIC , VerburgAD , et al. Cost‐effectiveness of nutritional intervention in elderly subjects after hip fracture. A randomized controlled trial. Osteoporosis International2013;24(1):151‐62. ">Wyers 2013</a> reported no adverse effects in either group. Pooling of data from those trials providing data for both intervention and control groups showed no difference between the two groups (18/231 versus 11/211; RR 0.99, 95% CI 0.47 to 2.05; 6 studies; I<sup>2</sup> = 49%; very low‐quality evidence downgraded three levels due to risk of bias, inconsistency and imprecision; <a href="./references#CD001880-fig-0013" title="">Analysis 1.6</a>). </p> </section> <section id="CD001880-sec-0121"> <p><b>Compliance</b></p> <p><a href="./references#CD001880-bbs2-0001" title="AnbarR , BelooseskyY , CohenJ , MadarZ , WeissA , TheillaM , et al. Tight calorie control in geriatric patients following hip fracture decreases complications: a randomized, controlled study. Clinical Nutrition2014;33:23‐8. AnbarR , BelooseskyY , MadarZ , TheillaM , Koren‐HakimT , WeissA , et al. Tight calorie control (TICACOS) in geriatric hip fracture patients. Clinical Nutrition, Supplement2012;7(1):18. AnbarR , BelooseskyY , MadarZ , TheillaM , Koren‐HakimT , WeissA , et al. Tight calorie control in geriatric hip fracture patients: preliminary results of the geriatric TICACOS study. Clinical Nutrition, Supplement2011;6(1):155. SingerP . Tight caloric balance in geriatric patients (TICACOSiGP). clinicaltrials.gov/show/NCT01735435 (accessed 3 December 2015). ">Anbar 2014</a> reported that the supplemented group had a significantly higher mean daily energy and protein intake during the first 11 postoperative days (reported P = 0.001). <a href="./references#CD001880-bbs2-0005" title="Botella‐CarreteroJI . Personal communication 23 January 2009. Botella‐CarreteroJI , IglesiasB , BalsaJA , ZamarronI , ArrietaF , VazquezC . Effects of oral nutritional supplements in normally nourished or mildly undernourished geriatric patients after surgery for hip fracture: a randomized clinical trial. Journal of Parenteral and Enteral Nutrition2008;32(2):120‐8. [MEDLINE: 18407904] IglesiasB , Botella‐CarreteroJI , BalsaJA , ArrietaF , ZamarronI , VazquezC . Effects of oral nutritional supplements in geriatric patients after surgery for hip fracture. Clinical Nutrition Supplements2007;2(2):97. ">Botella‐Carretero 2008</a> reported mean consumption of 41% for the protein supplement and 51% for the protein and energy supplement. <a href="./references#CD001880-bbs2-0006" title="Botella‐CarreteroJI . Personal communication 26 October 2014. Botella‐CarreteroJI , IglesiasB , BalsaJA , ArrietaF , ZamarronI , VazquezC . Perioperative oral nutritional supplements in normally and mildly undernourished geriatric patients submitted to surgery for hip fracture: a randomized clinical trial. Clinical Nutrition2010;29(5):574‐9. ">Botella‐Carretero 2010</a> found that 52% of supplementation was ingested. <a href="./references#CD001880-bbs2-0008" title="BruceD . Personal communication. October 2003. BruceD , LauranceI , McGuinessM , RidleyM , GoldswainP . Nutritional supplements after hip fracture: poor compliance limits effectiveness. Clinical Nutrition2003;22(5):497‐500. [MEDLINE: 14512038] ">Bruce 2003</a> reported a mean consumption of 20.6 cans of supplement, out of a maximum possible of 28. <a href="./references#CD001880-bbs2-0011" title="BonjourJP , RapinCH , RizzoliR , TkatchL , DelmiM , ChevalleyT , et al. Hip fracture, femoral bone mineral density, and protein supply in elderly patients. In: MunroHN , SchlierfG editor(s). Nutrition of the elderly. Nestlé nutrition workshop series. Vol. 29, New York: Raven Press, 1992:151‐9. [ISBN 0881678740 ] BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. BonjourJP , SchürchMA , RizzoliR . Nutritional aspects of hip fractures. Bone1996;18(3 Suppl):139S‐44S. BonjourJP , SchürchMA , RizzoliR . Proteins and bone health. Pathologie‐Biologie1997;45(1):57‐9. DelmiM , RapinC‐H , BengoaJ‐M , DelmasPD , VaseyH , BonjourJ‐P . Dietary supplementation in elderly patients with fractured neck of the femur. Lancet1990;335:1013‐6. [MEDLINE: 1970070] RapinCH , BengoaJM , KahnJM , DelmiM , BonjourJP , VaseyH . A prospective randomised control study of oral dietary supplementation in patients with fractured necks of femur. Journal of Parenteral and Enteral Nutrition1989;13(1):9S. ">Delmi 1990</a> reported that the supplement did not reduce volitional food intake, and compliance appeared not to be a problem. <a href="./references#CD001880-bbs2-0016" title="FlodinL . Effects of bisphosphonates and nutritional supplementation after a hip fracture. clinicaltrials.gov/show/NCT01950169 2013 (accessed 3 December 2015). FlodinL . Personal communication. Personal communication 15 December 2014. FlodinL , SaafM , CederholmT , Al‐AniAN , AckermannPW , SanegardE , et al. Additive effects of nutritional supplementation, together with bisphosphonates, on bone mineral density after hip fracture: a 12‐month randomized controlled study. Clinical Interventions in Aging2014;9:1043‐50. ">Flodin 2014</a> reported that 7 of 18 participants complied with supplement prescription, and the remaining participants took half the prescribed supplementation. <a href="./references#CD001880-bbs2-0019" title="HankinsC . Dietary supplementation with sustagen in elderly patients with fractured neck of femur [MSc dissertation]. Sydney (Australia): University of Sydney, 1996. HankinsC . Personal communication 11 June 1999. ">Hankins 1996</a> found that only 65% of participants managed to complete the full 30 days of supplementation. However, the supplement had no significant effect on ordinary food intake. <a href="./references#CD001880-bbs2-0022" title="HouwingR . Personal communication 29 October 2003. HouwingR , RozendaalM , Wouters‐WesselingW , BeulensJ , BuskensE , HaalboomJ . The effect of nutritional supplementation on the prevention of pressure ulcers (PU) in hip‐fracture patients. Clinical Nutrition2002;21(Suppl 1):84. HouwingRH , RozendaalM , Wouters‐WesselingW , BeulensJW , BuskensE , HaalboomJR . A randomised, double‐blind assessment of the effect of nutritional supplementation on the prevention of pressure ulcers in hip‐fracture patients. Clinical Nutrition2003;22(4):401‐5. [MEDLINE: 12880608] ">Houwing 2003</a> found that the mean daily intake of the active or placebo supplements was 77% in both groups. <a href="./references#CD001880-bbs2-0024" title="LuoM . Personal communication 17 November 2014. LuoM , GolubevG , KlyukvinI , ReznikL , KuropatkinG , OliverJS , et al. Oral nutrition supplement improved nutritional status in malnourished hip fracture patients: a randomized controlled study. Journal of Scientific Research and Reports2015;4(6):480‐9. LuoM , GolybevG , KlyukvinI , ReznikL , KuropatkinG , VossAC . Oral nutritional supplement (ONS) improved nutritional status in malnourished patients receiving hip fracture surgery. Clinical Nutrition Supplements2011;6:151. SwearenginB . Effect of a medical food supplement in hospitalized patients recovering from surgery. clinicaltrials.gov/ct2/show/NCT01011608 (accessed 4 December 2015). ">Luo 2015</a> reported good compliance with intervention participants consuming 91% to 100% of recommended intake. <a href="./references#CD001880-bbs2-0025" title="MadiganC . Benefits of dietary supplementation in elderly patients with fractured neck of femur. Sydney (Australia): University of Sydney, 1994. ">Madigan 1994</a> also found that the oral supplement did not significantly affect volitional intake, but made no comment on compliance. <a href="./references#CD001880-bbs2-0027" title="MyintMW . Personal communication 6 January 2015. MyintMW , WuJ , WongE , ChanSP , ToTS , ChauMW , et al. Clinical benefits of oral nutritional supplementation for elderly hip fracture patients: a single blind randomised controlled trial. Age and Ageing2013;42(1):39‐45. MyintMWW . A randomized controlled study of nutritional intervention for geriatric hip fracture patients and its effect on rehabilitation outcomes. clinicaltrials.gov/ct2/show/NCT01088139 (accessed 4 December 2015). ">Myint 2013</a> reported an overall compliance rate for supplements of 78%. <a href="./references#CD001880-bbs2-0041" title="Breedveld‐PetersJ , ReijvenPL , WyersCE , HendrikxAA , VerburgAD , ScholsJM , et al. Qualitative analysis of barriers and facilitators for nutritional intervention in hip fracture patients. Clinical Nutrition, Supplement2012;7(1):234. Breedveld‐PetersJJ , ReijvenPL , WyersCE , HendrikxAA , VerburgAD , ScholsJM , et al. Barriers and facilitators of nutritional intervention after hip fracture in integrated care as perceived by the different health care professionals: a qualitative interview study. e‐SPEN Journal2012;7(5):e182‐8. Breedveld‐PetersJJ , ReijvenPL , WyersCE , VanHeldenS , ArtsJJ , MeestersB , et al. Integrated nutritional intervention in the elderly after hip fracture. A process evaluation. Clinical Nutrition, Supplement2012;31(1):199‐205. Breedveld‐PetersJJ , ReijvenPL , WyersCE , VanHeldenS , ArtsJJ , MeestersB , et al. Integrated nutritional intervention in the elderly after hip fracture. A process evaluation. Clinical Nutrition, Supplement2012;7(1):43. DagneliePC . Effectiveness and cost‐effectiveness of nutritional screening and intervention in elderly subjects after hip fracture. clinicaltrials.gov/show/NCT00523575 (accessed 8 November 2009). WyersC , ReijvenPL , EversSM , WillemsPC , HeyligersIC , VerburgAD , et al. Cost‐effectiveness of nutritional intervention in hip fracture patients: a multi‐centre randomised controlled trial (RCT). Clinical Nutrition, Supplement2012;7(1):49. WyersCE . PhD thesis. Maastricht, the Netherlands: Maastricht University, 2012. WyersCE , Breedveld‐PetersJJ , ReijvenPL , ArtsC , ThomassenBJ , VerburgAD , et al. Effect of nutritional intervention on nutritional intake and status in hip fracture patients: a multicentre randomised controlled trial (RCT). Clinical Nutrition, Supplement2012;7(1):50‐1. WyersCE , Breedveld‐PetersJJ , ReijvenPL , VanHeldenS , GuldemondNA , SeverensJL , et al. Efficacy and cost‐effectiveness of nutritional intervention in elderly after hip fracture: design of a randomized controlled trial. BMC Public Health2010;10:212. WyersCE , ReijvenPL , EversSM , WillemsPC , HeyligersIC , VerburgAD , et al. Cost‐effectiveness of nutritional intervention in elderly subjects after hip fracture. A randomized controlled trial. Osteoporosis International2013;24(1):151‐62. ">Wyers 2013</a> found that 67% of the participants adhered to the nutritional recommendations from the dietician and 79% were adherent to the supplements in hospital. After discharge, the adherence was 73% and 80%, respectively. </p> <p>Neither <a href="./references#CD001880-bbs2-0007" title="BrownKM . Personal communicationMay 1999. BrownKM , SeabrookNA . Effect of nutrition on recovery after fractured femur. Medical Audit News1992;2(1):10‐2. BrownKM , SeabrookNA . Nutritional influences on recovery and length of hospital stay in elderly women following femoral fracture. Proceedings of the Nutrition Society1992;51(2):132A. ">Brown 1992b</a>, <a href="./references#CD001880-bbs2-0038" title="CarlssonP , TidermarkJ , PonzerS , SoderqvistA , CederholmT . Food habits and appetite of elderly women at the time of a femoral neck fracture and after nutritional and anabolic support. Journal of Human Nutrition and Dietetics2005;18(2):117‐20. [MEDLINE: 15788020] TengstrandB , CederholmT , SoderqvistA , TidermarkJ . Effects of protein‐rich supplementation and nandrolone on bone tissue after a hip fracture. Clinical Nutrition2007;26(4):460‐5. [MEDLINE: 17498850] TidermarkJ . Personal communication 14 October 2004. TidermarkJ . Quality of life and femoral neck fractures. Acta Orthopaedica Scandinavica. Supplementum2003;74(309):1‐42. TidermarkJ , PonzerS , CarlssonP , SoderqvistA , BrismarK , TengstrandB , et al. Effects of protein‐rich supplementation and nandrolone in lean elderly women with femoral neck fractures. Clinical Nutrition2004;23(4):587‐96. TidermarkJ , PonzerS , TengstrandB , CederholmT . Liquid supplementation and nandrolone to elderly women. Clinical Nutrition2002;21(Suppl 1):40. ">Tidermark 2004</a> nor <a href="./references#CD001880-bbs2-0035" title="StableforthPG . Supplement feeds and nitrogen and calorie balance following femoral neck fracture. British Journal of Surgery1986;73:651‐5. ">Stableforth 1986</a> gave details on volitional food intake or compliance with the supplements. Specific data on adherence for participants with hip fracture in the nutrition‐supplementation only group of <a href="./references#CD001880-bbs2-0026" title="CrottyM . Personal communication 20 February 2009. DanielsLA , MillerM , BannermanE , WhiteheadC , CrottyM . Weight loss post lower limb fracture despite an intensive oral nutrition and exercise intervention. Clinical Nutrition2003;22 Suppl:S86. DanielsLA , MillerMD , BannermannE , CrottyM . Adherence to nutritional supplements amongst orthopedic patients: an important clinical and study design issue. Clinical Nutrition2005;24:535. MillerMD , BannermanE , DanielsLA , CrottyM . Lower limb fracture, cognitive impairment and risk of subsequent malnutrition: a prospective evaluation of dietary energy and protein intake on an orthopaedic ward. European Journal of Clinical Nutrition2006;60(7):853‐61. [MEDLINE: 16452913] MillerMD , CrottyM , WhiteheadC , BannermanE , DanielsLA . Nutritional supplementation and resistance training in nutritionally at risk older adults following lower limb fracture: a randomized controlled trial. Clinical Rehabilitation2006;20(4):311‐23. MillerMD , DanielsLA , BannermanE , CrottyM . Adherence to nutrition supplements among patients with a fall‐related lower limb fracture. Nutrition in Clinical Practice2005;20(5):569‐78. [MEDLINE: 16207699] ">Miller 2006</a> were not available. </p> </section> <section id="CD001880-sec-0122"> <p><b>Carer burden and stress</b></p> <p>No study provided data for this outcome.</p> </section> </section> <section id="CD001880-sec-0123"> <h6 class="title">Economic outcomes</h6> <p><a href="./references#CD001880-bbs2-0041" title="Breedveld‐PetersJ , ReijvenPL , WyersCE , HendrikxAA , VerburgAD , ScholsJM , et al. Qualitative analysis of barriers and facilitators for nutritional intervention in hip fracture patients. Clinical Nutrition, Supplement2012;7(1):234. Breedveld‐PetersJJ , ReijvenPL , WyersCE , HendrikxAA , VerburgAD , ScholsJM , et al. Barriers and facilitators of nutritional intervention after hip fracture in integrated care as perceived by the different health care professionals: a qualitative interview study. e‐SPEN Journal2012;7(5):e182‐8. Breedveld‐PetersJJ , ReijvenPL , WyersCE , VanHeldenS , ArtsJJ , MeestersB , et al. Integrated nutritional intervention in the elderly after hip fracture. A process evaluation. Clinical Nutrition, Supplement2012;31(1):199‐205. Breedveld‐PetersJJ , ReijvenPL , WyersCE , VanHeldenS , ArtsJJ , MeestersB , et al. Integrated nutritional intervention in the elderly after hip fracture. A process evaluation. Clinical Nutrition, Supplement2012;7(1):43. DagneliePC . Effectiveness and cost‐effectiveness of nutritional screening and intervention in elderly subjects after hip fracture. clinicaltrials.gov/show/NCT00523575 (accessed 8 November 2009). WyersC , ReijvenPL , EversSM , WillemsPC , HeyligersIC , VerburgAD , et al. Cost‐effectiveness of nutritional intervention in hip fracture patients: a multi‐centre randomised controlled trial (RCT). Clinical Nutrition, Supplement2012;7(1):49. WyersCE . PhD thesis. Maastricht, the Netherlands: Maastricht University, 2012. WyersCE , Breedveld‐PetersJJ , ReijvenPL , ArtsC , ThomassenBJ , VerburgAD , et al. Effect of nutritional intervention on nutritional intake and status in hip fracture patients: a multicentre randomised controlled trial (RCT). Clinical Nutrition, Supplement2012;7(1):50‐1. WyersCE , Breedveld‐PetersJJ , ReijvenPL , VanHeldenS , GuldemondNA , SeverensJL , et al. Efficacy and cost‐effectiveness of nutritional intervention in elderly after hip fracture: design of a randomized controlled trial. BMC Public Health2010;10:212. WyersCE , ReijvenPL , EversSM , WillemsPC , HeyligersIC , VerburgAD , et al. Cost‐effectiveness of nutritional intervention in elderly subjects after hip fracture. A randomized controlled trial. Osteoporosis International2013;24(1):151‐62. ">Wyers 2013</a> in the Netherlands undertook an economic evaluation of supplementation and dietetic support for three months. Based on QALYs and a societal perspective, the Incremental Cost‐Effectiveness Ratio was 36,943 EUR/QALY. Based on total societal costs and a willingness to pay of EUR 20,000, the probability that the intervention was cost‐effective was 45%. </p> </section> </section> <section id="CD001880-sec-0124"> <h5 class="title">Nasogastric tube feeding</h5> <section id="CD001880-sec-0125"> <h6 class="title">Primary outcomes</h6> <p>Four studies examined nasogastric multinutrient supplementation <i>(</i><a href="./references#CD001880-bbs2-0002" title="AllisonSP . Personal communication 15 February 2000. AllisonSP . Reflections on a study of nutrition support in patients with femur neck fracture. Nutrition1995;11(3):322‐7. BastowMD , RawlingsJ , AllisonSP . Benefits of supplementary tube feeding after fractured neck of femur: a randomised controlled trial. British Medical Journal (Clinical Research Edition)1983;287(6405):1589‐92. [MEDLINE: 6416514] BastowMD , RawlingsJ , AllisonSP . Controlled trial showing clinical benefit of tube feeding in elderly patients with fractured femur. Clinical Nutrition1984;2 Suppl:57. BastowMD , RawlingsJ , AllisonSP . Overnight nasogastric tube feeding. Clinical Nutrition1985;4(1):7‐11. ">Bastow 1983b</a>; <a href="./references#CD001880-bbs2-0017" title="GallagherJ , SchermbeckJ , DixonL , Labbe‐BellM . Aggressive early management of malnutrition in hip fracture patients. Journal of Parenteral and Enteral Nutrition1992;16(1):19S. KoretzR . Personal communication 7 September 1999. ">Gallagher 1992</a>; <a href="./references#CD001880-bbs2-0020" title="HartgrinkHH . Personal communication 23 June 1999. HartgrinkHH , WilleJ , KönigP , HermansJ , BreslauPJ . Pressure sores and tube feeding in patients with a fracture of the hip: a randomized clinical trial. Clinical Nutrition1998;17:287‐92. ">Hartgrink 1998</a>; <a href="./references#CD001880-bbs2-0036" title="SullivanDH . Personal communication 10 February 2000. SullivanDH , NelsonCL , BoppMM , Puskarich‐MayCL , WallsRC . Nightly enteral nutrition support of elderly fracture patients: a phase I trial. Journal of the American College of Nutrition1998;17(1):155‐61. ">Sullivan 1998</a>). <a href="./references#CD001880-bbs2-0017" title="GallagherJ , SchermbeckJ , DixonL , Labbe‐BellM . Aggressive early management of malnutrition in hip fracture patients. Journal of Parenteral and Enteral Nutrition1992;16(1):19S. KoretzR . Personal communication 7 September 1999. ">Gallagher 1992</a>, which was only published as an abstract, gave no denominators and so could not be included in the meta‐analyses. Information provided by Ronald Koretz (personal communication), based on notes taken at a conference presentation by <a href="./references#CD001880-bbs2-0017" title="GallagherJ , SchermbeckJ , DixonL , Labbe‐BellM . Aggressive early management of malnutrition in hip fracture patients. Journal of Parenteral and Enteral Nutrition1992;16(1):19S. KoretzR . Personal communication 7 September 1999. ">Gallagher 1992</a>, indicated a possible failure to undertake intention‐to‐treat analysis. It seems likely that 12 participants allocated to the intervention group, who had feeding discontinued when their tube was pulled out, were crossed over to the control group in the analysis. There were also some differences in the results presented at the conference and in the published abstract. </p> <p><a href="./references#CD001880-bbs2-0017" title="GallagherJ , SchermbeckJ , DixonL , Labbe‐BellM . Aggressive early management of malnutrition in hip fracture patients. Journal of Parenteral and Enteral Nutrition1992;16(1):19S. KoretzR . Personal communication 7 September 1999. ">Gallagher 1992</a> gave no information on mortality in the published abstract; two deaths were reported in the conference presentation. Pooling of mortality data from the other three studies showed no evidence of an effect (14/142 versus 14/138; RR 0.99, 95% CI 0.50 to 1.97; I<sup>2</sup> = 69%; very low‐quality evidence downgraded two levels for serious risk of bias and one level for inconsistency given the considerable heterogeneity; <a href="./references#CD001880-fig-0008" title="">Analysis 1.1</a>: <a href="#CD001880-fig-0004">Figure 4</a>). All seven deaths in <a href="./references#CD001880-bbs2-0020" title="HartgrinkHH . Personal communication 23 June 1999. HartgrinkHH , WilleJ , KönigP , HermansJ , BreslauPJ . Pressure sores and tube feeding in patients with a fracture of the hip: a randomized clinical trial. Clinical Nutrition1998;17:287‐92. ">Hartgrink 1998</a> occurred in the intervention group during the two‐week period of observation. This could have been due to chance, as the deaths were not obviously related to tube feeding (anaesthetic death, cardiac arrest, stroke and multi‐organ failure), and did not appear to relate to aspiration pneumonia, a complication of tube feeding. Four of the deaths occurred in participants in whom tube feeding had not started, although the tube had been placed. It was evident that tube feeding was poorly tolerated, with only 26% of the intervention group tolerating feeding for the full two weeks. Conversely all five deaths occurred in the control group in <a href="./references#CD001880-bbs2-0036" title="SullivanDH . Personal communication 10 February 2000. SullivanDH , NelsonCL , BoppMM , Puskarich‐MayCL , WallsRC . Nightly enteral nutrition support of elderly fracture patients: a phase I trial. Journal of the American College of Nutrition1998;17(1):155‐61. ">Sullivan 1998</a>; this might in part reflect the greater frailty of the control group at recruitment.<br/> <br/> The four trials were heterogeneous in the nutritional status of the study participants. Unlike <a href="./references#CD001880-bbs2-0020" title="HartgrinkHH . Personal communication 23 June 1999. HartgrinkHH , WilleJ , KönigP , HermansJ , BreslauPJ . Pressure sores and tube feeding in patients with a fracture of the hip: a randomized clinical trial. Clinical Nutrition1998;17:287‐92. ">Hartgrink 1998</a>, <a href="./references#CD001880-bbs2-0002" title="AllisonSP . Personal communication 15 February 2000. AllisonSP . Reflections on a study of nutrition support in patients with femur neck fracture. Nutrition1995;11(3):322‐7. BastowMD , RawlingsJ , AllisonSP . Benefits of supplementary tube feeding after fractured neck of femur: a randomised controlled trial. British Medical Journal (Clinical Research Edition)1983;287(6405):1589‐92. [MEDLINE: 6416514] BastowMD , RawlingsJ , AllisonSP . Controlled trial showing clinical benefit of tube feeding in elderly patients with fractured femur. Clinical Nutrition1984;2 Suppl:57. BastowMD , RawlingsJ , AllisonSP . Overnight nasogastric tube feeding. Clinical Nutrition1985;4(1):7‐11. ">Bastow 1983b</a> targeted nasogastric feeding on thin and very thin participants, defined by anthropometry. Seventy‐eight per cent of participants tolerated nasogastric feeding until discharge from the ward, although 18 in the intervention group developed diarrhoea, which was ascribed to antibiotics in 16. <a href="./references#CD001880-bbs2-0002" title="AllisonSP . Personal communication 15 February 2000. AllisonSP . Reflections on a study of nutrition support in patients with femur neck fracture. Nutrition1995;11(3):322‐7. BastowMD , RawlingsJ , AllisonSP . Benefits of supplementary tube feeding after fractured neck of femur: a randomised controlled trial. British Medical Journal (Clinical Research Edition)1983;287(6405):1589‐92. [MEDLINE: 6416514] BastowMD , RawlingsJ , AllisonSP . Controlled trial showing clinical benefit of tube feeding in elderly patients with fractured femur. Clinical Nutrition1984;2 Suppl:57. BastowMD , RawlingsJ , AllisonSP . Overnight nasogastric tube feeding. Clinical Nutrition1985;4(1):7‐11. ">Bastow 1983b</a> did not report gastrointestinal complications in the control group. <a href="./references#CD001880-bbs2-0002" title="AllisonSP . Personal communication 15 February 2000. AllisonSP . Reflections on a study of nutrition support in patients with femur neck fracture. Nutrition1995;11(3):322‐7. BastowMD , RawlingsJ , AllisonSP . Benefits of supplementary tube feeding after fractured neck of femur: a randomised controlled trial. British Medical Journal (Clinical Research Edition)1983;287(6405):1589‐92. [MEDLINE: 6416514] BastowMD , RawlingsJ , AllisonSP . Controlled trial showing clinical benefit of tube feeding in elderly patients with fractured femur. Clinical Nutrition1984;2 Suppl:57. BastowMD , RawlingsJ , AllisonSP . Overnight nasogastric tube feeding. Clinical Nutrition1985;4(1):7‐11. ">Bastow 1983b</a> provided separate mortality data for the two participant subgroups (thin group: 5/39 versus 4/35; very thin group: 2/25 versus 5/25); a test for interaction did not indicate a subgroup difference P = 0.31 (analysis not shown). Malnourished participants were not specifically targeted in <a href="./references#CD001880-bbs2-0036" title="SullivanDH . Personal communication 10 February 2000. SullivanDH , NelsonCL , BoppMM , Puskarich‐MayCL , WallsRC . Nightly enteral nutrition support of elderly fracture patients: a phase I trial. Journal of the American College of Nutrition1998;17(1):155‐61. ">Sullivan 1998</a>. In <a href="./references#CD001880-bbs2-0036" title="SullivanDH . Personal communication 10 February 2000. SullivanDH , NelsonCL , BoppMM , Puskarich‐MayCL , WallsRC . Nightly enteral nutrition support of elderly fracture patients: a phase I trial. Journal of the American College of Nutrition1998;17(1):155‐61. ">Sullivan 1998</a><i>,</i> the intervention group received supplements until discharge or until a good oral intake was achieved. People with low serum albumin readings, described as malnourished, were targeted in <a href="./references#CD001880-bbs2-0017" title="GallagherJ , SchermbeckJ , DixonL , Labbe‐BellM . Aggressive early management of malnutrition in hip fracture patients. Journal of Parenteral and Enteral Nutrition1992;16(1):19S. KoretzR . Personal communication 7 September 1999. ">Gallagher 1992</a>. </p> <p>Only <a href="./references#CD001880-bbs2-0036" title="SullivanDH . Personal communication 10 February 2000. SullivanDH , NelsonCL , BoppMM , Puskarich‐MayCL , WallsRC . Nightly enteral nutrition support of elderly fracture patients: a phase I trial. Journal of the American College of Nutrition1998;17(1):155‐61. ">Sullivan 1998</a> provided data on participants developing medical complications in intervention and control groups (1/8 versus 8/10; RR 1.09, 99% CI 0.64 to 1.86; very low‐quality evidence downgraded two levels for serious risk of bias and one level for imprecision; <a href="./references#CD001880-fig-0009" title="">Analysis 1.2:</a><a href="#CD001880-fig-0005">Figure 5</a>). No study provided information on 'unfavourable outcome'. </p> </section> <section id="CD001880-sec-0126"> <h6 class="title">Secondary outcomes</h6> <p>Three studies provided information on length of hospital stay. In the published abstract, <a href="./references#CD001880-bbs2-0017" title="GallagherJ , SchermbeckJ , DixonL , Labbe‐BellM . Aggressive early management of malnutrition in hip fracture patients. Journal of Parenteral and Enteral Nutrition1992;16(1):19S. KoretzR . Personal communication 7 September 1999. ">Gallagher 1992</a> found that rehabilitation length of stay was 25 days in the intervention group and 33 days in the control group (reported P = 0.058). However, in the notes taken from the conference presentation by <a href="./references#CD001880-bbs2-0017" title="GallagherJ , SchermbeckJ , DixonL , Labbe‐BellM . Aggressive early management of malnutrition in hip fracture patients. Journal of Parenteral and Enteral Nutrition1992;16(1):19S. KoretzR . Personal communication 7 September 1999. ">Gallagher 1992</a>, the length of stay was 22.7 days for the control group and 22.6 days for the intervention group. <a href="./references#CD001880-bbs2-0036" title="SullivanDH . Personal communication 10 February 2000. SullivanDH , NelsonCL , BoppMM , Puskarich‐MayCL , WallsRC . Nightly enteral nutrition support of elderly fracture patients: a phase I trial. Journal of the American College of Nutrition1998;17(1):155‐61. ">Sullivan 1998</a> reported no significant difference between the two groups in the length of acute care stay for survivors (38.2 days versus 23.7 days: MD 14.50 days, 99% CI ‐24.34 to 53.34 days). <a href="./references#CD001880-bbs2-0002" title="AllisonSP . Personal communication 15 February 2000. AllisonSP . Reflections on a study of nutrition support in patients with femur neck fracture. Nutrition1995;11(3):322‐7. BastowMD , RawlingsJ , AllisonSP . Benefits of supplementary tube feeding after fractured neck of femur: a randomised controlled trial. British Medical Journal (Clinical Research Edition)1983;287(6405):1589‐92. [MEDLINE: 6416514] BastowMD , RawlingsJ , AllisonSP . Controlled trial showing clinical benefit of tube feeding in elderly patients with fractured femur. Clinical Nutrition1984;2 Suppl:57. BastowMD , RawlingsJ , AllisonSP . Overnight nasogastric tube feeding. Clinical Nutrition1985;4(1):7‐11. ">Bastow 1983b</a> stated the median lengths of stay for the very thin group only (including those who died): a median of 29 days for the intervention group and 38 days for the control group (reported P = 0.04). <a href="./references#CD001880-bbs2-0020" title="HartgrinkHH . Personal communication 23 June 1999. HartgrinkHH , WilleJ , KönigP , HermansJ , BreslauPJ . Pressure sores and tube feeding in patients with a fracture of the hip: a randomized clinical trial. Clinical Nutrition1998;17:287‐92. ">Hartgrink 1998</a> gave no information about length of stay but reported that the intervention group were less likely to have left hospital by two weeks (still in hospital at two weeks: 55/62 versus 53/67; RR 1.12, 99% CI 0.92 to 1.37; analysis not shown). </p> <p>Where reported, physiotherapy goals were achieved more quickly in the intervention groups: <a href="./references#CD001880-bbs2-0017" title="GallagherJ , SchermbeckJ , DixonL , Labbe‐BellM . Aggressive early management of malnutrition in hip fracture patients. Journal of Parenteral and Enteral Nutrition1992;16(1):19S. KoretzR . Personal communication 7 September 1999. ">Gallagher 1992</a> (published abstract), 12.7 days versus 16.2 days (reported P = not significant); <a href="./references#CD001880-bbs2-0002" title="AllisonSP . Personal communication 15 February 2000. AllisonSP . Reflections on a study of nutrition support in patients with femur neck fracture. Nutrition1995;11(3):322‐7. BastowMD , RawlingsJ , AllisonSP . Benefits of supplementary tube feeding after fractured neck of femur: a randomised controlled trial. British Medical Journal (Clinical Research Edition)1983;287(6405):1589‐92. [MEDLINE: 6416514] BastowMD , RawlingsJ , AllisonSP . Controlled trial showing clinical benefit of tube feeding in elderly patients with fractured femur. Clinical Nutrition1984;2 Suppl:57. BastowMD , RawlingsJ , AllisonSP . Overnight nasogastric tube feeding. Clinical Nutrition1985;4(1):7‐11. ">Bastow 1983b</a> thin group: 10 days (range 4 to 20) versus 12 days (range 5 to 26) (reported P = 0.04); <a href="./references#CD001880-bbs2-0002" title="AllisonSP . Personal communication 15 February 2000. AllisonSP . Reflections on a study of nutrition support in patients with femur neck fracture. Nutrition1995;11(3):322‐7. BastowMD , RawlingsJ , AllisonSP . Benefits of supplementary tube feeding after fractured neck of femur: a randomised controlled trial. British Medical Journal (Clinical Research Edition)1983;287(6405):1589‐92. [MEDLINE: 6416514] BastowMD , RawlingsJ , AllisonSP . Controlled trial showing clinical benefit of tube feeding in elderly patients with fractured femur. Clinical Nutrition1984;2 Suppl:57. BastowMD , RawlingsJ , AllisonSP . Overnight nasogastric tube feeding. Clinical Nutrition1985;4(1):7‐11. ">Bastow 1983b</a> very thin group: 16 days (range 5 to 34) versus 23 days (range 10 to 45) (reported P = 0.02). <a href="./references#CD001880-bbs2-0036" title="SullivanDH . Personal communication 10 February 2000. SullivanDH , NelsonCL , BoppMM , Puskarich‐MayCL , WallsRC . Nightly enteral nutrition support of elderly fracture patients: a phase I trial. Journal of the American College of Nutrition1998;17(1):155‐61. ">Sullivan 1998</a> showed no statistically significant difference between intervention and control groups for activities of daily living at discharge (Katz index (0 = independent to 12 = totally dependent): 4.1 versus 5.9; MD ‐1.80, 99% CI ‐7.17 to 3.57). </p> <p><a href="./references#CD001880-bbs2-0036" title="SullivanDH . Personal communication 10 February 2000. SullivanDH , NelsonCL , BoppMM , Puskarich‐MayCL , WallsRC . Nightly enteral nutrition support of elderly fracture patients: a phase I trial. Journal of the American College of Nutrition1998;17(1):155‐61. ">Sullivan 1998</a> reported that three out of eight in the intervention group had bloating in the early morning and none in the control group; there was no feed‐induced diarrhoea. <a href="./references#CD001880-bbs2-0036" title="SullivanDH . Personal communication 10 February 2000. SullivanDH , NelsonCL , BoppMM , Puskarich‐MayCL , WallsRC . Nightly enteral nutrition support of elderly fracture patients: a phase I trial. Journal of the American College of Nutrition1998;17(1):155‐61. ">Sullivan 1998</a> did not report on aspiration pneumonia. <a href="./references#CD001880-bbs2-0020" title="HartgrinkHH . Personal communication 23 June 1999. HartgrinkHH , WilleJ , KönigP , HermansJ , BreslauPJ . Pressure sores and tube feeding in patients with a fracture of the hip: a randomized clinical trial. Clinical Nutrition1998;17:287‐92. ">Hartgrink 1998</a> reported no cases of aspiration pneumonia, a putative side effect, related to the tube feeding. </p> <p><a href="./references#CD001880-bbs2-0036" title="SullivanDH . Personal communication 10 February 2000. SullivanDH , NelsonCL , BoppMM , Puskarich‐MayCL , WallsRC . Nightly enteral nutrition support of elderly fracture patients: a phase I trial. Journal of the American College of Nutrition1998;17(1):155‐61. ">Sullivan 1998</a> found that volitional food intake was not significantly affected by nasogastric feeding. <a href="./references#CD001880-bbs2-0002" title="AllisonSP . Personal communication 15 February 2000. AllisonSP . Reflections on a study of nutrition support in patients with femur neck fracture. Nutrition1995;11(3):322‐7. BastowMD , RawlingsJ , AllisonSP . Benefits of supplementary tube feeding after fractured neck of femur: a randomised controlled trial. British Medical Journal (Clinical Research Edition)1983;287(6405):1589‐92. [MEDLINE: 6416514] BastowMD , RawlingsJ , AllisonSP . Controlled trial showing clinical benefit of tube feeding in elderly patients with fractured femur. Clinical Nutrition1984;2 Suppl:57. BastowMD , RawlingsJ , AllisonSP . Overnight nasogastric tube feeding. Clinical Nutrition1985;4(1):7‐11. ">Bastow 1983b</a> found that nasogastric feeding significantly suppressed oral intake in the thin group but not in the very thin group. The suppression of food intake in the thin group amounted to 1.1 MJ, compared with daily nasogastric feeding which provided 4.2 MJ. </p> </section> </section> <section id="CD001880-sec-0127"> <h5 class="title">Nasogastric tube feeding and oral supplements</h5> <p><a href="./references#CD001880-bbs2-0037" title="SullivanDH . Personal communication 14 April 2006. SullivanDH , NelsonCL , KlimbergVS , BoppMM . Nightly enteral nutrition support of elderly hip fracture patients: a pilot study. Journal of the American College of Nutrition2004;23(6):683‐91. [MEDLINE: 15637216] ">Sullivan 2004</a> evaluated nightly nasogastric feeding tailored to the calculated energy requirements of individual participants after taking account of the intake from meals. If the difference between calculated requirements and food intake decreased to 240 to 480 kcal/day participants were asked to drink one or two cans of the supplement orally instead of nasogastric feeding. This regimen was compared with standard care. The evidence for all outcomes was very low quality, downgraded by two levels for risk of bias and one level for imprecision. At six months there was very low‐quality evidence of no significant differences between the two groups in mortality (4/27 versus 6/30; RR 0.74, 99% CI 0.16 to 3.37; <a href="./references#CD001880-fig-0008" title="">Analysis 1.1</a>; <a href="#CD001880-fig-0004">Figure 4</a>) or postoperative complications (18/27 versus 18/30; RR 1.11, 99% CI 0.66 to 1.87; <a href="./references#CD001880-fig-0009" title="">Analysis 1.2</a>; <a href="#CD001880-fig-0005">Figure 5</a>).<br/> <br/> There was no significant difference in hospital length of stay. The median (interquartile range) length of hospital stay for the intervention group was 9 days (7 to 21) and for the control group 9 days (7 to 15), reported P = 0.817). </p> <p><a href="./references#CD001880-bbs2-0037" title="SullivanDH . Personal communication 14 April 2006. SullivanDH , NelsonCL , KlimbergVS , BoppMM . Nightly enteral nutrition support of elderly hip fracture patients: a pilot study. Journal of the American College of Nutrition2004;23(6):683‐91. [MEDLINE: 15637216] ">Sullivan 2004</a> found no significant difference between intervention and control groups in the Katz Index of activities of daily living scores on discharge (median (interquartile range): 8 (4 to 11) versus 9 (7 to 11); reported P = 0.503), or the rate of discharge to an institution (25/27 versus 27/30; RR 1.03, 99% CI 0.83 to 1.27; analysis not shown). </p> <p>Five of the 27 intervention group participants never started tube feeding because of either refusal of tube placement or lack of toleration of the feeding tube. Targeted tube feeding was continued until the oral intake was deemed to be adequate in only five of the remainder, and only two participants required no tube reinsertions. Though there was no significant difference between the two groups in the incidence of diarrhoea (5/27 versus 3/30; RR 1.85, 99% CI 0.32 to 10.68; <a href="./references#CD001880-fig-0013" title="">Analysis 1.6</a>), <a href="./references#CD001880-bbs2-0037" title="SullivanDH . Personal communication 14 April 2006. SullivanDH , NelsonCL , KlimbergVS , BoppMM . Nightly enteral nutrition support of elderly hip fracture patients: a pilot study. Journal of the American College of Nutrition2004;23(6):683‐91. [MEDLINE: 15637216] ">Sullivan 2004</a> reported that the diarrhoea in the intervention group was more difficult to control. In the first week, the intervention group met 86% of their calculated energy requirements compared with 63% for the control group (reported P = 0.002); the difference between the two groups was not significant for the 22 trial participants assessed in the second week (96% versus 95%; reported P = 0.942). </p> </section> <section id="CD001880-sec-0128"> <h5 class="title">Intravenous feeding and oral supplements</h5> <p><a href="./references#CD001880-bbs2-0013" title="EnerothM . Personal communication 10 February 2009. EnerothM . Personal communication 17 March 2006. EnerothM , OlssonU‐B , ThorngrenK‐G . Combined parenteral and oral nutritional supplementation decreases fracture‐related complications. A prospective randomised trial of 80 patients with hip fractures. Journal of Bone and Joint Surgery ‐ British Volume2006;88(Suppl 1):44. EnerothM , OlssonU‐B , ThorngrenK‐G . Insufficient fluid and energy intake in hospitalised patients with hip fracture. A prospective randomised study of 80 patients. Clinical Nutrition2005;24:297‐303. [MEDLINE: 15784492] EnerothM , OlssonUB , ThorngrenKG . Nutritional supplementation decreases hip fracture‐related complications. Clinical Orthopaedics and Related Research2006;(451):212‐7. [MEDLINE: 16770284] ">Eneroth 2006</a> evaluated three days of intravenous feeding followed by seven days of oral supplements compared with standard care in 80 participants. The only reported deaths were in the control group (0/40 versus 4/40: RR 0.11, 99% CI 0.00 to 4.95; very low‐quality evidence downgraded one level from serious risk of bias and two from imprecision; <a href="./references#CD001880-fig-0008" title="">Analysis 1.1</a>; <a href="#CD001880-fig-0004">Figure 4</a>). In contrast, there was a significant reduction in participants with complications in the supplementation group (6/40 versus 28/40; RR 0.21, 99% CI 0.08 to 0.59; very low‐quality evidence downgraded one level for risk of bias, one level for imprecision (small single trial) and one for indirectness, since this intervention is usually reserved for people with non‐functioning gastrointestinal tracts, which is unlikely in this population; <a href="./references#CD001880-fig-0009" title="">Analysis 1.2</a>; <a href="#CD001880-fig-0005">Figure 5</a>). The mean length of hospital stay for both groups was 12.5 days. There was no significant difference between the two groups for those who were discharged to their own homes (14/40 versus 22/40, RR 0.64, 99% CI 0.33 to 1.24; analysis not shown). There were three reports of venous thrombosis or thrombophlebitis in the control group and one report in the intervention group. </p> </section> <section id="CD001880-sec-0129"> <h5 class="title">Multinutrient supplements ‐ overall results</h5> <p>There was no clear difference between intervention and control groups in overall mortality when pooling the results of oral, nasogastric and intravenous multinutrient supplementation studies (42/695 versus 55/689; RR 0.79, 95% CI 0.55 to 1.15; 1385 participants; 20 studies; I<sup>2</sup> = 0%; low‐quality evidence downgraded two levels for risk of bias and imprecision; see <a href="./references#CD001880-fig-0008" title="">Analysis 1.1</a>; <a href="#CD001880-fig-0004">Figure 4</a>). Funnel plot examination (<a href="#CD001880-fig-0006">Figure 6</a>) did not show clear evidence of small study bias. </p> <div class="figure" id="CD001880-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Multinutrient supplements (oral, nasogastric, intravenous) versus control, outcome: 1.1 Mortality by end of study" data-id="CD001880-fig-0006" src="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Multinutrient supplements (oral, nasogastric, intravenous) versus control, outcome: 1.1 Mortality by end of study </p> </div> </div> </div> <p>There were fewer participants with complications in the intervention compared with the control groups (154/445 versus 211/437; RR 0.69, 95% CI 0.59 to 0.81; 882 participants; 14 studies; <a href="./references#CD001880-fig-0009" title="">Analysis 1.2</a>; <a href="#CD001880-fig-0005">Figure 5</a>). However, although there was substantial heterogeneity for this outcome (I² = 60%, Chi² = 30.16, P = 0.003); the result using the random‐effects model was similar (RR 0.70, 95% CI 0.53 to 0.91; see <a href="./references#CD001880-fig-0010" title="">Analysis 1.3</a>). Funnel plot examination (<a href="#CD001880-fig-0007">Figure 7</a>) did not show clear evidence of small study bias. The significant heterogeneity was reduced by removing <a href="./references#CD001880-bbs2-0013" title="EnerothM . Personal communication 10 February 2009. EnerothM . Personal communication 17 March 2006. EnerothM , OlssonU‐B , ThorngrenK‐G . Combined parenteral and oral nutritional supplementation decreases fracture‐related complications. A prospective randomised trial of 80 patients with hip fractures. Journal of Bone and Joint Surgery ‐ British Volume2006;88(Suppl 1):44. EnerothM , OlssonU‐B , ThorngrenK‐G . Insufficient fluid and energy intake in hospitalised patients with hip fracture. A prospective randomised study of 80 patients. Clinical Nutrition2005;24:297‐303. [MEDLINE: 15784492] EnerothM , OlssonUB , ThorngrenKG . Nutritional supplementation decreases hip fracture‐related complications. Clinical Orthopaedics and Related Research2006;(451):212‐7. [MEDLINE: 16770284] ">Eneroth 2006</a> (resulting heterogeneity: I² = 35%, Chi² = 16.87, P = 0.11); RR 0.79, 95% CI 0.64 to 0.98 from the pooled results of the remaining trials; analysis not shown. </p> <div class="figure" id="CD001880-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Multinutrient supplements (oral, nasogastric, intravenous) versus control, outcome: 1.2 Participants with complications at end of study" data-id="CD001880-fig-0007" src="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-AFig-FIG07.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Multinutrient supplements (oral, nasogastric, intravenous) versus control, outcome: 1.2 Participants with complications at end of study </p> </div> </div> </div> <p>There were no data from nasogastric or intravenous trials on 'unfavourable outcome' (see <a href="./references#CD001880-fig-0011" title="">Analysis 1.4</a>). </p> <section id="CD001880-sec-0130"> <h6 class="title">Subgroup and sensitivity analysis</h6> <section id="CD001880-sec-0131"> <p><b>Nutritional status of trial populations</b></p> <p>Subgrouping the trials according to whether they targeted malnourished participants or not showed a potential reduction in terms of mortality for supplementation in those that targeted malnourished participants (RR 0.55, 95% CI 0.27 to 1.11; 388 participants, 6 studies) compared with those that did not (RR 0.92, 95% CI 0.59 to 1.42; 997 participants, 14 studies); <a href="./references#CD001880-fig-0014" title="">Analysis 2.1</a>. The results of the groups were not statistically significantly different from each other (test for interaction: P = 0.23, I<sup>2</sup> = 31.7%) and thus the evidence does not confirm that malnourished participants are more likely to benefit. While there was greater contrast between the two subgroup groups when the data were restricted to oral supplementation, the test for interaction similarly did not confirm a difference between the two subgroups (P = 0.15, I<sup>2</sup> = 52.1%); <a href="./references#CD001880-fig-0015" title="">Analysis 2.2</a>. </p> <p>The analyses for complications (see <a href="./references#CD001880-fig-0016" title="">Analysis 2.3</a>) and 'unfavourable outcome' (see <a href="./references#CD001880-fig-0017" title="">Analysis 2.4</a>) are also presented, but the greatly reduced available data for people who were malnourished limit their usefulness. The tests for subgroup differences indicated there were no differences for both outcomes (I<sup>2</sup> = 0). </p> </section> <section id="CD001880-sec-0132"> <p><b>Methodological quality</b></p> <p>We have presented the results for mortality subgrouped by whether allocation was concealed (low, unclear or high risk of bias) in the individual studies in <a href="./references#CD001880-fig-0018" title="">Analysis 3.1</a>. A test for interaction confirms the visual impression that the pooled results of the 10 trials with low risk of bias are not statistically significantly different from those of the three trials where allocation was high risk, or the seven trials where allocation concealment was of unclear risk (P = 0.21). The 'unclear concealment' group is clearly heterogeneous (I² = 52%) and it is inadvisable to draw any conclusions from the above test of interaction result. For the seven trials using oral supplementation alone and at low risk of allocation concealment, the risk ratio was 0.63 (95% CI 0.32 to 1.25, data not shown). </p> <p>The results (<a href="./references#CD001880-fig-0019" title="">Analysis 3.2</a>) for participants with complications were subgrouped by whether allocation was concealed (low or unclear; no trials with high risk of bias). The five trials with unclear risk of bias had a lower risk of complications (19/127 versus 47/133; RR 0.38, 95% CI 0.24 to 0.61) than the nine trials with low risk of bias (135/318 versus 164/304; RR 0.78, 95% CI 0.66 to 0.92), test for subgroup differences P = 0.005, I<sup>2</sup> = 87.5%). Both groups of trials were clearly heterogeneous, I<sup>2</sup> was 51% and 45% respectively, and it is inadvisable, therefore, to draw any conclusions from the above test of interaction result. For the seven trials using oral supplementation alone with low risk of bias relating to allocation concealment, the risk ratio was 0.72 (95% CI 0.60 to 0.88, data not shown). </p> </section> </section> </section> </section> <section id="CD001880-sec-0133"> <h4 class="title">High protein‐containing supplements versus low‐protein or non‐protein‐containing supplements</h4> <section id="CD001880-sec-0134"> <h5 class="title">Primary outcomes</h5> <p>Three studies (<a href="./references#CD001880-bbs2-0014" title="EspaulellaJ , GuyerH , Diaz‐EscriuF , Mellado‐NavasJA , CastellsM , PladevallM . Nutritional supplementation of elderly hip fracture patients. A randomized, double‐blind, placebo‐controlled trial. Age and Ageing2000;29(5):425‐31. [MEDLINE: 11108415] GuyerH . Personal communication 13 June 2000. ">Espaulella 2000</a>; <a href="./references#CD001880-bbs2-0032" title="BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. RizzoliR , SchürchMA , BonjourJP . Protein supplements after osteoporotic hip fracture. Annals of Internal Medicine1998;129:1076. SchürchM‐A , BonjourJ‐P , SlosmanD , RizzoliR . Protein supplements favourably influence the outcome after hip fracture [Un supplement proteique ameliore les suites d'une fracture du femur proximal]. Medecine et Hygiene1999;57(2271):1876‐8. SchürchMA , RizzoliR , SlosmanD , BonjourJP . Protein supplements increase serum IGF‐1 and decrease proximal femur bone loss in patients with a recent hip fracture. Osteoporosis 1996: Proceedings of the 1996 World Congress on Osteoporosis; 1996 May 18‐23; Amsterdam, The Netherlands. Amsterdam: Elsevier, 1996:327‐9. SchürchMA , RizzoliR , SlosmanD , VadasL , VergnaudP , BonjourJP . Protein supplements increase serum insulin‐like growth factor‐I levels and attenuate proximal femur bone loss in patients with recent hip fracture. A randomized, double‐blind, placebo‐controlled trial. Annals of Internal Medicine1998;128(10):801‐9. ">Schürch 1998</a>; <a href="./references#CD001880-bbs2-0039" title="BonjourJP , RapinCH , RizzoliR , TkatchL , DelmiM , ChevalleyT , et al. Hip fracture, femoral bone mineral density, and protein supply in elderly patients. In: MunroH , SchlierfG editor(s). Nutrition of the elderly. Nestle nutrition workshop series. Vol. 29, New York: Raven Press, 1992:151‐9. BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. BonjourJP , SchürchMA , RizzoliR . Nutritional aspects of hip fractures. Bone1996;18(Suppl 3):139S‐44S. BonjourJP , SchürchMA , RizzoliR . Proteins and bone health. Patholgie‐Biologie1997;45(1):57‐9. TkatchL , RapinCH , RizzoliR , SlosmanD , NydeggerV , VaseyH , et al. Benefits of oral protein supplementation in elderly patients with fracture of the proximal femur. Journal of the American College of Nutrition1992;11(5):519‐25. ">Tkatch 1992</a>) investigated whether approximately 20 g of protein provided within an oral supplement on a daily basis influenced outcome from hip fracture. <a href="./references#CD001880-bbs2-0028" title="JensenG . Personal communication 6 January 2005. NeumannM , FriedmannJ , RoyMA , JensenGL . Provision of high‐protein supplement for patients recovering from hip fracture. Nutrition2004;20(5):415‐9. [MEDLINE: 15105027] NeumannMM , FriedmannJM , JensenGL . Provision of high protein supplement for patients recovering from hip fracture. Journal of Parenteral and Enteral Nutrition2004;28(Suppl 1):S30. ">Neumann 2004</a> investigated whether a high‐protein supplement providing an extra 12.2 g or more of protein (with some differences in vitamins and minerals also) influenced outcome. All four studies failed to carry out intention‐to‐treat analyses (although information was later provided on mortality and hospital complications of excluded participants in <a href="./references#CD001880-bbs2-0014" title="EspaulellaJ , GuyerH , Diaz‐EscriuF , Mellado‐NavasJA , CastellsM , PladevallM . Nutritional supplementation of elderly hip fracture patients. A randomized, double‐blind, placebo‐controlled trial. Age and Ageing2000;29(5):425‐31. [MEDLINE: 11108415] GuyerH . Personal communication 13 June 2000. ">Espaulella 2000</a>). Denominators were sometimes missing or unclear. <a href="./references#CD001880-bbs2-0039" title="BonjourJP , RapinCH , RizzoliR , TkatchL , DelmiM , ChevalleyT , et al. Hip fracture, femoral bone mineral density, and protein supply in elderly patients. In: MunroH , SchlierfG editor(s). Nutrition of the elderly. Nestle nutrition workshop series. Vol. 29, New York: Raven Press, 1992:151‐9. BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. BonjourJP , SchürchMA , RizzoliR . Nutritional aspects of hip fractures. Bone1996;18(Suppl 3):139S‐44S. BonjourJP , SchürchMA , RizzoliR . Proteins and bone health. Patholgie‐Biologie1997;45(1):57‐9. TkatchL , RapinCH , RizzoliR , SlosmanD , NydeggerV , VaseyH , et al. Benefits of oral protein supplementation in elderly patients with fracture of the proximal femur. Journal of the American College of Nutrition1992;11(5):519‐25. ">Tkatch 1992</a> excluded some of the intervention group for poor compliance with supplement taking, whilst some of the controls were excluded for later taking a dietary supplement. <a href="./references#CD001880-bbs2-0014" title="EspaulellaJ , GuyerH , Diaz‐EscriuF , Mellado‐NavasJA , CastellsM , PladevallM . Nutritional supplementation of elderly hip fracture patients. A randomized, double‐blind, placebo‐controlled trial. Age and Ageing2000;29(5):425‐31. [MEDLINE: 11108415] GuyerH . Personal communication 13 June 2000. ">Espaulella 2000</a> excluded five people from the intervention group and three from the control group for protocol violations, and two from the control group because they were unable to swallow. Thus, unavoidably, the results presented here are not intention‐to‐treat analyses. No significant effect on mortality could be demonstrated for the high protein supplement (30/181 versus 21/180; RR 1.42 favouring the control group, 95% CI 0.85 to 2.37; 4 studies; low‐quality evidence, downgraded one level for risk of bias and one level for imprecision; <a href="./references#CD001880-fig-0020" title="">Analysis 4.1</a>). </p> <p>None of the four trials provided sufficient information to evaluate numbers of participants with complications at the end of the study. <a href="./references#CD001880-bbs2-0014" title="EspaulellaJ , GuyerH , Diaz‐EscriuF , Mellado‐NavasJA , CastellsM , PladevallM . Nutritional supplementation of elderly hip fracture patients. A randomized, double‐blind, placebo‐controlled trial. Age and Ageing2000;29(5):425‐31. [MEDLINE: 11108415] GuyerH . Personal communication 13 June 2000. ">Espaulella 2000</a> reported that 44 out of 61 in the intervention group and 57 of 67 in the control group developed at least one complication during the six months of the study (RR 0.85, 99% CI 0.66 to 1.08; analysis not shown). <a href="./references#CD001880-bbs2-0028" title="JensenG . Personal communication 6 January 2005. NeumannM , FriedmannJ , RoyMA , JensenGL . Provision of high‐protein supplement for patients recovering from hip fracture. Nutrition2004;20(5):415‐9. [MEDLINE: 15105027] NeumannMM , FriedmannJM , JensenGL . Provision of high protein supplement for patients recovering from hip fracture. Journal of Parenteral and Enteral Nutrition2004;28(Suppl 1):S30. ">Neumann 2004</a> reported that there were no differences between the groups for complications or adverse events. Taken together, these findings constitute very low‐quality evidence downgraded two levels for risk of bias and one level for imprecision. </p> <p>'Unfavourable outcome' (for <a href="./references#CD001880-bbs2-0014" title="EspaulellaJ , GuyerH , Diaz‐EscriuF , Mellado‐NavasJA , CastellsM , PladevallM . Nutritional supplementation of elderly hip fracture patients. A randomized, double‐blind, placebo‐controlled trial. Age and Ageing2000;29(5):425‐31. [MEDLINE: 11108415] GuyerH . Personal communication 13 June 2000. ">Espaulella 2000</a>: death or complication by the end of the study; for <a href="./references#CD001880-bbs2-0039" title="BonjourJP , RapinCH , RizzoliR , TkatchL , DelmiM , ChevalleyT , et al. Hip fracture, femoral bone mineral density, and protein supply in elderly patients. In: MunroH , SchlierfG editor(s). Nutrition of the elderly. Nestle nutrition workshop series. Vol. 29, New York: Raven Press, 1992:151‐9. BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. BonjourJP , SchürchMA , RizzoliR . Nutritional aspects of hip fractures. Bone1996;18(Suppl 3):139S‐44S. BonjourJP , SchürchMA , RizzoliR . Proteins and bone health. Patholgie‐Biologie1997;45(1):57‐9. TkatchL , RapinCH , RizzoliR , SlosmanD , NydeggerV , VaseyH , et al. Benefits of oral protein supplementation in elderly patients with fracture of the proximal femur. Journal of the American College of Nutrition1992;11(5):519‐25. ">Tkatch 1992</a>: death by the end of the study or, for survivors, a major complication or two or more minor complications present at the end of the study) was significantly reduced by protein supplementation (66/113 versus 82/110; RR 0.78, 95% CI 0.65 to 0.95; very low‐quality evidence downgraded two levels for risk of bias and one for imprecision reflecting insufficiency in the available data; <a href="./references#CD001880-fig-0021" title="">Analysis 4.2</a>); this outcome was not reported by the other two studies. </p> <p>An exploratory analysis looking at the effect of assuming that all excluded participants in the protein supplementation group had an 'unfavourable outcome' could not be undertaken. However the results for <a href="./references#CD001880-bbs2-0014" title="EspaulellaJ , GuyerH , Diaz‐EscriuF , Mellado‐NavasJA , CastellsM , PladevallM . Nutritional supplementation of elderly hip fracture patients. A randomized, double‐blind, placebo‐controlled trial. Age and Ageing2000;29(5):425‐31. [MEDLINE: 11108415] GuyerH . Personal communication 13 June 2000. ">Espaulella 2000</a> should be viewed in the context of the greater number of deaths in the protein supplementation group. In <a href="./references#CD001880-bbs2-0039" title="BonjourJP , RapinCH , RizzoliR , TkatchL , DelmiM , ChevalleyT , et al. Hip fracture, femoral bone mineral density, and protein supply in elderly patients. In: MunroH , SchlierfG editor(s). Nutrition of the elderly. Nestle nutrition workshop series. Vol. 29, New York: Raven Press, 1992:151‐9. BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. BonjourJP , SchürchMA , RizzoliR . Nutritional aspects of hip fractures. Bone1996;18(Suppl 3):139S‐44S. BonjourJP , SchürchMA , RizzoliR . Proteins and bone health. Patholgie‐Biologie1997;45(1):57‐9. TkatchL , RapinCH , RizzoliR , SlosmanD , NydeggerV , VaseyH , et al. Benefits of oral protein supplementation in elderly patients with fracture of the proximal femur. Journal of the American College of Nutrition1992;11(5):519‐25. ">Tkatch 1992</a>, neither the results for unfavourable outcome in acute hospital (9/33 versus 13/29; RR 0.61, 99% CI 0.25 to 1.50) nor in rehabilitation hospital (4/19 versus 14/22; RR 0.33, 99% CI 0.10 to 1.12) were statistically significant; analyses not shown. </p> </section> <section id="CD001880-sec-0135"> <h5 class="title">Secondary outcomes</h5> <p><a href="./references#CD001880-bbs2-0014" title="EspaulellaJ , GuyerH , Diaz‐EscriuF , Mellado‐NavasJA , CastellsM , PladevallM . Nutritional supplementation of elderly hip fracture patients. A randomized, double‐blind, placebo‐controlled trial. Age and Ageing2000;29(5):425‐31. [MEDLINE: 11108415] GuyerH . Personal communication 13 June 2000. ">Espaulella 2000</a> reported an acute hospital stay of 16.4 days in the intervention group and 17.2 days in the control group (MD ‐0.80 days, 99% CI ‐3.62 to 2.02 days). <a href="./references#CD001880-bbs2-0039" title="BonjourJP , RapinCH , RizzoliR , TkatchL , DelmiM , ChevalleyT , et al. Hip fracture, femoral bone mineral density, and protein supply in elderly patients. In: MunroH , SchlierfG editor(s). Nutrition of the elderly. Nestle nutrition workshop series. Vol. 29, New York: Raven Press, 1992:151‐9. BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. BonjourJP , SchürchMA , RizzoliR . Nutritional aspects of hip fractures. Bone1996;18(Suppl 3):139S‐44S. BonjourJP , SchürchMA , RizzoliR . Proteins and bone health. Patholgie‐Biologie1997;45(1):57‐9. TkatchL , RapinCH , RizzoliR , SlosmanD , NydeggerV , VaseyH , et al. Benefits of oral protein supplementation in elderly patients with fracture of the proximal femur. Journal of the American College of Nutrition1992;11(5):519‐25. ">Tkatch 1992</a> reported a statistically significantly (P &lt; 0.05) lower median length of acute and rehabilitation hospital stay in the intervention group (combined stay: median 69.4 days versus 101.6 days; acute hospital stay: median 23.5 days versus 24.7 days; rehabilitation hospital: 78.6 days versus 91.8 days). <a href="./references#CD001880-bbs2-0032" title="BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. RizzoliR , SchürchMA , BonjourJP . Protein supplements after osteoporotic hip fracture. Annals of Internal Medicine1998;129:1076. SchürchM‐A , BonjourJ‐P , SlosmanD , RizzoliR . Protein supplements favourably influence the outcome after hip fracture [Un supplement proteique ameliore les suites d'une fracture du femur proximal]. Medecine et Hygiene1999;57(2271):1876‐8. SchürchMA , RizzoliR , SlosmanD , BonjourJP . Protein supplements increase serum IGF‐1 and decrease proximal femur bone loss in patients with a recent hip fracture. Osteoporosis 1996: Proceedings of the 1996 World Congress on Osteoporosis; 1996 May 18‐23; Amsterdam, The Netherlands. Amsterdam: Elsevier, 1996:327‐9. SchürchMA , RizzoliR , SlosmanD , VadasL , VergnaudP , BonjourJP . Protein supplements increase serum insulin‐like growth factor‐I levels and attenuate proximal femur bone loss in patients with recent hip fracture. A randomized, double‐blind, placebo‐controlled trial. Annals of Internal Medicine1998;128(10):801‐9. ">Schürch 1998</a> reported mean figures of 18.0 days versus 16.9 days on the acute ward, and median stays of 33 versus 54 days in the rehabilitation ward (reported difference 21 days, 95% CI 4 to 25 days; P = 0.018). <a href="./references#CD001880-bbs2-0028" title="JensenG . Personal communication 6 January 2005. NeumannM , FriedmannJ , RoyMA , JensenGL . Provision of high‐protein supplement for patients recovering from hip fracture. Nutrition2004;20(5):415‐9. [MEDLINE: 15105027] NeumannMM , FriedmannJM , JensenGL . Provision of high protein supplement for patients recovering from hip fracture. Journal of Parenteral and Enteral Nutrition2004;28(Suppl 1):S30. ">Neumann 2004</a> reported the rehabilitation stay was not significantly different between the two groups (23.2 days versus 28.0 days; MD ‐4.80 days, 99% CI ‐12.29 to 2.69 days). <a href="./references#CD001880-bbs2-0028" title="JensenG . Personal communication 6 January 2005. NeumannM , FriedmannJ , RoyMA , JensenGL . Provision of high‐protein supplement for patients recovering from hip fracture. Nutrition2004;20(5):415‐9. [MEDLINE: 15105027] NeumannMM , FriedmannJM , JensenGL . Provision of high protein supplement for patients recovering from hip fracture. Journal of Parenteral and Enteral Nutrition2004;28(Suppl 1):S30. ">Neumann 2004</a> also reported no significant difference in the destination at discharge between the two groups.<br/> <br/> <a href="./references#CD001880-bbs2-0014" title="EspaulellaJ , GuyerH , Diaz‐EscriuF , Mellado‐NavasJA , CastellsM , PladevallM . Nutritional supplementation of elderly hip fracture patients. A randomized, double‐blind, placebo‐controlled trial. Age and Ageing2000;29(5):425‐31. [MEDLINE: 11108415] GuyerH . Personal communication 13 June 2000. ">Espaulella 2000</a> found no difference between intervention and control groups for mobility or Barthel Index scores six months after recruitment. <a href="./references#CD001880-bbs2-0032" title="BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. RizzoliR , SchürchMA , BonjourJP . Protein supplements after osteoporotic hip fracture. Annals of Internal Medicine1998;129:1076. SchürchM‐A , BonjourJ‐P , SlosmanD , RizzoliR . Protein supplements favourably influence the outcome after hip fracture [Un supplement proteique ameliore les suites d'une fracture du femur proximal]. Medecine et Hygiene1999;57(2271):1876‐8. SchürchMA , RizzoliR , SlosmanD , BonjourJP . Protein supplements increase serum IGF‐1 and decrease proximal femur bone loss in patients with a recent hip fracture. Osteoporosis 1996: Proceedings of the 1996 World Congress on Osteoporosis; 1996 May 18‐23; Amsterdam, The Netherlands. Amsterdam: Elsevier, 1996:327‐9. SchürchMA , RizzoliR , SlosmanD , VadasL , VergnaudP , BonjourJP . Protein supplements increase serum insulin‐like growth factor‐I levels and attenuate proximal femur bone loss in patients with recent hip fracture. A randomized, double‐blind, placebo‐controlled trial. Annals of Internal Medicine1998;128(10):801‐9. ">Schürch 1998</a> also reported non‐significant improvements in biceps muscle strength and activities of daily living score at six months; these were not reported as being measured by <a href="./references#CD001880-bbs2-0039" title="BonjourJP , RapinCH , RizzoliR , TkatchL , DelmiM , ChevalleyT , et al. Hip fracture, femoral bone mineral density, and protein supply in elderly patients. In: MunroH , SchlierfG editor(s). Nutrition of the elderly. Nestle nutrition workshop series. Vol. 29, New York: Raven Press, 1992:151‐9. BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. BonjourJP , SchürchMA , RizzoliR . Nutritional aspects of hip fractures. Bone1996;18(Suppl 3):139S‐44S. BonjourJP , SchürchMA , RizzoliR . Proteins and bone health. Patholgie‐Biologie1997;45(1):57‐9. TkatchL , RapinCH , RizzoliR , SlosmanD , NydeggerV , VaseyH , et al. Benefits of oral protein supplementation in elderly patients with fracture of the proximal femur. Journal of the American College of Nutrition1992;11(5):519‐25. ">Tkatch 1992</a>. <a href="./references#CD001880-bbs2-0032" title="BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. RizzoliR , SchürchMA , BonjourJP . Protein supplements after osteoporotic hip fracture. Annals of Internal Medicine1998;129:1076. SchürchM‐A , BonjourJ‐P , SlosmanD , RizzoliR . Protein supplements favourably influence the outcome after hip fracture [Un supplement proteique ameliore les suites d'une fracture du femur proximal]. Medecine et Hygiene1999;57(2271):1876‐8. SchürchMA , RizzoliR , SlosmanD , BonjourJP . Protein supplements increase serum IGF‐1 and decrease proximal femur bone loss in patients with a recent hip fracture. Osteoporosis 1996: Proceedings of the 1996 World Congress on Osteoporosis; 1996 May 18‐23; Amsterdam, The Netherlands. Amsterdam: Elsevier, 1996:327‐9. SchürchMA , RizzoliR , SlosmanD , VadasL , VergnaudP , BonjourJP . Protein supplements increase serum insulin‐like growth factor‐I levels and attenuate proximal femur bone loss in patients with recent hip fracture. A randomized, double‐blind, placebo‐controlled trial. Annals of Internal Medicine1998;128(10):801‐9. ">Schürch 1998</a> reported that seven participants in the intervention group and 13 in the control group developed vertebral deformities after one year. Again denominators were not given; the difference was reported not to be statistically significant. <a href="./references#CD001880-bbs2-0028" title="JensenG . Personal communication 6 January 2005. NeumannM , FriedmannJ , RoyMA , JensenGL . Provision of high‐protein supplement for patients recovering from hip fracture. Nutrition2004;20(5):415‐9. [MEDLINE: 15105027] NeumannMM , FriedmannJM , JensenGL . Provision of high protein supplement for patients recovering from hip fracture. Journal of Parenteral and Enteral Nutrition2004;28(Suppl 1):S30. ">Neumann 2004</a> found no significant difference between groups for the mobility subscale of the Functional Independence Measure at any time point including at three months post discharge. </p> <p>Neither <a href="./references#CD001880-bbs2-0032" title="BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. RizzoliR , SchürchMA , BonjourJP . Protein supplements after osteoporotic hip fracture. Annals of Internal Medicine1998;129:1076. SchürchM‐A , BonjourJ‐P , SlosmanD , RizzoliR . Protein supplements favourably influence the outcome after hip fracture [Un supplement proteique ameliore les suites d'une fracture du femur proximal]. Medecine et Hygiene1999;57(2271):1876‐8. SchürchMA , RizzoliR , SlosmanD , BonjourJP . Protein supplements increase serum IGF‐1 and decrease proximal femur bone loss in patients with a recent hip fracture. Osteoporosis 1996: Proceedings of the 1996 World Congress on Osteoporosis; 1996 May 18‐23; Amsterdam, The Netherlands. Amsterdam: Elsevier, 1996:327‐9. SchürchMA , RizzoliR , SlosmanD , VadasL , VergnaudP , BonjourJP . Protein supplements increase serum insulin‐like growth factor‐I levels and attenuate proximal femur bone loss in patients with recent hip fracture. A randomized, double‐blind, placebo‐controlled trial. Annals of Internal Medicine1998;128(10):801‐9. ">Schürch 1998</a> nor <a href="./references#CD001880-bbs2-0039" title="BonjourJP , RapinCH , RizzoliR , TkatchL , DelmiM , ChevalleyT , et al. Hip fracture, femoral bone mineral density, and protein supply in elderly patients. In: MunroH , SchlierfG editor(s). Nutrition of the elderly. Nestle nutrition workshop series. Vol. 29, New York: Raven Press, 1992:151‐9. BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. BonjourJP , SchürchMA , RizzoliR . Nutritional aspects of hip fractures. Bone1996;18(Suppl 3):139S‐44S. BonjourJP , SchürchMA , RizzoliR . Proteins and bone health. Patholgie‐Biologie1997;45(1):57‐9. TkatchL , RapinCH , RizzoliR , SlosmanD , NydeggerV , VaseyH , et al. Benefits of oral protein supplementation in elderly patients with fracture of the proximal femur. Journal of the American College of Nutrition1992;11(5):519‐25. ">Tkatch 1992</a> gave information about the effect of the supplements on voluntary food intake. However, <a href="./references#CD001880-bbs2-0032" title="BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. RizzoliR , SchürchMA , BonjourJP . Protein supplements after osteoporotic hip fracture. Annals of Internal Medicine1998;129:1076. SchürchM‐A , BonjourJ‐P , SlosmanD , RizzoliR . Protein supplements favourably influence the outcome after hip fracture [Un supplement proteique ameliore les suites d'une fracture du femur proximal]. Medecine et Hygiene1999;57(2271):1876‐8. SchürchMA , RizzoliR , SlosmanD , BonjourJP . Protein supplements increase serum IGF‐1 and decrease proximal femur bone loss in patients with a recent hip fracture. Osteoporosis 1996: Proceedings of the 1996 World Congress on Osteoporosis; 1996 May 18‐23; Amsterdam, The Netherlands. Amsterdam: Elsevier, 1996:327‐9. SchürchMA , RizzoliR , SlosmanD , VadasL , VergnaudP , BonjourJP . Protein supplements increase serum insulin‐like growth factor‐I levels and attenuate proximal femur bone loss in patients with recent hip fracture. A randomized, double‐blind, placebo‐controlled trial. Annals of Internal Medicine1998;128(10):801‐9. ">Schürch 1998</a> did report that six participants (15%) dropped out because of nausea or diarrhoea in the intervention group and five participants (12%) in the control group. <a href="./references#CD001880-bbs2-0039" title="BonjourJP , RapinCH , RizzoliR , TkatchL , DelmiM , ChevalleyT , et al. Hip fracture, femoral bone mineral density, and protein supply in elderly patients. In: MunroH , SchlierfG editor(s). Nutrition of the elderly. Nestle nutrition workshop series. Vol. 29, New York: Raven Press, 1992:151‐9. BonjourJP , SchürchMA , ChevalleyP , AmmannP , RizzoliR . Protein intake, IGF‐1 and osteoporosis. Osteoporosis International1997;7 Suppl 3:S36‐42. BonjourJP , SchürchMA , RizzoliR . Nutritional aspects of hip fractures. Bone1996;18(Suppl 3):139S‐44S. BonjourJP , SchürchMA , RizzoliR . Proteins and bone health. Patholgie‐Biologie1997;45(1):57‐9. TkatchL , RapinCH , RizzoliR , SlosmanD , NydeggerV , VaseyH , et al. Benefits of oral protein supplementation in elderly patients with fracture of the proximal femur. Journal of the American College of Nutrition1992;11(5):519‐25. ">Tkatch 1992</a> reported no digestive disturbances during hospitalisation in the protein supplemented group, and seven events in the control group. <a href="./references#CD001880-bbs2-0014" title="EspaulellaJ , GuyerH , Diaz‐EscriuF , Mellado‐NavasJA , CastellsM , PladevallM . Nutritional supplementation of elderly hip fracture patients. A randomized, double‐blind, placebo‐controlled trial. Age and Ageing2000;29(5):425‐31. [MEDLINE: 11108415] GuyerH . Personal communication 13 June 2000. ">Espaulella 2000</a> reported that 64.7% (55/85) of the intervention group and 74.4% (64/86) of the control group had good consumption of the supplement. <a href="./references#CD001880-bbs2-0028" title="JensenG . Personal communication 6 January 2005. NeumannM , FriedmannJ , RoyMA , JensenGL . Provision of high‐protein supplement for patients recovering from hip fracture. Nutrition2004;20(5):415‐9. [MEDLINE: 15105027] NeumannMM , FriedmannJM , JensenGL . Provision of high protein supplement for patients recovering from hip fracture. Journal of Parenteral and Enteral Nutrition2004;28(Suppl 1):S30. ">Neumann 2004</a> reported that participants had 19.8 days of the high‐protein supplement, compared with 21.1 days for the lower‐protein supplement. They found that energy intakes were not significantly different between the groups, but that the high‐protein group also had significantly greater daily intakes of dietary fibre, vitamin C and polyunsaturated fatty acids. </p> </section> </section> <section id="CD001880-sec-0136"> <h4 class="title">Comparison of different protein sources</h4> <p><a href="./references#CD001880-bbs2-0009" title="ChevalleyT . Personal communication 14 October 2014. ChevalleyT , HoffmeyerP , BonjourJ‐P , RizzoliR . Early serum IGF‐I response to oral protein supplements in elderly women with a recent hip fracture. Clinical Nutrition2010;29(1):78‐83. ">Chevalley 2010</a> compared 20 g daily of oral casein protein versus 20 g of oral whey protein versus 15 g of oral whey protein and 5 g of essential amino acids in a ratio identical to casein for a month. Five people from 15 of the casein group dropped out (2 refusal, 2 nausea, 1 diarrhoea), four from 15 of the whey group (2 refusal, 1 nausea, 1 diarrhoea) and two from 15 of the whey and amino acid group (1 refusal, 1 nausea). The type of supplement was reported as not influencing adherence. No other outcomes relevant to this review were reported. </p> </section> <section id="CD001880-sec-0137"> <h4 class="title">Vitamin supplementation versus control or lower dose supplementation</h4> <p><a href="./references#CD001880-bbs2-0010" title="DayJJ . Personal communication 27 May 1999. DayJJ , BayerAJ , McMahonM , PathyMS , SpraggBP , RowlandsDC . Thiamine status, vitamin supplements and postoperative confusion. Age and Ageing1988;17:29‐34. ">Day 1988</a> tested whether intravenous thiamin (vitamin B1) and other water soluble vitamins influenced postoperative mental function in participants. The daily dose of thiamin (250 mg) provided over 300 times the UK reference nutrient intake for this vitamin; that of riboflavin, 3.6 times; of pyridoxine, 42 times; of nicotinamide and ascorbic acid, 13 times. Sixty‐one per cent of the intervention group and 75% of the control group had satisfactory thiamin status at baseline. There was no significant difference in mortality (see <a href="./references#CD001880-fig-0022" title="">Analysis 5.1</a>: 6/28 versus 5/32; RR 1.37, 99% CI 0.33 to 5.62) or in the numbers of participants with complications (see <a href="./references#CD001880-fig-0023" title="">Analysis 5.2</a>: 15/28 versus 13/32; RR 1.32, 99% CI 0.65 to 2.69). Likewise, the incidence of acute postoperative confusion, the primary outcome of <a href="./references#CD001880-bbs2-0010" title="DayJJ . Personal communication 27 May 1999. DayJJ , BayerAJ , McMahonM , PathyMS , SpraggBP , RowlandsDC . Thiamine status, vitamin supplements and postoperative confusion. Age and Ageing1988;17:29‐34. ">Day 1988</a>, did not differ between the two groups (11/28 versus 12/32; RR 1.05, 99% CI 0.45 to 2.44; analysis not shown). The length of hospital stay was not affected (MD 6 days, 99% CI ‐15.75 to 27.75 days), and residence at final follow‐up was reported not to be affected by the intervention. </p> <p><a href="./references#CD001880-bbs2-0021" title="HoikkaV , AlhavaEM , AroA , KarjalainenP , RehnbergV . Treatment of osteoporosis with 1‐alpha‐hydroxycholecalciferol and calcium. Acta Medica Scandinavica1980;207(3):221‐4. [MEDLINE: 6989171] RobertsonJ . Personal communication 2 February 1999. ">Hoikka 1980</a> compared oral 1‐alpha‐hydroxycholecalciferol (an active form of vitamin D) and 1 g calcium carbonate versus 1g calcium carbonate. No data from main outcomes were reported, except for complications. Six, including two severe cases, out of 19 in the intervention group and two out of 18 in the control group developed hypercalcaemia (see <a href="./references#CD001880-fig-0024" title="">Analysis 6.1</a>: 6/19 versus 2/18; RR 2.84, 99% CI 0.41 to 19.48). <a href="./references#CD001880-bbs2-0021" title="HoikkaV , AlhavaEM , AroA , KarjalainenP , RehnbergV . Treatment of osteoporosis with 1‐alpha‐hydroxycholecalciferol and calcium. Acta Medica Scandinavica1980;207(3):221‐4. [MEDLINE: 6989171] RobertsonJ . Personal communication 2 February 1999. ">Hoikka 1980</a>reported that there was no effect on hand muscle strength over the six months post‐fracture observation period. </p> <p><a href="./references#CD001880-bbs2-0029" title="PapaioannouA . A randomised, controlled comparison of vitamin D strategies in acute hip fracture patients. clinicaltrials.gov/show/NCT00424619 (accessed 4 December 2015). PapaioannouA , KennedyCC , GiangregorioL , IoannidisG , PritchardJ , HanleyDA , et al. A randomized controlled trial of vitamin D dosing strategies after acute hip fracture: no advantage of loading doses over daily supplementation. BMC Musculoskeletal Disorders2011;12:135. PapaioannouA , KennedyCC , IoannidisG , AdachiJD , HanleyD , GiangregorioL , et al. High versus low vitamin D in acute hip fracture patients: a randomised, controlled trial. Osteoporosis International2010;21(Suppl 1):S201. ">Papaioannou 2011</a> compared an initial oral bolus dose of 100,000 IU vitamin D2 versus 50,000 IU vitamin D2 versus placebo; followed by 1000 IU vitamin D3 for 90 days in all groups. Combining both vitamin D groups and comparing these with the placebo group, there was no significant difference found in the number of participants with a serious adverse event (this included death): 4/44 versus 1/21; RR 1.91, 99% CI 0.12 to 31.32; analysis not shown. There were two serious adverse events in each of the two vitamin D groups. Compliance in hospital was 90%, 87% and 97%, for high dose, low dose vitamin D groups and placebo; and 92%, 96% and 84% at home. </p> <p><a href="./references#CD001880-bbs2-0004" title="Bischoff‐FerrariH . Early rehabilitation after hip fracture. clinicaltrials.gov/ct2/show/NCT00133640 (accessed 7 September 2015). Bischoff‐FerrariH , Dawson‐HughesB , OravE , WillettW , EgliA , MaetzelA , et al. The economic consequences of hip fractures: impact of home exercise and high dose‐vitamin D. 32nd Annual Meeting of the American Society for Bone and Mineral Research Annual Meeting; 2010 Oct 15‐9; Toronto, Canada. (accessed 3 December 2015); Vol. www.asbmr.org/education/2010‐abstracts. Bischoff‐FerrariHA , Dawson‐HughesB , PlatzA , OravEJ , StahelinHB , WillettWC , et al. Effect of high‐dosage cholecalciferol and extended physiotherapy on complications after hip fracture. A randomized controlled trial. Archives of Internal Medicine2010;170(9):813‐20. ">Bischoff‐Ferrari 2010</a> investigated daily 2000 IU vitamin D3 compared with daily 800 IU vitamin D3; all participants also received 1g of calcium as calcium carbonate daily over one year, in a factorial design with standard or extended physiotherapy. Mortality (10/86 versus 10/87; RR 1.01, 99% CI 0.44 to 2.31; <a href="./references#CD001880-fig-0025" title="">Analysis 6.2</a>), participants with fall‐related injury requiring hospital readmission (7/86 versus 18/87; RR 0.39, 99% CI 0.13 to 1.16), participants with infection (1/86 versus 10/87; RR 0.10, 99% CI 0.01 to 1.47), participants with other complications requiring hospital readmission (18/86 versus 13/87; RR 1.40, 99% CI 0.60 to 3.28) did not differ significantly between the two vitamin D intervention groups. The numbers of participants with complications were not provided. Mild hypercalcaemia was reported in one participant in the high dose vitamin D group and two in the low dose early in the study, and for two participants in the high dose group and one participant in the low dose group at the end of six months' follow‐up. </p> <p><a href="./references#CD001880-bbs2-0004" title="Bischoff‐FerrariH . Early rehabilitation after hip fracture. clinicaltrials.gov/ct2/show/NCT00133640 (accessed 7 September 2015). Bischoff‐FerrariH , Dawson‐HughesB , OravE , WillettW , EgliA , MaetzelA , et al. The economic consequences of hip fractures: impact of home exercise and high dose‐vitamin D. 32nd Annual Meeting of the American Society for Bone and Mineral Research Annual Meeting; 2010 Oct 15‐9; Toronto, Canada. (accessed 3 December 2015); Vol. www.asbmr.org/education/2010‐abstracts. Bischoff‐FerrariHA , Dawson‐HughesB , PlatzA , OravEJ , StahelinHB , WillettWC , et al. Effect of high‐dosage cholecalciferol and extended physiotherapy on complications after hip fracture. A randomized controlled trial. Archives of Internal Medicine2010;170(9):813‐20. ">Bischoff‐Ferrari 2010</a> reported that comparing high dose with low dose vitamin D did not reduce the rate of falls or improve muscle strength or function. The adjusted odds ratio for new nursing home admission for high versus low dose vitamin D was reported as 0.66, 95% 0.31 to 1.41). Compliance was reported as 93.6% for high dose vitamin D and 92.2% for low dose vitamin D. An abstract reported that the higher versus standard dose of vitamin D was cost neutral. </p> </section> <section id="CD001880-sec-0138"> <h4 class="title">Comparison of different vitamin D sources</h4> <p><a href="./references#CD001880-bbs2-0018" title="ChewG , GlendenningP , TarantoM , InderjeethC . Ergocalciferol and cholecalciferol induce comparable increases in vitamin D binding protein and free 25‐hydroxy‐vitamin D with no significant change in free 1,25‐dihydroxyvitamin D in hip fracture patients. 32nd Annual Meeting of the American Society for Bone and Mineral Research Annual Meeting; Oct 15‐9; Toronto, Canada 2010 (accessed 3 December 2015); Vol. www.asbmr.org/education/2010‐abstracts. GlendenningP , ChewGT , InderjeethCA , TarantoM , FraserWD . Calculated free and bioavailable vitamin D metabolite concentrations in vitamin D‐deficient hip fracture patients after supplementation with cholecalciferol and ergocalciferol. Bone2013;56(2):271‐5. GlendenningP , ChewGT , SeymourHM , GillettMJ , GoldswainPR , InderjeethCA , et al. Serum 25‐hydroxyvitamin D levels in vitamin D‐insufficent hip fracture patients after supplementation with ergocalciferol and cholecalciferol. Bone2009;45(5):870‐5. ">Glendenning 2009</a> compared oral vitamin D3 1000 IU/d and calcium carbonate equivalent to 600 mg/d versus vitamin D2 1000 IU/d and calcium carbonate equivalent to 600 mg/d for three months. Three of 47 participants from the vitamin D3 group died by three months compared with seven from 48 participants from the vitamin D2 group (RR 0.44, 99% CI 0.08 to 2.39). One participant from the vitamin D3 group and three participants from the vitamin D group had mild hypercalcaemia (RR 0.34, 99% CI 0.02 to 6.36). Forty‐seven percent of vitamin D3 participants compared with 59% of vitamin D2 participants took more than 80% of their tablets. </p> </section> <section id="CD001880-sec-0139"> <h4 class="title">Iron supplementation versus control</h4> <p>Three studies with 568 participants compared oral or intravenous iron supplementation versus no intervention or placebo in the first month after hip fracture, as faster correction of anaemia as a consequence of surgery might help improve recovery (<a href="./references#CD001880-bbs2-0030" title="ParkerM . Personal communication 16 October 2014. ParkerM . Randomised trial comparing iron supplementation versus placebo in the treatment of anaemia after hip fracture. clinicaltrials.gov/show/NCT00919230 (accessed 4 December 2015). ParkerMJ . Iron supplementation for anemia after hip fracture surgery. A randomized trial of 300 patients. Journal of Bone and Joint Surgery ‐ American Volume2010;92(2):265‐9. ">Parker 2010</a>; <a href="./references#CD001880-bbs2-0031" title="PrasadN . Personal communication 24 October 2014. PrasadN , RajamaniV , HullinD , MurrayJM . Post‐operative anaemia in femoral neck fracture patients: does it need treatment? A single blinded prospective randomised controlled trial. Injury2009;40(10):1073‐6. ">Prasad 2009</a>; <a href="./references#CD001880-bbs2-0034" title="Serrano‐TrenasJA , UgaldePF , CabelloLM , ChoflesLC , LazaroPS , BenitezPC . Role of perioperative intravenous iron therapy in elderly hip fracture patients: a single‐center randomized controlled trial. Transfusion2011;51(1):97‐104. ">Serrano‐Trenas 2011</a>). Based on low‐quality evidence (downgraded due to risk of bias and imprecision from low number of events), there was no benefit of iron supplementation compared with not prescribing iron supplementation on mortality (39/282 versus 40/284; RR 0.97, 95% CI 0.65 to 1.46; 3 trials; <a href="./references#CD001880-fig-0026" title="">Analysis 7.1</a>) or on complications (16/132 versus 13/134; RR 1.23, 95% CI 0.63 to 2.42; 2 trials; <a href="./references#CD001880-fig-0027" title="">Analysis 7.2</a>). Purported adverse events related to supplementation were reported for 3/100 intervention participants randomised in <a href="./references#CD001880-bbs2-0034" title="Serrano‐TrenasJA , UgaldePF , CabelloLM , ChoflesLC , LazaroPS , BenitezPC . Role of perioperative intravenous iron therapy in elderly hip fracture patients: a single‐center randomized controlled trial. Transfusion2011;51(1):97‐104. ">Serrano‐Trenas 2011</a> (one participant skin rash, two participants 'general discomfort'); 2/32 intervention participants in <a href="./references#CD001880-bbs2-0031" title="PrasadN . Personal communication 24 October 2014. PrasadN , RajamaniV , HullinD , MurrayJM . Post‐operative anaemia in femoral neck fracture patients: does it need treatment? A single blinded prospective randomised controlled trial. Injury2009;40(10):1073‐6. ">Prasad 2009</a> (constipation requiring laxatives), and 26/150 participants randomised in <a href="./references#CD001880-bbs2-0030" title="ParkerM . Personal communication 16 October 2014. ParkerM . Randomised trial comparing iron supplementation versus placebo in the treatment of anaemia after hip fracture. clinicaltrials.gov/show/NCT00919230 (accessed 4 December 2015). ParkerMJ . Iron supplementation for anemia after hip fracture surgery. A randomized trial of 300 patients. Journal of Bone and Joint Surgery ‐ American Volume2010;92(2):265‐9. ">Parker 2010</a> (13 required discontinuation as a result of abdominal pain or altered bowel habit). Length of stay was shorter for participants receiving iron in <a href="./references#CD001880-bbs2-0030" title="ParkerM . Personal communication 16 October 2014. ParkerM . Randomised trial comparing iron supplementation versus placebo in the treatment of anaemia after hip fracture. clinicaltrials.gov/show/NCT00919230 (accessed 4 December 2015). ParkerMJ . Iron supplementation for anemia after hip fracture surgery. A randomized trial of 300 patients. Journal of Bone and Joint Surgery ‐ American Volume2010;92(2):265‐9. ">Parker 2010</a> (MD ‐2.50 days, 99% CI ‐8.17 to 3.17 days), and longer in <a href="./references#CD001880-bbs2-0034" title="Serrano‐TrenasJA , UgaldePF , CabelloLM , ChoflesLC , LazaroPS , BenitezPC . Role of perioperative intravenous iron therapy in elderly hip fracture patients: a single‐center randomized controlled trial. Transfusion2011;51(1):97‐104. ">Serrano‐Trenas 2011</a> for participants receiving iron (MD 0.40 days, 99% CI ‐2.18 to 2.98 days). </p> </section> <section id="CD001880-sec-0140"> <h4 class="title">Vitamin, mineral and amino acid supplementation versus control</h4> <p><a href="./references#CD001880-bbs2-0033" title="DerossiD , BoA , BergonziR , ScivolettoG . Six‐week administration of a mixture of ergogenic and osteotrophic ingredients (RestorfastTM) improves the clinical course of elderly patients after hip fracture surgery [La somministrazione per sei settimane di un composto a base di sostanze osteotrofiche ed ergogene (RestorfastTM) migliora il decorso clinico in anziani sottoposti a chirurgia del femore]. Trends in Medicine2009;9(4):235‐42. ScivolettoG , BoA , DerossiD , BergonziR . Ten week administration of a polynutritional supplement with muscle tone action (RiabylexTM) improves the functional recovery in elderly hip fracture patients during home rehabilitation [In anziani in terapia riabilitativa domiciliare per pregressa frattura del femore, l'assunzione di un polinutriente ad azione muscolotonica (RiabylexTM) per 10 settimane migliora il recupero funzionale]. Trends in Medicine2010;10(2):113‐20. ">Scivoletto 2010</a> investigated six weeks of an oral Restorfast supplement daily (L‐carnitine, calcium, magnesium, vitamin D3, L‐leucine) followed by 10 weeks of an oral Riabylex supplement daily (creatine, L‐carnitine, coenzyme Q10, nicotinamide, pantothenic acid, riboflavin) compared with no supplementation. Only 53 of 107 participants were available for follow‐up at the end of the study. </p> <p>Length of hospital stay was shorter for participants receiving supplementation in <a href="./references#CD001880-bbs2-0033" title="DerossiD , BoA , BergonziR , ScivolettoG . Six‐week administration of a mixture of ergogenic and osteotrophic ingredients (RestorfastTM) improves the clinical course of elderly patients after hip fracture surgery [La somministrazione per sei settimane di un composto a base di sostanze osteotrofiche ed ergogene (RestorfastTM) migliora il decorso clinico in anziani sottoposti a chirurgia del femore]. Trends in Medicine2009;9(4):235‐42. ScivolettoG , BoA , DerossiD , BergonziR . Ten week administration of a polynutritional supplement with muscle tone action (RiabylexTM) improves the functional recovery in elderly hip fracture patients during home rehabilitation [In anziani in terapia riabilitativa domiciliare per pregressa frattura del femore, l'assunzione di un polinutriente ad azione muscolotonica (RiabylexTM) per 10 settimane migliora il recupero funzionale]. Trends in Medicine2010;10(2):113‐20. ">Scivoletto 2010</a> (MD ‐2.50 days, 99% CI ‐6.21 to 1.21 days); time to ambulation was also shorter (MD ‐1.20 days, 99% CI ‐10.16 to 7.76 days). There was no benefit of supplementation on pressure sores in hospital (3/38 versus 6/41; RR 0.54, 99% CI 0.10 to 3.03). For the 53 remaining participants, no difference between groups was found for functional recovery (14/27 versus 10/26; RR 1.35, 99% CI 0.61 to 2.99). </p> </section> <section id="CD001880-sec-0141"> <h4 class="title">Isonitrogenous ornithine alpha‐ketoglutarate versus peptide supplements</h4> <p><a href="./references#CD001880-bbs2-0003" title="BeanN , ReddenJ , GoodeH , GrimbleG , AllisonSP . Double‐blind pilot trial, in elderly women with fractured femur, of ornithine alpha‐ketoglutarate v. a defined formula oral supplement. Proceedings of the Nutrition Society1994;53(3):203A. ">Bean 1994</a>, published only in abstract, investigated the effect of oral ornithine alpha‐ketoglutarate, compared to an isonitrogenous peptide supplement, in 59 relatively undernourished older women with hip fracture. Unfortunately, no denominators for the intention‐to‐treat analyses were provided in the abstract, which reported that recruitment was slow and that compliance with the supplements for the full two months was poor. <a href="./references#CD001880-bbs2-0003" title="BeanN , ReddenJ , GoodeH , GrimbleG , AllisonSP . Double‐blind pilot trial, in elderly women with fractured femur, of ornithine alpha‐ketoglutarate v. a defined formula oral supplement. Proceedings of the Nutrition Society1994;53(3):203A. ">Bean 1994</a> reported that there was no difference in mortality (ornithine alpha‐ketoglutarate supplemented 12.5%, control 11.1%, no denominators provided), compliance, duration of treatment or hospitalisation between the two groups. <a href="./references#CD001880-bbs2-0003" title="BeanN , ReddenJ , GoodeH , GrimbleG , AllisonSP . Double‐blind pilot trial, in elderly women with fractured femur, of ornithine alpha‐ketoglutarate v. a defined formula oral supplement. Proceedings of the Nutrition Society1994;53(3):203A. ">Bean 1994</a> reported there was no significant difference in complications but that major complications were significantly delayed in the intervention group (reported P &lt; 0.03). No information was given in the abstract about the effect of the supplements on volitional food intake, although food diaries were kept. </p> </section> <section id="CD001880-sec-0142"> <h4 class="title">Taurine versus placebo</h4> <p><a href="./references#CD001880-bbs2-0040" title="HoudijkAPJ . The effect of taurine on morbidity and mortality in the elderly hip fracture patient. clinicaltrials.gov/ct2/show/NCT00497978 (accessed 15 December 2015). VanStijnMF , BruinsAA , VermeulenMA , WitloxJ , TeerlinkT , SchoorlMG , et al. Effect of oral taurine on morbidity and mortality in elderly hip fracture patients: a randomized trial. International Journal of Molecular Sciences2015;16(6):12288‐306. [DOI: 10.3390/ijms160612288; PUBMED: 26035756] ">Van Stijn 2015</a> compared oral taurine prescribed during the first six postoperative days following hip fracture surgery with placebo. Data were available for 187 participants at 12 months. There was no significant effect of the intervention on mortality (23/113 versus 27/123; RR 0.93, 99% CI 0.57 to 1.52; <a href="./references#CD001880-fig-0028" title="">Analysis 8.1</a>). </p> <p>The total number of participants with complications at the end of the study was not reported. However data for six relevant postoperative complications were reported within the follow‐up period in <a href="./references#CD001880-bbs2-0040" title="HoudijkAPJ . The effect of taurine on morbidity and mortality in the elderly hip fracture patient. clinicaltrials.gov/ct2/show/NCT00497978 (accessed 15 December 2015). VanStijnMF , BruinsAA , VermeulenMA , WitloxJ , TeerlinkT , SchoorlMG , et al. Effect of oral taurine on morbidity and mortality in elderly hip fracture patients: a randomized trial. International Journal of Molecular Sciences2015;16(6):12288‐306. [DOI: 10.3390/ijms160612288; PUBMED: 26035756] ">Van Stijn 2015</a>. There was no difference between the groups for these complications that included infection (11/110 vs 18/122, RR 0.68, 99% CI 0.27 to 1.71), cardiovascular events (5/110 vs 13/122, RR 0.43, 99% CI 0.11 to 1.58), stroke (1/110 vs 2/122, RR 0.55, 99% CI 0.02 to 12.77), delirium (26/110 vs 27/122, RR 1.07, 99% CI 0.57 to 1.99), the requirement for a blood transfusion (19/110 vs 20/122, RR 1.05, 99% CI 0.50 to 2.24) and reoperation (6/110 vs 6/122, RR 1.11, 99% CI 0.26 to 4.72). Length of hospital stay was reported as 13 days (SD 10) for the intervention group and 13 days (SD 11) for the control group, reported P = 0.83; denominators unclear. </p> </section> <section id="CD001880-sec-0143"> <h4 class="title">Dietetic assistants versus usual care</h4> <p><a href="./references#CD001880-bbs2-0012" title="DuncanD . Personal communication March 15 2006. DuncanD , MurisonJ , MartinR , BeckS , JohansenA . Adequacy of oral feeding among elderly patients with hip fracture. Age and Ageing2001;30(Suppl 2):22. DuncanDG , BeckSJ . Using dietetic assistants to improve the outcome of hip fracture ‐ a randomised controlled trial of nutritional support in an acute trauma ward. Clinical Nutrition2002;21(Suppl 1):41. DuncanDG , BeckSJ , HoodK , JohansenA . Using dietetic assistants to improve the outcome of hip fracture ‐ a randomised controlled trial of nutritional support in an acute trauma ward. Age and Ageing2006;35(Suppl 3):i43. DuncanDG , BeckSJ , HoodK , JohansenA . Using dietetic assistants to improve the outcome of hip fracture: a randomised controlled trial of nutritional support in an acute trauma ward. Age and Ageing2006;35(2):148‐53. [MEDLINE: 16354710] DuncanDG , BeckSJ , JohansenA . Using dietetic assistants to improve the outcome of hip fracture ‐ a randomised controlled trial of nutritional support in an acute trauma ward. Journal of Human Nutrition and Dietetics2002;15:461. JohansenA . Using dietetic assistants to improve the outcome of hip fracture. In: The National Research Register, Issue 1, 2002. Oxford: Update Software2002. ">Duncan 2006</a> evaluated the use of dietetic assistants, who checked food preferences, helped order meals and supplements, provided feeding aids, assisted with food choice, and assisted with feeding at meal times. Since this trial was a sufficiently powered trial for mortality, 95% CIs are also reported for this outcome. </p> <p>Based on absolute number of deaths by four months postoperative, the risk of death was significantly lower (P = 0.03) in the intervention group (19/145 versus 36/157; RR 0.57, 95% CI 0.34 to 0.95). However, the possibility of increased mortality in the intervention group could not be ruled out when applying our stricter criteria (P &lt; 0.01): RR 0.57, 99% CI 0.29 to 1.11; low‐quality evidence downgraded one level for risk of bias and one level for imprecision; <a href="./references#CD001880-fig-0029" title="">Analysis 9.1</a>. The incidence of complications was similar in the two groups (79/130 versus 84/125; RR 0.90, 99% CI 0.71 to 1.15; low‐quality evidence downgraded one level for risk of bias and one level for imprecision; <a href="./references#CD001880-fig-0030" title="">Analysis 9.2</a>). <a href="./references#CD001880-bbs2-0012" title="DuncanD . Personal communication March 15 2006. DuncanD , MurisonJ , MartinR , BeckS , JohansenA . Adequacy of oral feeding among elderly patients with hip fracture. Age and Ageing2001;30(Suppl 2):22. DuncanDG , BeckSJ . Using dietetic assistants to improve the outcome of hip fracture ‐ a randomised controlled trial of nutritional support in an acute trauma ward. Clinical Nutrition2002;21(Suppl 1):41. DuncanDG , BeckSJ , HoodK , JohansenA . Using dietetic assistants to improve the outcome of hip fracture ‐ a randomised controlled trial of nutritional support in an acute trauma ward. Age and Ageing2006;35(Suppl 3):i43. DuncanDG , BeckSJ , HoodK , JohansenA . Using dietetic assistants to improve the outcome of hip fracture: a randomised controlled trial of nutritional support in an acute trauma ward. Age and Ageing2006;35(2):148‐53. [MEDLINE: 16354710] DuncanDG , BeckSJ , JohansenA . Using dietetic assistants to improve the outcome of hip fracture ‐ a randomised controlled trial of nutritional support in an acute trauma ward. Journal of Human Nutrition and Dietetics2002;15:461. JohansenA . Using dietetic assistants to improve the outcome of hip fracture. In: The National Research Register, Issue 1, 2002. Oxford: Update Software2002. ">Duncan 2006</a> found no significant difference between the two groups in the lengths of stay in the acute ward (median 16 days versus 17 days; reported P = 0.44) or in hospital (34 days versus 32 days; reported P = 0.81). Using their own scoring scheme, <a href="./references#CD001880-bbs2-0012" title="DuncanD . Personal communication March 15 2006. DuncanD , MurisonJ , MartinR , BeckS , JohansenA . Adequacy of oral feeding among elderly patients with hip fracture. Age and Ageing2001;30(Suppl 2):22. DuncanDG , BeckSJ . Using dietetic assistants to improve the outcome of hip fracture ‐ a randomised controlled trial of nutritional support in an acute trauma ward. Clinical Nutrition2002;21(Suppl 1):41. DuncanDG , BeckSJ , HoodK , JohansenA . Using dietetic assistants to improve the outcome of hip fracture ‐ a randomised controlled trial of nutritional support in an acute trauma ward. Age and Ageing2006;35(Suppl 3):i43. DuncanDG , BeckSJ , HoodK , JohansenA . Using dietetic assistants to improve the outcome of hip fracture: a randomised controlled trial of nutritional support in an acute trauma ward. Age and Ageing2006;35(2):148‐53. [MEDLINE: 16354710] DuncanDG , BeckSJ , JohansenA . Using dietetic assistants to improve the outcome of hip fracture ‐ a randomised controlled trial of nutritional support in an acute trauma ward. Journal of Human Nutrition and Dietetics2002;15:461. JohansenA . Using dietetic assistants to improve the outcome of hip fracture. In: The National Research Register, Issue 1, 2002. Oxford: Update Software2002. ">Duncan 2006</a> reported that patient satisfaction was significantly greater in the intervention group at discharge (reported P &lt; 0.0001). The mean daily energy intake was 349 kcal higher in the intervention group; this was mostly from supplements. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD001880-sec-0144" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001880-sec-0144">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD001880-sec-0208">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD001880-sec-0144"></div> <section id="CD001880-sec-0145"> <h3 class="title" id="CD001880-sec-0145">Summary of main results</h3> <p>The variety of interventions examined for hip fracture recovery and outcomes limited data synthesis, with the exception of multinutrient supplements providing non‐protein energy, protein, some vitamins and minerals. The failure to confirm an effect does not mean that there is no effect, but may simply reflect few trials, poor study design and inadequate sample size. </p> <section id="CD001880-sec-0146"> <h4 class="title">Multinutrient supplementation</h4> <section id="CD001880-sec-0147"> <h5 class="title">Oral supplements</h5> <p>Eighteen trials evaluated oral multinutrient feeds that provided non‐protein energy, protein, vitamins and minerals. There was low‐quality evidence that oral supplementation had little effect on mortality, with the 95% confidence interval (CI) including the possibility that oral supplementation could result in lower or higher mortality (risk ratio (RR) 0.81 favouring supplementation, 95% CI 0.49 to 1.32; 968 participants, 15 studies). Based on an illustrative risk of mortality of 72 per 1000 people with hip fracture (median mortality risk at 1 to 12 months' follow‐up from study control groups featuring at least one death), this equates to 13 fewer deaths per 1000 (95% CI 36 fewer to 23 more deaths) over 1 to 12 months' follow‐up. In high risk populations (i.e. people over 80 years old with an estimated mortality of 250 per 1000; <a href="./references#CD001880-bbs2-0102" title="BentlerSE , LiuL , ObrizanM , CookEA , WrightKB , GewekeJF , et al. The aftermath of hip fracture: discharge placement, functional status change, and mortality. American Journal of Epidemiology2009;170(10):1290‐9. ">Bentler 2009</a>; <a href="./references#CD001880-bbs2-0130" title="MaricondaM , CostaGG , CerbasiS , RecanoP , AitantiE , GambacortaM , et al. The determinants of mortality and morbidity during the year following fracture of the hip. Bone and Joint Journal2015;97(3):383‐90. ">Mariconda 2015</a>), this equates to 47 fewer deaths per 1000 (95% CI 127 fewer to 78 more deaths; <a href="./full#CD001880-tbl-0001">summary of findings Table for the main comparison</a>). A subgroup analysis separating out trials that did or did not target malnourished people did not confirm a difference in treatment effect between the two subgroups. </p> <p>There was low‐quality evidence that oral supplementation resulted in fewer complications (RR 0.71, 95% CI 0.59 to 0.86; 727 participants, 11 studies). Based on an illustrative risk of postoperative complications of 443 per 1000 people with hip fracture, this equates to 128 fewer people with complications per 1000 (95% CI 62 to 181 fewer) over 1 to 12 months' follow‐up. In moderate risk populations (i.e. people in the study by <a href="./references#CD001880-bbs2-0130" title="MaricondaM , CostaGG , CerbasiS , RecanoP , AitantiE , GambacortaM , et al. The determinants of mortality and morbidity during the year following fracture of the hip. Bone and Joint Journal2015;97(3):383‐90. ">Mariconda 2015</a> with a complication rate of 290 per 1000), this equates to 84 fewer people per 1000 (95% CI 40 to 119 fewer complications). </p> <p>Based on very low‐quality evidence, oral supplements may result in lower numbers of 'unfavourable outcome' (death or complications): RR 0.67, 95% CI 0.51 to 0.89; 334 participants, 6 studies. As seen in <a href="./full#CD001880-tbl-0001">summary of findings Table for the main comparison</a>, based on an illustrative risk of unfavourable outcomes for 500 per 1000 people with hip fracture, this equates to 165 fewer people with unfavourable outcomes per 1000 (95% CI 45 to 245 people with fewer unfavourable outcomes) over 1 to 12 months' follow‐up. </p> <p>There was very low‐quality evidence that oral supplementation did not result in an increased incidence of vomiting and diarrhoea (RR 0.99, 95% CI 0.47 to 2.05; 442 participants, 6 studies). </p> </section> <section id="CD001880-sec-0148"> <h5 class="title">Nasogastric tube feeding</h5> <p>Four trials examined nasogastric multinutrient feeding. As summarised in <a href="./full#CD001880-tbl-0002">summary of findings Table 2</a>, there was very low‐quality evidence that nasogastric tube feeding did not reduce mortality (RR 0.99, 95% CI 0.50 to 1.97; 280 participants, 3 studies; I<sup>2</sup> = 69%). Based on an illustrative risk of mortality of 156 per 1000 people with hip fracture, this result equates to 1 fewer death per 1000 (95% CI 88 fewer to 152 more deaths) over 1 to 12 months. There was very low‐quality evidence from just one study of 18 male participants of no clear difference between nasogastric tube feeding and no supplementation in complications following hip fracture surgery at six months' follow‐up (7/8 versus 8/10; RR 1.09, 95% CI 0.73 to 1.64). No study reported on unfavourable outcome (death or complication). Tube feeding was often poorly tolerated. There was no report of aspiration pneumonia. While 18 intervention group participants (28% of 64) had diarrhoea in one study, only two were attributed to tube feeding and the control rate was not reported. </p> </section> <section id="CD001880-sec-0149"> <h5 class="title">Nasogastric tube feeding and oral supplements</h5> <p>There is very low‐quality evidence from one trial of 57 participants, most of whom were male, of no clear effect of tube feeding followed by oral supplementation on mortality or complications. Tube feeding, however, was poorly tolerated. </p> </section> <section id="CD001880-sec-0150"> <h5 class="title">Intravenous feeding and oral supplements</h5> <p>There is very low‐quality evidence from one trial of 80 participants that a combination of intravenous feeding and oral supplements may not affect mortality but could reduce complications. However, it is notable that intravenous feeding is an expensive, technically complex intervention that is usually reserved for people with non‐functioning gastrointestinal tracts, which is unlikely in this trial and thus the evidence was downgraded for 'indirectness'. </p> </section> <section id="CD001880-sec-0151"> <h5 class="title">Nutritional status subgroup analysis</h5> <p>There was no evidence of a difference in risk or benefit between the results (mortality and participants with complications) of trials specifically targeting malnourished participants and those not targeting this population. Thus, there is no clear evidence to confirm that malnourished participants are more likely to benefit from multinutrient supplementation than those participants who are not malnourished. </p> </section> </section> <section id="CD001880-sec-0152"> <h4 class="title">Increasing protein intake</h4> <p>The four studies testing the effects of a higher protein intake are flawed by their failure to account for all participants. In particular, the results for mortality (greater in the high protein group) and 'unfavourable outcome' (fewer in the high protein group for <a href="./references#CD001880-bbs2-0014" title="EspaulellaJ , GuyerH , Diaz‐EscriuF , Mellado‐NavasJA , CastellsM , PladevallM . Nutritional supplementation of elderly hip fracture patients. A randomized, double‐blind, placebo‐controlled trial. Age and Ageing2000;29(5):425‐31. [MEDLINE: 11108415] GuyerH . Personal communication 13 June 2000. ">Espaulella 2000</a> are contradictory and while many reasons for this, including that of random variation, can be put forward, none can be confirmed. Overall, there was low‐quality evidence of no clear effect of a higher intake of protein on mortality (4 trials) or number of complications (data not presented from two trials) and very low‐quality evidence for a reduction in unfavourable outcome. There was no evidence that higher protein intake led to an increase in adverse events such as nausea or diarrhoea. </p> </section> <section id="CD001880-sec-0153"> <h4 class="title">Other supplements</h4> <p>No evidence can be found from the two studies of <a href="./references#CD001880-bbs2-0010" title="DayJJ . Personal communication 27 May 1999. DayJJ , BayerAJ , McMahonM , PathyMS , SpraggBP , RowlandsDC . Thiamine status, vitamin supplements and postoperative confusion. Age and Ageing1988;17:29‐34. ">Day 1988</a> and <a href="./references#CD001880-bbs2-0021" title="HoikkaV , AlhavaEM , AroA , KarjalainenP , RehnbergV . Treatment of osteoporosis with 1‐alpha‐hydroxycholecalciferol and calcium. Acta Medica Scandinavica1980;207(3):221‐4. [MEDLINE: 6989171] RobertsonJ . Personal communication 2 February 1999. ">Hoikka 1980</a> to recommend the supplementation of vitamin B1 and other water soluble vitamins, or 1‐alpha‐hydroxycholecalciferol. Giving bolus vitamin D soon after hip fracture did not appear to have a beneficial affect on mortality or adverse events. Giving vitamin D2 compared to vitamin D3, or 2000 IU vitamin D3 daily compared to 800 IU vitamin D3 also did not appear to influence outcomes. Intravenous or oral iron supplementation did not appear to help recovery, and may increase gastrointestinal adverse events. </p> <p>Vitamin, mineral and amino acid supplementation was reported to improve functional recovery in one trial (<a href="./references#CD001880-bbs2-0033" title="DerossiD , BoA , BergonziR , ScivolettoG . Six‐week administration of a mixture of ergogenic and osteotrophic ingredients (RestorfastTM) improves the clinical course of elderly patients after hip fracture surgery [La somministrazione per sei settimane di un composto a base di sostanze osteotrofiche ed ergogene (RestorfastTM) migliora il decorso clinico in anziani sottoposti a chirurgia del femore]. Trends in Medicine2009;9(4):235‐42. ScivolettoG , BoA , DerossiD , BergonziR . Ten week administration of a polynutritional supplement with muscle tone action (RiabylexTM) improves the functional recovery in elderly hip fracture patients during home rehabilitation [In anziani in terapia riabilitativa domiciliare per pregressa frattura del femore, l'assunzione di un polinutriente ad azione muscolotonica (RiabylexTM) per 10 settimane migliora il recupero funzionale]. Trends in Medicine2010;10(2):113‐20. ">Scivoletto 2010</a>). However more than half the participants were lost to follow‐up, so this very low‐quality evidence should be interpreted with great caution. Based on low‐quality evidence, there was no beneficial effect of providing taurine supplements during the first six postoperative days on postoperative mortality or complications including requirement for blood transfusion in one trial (<a href="./references#CD001880-bbs2-0040" title="HoudijkAPJ . The effect of taurine on morbidity and mortality in the elderly hip fracture patient. clinicaltrials.gov/ct2/show/NCT00497978 (accessed 15 December 2015). VanStijnMF , BruinsAA , VermeulenMA , WitloxJ , TeerlinkT , SchoorlMG , et al. Effect of oral taurine on morbidity and mortality in elderly hip fracture patients: a randomized trial. International Journal of Molecular Sciences2015;16(6):12288‐306. [DOI: 10.3390/ijms160612288; PUBMED: 26035756] ">Van Stijn 2015</a>). Ornithine alpha‐ketoglutarate, compared with an isonitrogenous peptide supplement, may delay the onset of complications post hip‐fracture, but this is based on very low‐quality evidence from one unpublished study (<a href="./references#CD001880-bbs2-0003" title="BeanN , ReddenJ , GoodeH , GrimbleG , AllisonSP . Double‐blind pilot trial, in elderly women with fractured femur, of ornithine alpha‐ketoglutarate v. a defined formula oral supplement. Proceedings of the Nutrition Society1994;53(3):203A. ">Bean 1994</a>) and no benefit on reducing the risks of postoperative complications. No trials examined the effect of specific amino acid formulations. </p> </section> <section id="CD001880-sec-0154"> <h4 class="title">Dietetic assistants</h4> <p>Based on low‐quality evidence, the use of dietetic assistants may reduce mortality but there is no clear effect on complications or length of hospital stay. <a href="./references#CD001880-bbs2-0012" title="DuncanD . Personal communication March 15 2006. DuncanD , MurisonJ , MartinR , BeckS , JohansenA . Adequacy of oral feeding among elderly patients with hip fracture. Age and Ageing2001;30(Suppl 2):22. DuncanDG , BeckSJ . Using dietetic assistants to improve the outcome of hip fracture ‐ a randomised controlled trial of nutritional support in an acute trauma ward. Clinical Nutrition2002;21(Suppl 1):41. DuncanDG , BeckSJ , HoodK , JohansenA . Using dietetic assistants to improve the outcome of hip fracture ‐ a randomised controlled trial of nutritional support in an acute trauma ward. Age and Ageing2006;35(Suppl 3):i43. DuncanDG , BeckSJ , HoodK , JohansenA . Using dietetic assistants to improve the outcome of hip fracture: a randomised controlled trial of nutritional support in an acute trauma ward. Age and Ageing2006;35(2):148‐53. [MEDLINE: 16354710] DuncanDG , BeckSJ , JohansenA . Using dietetic assistants to improve the outcome of hip fracture ‐ a randomised controlled trial of nutritional support in an acute trauma ward. Journal of Human Nutrition and Dietetics2002;15:461. JohansenA . Using dietetic assistants to improve the outcome of hip fracture. In: The National Research Register, Issue 1, 2002. Oxford: Update Software2002. ">Duncan 2006</a> reported increased consumption of supplements and greater patient satisfaction in the intervention group. These favourable results need to be checked in further randomised controlled trials involving more hospitals. </p> </section> </section> <section id="CD001880-sec-0155"> <h3 class="title" id="CD001880-sec-0155">Overall completeness and applicability of evidence</h3> <p>Given that people with hip fracture are often malnourished, it is notable that this review gives no clear evidence that those who are malnourished are more likely to benefit from multinutrient supplementation than those who are not malnourished. The lack of difference in results of trials may be due not only to the small sample sizes, but also to the different definitions of malnutrition in individual trials. Possibly people who are malnourished benefit more from nutritional supplementation, but their malnutrition could be a marker for other co‐morbidities which are more important in determining outcomes. Many of the most frail participants, who are more likely to be malnourished, were excluded from these trials, for example, participants with cognitive impairment. </p> <p>Incomplete compliance with nutritional supplementation was a major problem in these studies. Inability to tolerate nasogastric tubes and problems with palatability of oral feeds are common, particularly in confused, frail people. Malnutrition in itself produces mental apathy (<a href="./references#CD001880-bbs2-0120" title="KeysA , BrozekJ , HenschelA , MickelsenO , TaylorHL , editors. The Biology of Human Starvation. Minneapolis: University of Minnesota, 1950. ">Keys 1950</a>), which may further reduce supplement intake. Ensuring increased nutritional intake thus has a major implication for nursing care, and has ethical implications when a person appears unwilling to feed or tolerate nasogastric feeding. While the combined intervention of nutritional supplementation and exercises investigated in <a href="./references#CD001880-bbs2-0026" title="CrottyM . Personal communication 20 February 2009. DanielsLA , MillerM , BannermanE , WhiteheadC , CrottyM . Weight loss post lower limb fracture despite an intensive oral nutrition and exercise intervention. Clinical Nutrition2003;22 Suppl:S86. DanielsLA , MillerMD , BannermannE , CrottyM . Adherence to nutritional supplements amongst orthopedic patients: an important clinical and study design issue. Clinical Nutrition2005;24:535. MillerMD , BannermanE , DanielsLA , CrottyM . Lower limb fracture, cognitive impairment and risk of subsequent malnutrition: a prospective evaluation of dietary energy and protein intake on an orthopaedic ward. European Journal of Clinical Nutrition2006;60(7):853‐61. [MEDLINE: 16452913] MillerMD , CrottyM , WhiteheadC , BannermanE , DanielsLA . Nutritional supplementation and resistance training in nutritionally at risk older adults following lower limb fracture: a randomized controlled trial. Clinical Rehabilitation2006;20(4):311‐23. MillerMD , DanielsLA , BannermanE , CrottyM . Adherence to nutrition supplements among patients with a fall‐related lower limb fracture. Nutrition in Clinical Practice2005;20(5):569‐78. [MEDLINE: 16207699] ">Miller 2006</a> was excluded from this review, the potential interaction between these two interventions merits further investigation. </p> <p>Nasogastric feeding, if tolerated, allows the provision of higher supplements of energy (3.90 MJ to 6.28 MJ, or 933 kcal to 1500 kcal daily, in the studies in this review), whereas oral supplements in the studies reviewed here generally provided under 2.51 MJ (800 kcal) daily. Thus nasogastric feeding, which potentially has more risk of complications, is likely to be targeted at those requiring higher levels of supplementation. Attempts to overcome the poor palatability of oral supplements, and thus increase intakes further, include special high energy hospital meals and the provision of frequent small snacks (<a href="./references#CD001880-bbs2-0109" title="GallMJ , GrimbleGK , ReeveNJ , ThomasSJ . Effect of providing fortified meals and between‐meal snacks on energy and protein intake of hospital patients. Clinical Nutrition1998;17:259‐64. ">Gall 1998</a>). Related to this are other measures taken to encourage consumption of food by patients. For example, one of the excluded studies examined the effects of actively involving patients in their own dietary care, a procedure based on Salling's nursing model involving a dietary journal, information, guidance and instruction (<a href="./references#CD001880-bbs2-0074" title="PedersenPU . Dietary intervention in elderly patients prevents loss of activities of daily living after orthopaedic surgery [Kostintervention forebygger postoperativt aktivitetstab hos aeldre ortopaedkirurgiske patienter]. Videnskab &amp; Sygepleje1999;43:52‐74. PedersenPU . Nutritional care: the effectiveness of actively involving older patients. Journal of Clinical Nursing2005;14:247‐55. [MEDLINE: 15669934] PedersenPU , CameronU , JensenL . Active involvement of elderly surgical orthopaedic patients in their own dietary care increases postoperative energy and protein intake [Aktiv inddragelse af aeldre ortopaedkirurgiske patienter i egen kostforplejning oger energi‐ og proteinindtagelsen postoperativt]. Videnskab &amp; Sygepleje1999;21:28‐44. ">Pedersen 1999</a>). Dietetic assistants may be another way to increase food and supplement intake, as in <a href="./references#CD001880-bbs2-0012" title="DuncanD . Personal communication March 15 2006. DuncanD , MurisonJ , MartinR , BeckS , JohansenA . Adequacy of oral feeding among elderly patients with hip fracture. Age and Ageing2001;30(Suppl 2):22. DuncanDG , BeckSJ . Using dietetic assistants to improve the outcome of hip fracture ‐ a randomised controlled trial of nutritional support in an acute trauma ward. Clinical Nutrition2002;21(Suppl 1):41. DuncanDG , BeckSJ , HoodK , JohansenA . Using dietetic assistants to improve the outcome of hip fracture ‐ a randomised controlled trial of nutritional support in an acute trauma ward. Age and Ageing2006;35(Suppl 3):i43. DuncanDG , BeckSJ , HoodK , JohansenA . Using dietetic assistants to improve the outcome of hip fracture: a randomised controlled trial of nutritional support in an acute trauma ward. Age and Ageing2006;35(2):148‐53. [MEDLINE: 16354710] DuncanDG , BeckSJ , JohansenA . Using dietetic assistants to improve the outcome of hip fracture ‐ a randomised controlled trial of nutritional support in an acute trauma ward. Journal of Human Nutrition and Dietetics2002;15:461. JohansenA . Using dietetic assistants to improve the outcome of hip fracture. In: The National Research Register, Issue 1, 2002. Oxford: Update Software2002. ">Duncan 2006</a>, which requires examination in further research, including an economic evaluation. </p> <p>Intravenous feeding used in <a href="./references#CD001880-bbs2-0013" title="EnerothM . Personal communication 10 February 2009. EnerothM . Personal communication 17 March 2006. EnerothM , OlssonU‐B , ThorngrenK‐G . Combined parenteral and oral nutritional supplementation decreases fracture‐related complications. A prospective randomised trial of 80 patients with hip fractures. Journal of Bone and Joint Surgery ‐ British Volume2006;88(Suppl 1):44. EnerothM , OlssonU‐B , ThorngrenK‐G . Insufficient fluid and energy intake in hospitalised patients with hip fracture. A prospective randomised study of 80 patients. Clinical Nutrition2005;24:297‐303. [MEDLINE: 15784492] EnerothM , OlssonUB , ThorngrenKG . Nutritional supplementation decreases hip fracture‐related complications. Clinical Orthopaedics and Related Research2006;(451):212‐7. [MEDLINE: 16770284] ">Eneroth 2006</a> provided an additional 1000 kcal and 53 g protein daily, thus also allowing higher levels of supplementation. However, it also carried risks of fluid and electrolyte imbalance, hyperglycaemia and thrombophlebitis when delivered through a peripheral vein. </p> <p>Nutritional supplementation should also be viewed in the context of general nutrition in hospitals. Given the high numbers of hip fracture patients with prior malnutrition, and the prolonged length of stay, it is surprising that nutrition, including the provision and uptake of basic foodstuffs, is often understated, or even overlooked, as a component of rehabilitative care programmes. </p> <p>There is interest in the hypothesis that nutritional supplementation may attenuate bone loss after fracture, which may also help to decrease the risk of further fractures (<a href="./references#CD001880-bbs2-0138" title="SchürchMA , RizzoliR , SlosmanD , VadasL , VergnaudP , BonjourJP . Protein supplements increase serum insulin‐like growth factor‐I levels and attenuate proximal femur bone loss in patients with recent hip fracture. A randomized, double‐blind, placebo‐controlled trial. Annals of Internal Medicine1998;128(10):801‐9. ">Schürch 1998a</a>). </p> </section> <section id="CD001880-sec-0156"> <h3 class="title" id="CD001880-sec-0156">Quality of the evidence</h3> <p>Following the GRADE assessment for the primary outcomes in this review, the quality of the evidence ranged from very low to low. For details for the oral and nasogastric multinutrient supplementation comparisons, please see <a href="./full#CD001880-tbl-0001">summary of findings Table for the main comparison</a> and <a href="./full#CD001880-tbl-0002">summary of findings Table 2</a>. Overall, the evidence was downgraded two or three levels due to a high risk of bias, limitations in the detailed design and execution of the trials, imprecision of the data and, less frequently, inconsistency and indirectness. Items for risk of bias assessment were often inadequately reported. The studies were often small and limited further by insufficient ascertainment of important outcomes, incomplete outcome data (especially for secondary outcomes), inadequate period of follow‐up for recovery from fracture and selective reporting of outcomes. Due to the small number of events such as unfavourable outcomes and complications, the evidence was frequently downgraded due to imprecision. This was particularly the case for interventions that were tested by only a small number of trials. </p> </section> <section id="CD001880-sec-0157"> <h3 class="title" id="CD001880-sec-0157">Potential biases in the review process</h3> <p>We think that it is unlikely that the review process itself has introduced bias. Our search, updated fully on a regular basis, is comprehensive and we actively pursued unpublished trials and data as well as ongoing and newly registered trials. We have used robust methodology, including independent trial selection and review of included trials, throughout the review and updating processes. One potential issue is that we have pooled mortality, participants with complications, and unfavourable outcome data irrespective of length of follow‐up. While, the influence of nutritional supplementation is more likely in the period immediately after hip fracture, we do not anticipate that our mixed follow‐up approach would bias the results. In future updates, we will consider whether quality of life should become a main outcome. </p> </section> <section id="CD001880-sec-0158"> <h3 class="title" id="CD001880-sec-0158">Agreements and disagreements with other studies or reviews</h3> <p>One review author (AA) has contributed to two more general systematic reviews of protein and energy supplementation in older people at risk from malnutrition (<a href="./references#CD001880-bbs2-0131" title="MilneAC , AvenellA , PotterJ . Protein and energy supplementation in older people: a meta‐analysis. Annals of Internal Medicine2006;144:37‐48. ">Milne 2006</a>; <a href="./references#CD001880-bbs2-0132" title="MilneAC , PotterJ , VivantiA , AvenellA . Protein and energy supplementation in elderly people at risk from malnutrition. Cochrane Database of Systematic Reviews2009, Issue 2. [DOI: 10.1002/14651858.CD003288.pub3] ">Milne 2009</a>). The above described limitations in the studies of this review also apply to nutritional intervention trials for other patient groups. <a href="./references#CD001880-bbs2-0132" title="MilneAC , PotterJ , VivantiA , AvenellA . Protein and energy supplementation in elderly people at risk from malnutrition. Cochrane Database of Systematic Reviews2009, Issue 2. [DOI: 10.1002/14651858.CD003288.pub3] ">Milne 2009</a> found that while there was no significant reduction in mortality in the supplemented compared with control groups overall, mortality results were statistically significant when limited to trials in which participants (N = 2461) were defined as undernourished. They concluded that there was a beneficial effect on complications, as found here, but considered this needs confirmation. </p> <p>One recent systematic review of protein and energy supplementation after hip fracture from China (<a href="./references#CD001880-bbs2-0126" title="LiuM , YangJ , YuX , HuangX , VaidyaS , HuangF , et al. The role of perioperative oral nutritional supplementation in elderly patients after hip fracture surgery. Clinical Interventions in Aging2015;10:849‐58. ">Liu 2015</a>), with studies published up until 2011, reached similar conclusions for mortality and complications, but with limited discussion of the quality of the evidence. </p> <p>One systematic review of six small trials of oral nutritional support (<a href="./references#CD001880-bbs2-0100" title="BeckAM , HolstM , RasmussenHH . Oral nutritional support of older (65 years+) medical and surgical patients after discharge from hospital: systematic review and meta‐analysis of randomized controlled trials. Clinical Rehabilitation2013;27:19‐27. [DOI: 10.1177/0269215512445396] ">Beck 2013</a>) for medical and surgical patients starting after discharge from hospital was unable to demonstrate clear benefits on mortality and complications. Of note, is that our trials commenced supplementation whilst participants were still hospitalised, when they were at highest risk of underfeeding. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD001880-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/urn:x-wiley:14651858:media:CD001880:CD001880-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_t/tCD001880-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram" data-id="CD001880-fig-0001" src="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/full#CD001880-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001880-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/urn:x-wiley:14651858:media:CD001880:CD001880-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_t/tCD001880-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies" data-id="CD001880-fig-0002" src="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/full#CD001880-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001880-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/urn:x-wiley:14651858:media:CD001880:CD001880-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_t/tCD001880-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study" data-id="CD001880-fig-0003" src="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/full#CD001880-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001880-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/urn:x-wiley:14651858:media:CD001880:CD001880-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_t/tCD001880-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Multinutrient supplements (oral, nasogastric, intravenous) versus control, outcome: 1.1 Mortality by end of study" data-id="CD001880-fig-0004" src="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Multinutrient supplements (oral, nasogastric, intravenous) versus control, outcome: 1.1 Mortality by end of study </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/full#CD001880-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001880-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/urn:x-wiley:14651858:media:CD001880:CD001880-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_t/tCD001880-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Multinutrient supplements (oral, nasogastric, intravenous) versus control, outcome: 1.2 Participants with complications at end of study" data-id="CD001880-fig-0005" src="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Multinutrient supplements (oral, nasogastric, intravenous) versus control, outcome: 1.2 Participants with complications at end of study </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/full#CD001880-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001880-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/urn:x-wiley:14651858:media:CD001880:CD001880-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_t/tCD001880-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Multinutrient supplements (oral, nasogastric, intravenous) versus control, outcome: 1.1 Mortality by end of study" data-id="CD001880-fig-0006" src="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Multinutrient supplements (oral, nasogastric, intravenous) versus control, outcome: 1.1 Mortality by end of study </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/full#CD001880-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001880-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/urn:x-wiley:14651858:media:CD001880:CD001880-AFig-FIG07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_t/tCD001880-AFig-FIG07.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Multinutrient supplements (oral, nasogastric, intravenous) versus control, outcome: 1.2 Participants with complications at end of study" data-id="CD001880-fig-0007" src="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-AFig-FIG07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Multinutrient supplements (oral, nasogastric, intravenous) versus control, outcome: 1.2 Participants with complications at end of study </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/full#CD001880-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-AFig-FIG07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001880-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/urn:x-wiley:14651858:media:CD001880:CD001880-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_t/tCD001880-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Multinutrient supplements (oral, nasogastric, intravenous) versus control, Outcome 1 Mortality by end of study." data-id="CD001880-fig-0008" src="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Multinutrient supplements (oral, nasogastric, intravenous) versus control, Outcome 1 Mortality by end of study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/references#CD001880-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001880-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/urn:x-wiley:14651858:media:CD001880:CD001880-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_t/tCD001880-CMP-001-02.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Multinutrient supplements (oral, nasogastric, intravenous) versus control, Outcome 2 Participants with complications at end of study." data-id="CD001880-fig-0009" src="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Multinutrient supplements (oral, nasogastric, intravenous) versus control, Outcome 2 Participants with complications at end of study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/references#CD001880-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001880-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/urn:x-wiley:14651858:media:CD001880:CD001880-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_t/tCD001880-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Multinutrient supplements (oral, nasogastric, intravenous) versus control, Outcome 3 Participants with complications at end of study: random‐effects model." data-id="CD001880-fig-0010" src="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Multinutrient supplements (oral, nasogastric, intravenous) versus control, Outcome 3 Participants with complications at end of study: random‐effects model. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/references#CD001880-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001880-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/urn:x-wiley:14651858:media:CD001880:CD001880-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_t/tCD001880-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Multinutrient supplements (oral, nasogastric, intravenous) versus control, Outcome 4 Unfavourable outcome (death or complications) at end of study." data-id="CD001880-fig-0011" src="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Multinutrient supplements (oral, nasogastric, intravenous) versus control, Outcome 4 Unfavourable outcome (death or complications) at end of study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/references#CD001880-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001880-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/urn:x-wiley:14651858:media:CD001880:CD001880-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_t/tCD001880-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Multinutrient supplements (oral, nasogastric, intravenous) versus control, Outcome 5 Unfavourable outcome (death or complications) ‐ oral supplements extra analyses." data-id="CD001880-fig-0012" src="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Multinutrient supplements (oral, nasogastric, intravenous) versus control, Outcome 5 Unfavourable outcome (death or complications) ‐ oral supplements extra analyses. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/references#CD001880-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001880-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/urn:x-wiley:14651858:media:CD001880:CD001880-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_t/tCD001880-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Multinutrient supplements (oral, nasogastric, intravenous) versus control, Outcome 6 Adverse effects (putatively related to treatment)." data-id="CD001880-fig-0013" src="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Multinutrient supplements (oral, nasogastric, intravenous) versus control, Outcome 6 Adverse effects (putatively related to treatment). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/references#CD001880-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001880-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/urn:x-wiley:14651858:media:CD001880:CD001880-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_t/tCD001880-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Multinutrient supplements (oral, nasogastric routes, intravenous) versus control (split by nutritional status), Outcome 1 Mortality by end of study." data-id="CD001880-fig-0014" src="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Multinutrient supplements (oral, nasogastric routes, intravenous) versus control (split by nutritional status), Outcome 1 Mortality by end of study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/references#CD001880-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001880-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/urn:x-wiley:14651858:media:CD001880:CD001880-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_t/tCD001880-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Multinutrient supplements (oral, nasogastric routes, intravenous) versus control (split by nutritional status), Outcome 2 Mortality by end of study ‐ oral supplements only." data-id="CD001880-fig-0015" src="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Multinutrient supplements (oral, nasogastric routes, intravenous) versus control (split by nutritional status), Outcome 2 Mortality by end of study ‐ oral supplements only. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/references#CD001880-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001880-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/urn:x-wiley:14651858:media:CD001880:CD001880-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_t/tCD001880-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Multinutrient supplements (oral, nasogastric routes, intravenous) versus control (split by nutritional status), Outcome 3 Participants with complications at end of study." data-id="CD001880-fig-0016" src="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Multinutrient supplements (oral, nasogastric routes, intravenous) versus control (split by nutritional status), Outcome 3 Participants with complications at end of study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/references#CD001880-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001880-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/urn:x-wiley:14651858:media:CD001880:CD001880-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_t/tCD001880-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Multinutrient supplements (oral, nasogastric routes, intravenous) versus control (split by nutritional status), Outcome 4 Unfavourable outcome (death or complications) at end of study." data-id="CD001880-fig-0017" src="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Multinutrient supplements (oral, nasogastric routes, intravenous) versus control (split by nutritional status), Outcome 4 Unfavourable outcome (death or complications) at end of study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/references#CD001880-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001880-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/urn:x-wiley:14651858:media:CD001880:CD001880-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_t/tCD001880-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Multinutrient supplements (oral, nasogastric routes, intravenous) versus control (by allocation concealment), Outcome 1 Mortality by end of study by risk of bias for allocation concealment." data-id="CD001880-fig-0018" src="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Multinutrient supplements (oral, nasogastric routes, intravenous) versus control (by allocation concealment), Outcome 1 Mortality by end of study by risk of bias for allocation concealment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/references#CD001880-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001880-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/urn:x-wiley:14651858:media:CD001880:CD001880-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_t/tCD001880-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Multinutrient supplements (oral, nasogastric routes, intravenous) versus control (by allocation concealment), Outcome 2 Participants with complications at end of study by risk of bias for allocation concealment." data-id="CD001880-fig-0019" src="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Multinutrient supplements (oral, nasogastric routes, intravenous) versus control (by allocation concealment), Outcome 2 Participants with complications at end of study by risk of bias for allocation concealment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/references#CD001880-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001880-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/urn:x-wiley:14651858:media:CD001880:CD001880-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_t/tCD001880-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 High protein‐containing supplements versus low protein‐ or non‐protein‐containing supplements, Outcome 1 Mortality by end of study." data-id="CD001880-fig-0020" src="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 High protein‐containing supplements versus low protein‐ or non‐protein‐containing supplements, Outcome 1 Mortality by end of study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/references#CD001880-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001880-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/urn:x-wiley:14651858:media:CD001880:CD001880-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_t/tCD001880-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 High protein‐containing supplements versus low protein‐ or non‐protein‐containing supplements, Outcome 2 Unfavourable outcome (death or complications) at end of study." data-id="CD001880-fig-0021" src="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 High protein‐containing supplements versus low protein‐ or non‐protein‐containing supplements, Outcome 2 Unfavourable outcome (death or complications) at end of study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/references#CD001880-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001880-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/urn:x-wiley:14651858:media:CD001880:CD001880-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_t/tCD001880-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Thiamin (vitamin B1) and water soluble vitamins versus control, Outcome 1 Mortality by end of study." data-id="CD001880-fig-0022" src="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Thiamin (vitamin B1) and water soluble vitamins versus control, Outcome 1 Mortality by end of study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/references#CD001880-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001880-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/urn:x-wiley:14651858:media:CD001880:CD001880-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_t/tCD001880-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Thiamin (vitamin B1) and water soluble vitamins versus control, Outcome 2 Participants with complications at end of study." data-id="CD001880-fig-0023" src="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Thiamin (vitamin B1) and water soluble vitamins versus control, Outcome 2 Participants with complications at end of study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/references#CD001880-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001880-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/urn:x-wiley:14651858:media:CD001880:CD001880-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_t/tCD001880-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Vitamin D versus control or lower dose supplementation, Outcome 1 Participants with complications at end of study." data-id="CD001880-fig-0024" src="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Vitamin D versus control or lower dose supplementation, Outcome 1 Participants with complications at end of study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/references#CD001880-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001880-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/urn:x-wiley:14651858:media:CD001880:CD001880-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_t/tCD001880-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Vitamin D versus control or lower dose supplementation, Outcome 2 Mortality by end of study." data-id="CD001880-fig-0025" src="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 Vitamin D versus control or lower dose supplementation, Outcome 2 Mortality by end of study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/references#CD001880-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001880-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/urn:x-wiley:14651858:media:CD001880:CD001880-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_t/tCD001880-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Iron supplementation versus control, Outcome 1 Mortality by end of study." data-id="CD001880-fig-0026" src="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 Iron supplementation versus control, Outcome 1 Mortality by end of study.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/references#CD001880-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001880-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/urn:x-wiley:14651858:media:CD001880:CD001880-CMP-007-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_t/tCD001880-CMP-007-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Iron supplementation versus control, Outcome 2 Participants with complications at end of study." data-id="CD001880-fig-0027" src="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-007-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 Iron supplementation versus control, Outcome 2 Participants with complications at end of study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/references#CD001880-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-007-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001880-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/urn:x-wiley:14651858:media:CD001880:CD001880-CMP-008-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_t/tCD001880-CMP-008-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Taurine versus placebo, Outcome 1 Mortality by end of study." data-id="CD001880-fig-0028" src="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-008-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 Taurine versus placebo, Outcome 1 Mortality by end of study.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/references#CD001880-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-008-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001880-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/urn:x-wiley:14651858:media:CD001880:CD001880-CMP-009-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_t/tCD001880-CMP-009-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Dietetic assistants versus usual care, Outcome 1 Mortality by end of study." data-id="CD001880-fig-0029" src="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-009-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9 Dietetic assistants versus usual care, Outcome 1 Mortality by end of study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/references#CD001880-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-009-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001880-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/urn:x-wiley:14651858:media:CD001880:CD001880-CMP-009-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_t/tCD001880-CMP-009-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Dietetic assistants versus usual care, Outcome 2 Participants with complications at end of study." data-id="CD001880-fig-0030" src="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-009-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.2</div> <div class="figure-caption"> <p>Comparison 9 Dietetic assistants versus usual care, Outcome 2 Participants with complications at end of study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/references#CD001880-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/media/CDSR/CD001880/image_n/nCD001880-CMP-009-02.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD001880-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Multinutrient supplements (oral) versus control for hip fracture aftercare in older people</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Multinutrient supplements (oral) versus control for hip fracture aftercare in older people</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Older people undergoing hip fracture aftercare<br/> <b>Settings:</b> Acute hospital<br/> <b>Intervention:</b> Multinutrient supplements (<b>oral</b> route) in addition to standard care. (Typically, supplements were started either pre‐operatively or within 2 days postoperatively and continued for at least a month) </p> <p><b>Comparison:</b> Standard postoperative nutritional support and care in control groups </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Multinutrient supplements (oral) versus control</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Mortality by end of study</b> </p> <p>Follow‐up: 1‐12 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.81</b> <br/> (0.49 to 1.31) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>968<br/> (15 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>The statistical test for subgroup differences between the results for the 5 trials targeting malnourished participants and those 10 trials not targeting malnourished participants did not confirm a difference between the two subgroups for mortality </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>72 per 1000<sup>1</sup> </b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>59 per 1000</b> <br/> (36 to 95) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>High risk<sup>2</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>250 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>203 per 1000</b> <br/> (123 to 328) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Participants with complications (e.g. pressure sore, chest infection) at end of study</b> <br/> Follow‐up: 1‐12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.71</b> <br/> (0.59 to 0.86) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>727<br/> (11 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Only 2 trials targeting malnourished people reported these data</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>443 per 1000<sup>4</sup> </b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>315 per 1000</b> <br/> (262 to 381) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Moderate risk<sup>5</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>290 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>206 per 1000</b> <br/> (171 to 250) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Unfavourable outcome <sup>7</sup> by end of study</b> </p> <p>Follow‐up: 1‐12 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.67</b> </p> <p>(0.51 to 0.89)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>334</p> <p>(6 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>8</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Only 1 trial targeting malnourished people reported these data</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>500 per 1000<sup>4</sup> </b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>335 per 1000</p> <p>(255 to 445)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Putative side effects of treatment (e.g. vomiting and diarrhoea)</b> </p> <p>Follow‐up: during supplementation period</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>RR 0.99</b> </p> <p>(0.47 to 2.05)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>442</p> <p>(6 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>9</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Three of the 6 trials reported no adverse effects</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>50 per 1000<sup>4</sup> </b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>50 per 1000</p> <p>(24 to 103)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1.</sup> The control group risk is the median control group risk across the 9 studies that reported one or more deaths in the control group.<br/> <sup>2.</sup> The high control group risk is based on the one‐year mortality rate derived from <a href="./references#CD001880-bbs2-0102" title="BentlerSE , LiuL , ObrizanM , CookEA , WrightKB , GewekeJF , et al. The aftermath of hip fracture: discharge placement, functional status change, and mortality. American Journal of Epidemiology2009;170(10):1290‐9. ">Bentler 2009</a> (26%) and <a href="./references#CD001880-bbs2-0130" title="MaricondaM , CostaGG , CerbasiS , RecanoP , AitantiE , GambacortaM , et al. The determinants of mortality and morbidity during the year following fracture of the hip. Bone and Joint Journal2015;97(3):383‐90. ">Mariconda 2015</a> (24.7% for those over 80 years). Pooled estimate includes no effect and 95% confidence intervals encompass relative risk increase greater than 25%.<br/> <sup>3.</sup> Downgraded 1 level for high risk of bias and 1 level for imprecision.<br/> <sup>4.</sup> The control group risk is the median control group risk across studies.<br/> <sup>5.</sup> Moderate control risk is derived from participants whilst in hospital in <a href="./references#CD001880-bbs2-0130" title="MaricondaM , CostaGG , CerbasiS , RecanoP , AitantiE , GambacortaM , et al. The determinants of mortality and morbidity during the year following fracture of the hip. Bone and Joint Journal2015;97(3):383‐90. ">Mariconda 2015</a>.<br/> <sup>6.</sup> Downgraded 2 levels for very serious risk of bias.<br/> <sup>7.</sup> Unfavourable outcome was defined as the number of trial participants who died plus the number of survivors with complications. Where these data were unavailable, we accepted a slightly different definition (mortality or survivors with a major complication or two or more minor complications) provided in 3 trials.<br/> <sup>8.</sup> Downgraded 2 levels for serious risk of bias and 1 for indirectness reflecting the mixed definition of the outcome measure.<br/> 9. Downgraded 3 levels individually for risk of bias, inconsistency and imprecision. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Multinutrient supplements (oral) versus control for hip fracture aftercare in older people</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/full#CD001880-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD001880-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Multinutrient supplements (nasogastric) versus control for hip fracture aftercare in older people</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Multinutrient supplements (nasogastric) versus control for hip fracture aftercare in older people<sup>7</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Older people undergoing hip fracture aftercare<br/> <b>Settings:</b> Acute hospitals<br/> <b>Intervention:</b> Multinutrient supplements (nasogastric). (Started within 5 days of surgery and continued usually until oral intake was sufficient or hospital discharge.)<sup>1</sup> </p> <p><b>Comparison:</b> Standard postoperative nutritional support and care in control groups </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Multinutrient supplements (nasogastric) versus control</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Mortality by end of study</b> <br/> Follow‐up: 1‐12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study Population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR: 0.99</b> </p> <p>(0.50 to 1.97)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>280</p> <p>(3 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low<sup>3</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Only 1 trial targeting malnourished participants reported these data</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>156 per 1000<sup>2</sup> </b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>155 per 1000</b> </p> <p>(78 to 308)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Participants with complications (e.g. pressure sore, aspiration pneumonia) at end of study</b> <br/> Follow‐up: 6 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study Population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR: 1.09</b> </p> <p>(0.73 to 1.64)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>18</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low<sup>5</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>For consistency we have presented 95% CI here but have used 99% CI for single trial data in the main text: 99% CI 0.64 to 1.86.<sup>6</sup> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>800 per 1000<sup>4</sup> </b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>872 per 1000</b> </p> <p>(584 to 1000)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unfavourable outcome</b> </p> <p>Follow‐up: 1‐12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Putative side effects of treatment (e.g. aspiration pneumonia)</b> </p> <p>Follow‐up: during supplementation period</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Insufficient data to draw any conclusions. However, poor toleration of tube feeding was noted.<sup>1</sup> </p> <p>There was no report of aspiration pneumonia (1 study; 140 participants). One study reported 18 (28% of 64) participants in the intervention group developed diarrhoea ‐ this was ascribed to antibiotics in 16 ‐ but did not report on the control group. One study (18 participants) reported 3 cases of "bloating" in the intervention group; it found no feed‐induced diarrhoea </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change </p> <p>the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1.</sup> Nasogatric feeding was poorly tolerated but varied between studies. One study reported only 26% of the intervention group tolerated tube feeding for the full two weeks; another reported 78% completed the course (until hospital discharge).<br/> <sup>2.</sup> The control group risk is the median control group risk across studies.<br/> <sup>3.</sup> Downgraded 2 levels for serious risk of bias and one for inconsistency reflecting considerable heterogeneity (I<sup>2</sup> = 69%)<br/> <sup>4.</sup> The control group risk is that of the control group in the sole study contributing data.<br/> <sup>5.</sup> Downloaded 2 levels for serious risk of bias and one level for imprecision.<br/> <sup>6.</sup> The choice of 99% CIs reflected the extra burden of proof we considered appropriate for individual trials, in view of their generally poor quality. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Multinutrient supplements (nasogastric) versus control for hip fracture aftercare in older people</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/full#CD001880-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD001880-tbl-0003"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Length of hospital stay data used for significance testing</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p><b>Intervention<br/> (n, mean days, SD)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p><b>Control<br/> (n, mean days, SD)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean difference (99% confidence intervaI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>Multinutritional oral supplements</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001880-bbs2-0001" title="AnbarR , BelooseskyY , CohenJ , MadarZ , WeissA , TheillaM , et al. Tight calorie control in geriatric patients following hip fracture decreases complications: a randomized, controlled study. Clinical Nutrition2014;33:23‐8. AnbarR , BelooseskyY , MadarZ , TheillaM , Koren‐HakimT , WeissA , et al. Tight calorie control (TICACOS) in geriatric hip fracture patients. Clinical Nutrition, Supplement2012;7(1):18. AnbarR , BelooseskyY , MadarZ , TheillaM , Koren‐HakimT , WeissA , et al. Tight calorie control in geriatric hip fracture patients: preliminary results of the geriatric TICACOS study. Clinical Nutrition, Supplement2011;6(1):155. SingerP . Tight caloric balance in geriatric patients (TICACOSiGP). clinicaltrials.gov/show/NCT01735435 (accessed 3 December 2015). ">Anbar 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐2.40 days (‐5.60 to 0.80)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001880-bbs2-0006" title="Botella‐CarreteroJI . Personal communication 26 October 2014. Botella‐CarreteroJI , IglesiasB , BalsaJA , ArrietaF , ZamarronI , VazquezC . Perioperative oral nutritional supplements in normally and mildly undernourished geriatric patients submitted to surgery for hip fracture: a randomized clinical trial. Clinical Nutrition2010;29(5):574‐9. ">Botella‐Carretero 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.50 days (‐2.26 to 3.26)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001880-bbs2-0007" title="BrownKM . Personal communicationMay 1999. BrownKM , SeabrookNA . Effect of nutrition on recovery after fractured femur. Medical Audit News1992;2(1):10‐2. BrownKM , SeabrookNA . Nutritional influences on recovery and length of hospital stay in elderly women following femoral fracture. Proceedings of the Nutrition Society1992;51(2):132A. ">Brown 1992b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>37.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐21.00 days (‐65.15 to 23.15)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001880-bbs2-0008" title="BruceD . Personal communication. October 2003. BruceD , LauranceI , McGuinessM , RidleyM , GoldswainP . Nutritional supplements after hip fracture: poor compliance limits effectiveness. Clinical Nutrition2003;22(5):497‐500. [MEDLINE: 14512038] ">Bruce 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.10 days (‐3.53 to 5.73)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001880-bbs2-0025" title="MadiganC . Benefits of dietary supplementation in elderly patients with fractured neck of femur. Sydney (Australia): University of Sydney, 1994. ">Madigan 1994</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 day (‐8.51 to 10.51)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001880-bbs2-0027" title="MyintMW . Personal communication 6 January 2015. MyintMW , WuJ , WongE , ChanSP , ToTS , ChauMW , et al. Clinical benefits of oral nutritional supplementation for elderly hip fracture patients: a single blind randomised controlled trial. Age and Ageing2013;42(1):39‐45. MyintMWW . A randomized controlled study of nutritional intervention for geriatric hip fracture patients and its effect on rehabilitation outcomes. clinicaltrials.gov/ct2/show/NCT01088139 (accessed 4 December 2015). ">Myint 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐3.70 days (‐8.30 to 0.90)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>Nasogastric tube feeding</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001880-bbs2-0036" title="SullivanDH . Personal communication 10 February 2000. SullivanDH , NelsonCL , BoppMM , Puskarich‐MayCL , WallsRC . Nightly enteral nutrition support of elderly fracture patients: a phase I trial. Journal of the American College of Nutrition1998;17(1):155‐61. ">Sullivan 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36.90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23.70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14.50 days (‐24.34 to 53.34)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>High protein supplements</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001880-bbs2-0014" title="EspaulellaJ , GuyerH , Diaz‐EscriuF , Mellado‐NavasJA , CastellsM , PladevallM . Nutritional supplementation of elderly hip fracture patients. A randomized, double‐blind, placebo‐controlled trial. Age and Ageing2000;29(5):425‐31. [MEDLINE: 11108415] GuyerH . Personal communication 13 June 2000. ">Espaulella 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.80 days (‐3.62 to 2.02)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001880-bbs2-0028" title="JensenG . Personal communication 6 January 2005. NeumannM , FriedmannJ , RoyMA , JensenGL . Provision of high‐protein supplement for patients recovering from hip fracture. Nutrition2004;20(5):415‐9. [MEDLINE: 15105027] NeumannMM , FriedmannJM , JensenGL . Provision of high protein supplement for patients recovering from hip fracture. Journal of Parenteral and Enteral Nutrition2004;28(Suppl 1):S30. ">Neumann 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐4.80 days (‐12.29 to 2.69)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>Iron supplementation versus control</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001880-bbs2-0030" title="ParkerM . Personal communication 16 October 2014. ParkerM . Randomised trial comparing iron supplementation versus placebo in the treatment of anaemia after hip fracture. clinicaltrials.gov/show/NCT00919230 (accessed 4 December 2015). ParkerMJ . Iron supplementation for anemia after hip fracture surgery. A randomized trial of 300 patients. Journal of Bone and Joint Surgery ‐ American Volume2010;92(2):265‐9. ">Parker 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐2.50 days (‐8.17 to 3.17)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001880-bbs2-0034" title="Serrano‐TrenasJA , UgaldePF , CabelloLM , ChoflesLC , LazaroPS , BenitezPC . Role of perioperative intravenous iron therapy in elderly hip fracture patients: a single‐center randomized controlled trial. Transfusion2011;51(1):97‐104. ">Serrano‐Trenas 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.40 days (‐2.18 to 2.98)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>Vitamin B1</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001880-bbs2-0010" title="DayJJ . Personal communication 27 May 1999. DayJJ , BayerAJ , McMahonM , PathyMS , SpraggBP , RowlandsDC . Thiamine status, vitamin supplements and postoperative confusion. Age and Ageing1988;17:29‐34. ">Day 1988</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>35.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.00 days (‐15.75 to 27.75)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>Vitamin, mineral and amino acid supplementation versus control</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001880-bbs2-0033" title="DerossiD , BoA , BergonziR , ScivolettoG . Six‐week administration of a mixture of ergogenic and osteotrophic ingredients (RestorfastTM) improves the clinical course of elderly patients after hip fracture surgery [La somministrazione per sei settimane di un composto a base di sostanze osteotrofiche ed ergogene (RestorfastTM) migliora il decorso clinico in anziani sottoposti a chirurgia del femore]. Trends in Medicine2009;9(4):235‐42. ScivolettoG , BoA , DerossiD , BergonziR . Ten week administration of a polynutritional supplement with muscle tone action (RiabylexTM) improves the functional recovery in elderly hip fracture patients during home rehabilitation [In anziani in terapia riabilitativa domiciliare per pregressa frattura del femore, l'assunzione di un polinutriente ad azione muscolotonica (RiabylexTM) per 10 settimane migliora il recupero funzionale]. Trends in Medicine2010;10(2):113‐20. ">Scivoletto 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐2.50 days (‐6.21 to 1.21)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>Semi‐essential amino acid</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001880-bbs2-0040" title="HoudijkAPJ . The effect of taurine on morbidity and mortality in the elderly hip fracture patient. clinicaltrials.gov/ct2/show/NCT00497978 (accessed 15 December 2015). VanStijnMF , BruinsAA , VermeulenMA , WitloxJ , TeerlinkT , SchoorlMG , et al. Effect of oral taurine on morbidity and mortality in elderly hip fracture patients: a randomized trial. International Journal of Molecular Sciences2015;16(6):12288‐306. [DOI: 10.3390/ijms160612288; PUBMED: 26035756] ">Van Stijn 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>111</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>123</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.00 days (‐3.54 to 3.54)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p>SD: standard deviation</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Length of hospital stay data used for significance testing</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/full#CD001880-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001880-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Multinutrient supplements (oral, nasogastric, intravenous) versus control</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mortality by end of study <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1385</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.55, 1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Oral supplements</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>968</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.49, 1.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Nasogastric tube feeding</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>280</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.50, 1.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Nasogastric tube feeding and oral supplements</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.23, 2.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Intravenous feeding and oral supplements</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [0.01, 2.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Participants with complications at end of study <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>882</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.59, 0.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Oral supplements</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>727</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.59, 0.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Nasogastric tube feeding</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.73, 1.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Nasogastric tube feeding and oral supplements</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.11 [0.75, 1.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 Intravenous feeding and oral supplements</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [0.10, 0.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Participants with complications at end of study: random‐effects model <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>882</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.53, 0.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Oral supplements</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>727</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.58, 0.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Nasogastric tube feeding</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.73, 1.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Nasogastric tube feeding and oral supplements</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.11 [0.75, 1.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4 Intravenous feeding and oral supplements</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [0.10, 0.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Unfavourable outcome (death or complications) at end of study <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>334</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.51, 0.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Oral supplements</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>334</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.51, 0.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Nasogastric tube feeding</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Nasogastric tube feeding and oral supplements</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4 Intravenous feeding and oral supplements</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Unfavourable outcome (death or complications) ‐ oral supplements extra analyses <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Oral supplements: worst case scenario</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>353</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.62, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Oral supplements: Hankins 1996 acute hospital data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.71, 1.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 Oral supplements: Hankins 1996 post discharge</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.50, 2.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Adverse effects (putatively related to treatment) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Oral supplements (mainly diarrhoea or/and vomiting)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>442</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.47, 2.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Nasogatric tube feeding</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.56 [0.51, 144.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 Intravenous feeding and oral supplements</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.85 [0.49, 7.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4 Nasogastric tube feeding and oral supplements</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Multinutrient supplements (oral, nasogastric, intravenous) versus control</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/references#CD001880-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001880-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Multinutrient supplements (oral, nasogastric routes, intravenous) versus control (split by nutritional status)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mortality by end of study <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1385</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.55, 1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Malnourished targeted</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>388</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.27, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Malnourished not targeted</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>997</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.59, 1.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Mortality by end of study ‐ oral supplements only <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>968</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.49, 1.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Malnourished targeted</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>266</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.13, 1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Malnourished not targeted</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>702</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.56, 1.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Participants with complications at end of study <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>882</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.59, 0.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Malnourished targeted</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.46, 0.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Malnourished not targeted</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>732</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.59, 0.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Unfavourable outcome (death or complications) at end of study <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>334</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.51, 0.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Malnourished targeted</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.17, 1.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Malnourished not targeted</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>305</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.52, 0.93]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Multinutrient supplements (oral, nasogastric routes, intravenous) versus control (split by nutritional status)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/references#CD001880-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001880-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Multinutrient supplements (oral, nasogastric routes, intravenous) versus control (by allocation concealment)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mortality by end of study by risk of bias for allocation concealment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1385</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.55, 1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>682</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.32, 1.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Unclear risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>462</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.22 [0.65, 2.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 High risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>241</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.34, 1.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Participants with complications at end of study by risk of bias for allocation concealment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>882</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.59, 0.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>622</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.66, 0.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Unclear risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.24, 0.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 High risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Multinutrient supplements (oral, nasogastric routes, intravenous) versus control (by allocation concealment)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/references#CD001880-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001880-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">High protein‐containing supplements versus low protein‐ or non‐protein‐containing supplements</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mortality by end of study <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>361</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.42 [0.85, 2.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Protein‐containing supplement v non‐protein‐containing supplement</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>315</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.38 [0.82, 2.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 High protein‐containing supplement v low protein‐containing supplement</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.18 [0.21, 22.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Unfavourable outcome (death or complications) at end of study <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>223</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.65, 0.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Protein‐containing supplement v non‐protein‐containing supplement</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>223</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.65, 0.95]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">High protein‐containing supplements versus low protein‐ or non‐protein‐containing supplements</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/references#CD001880-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001880-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Thiamin (vitamin B1) and water soluble vitamins versus control</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mortality by end of study <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Participants with complications at end of study <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Thiamin (vitamin B1) and water soluble vitamins versus control</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/references#CD001880-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001880-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Vitamin D versus control or lower dose supplementation</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Participants with complications at end of study <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Mortality by end of study <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Vitamin D versus control or lower dose supplementation</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/references#CD001880-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001880-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Iron supplementation versus control</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mortality by end of study <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>566</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.65, 1.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Participants with complications at end of study <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>266</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.23 [0.63, 2.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Iron supplementation versus control</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/references#CD001880-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001880-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Taurine versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mortality by end of study <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Taurine versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/references#CD001880-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001880-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Dietetic assistants versus usual care</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mortality by end of study <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Participants with complications at end of study <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 99% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Dietetic assistants versus usual care</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001880.pub6/references#CD001880-tbl-0012">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD001880.pub6&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD001880-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD001880-note-0009">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD001880-note-0017">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD001880-note-0008">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD001880-note-0007">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD001880-note-0005">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD001880-note-0006">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pt#CD001880-note-0004">Português</a> </li> <li class="section-language"> <a class="" href="ru#CD001880-note-0003">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD001880-note-0002">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001880\x2epub6\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001880\x2epub6\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001880\x2epub6\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001880\x2epub6"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001880\x2epub6\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001880\x2epub6\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001880\x2epub6\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001880\x2epub6\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001880\x2epub6\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001880\x2epub6"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001880\x2epub6\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001880\x2epub6\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001880\x2epub6\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001880\x2epub6"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001880\x2epub6\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001880\x2epub6\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001880\x2epub6\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001880\x2epub6"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=PMzGcYGP&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001880.pub6&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD001880.pub6';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD001880.pub6/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD001880.pub6/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001880.pub6%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740719260638"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD001880.pub6/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740719260641"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD001880.pub6/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918de4682f979368',t:'MTc0MDcxOTI2MS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 